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There are significant concerns regarding the potential side effects from the chronic 
use of conventional drugs such as corticosteroids, especially in children. Herbal 
therapy is less expensive,  more readily available, and increasingly becoming common 
practice all over the world. Such practices have both their benefits and risks. However, 
herbal self-therapy might have serious health consequences due to incorrect self-
diagnosis, inappropriate choice of herbal remedy or adulterated herbal product. In 
addition, absence of clinical trials and other traditional safety mechanisms before 
medicines are introduced to the wider market results in questionable safe dosage 
ranges which may produce adverse and unexpected outcomes. Therefore, the use of 
herbal remedies requires sufficient knowledge about the efficacy, safety and proper 
use of such products. Hence, it is necessary to have baseline data regarding the use of 





















Bioactive Compounds in Phytomedicine
http://dx.doi.org/10.5772/2374
Edited by Iraj Rasooli
Contributors
Oscar Patiño, Luis Enrique Cuca Suárez, Juliet Angélica Prieto Rodríguez, Wagner Luiz Ramos Barbosa, Lucianna 
Pinto, Fernando Luiz Costa Maia, Jose Otavio Carrera Silva Junior, Antonio Jorge Ataide Souza, Danilo Oliveira, 
Myrth Soares De Nascimento, Mauricia Melo Monteiro, Amiraldo Peres, Luis Claudio Silva Malheiros, Patricia Miriam 
Sayiuri Sato Barros, Christian Barbosa De Freitas, Sandra Gallori, Franco Francesco Vincieri, David Stevenson, Marcos 
Soto-Hernández, Aicha Olfa Cherif, Jayadev Raju, Chinthalapally V. Rao, Nitin Verma, Rattan Lal Khosa, Víctor Manuel 
Hernández, Ludmila Elisa Guzm&Atilde;&iexcl;n-Pantoja, Laura Patricia Lina-García, Graciela Bustos Zagal, Pierpaolo 
Pacioni, Everaldo G. Attard
© The Editor(s) and the Author(s) 2012
The moral rights of the and the author(s) have been asserted.
All rights to the book as a whole are reserved by INTECH. The book as a whole (compilation) cannot be reproduced, 
distributed or used for commercial or non-commercial purposes without INTECH’s written permission.  
Enquiries concerning the use of the book should be directed to INTECH rights and permissions department 
(permissions@intechopen.com).
Violations are liable to prosecution under the governing Copyright Law.
Individual chapters of this publication are distributed under the terms of the Creative Commons Attribution 3.0 
Unported License which permits commercial use, distribution and reproduction of the individual chapters, provided 
the original author(s) and source publication are appropriately acknowledged. If so indicated, certain images may not 
be included under the Creative Commons license. In such cases users will need to obtain permission from the license 
holder to reproduce the material. More details and guidelines concerning content reuse and adaptation can be 
foundat http://www.intechopen.com/copyright-policy.html.
Notice
Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those 
of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published 
chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the 
use of any materials, instructions, methods or ideas contained in the book.
First published in Croatia, 2012 by INTECH d.o.o.
eBook (PDF) Published by  IN TECH d.o.o.
Place and year of publication of eBook (PDF): Rijeka, 2019.
IntechOpen is the global imprint of IN TECH d.o.o.
Printed in Croatia
Legal deposit, Croatia: National and University Library in Zagreb
Additional hard and PDF copies can be obtained from orders@intechopen.com
Bioactive Compounds in Phytomedicine
Edited by Iraj Rasooli
p. cm.
ISBN 978-953-307-805-2
eBook (PDF) ISBN 978-953-51-6632-0
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
3,350+ 




Contributors from top 500 universities




International  authors and editors
114M+ 
Downloads
We are IntechOpen,  
the first native scientific 




Dr. Iraj Rasooli was born in 1960 in Ahar, Iran. He re-
ceived his BSc in Microbiology from Shivaji University 
(India) before obtaining his MSc and PhD in 1992 and 
1998 respectively in Microbiology from Bombay Univer-
sity (India). He joined Shahed University in 1993 as an 
assistant professor where his focus has been on research 
activities on biological properties of essential oils from 
medicinal plants and he has published a number of papers in a number of 
notable national and international journals. He was awarded Razi festival 
prize by the president of Islamic Republic of Iran in 2002. Professor Rasooli 
went to the University of Calgary (Canada) in 2002 for his sabbatical where 
he accelerated his level of knowledge of molecular biology at Prof. Antho-
ny Schryver’s laboratory. To date he has published 86 full length papers 
on bioactivities of essential oils and molecular microbiology. He continues 
teaching and researching in his current role as Dean of Science faculty at 











Part 1 Herbal Therapy 1 
Chapter 1 Selecting Medicinal Plants for Development of 
Phytomedicine and Use in Primary Health Care 3 
Wagner Luiz Ramos Barbosa, Myrth Soares do Nascimento, 
Lucianna do Nascimento Pinto, Fernando Luiz Costa Maia,  
Antonio Jorge Ataíde Sousa, José Otávio Carréra Silva Júnior, 
Maurícia Melo Monteiro and Danilo Ribeiro de Oliveira 
Chapter 2 Hepatoprotective Effect of Zanthoxylum armatum DC 25 
Nitin Verma and Rattan Lal Khosa 
Chapter 3 Current Status:  
Mexican Medicinal Plants with Insecticidal Potential 39 
Ludmila Elisa Guzmán-Pantoja, Laura P. Lina-García, 
Graciela Bustos-Zagal and Víctor M. Hernández-Velázquez 
Part 2 Phytochemicals and Bioactive Compounds 67 
Chapter 4 Standardization of Herbal Drugs Derivatives  
with Special Reference to Brazilian Regulations 69 
Wagner Luiz Ramos Barbosa, Lucianna do Nascimento Pinto,  
Luiz Cláudio Silva Malheiros, Patricia Miriam Sayuri Sato Barros, 
Christian Barbosa de Freitas, Jose Otavio Carrera Silva Junior, 
Sandra Gallori and Franco Francesco Vincieri 
Chapter 5 The Phytochemical and In Vitro  
Pharmacological Testing of Maltese Medicinal Plants 93 
Everaldo Attard and Pierpaolo Pacioni 
Chapter 6 Phytochemicals Components as Bioactive Foods 113 
Aicha Olfa Cherif 
Contents 
Preface XI 
Part 1 Herbal Therapy 1 
Chapter 1 Selecting Medicinal Plants for Development of 
Phytomedicine and Use in Primary Health Care 3 
Wagner Luiz Ramos Barbosa, Myrth Soares do Nascimento, 
Lucianna do Nascimento Pinto, Fernando Luiz Costa Maia,  
Antonio Jorge Ataíde Sousa, José Otávio Carréra Silva Júnior, 
Maurícia Melo Monteiro and Danilo Ribeiro de Oliveira 
Chapter 2 Hepatoprotective Effect of Zanthoxylum armatum DC 25 
Nitin Verma and Rattan Lal Khosa 
Chapter 3 Current Status: 
Mexican Medicinal Plants with Insecticidal Potential 39 
Ludmila Elisa Guzmán-Pantoja, Laura P. Lina-García, 
Graciela Bustos-Zagal and Víctor M. Hernández-Velázquez 
Part 2 Phytochemicals and Bioactive Compounds 67 
Chapter 4 Standardization of Herbal Drugs Derivatives 
with Special Reference to Brazilian Regulations 69 
Wagner Luiz Ramos Barbosa, Lucianna do Nascimento Pinto,  
Luiz Cláudio Silva Malheiros, Patricia Miriam Sayuri Sato Barros, 
Christian Barbosa de Freitas, Jose Otavio Carrera Silva Junior, 
Sandra Gallori and Franco Francesco Vincieri 
Chapter 5 The Phytochemical and In Vitro  
Pharmacological Testing of Maltese Medicinal Plants 93 
Everaldo Attard and Pierpaolo Pacioni 
Chapter 6 Phytochemicals Components as Bioactive Foods 113 
Aicha Olfa Cherif 
X Contents
Chapter 7 Diosgenin, a Steroid Saponin 
Constituent of Yams and Fenugreek:  
Emerging Evidence for Applications in Medicine 125 
Jayadev Raju and Chinthalapally V. Rao 
Chapter 8 Polyphenols as Adaptogens – 
The Real Mechanism of the Antioxidant Effect? 143 
David E. Stevenson 
Chapter 9 Erythrina, 
a Potential Source of Chemicals from the Neotropics 163 
R. Marcos Soto-Hernández, Rosario García-Mateos, 
Rubén San Miguel-Chávez, Geoffrey Kite, 
Mariano Martínez-Vázquez and Ana C. Ramos-Valdivia 
Chapter 10 Zanthoxylum Genus 
as Potential Source of Bioactive Compounds 185 
L. Oscar Javier Patiño, R. Juliet Angélica Prieto  









Individuals are increasingly taking personal responsibility over their health, both in 
the prevention and treatment of disease. This is particularly true for a wide variety of 
chronic or incurable diseases such as cancer, diabetes, arthritis or acute illnesses 
readily treated at home like common cold. During the last fifty years the practice of 
herbalism has become mainstream throughout the world. This is due in part to the 
recognition of the value of traditional medical systems, particularly of Asian origin, 
and the identification of medicinal plants from indigenous pharmacopeias that have 
been shown to have significant healing power, either in their natural state or as the 
source of new pharmaceuticals. When mixtures of several crude extracts are used in 
formulations, enhancement of the beneficial effects or greater toxicity is expected 
through either synergistic amplification or diminishment of possible adverse side 
effects. It is also presumed that their combination could prevent the gradual decline in 
efficacy that is frequently observed when single drugs are given over long periods of 
time. Nowadays such remedies can still be found in ethnic and health food stores, but 
are also available in pharmacies and grocery stores. Unfortunately there is no 
universal regulatory system that ensures that these remedies are what they say they 
are, do what is claimed, or most importantly, are safe. Many patients with chronic 
allergic conditions seek complementary and alternative medicine therapies. This trend 
has begun to attract interest from mainstream health care providers and scientific 
investigators and has stimulated government agencies to provide support and 
guidance for the scientific investigation of complementary and alternative medicine. 
This effort may lead to improved therapies and better health care/patient outcomes. 
This book presents an update on the most promising herbal remedies. The objectives 
of this book were to determine the bioactivities of herbal medicines by giving some 
examples of recent research outputs. Results of this study are aimed toward helping 
avoid potential drug-herb interactions; helping decision makers to decide on the 
proper policies in the medical and the non-medical fields concerning herbal remedies 
and other types of complementary and alternative medicine. 
Prof. Iraj Rasooli 
Department of Biology, 
Shahed University, 
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1. Introduction 
The world market for herbal medicines is around US$ 40 billion, whereas in Brazil it is 
estimated to be around US$ 1 billion. Data from the World Health Organization (WHO) 
shows that more than a half of the world population makes use of some type of medicinal 
herb searching for relief for painful or unpleasant symptoms. From that total at least 30% are 
provided by medical prescription (WHO, 1978). 
The application of traditional or popular knowledge about the use of healing plants, in the 
development of herbal drugs proves to be a fairly consequent and consistent strategy, as it 
can generate employment and income from the participation of the organized community in 
the process of development, production and insertion of the so developed product in the 
pharmaceutical market. It still may be appropriate from an ecological standpoint, when the 
botanical raw material for the production of this herbal medicine is obtained from 
specimens grown in deforested areas. When a project with this design is originated and 
developed in the scope of Pharmaceutical Sciences it is called an Ethnopharmaceutical study 
(BARBOSA, 1998). 
Since 2006, the Popular Phytotherapy became a therapeutical option supported by the 
Brazilian government, through the National Policy on Integrative and Complementary 
Practices (BRAZIL, 2006). After that, new regulatory documents have been promulgated to 
standardize the use of medicinal herbs. The National Policy on Phytopharmaceuticals and 
Medicinal Plants in its guidelines, establishes that a list of regional plants is to be defined, 
representing the Regional Popular Phytotherapy (BRAZIL, 2006b). These policies advocate the 
inclusion of the use of medicinal plants in primary health care, which shall be employed with 
highest efficacy and safety and must be object of the actions of Pharmaceutical Services, 
which are also to be applied to manufactured drugs (BARBOSA & PINTO, 2005). 
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The National Policy on Phytopharmaceuticals and Medicinal Plants (BRAZIL, 2006b) has the 
overall objective “to ensure the Brazilian population the safe access and rational use of 
medicinal plants and herbal medicines.” The Pharmaceutical Sciences can contribute 
strongly to this purpose, attending the first specific objective of the document, "expand the 
therapeutic options for users with guaranteed access to medicinal plants, herbal medicines 
and services related to herbal medicine, with safety, efficacy and quality regarding the 
integrality of health care, considering the traditional knowledge about medicinal plants.” 
Achieving this goal requires the combination of elements of Pharmaceutical Sciences such as 
Pharmaceutical Care and Quality Control, with traditional knowledge. 
This concern of the regulatory agency promotes the standardization of herbal medicines 
facilitates the evaluation of important aspects such as efficacy and safety in the use of these 
medications, as the difficulties to standardize the active pharmaceutical ingredient and the 
formulation development of phytomedicines from medicinal plants of popular use represent 
the major challenge in the country. 
Phytomedicines must contain as active ingredients exclusively plant material derivatives. 
The addition of an isolated substance from any source eliminates this characteristic of the 
product. Apart from the methodology chosen for processing  the plant material, one must 
consider the seasonality of its biochemistry, the soil and climate characteristics of its 
growing place or occurrence and the popular and scientific names of the plant (MACIEL, 
2002). Studies show that the secondary metabolism of the plant can vary considerably 
depending on factors such as: seasonality, temperature, water availability, UV radiation, 
nutrients, altitude, air pollution, and even induction by mechanic stimuli or attack by 
pathogens (GOBBO-NETO, 2007). Thus, for developing a phytomedicine it is determining to 
have a well defined plant species, including the unambiguous botanical characterization. 
How to define from which plant species an herbaceous medicine can be developed? 
There are some strategies to reach this definition and here we will discuss about some of 
them which are well known and a new one will be introduced, where therapeutic products 
are directly handled, and which was born within the Pharmaceutical Science. 
The WHO has recommended that member countries, especially the developing ones, shall 
seek to expand their therapeutic arsenal for public health through the use of medical home 
practices employed by the people. These recommendations are summarized in the four 
items mentioned below (MATOS, 2000): 
 Undertake regional surveys of plants used in the practice of people’s or traditional 
medicine and scientifically identify them; 
 Support the use of useful practices selected by their efficacy and safety;  
 Suppress the use of practices considered useless or harmful; 
 Develop governmental programs that allow the cultivation and use of the selected plants. 
The scientific research on medicinal plants generally originates medicines in shoter time, 
often with lower costs and therefore more accessible to the population, which in different 
places on the planet, can’t afford the high costs of medicines used to face the primary needs in 
health care, especially because in most cases the raw materials used in manufacturing these 
products are imported. For these reasons or deficiency of the public primary health care in 
Brazil, about 80% of the population lacks access to essential medicines (TOLEDO et. al., 2003). 
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From a socioeconomic perspective, it is necessary to highlight some aspects such as the 
demand for phytotherapy and the cost of the medicines, the potential for generating 
occupation and income in the phytopharmaceuticals productive arrangement, especially 
under the social economy, the efforts of research that prove, scientifically, the medicinal 
properties of plants, and the need for restructuring the health care system, including the 
preparation of professionals working in this area (NUNES et. al., 2003). 
The recovery and revaluation of the use of medicinal herbs in Brazil today are demanding a 
certain worry since many medicinal plants of high value may disappear from the forests and 
scrub lands, even before scientists can discover their properties, and turn them into 
medicines. The main step that must be taken is to develop techniques for cultivation and 
harvesting without compromising the reproduction of these species. Another measure is to 
prevent urban sprawl from causing the destruction of peripheral green areas which are rich 
in medicinal herbs (ADEODATO et. al., 1996). 
Medicinal plants, which have assessed their therapeutic efficacy and toxicology, or safety of 
use evaluated, among other properties, are scientifically approved to be used by people in 
their basic health needs, according to the ease of access, low cost and compatibility with 
cultural traditions. Since medicinal plants can be classified as natural products safe to use, 
the law allows them to be marketed by notification to the health regulatory agencies 
(BRAZIL, 2010), and they can be cultivated by those who follows agronomical good 
practices. So, the assisted self-medication is practiced in cases of health problems that might 
be considered simpler and more commonplace within a community. This practice tends to 
reduce the demand for health care professionals, rationalising and reducing the cost of 
Public Health Service (LORENZI & MATOS, 2002). 
Despite these recommendations, it seems that the use of medicinal plants in public health 
service is still not a reality in different localities in Brazil and, by extension, in the American 
Continent. This fact can be explained by the lack of scientific data on native species or the 
lack of systematization of the existing data. The lack of political interest signals that this 
issue is not a priority for many governments in different parts of the world. As long as the 
practice of phytotherapy does not bring financial rewards, private capital will not feel 
encouraged to invest in this niche of market, which meanwhile is interested in more 
profitable and less regulated activities. 
1.1 Techniques and methods for selecting medicinal plants 
In the investigation of medicinal plants, a relevant moment, which can set the course of the 
work and its impact on all points of view, is the criterion used for the selection of the plant 
species to study. Cuéllar and Guirado (2008) refer to genomics, metabolomics and 
ecological, botanical taxonomic and epidemiological based studies. On the other hand 
Albuquerque and Hanazaki (2006) point out other ways to study the medicinal plants, 
among which we highlight five basic types of approaches: the randomized, the ethological, 
the chemotaxonomic (also known as phylogenetic or chemosystematic), the ethnodirected 
(or ethno-oriented) and finally, the exploration of promising biological test results 
(ELIZABETSKY; SHANLEY, 1994). 
Some of these options are analyzed below. 
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1.2 The randomized approach  
Several important authors, here mentioned, recognize the randomized approach as an 
approach without criteria. Calderon (2000) and others who worked with forest plots, do not 
identify this form of selecting plants for research, as random. So, the question here to be 
discussed is whether it is a type of random selection criterion or whether it should be 
identified separately as another type of approach? 
The randomized investigations consist in random selection and collection of plant species 
for study, according to the plant availability. When carried out in regions with high 
diversity and endemism the probability of finding novel substances, bioactive or not, is 
certainly higher in this type of selection (MACIEL et al., 2002, OLIVEIRA et al., 2010). It is an 
indispensable approach, once it can demonstrate the potential of different plant species that 
had never been investigated. According to Souza Brito (1996), this type of selection provides 
an endless source of new structures, since nature is a vast chemical laboratory. However, 
there are many mistaken views and criticisms about this approach due to its randomness, 
which does not mean the absence of criteria (ALBUQUERQUE, HANAZAKI, 2006). 
1.3 The ecological approach  
The ecological approach, also known as field observations, consists in observations of 
interactions between organisms in their ecological environment, inducing to potential 
biological activity (antibacterial, antifungal, agrotoxic, pesticide) (GUIRA; CUÉLLAR, 2008). 
This approach searches for secondary metabolites and biological activities and it may be 
performed by the selection of young leaves x mature leaves for a given species, or between 
different species that are shadow resistant and not shadow resistant, among other 
characteristics (COLEY et al., 2003), though little explored, it has achieved excellent results.  
Briskin (2000) states that secondary metabolites present in plant species have ecological 
functions which can justify their use for application in the development of therapeutic 
resources for humans. For example, metabolites involved in plant defense against microbial 
pathogens may be useful as antimicrobial drugs in humans, since they are not very toxic. 
Likewise, secondary products with repellent action (e.g. unpleasant flavor or odour) against 
herbivores by neurotoxic activity could have beneficial effects in humans such as 
antidepressants, sedatives, muscle relaxants or anesthetics, through their action on the CNS. 
Therefore, the observation of these ecological relationships is a useful tool in the selection of 
plant species. 
According to Albuquerque and Hanazaki (2008) this approach intends to evaluate the use of 
secondary metabolites by animals or other non-nutritional substances from plants, aiming to 
combat diseases or controlling them, as it can be seen in the works developed by Carrai 
(2003) and Krief (2004). In the latter, it was observed that leaves of Trichilia rubescens Oliv. 
eaten by chimpanzees in Uganda showed antimalarial activity. This result shows the 
importance of the ethological approach in the discovery of useful plant species of medical 
and pharmaceutical interest. 
A variation of the ecological approach is zoopharmacognosy, also called animal self-
medication (self-medication in animals), which proposes the selection of species regularly 
ingested by animals, especially primates; to reduce microbial infestation, pain (BERRY; 
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MCFERREN; RODRIGUEZ, 1995. In: BIRD; BRIJESH; DASWANI, 2007). To the selection 
criterion based on the observation of the relationship between animals and plants, 
Albuquerque and Hanazaki (2008) attribute the term "ethological approach” based on the 
habits of animals, how they behave in their natural environment. 
1.4 The chemosystematic approach  
When the definition of a plant species, which will be source of a phytomedicine, is based on 
the structural analogy of the substances present in this plant material, with other known 
active substances present in different botanical family, genus or even species, we can infer 
that this strategy is based on chemosystematics, a system created by Professor Otto Richard 
Gottlieb (1982) to organize and understand the plants. This system consists in identifying 
groups of chemicals present in plants, considering the taxonomic organization of these 
plants. To illustrate this topic, consider the use of a plant species containing antiplasmodic 
indol derivatives as active principle in the development of an antimalarial phytomedicine. 
Would a plant species from a different genus, containing such substances, give origin to the 
same phytomedicine?  
Depending on the results the later plant produces in in vitro biological tests, it may be true. 
On the other hand, Mikania species (Asteraceae) which contain coumarin in their 
composition, exhibit different pharmacological activities and alleged popular use, including 
antimalarial properties. Therefore, the strategy based on chemosystematics can bring in it 
some uncertainty, once the chemical composition, which can explain the relationship 
between botanical species, genera and even families, is not decisive enough to guide the 
development of a phytomedicinal product and to validate the alleged use, as well as it does 
not confirm the safety and efficacy of the derivative proposed for the development of the 
product, requiring indeed the realization of a pharmacological prospection in order to 
characterize the wanted activity for the phytomedicine. The contribution of 
chemosystematics is to offer to the phytochemical analyst a range of possible chemical 
structures to be searched in the preparations obtained from the plant material. 
The chemosystematic approach, also called phylogenetic, consists of selecting a species from 
a family or genus, for which some phytochemical knowledge of at least one species of the 
group is known (ALBUQUERQUE, HANAZAKI, 2006). The presence of different 
compounds, which can be used as biosynthetic markers, is used by botanists in taxonomy 
studies and the chemosystematic approach is used as a successful tool in the selection of 
families, subfamilies and genera to be investigated in terms of produced metabolites 
(BASSO et al. 2005). That is, through the chemotaxonomy, one can select plants from known 
families and genera to produce certain classes of substances (e.g. alkaloids, flavonoids, 
steroids, etc.), especially those recognized by their biological activities and therapeutic 
applications, preferably associated to these metabolites. As an example we can cite the case 
of galantamine, used in the treatment of Alzheimer's disease, first isolated from the species 
Galanthus nivalis, Amaryllidaceae family. Since then, numerous chemosystematic studies 
verified the presence of galantamine and acetylcholinesterase inhibitory activity in several 
species of the genus Galanthus (MARSTON; KISSLING; HOSTETTMANN, 2002). Following 
the same line, Ronsted et al. (2008) continued searching for alkaloids with 
acetylcholinesterase inhibitory activity in several species of other genera of Amaryllidaceae 
family, especially Narcisus, obtaining excellent results. 
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Considering that in this case we deal with the selection of plant species for the development 
of herbal medicines or for direct use in primary health care, this feature of the method, 
enabling the discovery of molecules, does not influence the discussion and treatment of the 
theme in this chapter, without, however, making value judgments on this important 
application. Even within the pre-formulation studies carried out during the experimental 
stage of drug development it is an advantage for researchers to know in advance which 
class of metabolites to prospect in order to develop detection, characterization and 
quantification of markers of the active pharmaceutical ingredients and the final product, 
and with these data to establish their quality control process. This step of the process is 
determining for the registration of an herbal medicine in Brazil. 
2. The ethnoguided approach  
The ethnoguided approach consists of selecting plant species in accordance to the indication 
of specific population groups in certain contexts of use, emphasizing the search for the 
locally built knowledge regarding their natural resources and their application in their 
health systems (GUIRA; CUÉLLAR, 2008). Plant species are raised by a quali-quantitative 
survey. This survey usually relates symptoms, signs and diagnosis of low-gravity diseases 
to medicinal plants that the respondents know about and their use according to the cultural 
elements that characterize the ethnicity or human group to which they belong, considering 
the territory as the basis for this characterization.  
In this type of approach the ethnobotany, ethnopharmacology and ethnomedicine can be 
highlighted. Recently ethnopharmacy has been structured to provide an interface between 
Pharmaceutical Science and Popular Phytotherapy where medicinal plant species can be 
selected for the development of phytomedicines and for use in primary health care, in 
compliance with the requirements of safety and efficacy (BARBOSA, 2008). 
Below we schematically present the key steps for developing an herbal medicine 
considering as a starting point the selection of a medicinal plant according to the ethno-
oriented method. Note that the remaining steps of the process do not allow a review of the 
plant identity, once they are irreversible and consume the collected and processed plant 
material, making its selection and identification a crucial step of the process as a whole. In 
Figure 1 below, Material Plant, Crude Extract and Standardized Extract, direct derivatives of 
the medicinal plant, are shown in the purple sequence. The procedures to which these 
materials are subjected are in green and the blue area shows the pharmacological assays. 
Note that both standardized extracts as well as fractions of these extracts can be 
pharmacologically evaluated and taken to the  formulation step where the composition of 
the active pharmaceutical ingredient will determine the pharmaceutical form to be 
developed and the experiments required for this procedure. 
See below a schematic sequence of processes for developing phytomedicine (Fig.1). 
In Brazil, the National Health Surveillance Agency accepts ethno-oriented surveys as the 
basis for the registration of plant species which are used for the development of herbal 
medicines (BRAZIL, 2010) or for use in primary health care (BRAZIL, 2010b). The methods 
applied in these surveys produces plant species lists and information that provide the 
starting point for developing a formulation, when their allegation of use are already 
available. It is also associated with a historical use of the plant, often for a long period, 
 




Fig. 1. Schematic sequence of the steps in developing phytomedicines, starting from an 
ethnoguided survey. 
which being documented by scientific literature can contribute to validate its safe use based 
on official resolution. These requirements serve as the basis for the necessary experiments 
for pre-formulation studies. 
2.1 Ethnobotany 
Defining a medicinal plant for developing a phytomedicine under the vision of 
Ethnobotany, a survey of plant species used by a particular human group, certainly ensures 
botanical classification of the plant, since the core activities of Botany is to determine the 
taxa of a botanical sample. Moreover, important information for the production of plant 
material for the development process could also be provided by this approach. However, 
information like remedies preparation, allegations of use, including dosage, and evaluation 
of the remedy use and the relationship between user and derivatives prepared with plant 
material, are not part of the necessary instrumental for the practice of Ethnobotany. 
In order to introduce a discussion on the survey of medicinal plants which are traditionally 
or popularly used for medicinal purposes, and within a historical perspective, this is what 
the Ethnobotany is about, a term coined by Harschberger and, which according to Schultes, 
pointed out ways that could serve to the scientific research (SCHULTE, 1962). Amorozo & 
Gely (1988) complement that ethnobotany, when applied to medicinal plants, acts in 
complicity with ethnopharmacology and medical anthropology, as it contextualizes the use 
of these plants in a treatment system peculiar to a specific human group.  
According to Heinrich and Bremner (2006), the ethnobotany investigates the relationship 
between humans and plants in all its complexity, and is usually based on a detailed 
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observation and study of the plants used by a society, including all its cultural beliefs and 
practices associated with that use. For such research, the ethnobotanists use a complex set of 
methods derived from the social and cultural sciences, including the taking of detailed field 
notes and the carefully documented collection of plant samples that allow a precise 
determination of the corresponding species.  
Regarding the ethnobotanical approach method, Elisabetsky (1987) and De La Cruz Mota 
(1997) advocate the devolution or the return of prepared data to the communities and 
Martin (1986), supports the inclusion of the communities in the research so that the constant 
ethnobotanical making will promote the development and preservation of plant resources, 
knowledge of nature, the restoration of ecological balance with improved life quality. One 
must still think about the profits arising from the business performance of the technological 
development, which starts with the study of the ethnobotanical knowledge, whether in form 
of royalties or compensation to the communities participating in the research. 
2.2 Ethnopharmacology  
The relationship with the environment makes different human cultures absorb a wide 
variety of customs and knowledge from this environment in which they live. This 
knowledge evolves and over time is incorporated into the patterns of each population group 
across generations. The most representative and discussed case at a global level is the use of 
natural products arising from the knowledge of traditional peoples as Indians or riverbank 
people. In this case, a greater attention is given to those people who live in tropical regions 
where the natural range of options is presented in higher proportions, as in the Brazilian 
Amazon (PINTO & MADURO, 2003). 
The most accepted definition of Ethnopharmacology is "multidisciplinary scientific 
exploration of biologically active agents traditionally employed or observed by man" 
(SOUZA et al. 2004). Another useful definition was proposed by Dos Santos & Fleurentin 
(1990) as an "interdisciplinary scientific study of materials from animal, vegetable or mineral 
origin and related knowledge and practices that different cultures use to modify the state of 
a living organism by therapeutic (curative/prophylactic) or diagnostic purposes". According 
to Bourdy (2008), many ethnopharmacological studies seek to correlate pharmacological 
activities found in a traditional remedy with active pharmaceutical ingredients through 
natural products chemistry. Ethnopharmacology, therefore, in its interdisciplinary nature, 
attempts to associate at least three points of view, a cultural, a biological and a chemical 
ones in a complementary approach. 
The Ethnopharmacology seeks to know the illnesses that lead particular human groups to 
practice Herbalism; it discusses symptoms and signs, as well as, experimentally, applies 
pharmacological models to elucidate the action mechanism of phytoderivatives. This 
information is also very important for the development of herbal medicines, but the 
evaluation of the original form of use is decisive for the elaboration of the 
phytopharmaceutical formulation, moreover, it allows the use of medicinal plant in natura 
or in magistral or officinal formulations, after pharmaceutical manipulation in pharmacies. 
The ethnopharmacological method combines the study of popular knowledge with chemical 
and pharmacological techniques. Allegations of popular therapeutic use of a particular plant 
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species are important for the investigation of its pharmacological and toxicological effects 
(ELISABETSKY, 2003). 
Albuquerque and Hanazaki (2006) claim that the ethnopharmacological approach is the 
study of traditional preparations used in health systems and disease, which include, isolated 
or combined, plants, animals, fungi or minerals. According to Maciel et al. (2002), on this 
approach the selection of species is carried out according to the therapeutic use evidenced 
by a particular ethnic group and it most likely favors the discovery of bioactive substances, 
the development of herbal medicines and the introduction of medicinal plants in primary 
health care. Many studies based on ethnopharmacological approach, report results that 
range from strictly botanical information, such as plant taxonomy, to general information 
such as part of the plant used and alleged use (UBOM, 2010; GIUSTI & PTERONI , 2009; 
IGNACIMUTHU et al ., 2006; GIDAY,. 2001). 
Ethnopharmacological strategies have been widely used to conduct biological screening in 
various therapeutic areas such as cancer, immunomodulatory drugs, allergy drugs, 
analgesics, contraceptives, antimalarial, anti-diarrhea, antimicrobial, antiviral, etc. 
(ELIZABETSKY; SHANLEY , 1994). 
Ethnopharmacology, an important methodology for the study of plants used in folk 
medicine, is characterized as a strategy for the investigation of medicinal plants that 
combines information acquired from users of medicinal plants with chemical and 
pharmacological studies. This method, still according to Elisabetsky, allows the formulation 
of hypotheses about the pharmacological activity and the compound responsible for the 
reported therapeutic action. Elisabetsky says "Ethnopharmacology is not about 
superstitions, but of popular knowledge related to traditional medicine systems" 
(ELISABETSKY, 2003). 
2.3 The ethnomedical approach  
The Ethnomedicine refers to the study of diseases, their causes and therapeutic measures 
taken by the various societies of primitive peoples as well as by popular social communities. 
It deals with natural and ancient therapies used to combat diseases and emphasizes the 
relationship between the patient and caregiver, between the patient and society. 
Ethnomedical studies contribute to the knowledge of the techniques used by many ancient 
peoples with regard to the treatment and knowledge of diseases (BENSON, 1980). 
Since ancient times people treated their body and soul illnesses by asking for help to the 
supernatural. Certain peoples of northern Asia, where the tribal priest was called the 
shaman, used magical means, rites and knowledge of nature to heal health problems, 
associating them, among others, with knowledge about healing plants and connecting with 
their gods. So, they antagonized the disease with the active ingredient of the plant and with 
the ritualistic method, they incited the faith, the confidence in the procedure and in the 
shaman, who, in Brazilian Amazon, is called “pajé” or “benzedor” (shaman healer), 
according to more or less intimacy with the ”enchanted" and the "forest spirits" (MAUES & 
VILLACORTA, 2008). 
A significant part of what today is therapeutically used, started from information obtained 
from traditional communities that use natural products in their practices to survive and 
handle the environment. According to Guirado and Cuellar (2008) the ethnomedical 
 
Bioactive Compounds in Phytomedicine 
 
10
observation and study of the plants used by a society, including all its cultural beliefs and 
practices associated with that use. For such research, the ethnobotanists use a complex set of 
methods derived from the social and cultural sciences, including the taking of detailed field 
notes and the carefully documented collection of plant samples that allow a precise 
determination of the corresponding species.  
Regarding the ethnobotanical approach method, Elisabetsky (1987) and De La Cruz Mota 
(1997) advocate the devolution or the return of prepared data to the communities and 
Martin (1986), supports the inclusion of the communities in the research so that the constant 
ethnobotanical making will promote the development and preservation of plant resources, 
knowledge of nature, the restoration of ecological balance with improved life quality. One 
must still think about the profits arising from the business performance of the technological 
development, which starts with the study of the ethnobotanical knowledge, whether in form 
of royalties or compensation to the communities participating in the research. 
2.2 Ethnopharmacology  
The relationship with the environment makes different human cultures absorb a wide 
variety of customs and knowledge from this environment in which they live. This 
knowledge evolves and over time is incorporated into the patterns of each population group 
across generations. The most representative and discussed case at a global level is the use of 
natural products arising from the knowledge of traditional peoples as Indians or riverbank 
people. In this case, a greater attention is given to those people who live in tropical regions 
where the natural range of options is presented in higher proportions, as in the Brazilian 
Amazon (PINTO & MADURO, 2003). 
The most accepted definition of Ethnopharmacology is "multidisciplinary scientific 
exploration of biologically active agents traditionally employed or observed by man" 
(SOUZA et al. 2004). Another useful definition was proposed by Dos Santos & Fleurentin 
(1990) as an "interdisciplinary scientific study of materials from animal, vegetable or mineral 
origin and related knowledge and practices that different cultures use to modify the state of 
a living organism by therapeutic (curative/prophylactic) or diagnostic purposes". According 
to Bourdy (2008), many ethnopharmacological studies seek to correlate pharmacological 
activities found in a traditional remedy with active pharmaceutical ingredients through 
natural products chemistry. Ethnopharmacology, therefore, in its interdisciplinary nature, 
attempts to associate at least three points of view, a cultural, a biological and a chemical 
ones in a complementary approach. 
The Ethnopharmacology seeks to know the illnesses that lead particular human groups to 
practice Herbalism; it discusses symptoms and signs, as well as, experimentally, applies 
pharmacological models to elucidate the action mechanism of phytoderivatives. This 
information is also very important for the development of herbal medicines, but the 
evaluation of the original form of use is decisive for the elaboration of the 
phytopharmaceutical formulation, moreover, it allows the use of medicinal plant in natura 
or in magistral or officinal formulations, after pharmaceutical manipulation in pharmacies. 
The ethnopharmacological method combines the study of popular knowledge with chemical 
and pharmacological techniques. Allegations of popular therapeutic use of a particular plant 
 
Selecting Medicinal Plants for Development of Phytomedicine and Use in Primary Health Care 
 
11 
species are important for the investigation of its pharmacological and toxicological effects 
(ELISABETSKY, 2003). 
Albuquerque and Hanazaki (2006) claim that the ethnopharmacological approach is the 
study of traditional preparations used in health systems and disease, which include, isolated 
or combined, plants, animals, fungi or minerals. According to Maciel et al. (2002), on this 
approach the selection of species is carried out according to the therapeutic use evidenced 
by a particular ethnic group and it most likely favors the discovery of bioactive substances, 
the development of herbal medicines and the introduction of medicinal plants in primary 
health care. Many studies based on ethnopharmacological approach, report results that 
range from strictly botanical information, such as plant taxonomy, to general information 
such as part of the plant used and alleged use (UBOM, 2010; GIUSTI & PTERONI , 2009; 
IGNACIMUTHU et al ., 2006; GIDAY,. 2001). 
Ethnopharmacological strategies have been widely used to conduct biological screening in 
various therapeutic areas such as cancer, immunomodulatory drugs, allergy drugs, 
analgesics, contraceptives, antimalarial, anti-diarrhea, antimicrobial, antiviral, etc. 
(ELIZABETSKY; SHANLEY , 1994). 
Ethnopharmacology, an important methodology for the study of plants used in folk 
medicine, is characterized as a strategy for the investigation of medicinal plants that 
combines information acquired from users of medicinal plants with chemical and 
pharmacological studies. This method, still according to Elisabetsky, allows the formulation 
of hypotheses about the pharmacological activity and the compound responsible for the 
reported therapeutic action. Elisabetsky says "Ethnopharmacology is not about 
superstitions, but of popular knowledge related to traditional medicine systems" 
(ELISABETSKY, 2003). 
2.3 The ethnomedical approach  
The Ethnomedicine refers to the study of diseases, their causes and therapeutic measures 
taken by the various societies of primitive peoples as well as by popular social communities. 
It deals with natural and ancient therapies used to combat diseases and emphasizes the 
relationship between the patient and caregiver, between the patient and society. 
Ethnomedical studies contribute to the knowledge of the techniques used by many ancient 
peoples with regard to the treatment and knowledge of diseases (BENSON, 1980). 
Since ancient times people treated their body and soul illnesses by asking for help to the 
supernatural. Certain peoples of northern Asia, where the tribal priest was called the 
shaman, used magical means, rites and knowledge of nature to heal health problems, 
associating them, among others, with knowledge about healing plants and connecting with 
their gods. So, they antagonized the disease with the active ingredient of the plant and with 
the ritualistic method, they incited the faith, the confidence in the procedure and in the 
shaman, who, in Brazilian Amazon, is called “pajé” or “benzedor” (shaman healer), 
according to more or less intimacy with the ”enchanted" and the "forest spirits" (MAUES & 
VILLACORTA, 2008). 
A significant part of what today is therapeutically used, started from information obtained 
from traditional communities that use natural products in their practices to survive and 
handle the environment. According to Guirado and Cuellar (2008) the ethnomedical 
 
Bioactive Compounds in Phytomedicine 
 
12
approach consists in investigating the plant species on the basis of traditional use by 
different peoples, providing an interface between modern clinical medicine and folk 
medicine. 
2.4 Ethnopharmacy  
The strategy that can gather more information directly linked to the galenic development of 
a phytotherapeutical formulation is the ethnopharmaceutical approach of medicinal plants. 
Here, the semi-structured interviews script allows assessing, among other, the nosological 
profile of the approached human group and the medicinal plants used to treat the signals 
and symptoms mentioned by the interviewers. The method also evaluates the utilization of 
synthetic and herbal medicine by the group, and proposes the participatory observation of 
the remedies preparation using the most promising plant and finally observes aspects 
related to the plant itself. In this way it is possible to characterize the needs of this human 
group in terms of products which solve most of its health problems, this can be seen as a 
market analysis under the pharmacoeconomics point of view; also under this perspective, it 
is possible to determine the scale of this demand, verifying which synthetic medicines are 
not accessible to users and which herbal remedies they prepare to meet the lack of those 
products which are not distributed by the market (open or State), and also by observing the 
preparation of remedies by the community, a pharmacist can deduce a pharmaceutical form 
for the product under development and discover new procedures, as well as new 
pharmaceutical adjuvant. 
For Heinrich (2001), the Ethnopharmacy is the interdisciplinary science that deals with the 
study of pharmaceutical resources considered in relation to cultural determinants that 
characterize the use of these resources in a particular human group. It involves studies on the 
identification, classification and cognitive categorization of plant material from which the drug 
will be produced (Ethnobiology), preparation of dosage forms (ethnopharmaceutics), 
allegation of the effects associated with the preparation (ethnopharmacology) and socio-
medical aspects implied in these uses (ethnomedicine) (PIERONI et al., 2002).  
Heinrich (2007) returns to the subject stating that ethnopharmacy includes pharmacognosy, 
pharmacology, galenic, and also the pharmaceutical practice and clinical pharmacy, thus 
allowing the utilization of local resources in the primary health care, and therefore it 
provides an interface to the Pharmaceutical Assistance necessary to the implementation of 
Phytotherapy in Primary Health Care. 
The ethnopharmacy was introduced in Brazil in 1995 with the publication of the article 
"Ethnopharmaceutics: an approach to medicinal plants from the perspective of 
Pharmaceutical Sciences" (BARBOSA, SILVA, SOLER, 1996). The inventory of data from a 
group or local community on therapeutic resources shows itself as an adequate tool to 
document important information to design actions in the Pharmaceutical Sciences area, both 
from a technological standpoint as for healthcare, since it allows to obtain information about 
infectious diseases, the appropriate medicinal plants indicated for their treatment and it 
infers the most suitable methods for their preparation and use (PINTO, 2008). 
In Brazil, Ethnopharmacy is defined as an interdisciplinary science that investigates the 
perception and use of traditional remedies, within a human group. It deals with the study of 
pharmaceutical resources considering the relations with the cultural context of its use, or the 
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study of cultural determinants that characterize the uses of these resources in this culture. This 
study involves plant ethnotaxonomy, by which the drug is produced; the preparation of 
popular use form (ethnopharmaceutics); the biological evaluation of the pharmacological 
activity of such preparations (ethnopharmacology); clinic ethnopharmacy; medical 
anthropology or ethnomedicine; pharmacotherapeutic follow up and pharmacosurvaillance.  
As a set of materials and practices used to maintain and restore health within a regional 
cultural context, several papers have been published; Bulus (2003) reported the 
ethnopharmacy of malaria in Nigeria; Pieroni (2005), the therapeutic resources of a 
community rooted in the northern Albanian Alps; he has raised about 70 taxa and 160 
preparations; Thabrew (1991) described three species used as immunomodulators in liver 
disorders, in traditional herbal medicine in Sri Lanka. These papers report surveys 
conducted according to the ethnopharmaceutical methodology. 
The ethnopharmaceutical method was developed by integrating environmental and cultural 
elements, thereby becoming a strategy for preserving the cultural heritage of human groups 
and actions for recovering deforested areas (BARBOSA, 1998). 
Souza (2011) proposes the Ethnopharmacy as a science that permeates across the 
ethnosciences related to medicinal plants, especially regarding their use, articulating it with 
those belonging to the identities and cultural imagery of the focused human groups. 
Ethnopharmaceutical science seeks to understand the use of medicinal plants through the 
social representations of communities based on the oral diffusion of knowledge about the 
community's relationship with the environment, availability of medicinal plants, as these 
representations are keys to the establishment of the safety validation process and rational 
use of medicinal plants 
Thus, we propose two strands to the ethnopharmaceutical methodology: as a science (where 
there is an object, methodology and production of knowledge) and as a social technology 
where it develops products, methods and services together with communities, replicable in 
other communities, aimed in improving their life quality and favoring their social inclusion. 
To illustrate the proposal presented above, we show the figure 2 below that tries to 
characterize the composition and the insertion of Ethnopharmacy in the science and 
technology fields and thereby demonstrate the breadth and scope of its instruments when 
applied in Popular Phytotherapy survey, with the aim of pointing out plant species for 
phytomedicine development and their use in primary health care. 
The ethnopharmaceutical survey is an instrument of the quantitative research advocated by 
the social technology Ethnopharmacy, which brings together a methodology and a 
theoretical basis to leverage the popular herbal medicine as a basis for Pharmaceutical 
Attention in medicinal plants, after processing of the collected data by the Pharmaceutical 
Science. 
The contribution of accessed human groups is significant, as well as the participation of the 
academy and the public sector; the participation of the private productive sector is still 
lacking, which, in Brazil, needs to adequate its action and thought to the national sanitary 
surveillance rules in order to contribute in building this important economic and social 
sector that is the market for herbal medicines. 
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Fig. 2. Representative diagram of the interdisciplinarity of Ethnopharmacy. 
 
Fig. 3. Meeting of researchers in Ethnopharmacy of Para Federal University with members 
of local collectivities, including traditional specialists, discussing the local phytotherapy 
(Igarapé Miri, Para, BR) 
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2.4.1 The ethnopharmaceutical approach and the use of flora  
Different methodologies have taken into account the human and cultural component in their 
survey and approach of plant species with therapeutical popular use. The ethnobotany and 
ethnopharmacology dispute the antiquity: there are still ethnomedicine, the ethnobiology 
and there are others emerging. 
In the development of herbal medicine, ethnobotany and ethnopharmacology play an 
important role towards this approach when aiming the popular information retrieval, the 
empirical knowledge which has been transmitted from generation to generation by shamans 
and healers in all cultures and traditions. The ethno-oriented survey puts the popular 
information as an important reference for the experiments both with regards to the 
exploitation and use of herbal drugs and phytomedicines, as well as for the development of 
new remedies. 
Following this track, the instrumentation of methods and techniques has been established  
in the pursuit of a unique language that features not only recognition but also the 
application of traditional knowledge about plants and/or healing practices. One should also 
take into account the idea that the notion of illness and healing practices are understood 
through cultural references. In this context it is assumed that there are subjective factors 
related to the values and traditions of individuals and cultures that influence the formation 
of symptoms and how to treat them. This is therefore, the track that leads to the concept of 
the ethnopharmaceutical approach, demarcated on its roles and joints to other research 
areas by the objectives (BARBOSA, 1996):  
 To understand the cultural meaning of a given disease and its healing process in a 
given community; 
 To raise the traditional use of plant species in these communities while observing the 
social anthropological view, the inter-relationship of possible medicinal effects, their 
use in food and involved ritual habits as therapeutic tools for treatment of diseases; 
 To recognize the plant species used, their botanical and popular nomenclature; 
 To recognize in the traditional remedy the pharmaceutical form involved in its 
preparation; 
 To prepare, in an interdisciplinary way, a method to exploit the species involving from 
cultivation to marketing; 
 To propose, based on the plant investigation, from the scientific point of view, new 
applications for the species, either through pharmacological, biological and/or suitable 
technological approaches in the Pharmaceutical Sciences field; 
 To standardize the pharmacognostic, phytochemical and pharmacotechnical protocols 
for regulation and quality control in the marketing and use of herbal medicine, among 
others; 
 To produce knowledge from the results obtained during the development and use of 
the investigated medicinal plant. 
The cultural elements of the community, related to fundamental traditional healing practices 
regarding the use of plant species, have been undergoing a process of devaluation, even 
discredit, due to the scrapping of medical care, caused by political and economic reasons. 
Moreover, the easy access to the allopathic medicine, encouraged by official policies of 
distribution of these drugs without proper pharmaceutical care, has led, even in 
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communities with ancient traditions, such as indigenous peoples, a depreciation of the 
traditional healing practices, so that the only alternative that remains to the ordinary 
member of the community is to ingest the industrial drug according to color or flavor, with 
the (dis) orientation of hardworking, but unprepared people for this important task. 
In this context, briefly exposed, because it is matter for reflection in a specific chapter, the 
ethnopharmaceutical approach comes as an element of preservation and appreciation of 
traditional therapeutic practices, since all the experimental work is based on valuable 
information gathered from the plant user. This information is firstly systematized and 
documented, making it possible to provide a memory of the practices and the empirical 
knowledge of people about the plants used therapeutically. 
The empirical statements, allegations of a plant use, refer to symptoms that correspond to a 
pharmacological test model, which can validate the indication of the preparation traditionally 
used obtained according to pharmaceutical techniques properly deduced from the popular 
mode of preparation. These data, together with those obtained from the chemical analysis of 
the plant, will enable to propose a defined therapeutic formulation containing a biologically 
active extract or an active fraction of this extract, ingredient that may be monitored for quality 
because it was chemically analyzed and presents the original activity properly quantified 
(effective dose and "toxic" or lethal dose) indicated by the community. 
Among the information collected from communities, one should consider and seek to interpret 
the apparently unimportant data related to the symptoms described, to the collection of plant 
material, to the preparation of the medicine and to the usage of this drug. These data may be 
critical to the success of the experimental work. Details concerning these apparently mystical 
aspects of the plant use may indicate some procedures to be followed when preparing the 
material for testing and analysis, so it should not be seen merely as superstition. 
2.4.2 Data produced from selected species according to the ethnopharmaceutical 
method  
An ethnopharmaceutical survey conducted in 2008 in the State of Pará, Amazonia, Brazil 
showed that an Iridaceae (marupazinho) was indicated to treat diarrhoea, anaemia and 
abdominal pain. 
 







High blood pressure Garlic 67%
Gastritis Pirarucu 50%
Fever Catinga de Mulata 42%
Source: from Pinto, 2008, (yet unpublished data). 
Table 1. The alleged medicinal uses of plants according to the relative frequency of alleged 
use (RFAU) calculated according to Amorozo & Gely (1988). 
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Combining these symptoms and adding information obtained from a traditional specialist 
we can infer that this plant could be used to treat amoebiasis (yet unpublished data). Indeed, 
in the Amazon region this plant is an important therapeutic option, used in primary health 
care. Jardim et al (2007) had demonstrated the use of a tea from the bulbs of this plant in the 
popular phytotherapy, to treat diarrhoea. The here mentioned ethnopharmaceutical survey 
discloses a convergence of popular use (AMOROSO; GELY, 1988) of about 80% for 
diarrhoea (Table 2), which rises to about 100% when other symptoms of amoebiasis are 
associated. These surveys were carried out in different cities of the state of Pará. Additional 
phytochemical and galenic studies were performed and a formulation will soon be 
developed; furthermore, the data already obtained can indicate the plant to be accepted as a 
medicinal plant of interest to the Brazilian primary health care system (BRASIL, 2010). 
An ethnopharmaceutical approach started a multidisciplinary study on a Piperaceae and an 
Euphorbiaceae and enabled the development of formulations to control arterial 
hypertension and to treat bacterial skin affections, whose patenting processes are in course. 
A Bignoniaceae mentioned by virtually all respondents, more than 1,200 people (Table 1), as 
having anti-anaemic activity, also shows important antifungal activity on skin affections 
(BARBOSA, 2008) among others. After the extract administration in animals, the 
haematological parameters were evaluated in their collected blood samples. The extract did 
not affect the following parameters: leukocytes, red blood cells, haematocrit, haemoglobin, 
MCV, MCH and MCHC, however, a significant increase in platelet counts for the 
experimental group could be observed, what can indicate that the aqueous extract 
stimulates the production of platelets (yet unpublished data) (Table 2). 
 
Haematimetric Index Control group n=20 Experimental group n=20 P* value 
Haemocyte (/mm3) 5.7±1.6 6.2±0.9 0.6423 
Haematocrit (%) 41.3±9.2 41.5±3.7 0.4525 
Haemoglobin (g/dL) 13.8±2.7 13.7±1.1 0.4275 
MCV (fL) 50.2±2.7 51.6±1.9 0.1555 
MCH (pgL) 16.5±0.7 16.9±0.7 0.2164 
MCHC (g/dL) 33.1±1.2 33.09±1.6 0.9427 
Platelets (mm3) 702±244 888±201 0.0498 
Table 2. Haematimetric indices and platelet counts of animals exposed to plant extract and 
the control group. Hematologic parameters of control group are similar to other studies in 
which the same strain of mice was used, and corroborate the study by Pessoa et al. (2008) 
that observed the lack of significance between hematological parameters of Rattus norvegicus 
treated with plant extract. 
The approximation of ethnopharmacy with pharmaceutical care provided the establishment 
of a new attribution to the ethnopharmaceutical method, namely: the selection of popular 
medicinal herbs for introduction in primary health care. Eleuthrine plicata (BRAZIL, 2009), 
Arrabidea chica (BRAZIL, 2011) and Zingiber officinalis (BRAZIL, 2010B), are species listed in 
official documents that have been related in ethnopharmaceutical surveys conducted in 
different localities in the Amazonian state of Pará. 
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3. Comparison between the randomized and ethnoguided approach  
It is expected that the traditional knowledge about medicinal plants indicates the presence 
of biologically active substances. The collection of plants traditionally used for biological 
assessment can be a great advantage, or a shortcut, increasing the chances of discovering 
new drugs (ELIZABETSKY & SHANLEY, 1994). Table 3 shows the enormous potential of 
the ethnopharmacological approach found in several studies, compared with the 
randomized approach. 
Some studies have compared the results obtained by the random selection of plants with the 
ethnopharmacological approach, also called ethnoguided approach. In Rwanda, Africa, 100 
medicinal plants were tested for antimicrobial activity. From these, 68 were referred for 
infectious diseases, 37% of which were active, whereas for the 36 medicinal plants that were 
included by the random approach only 22% showed activity (VAN PUYVELDE & BOILY, 
1986). In another study conducted at Sinai (Egypt) for plants with antimicrobial activity, 
83.3% of the species obtained positive results by the ethnoguided approach against 41.7% in 
the randomized approach (KHAFAGI & DEWED, 2000). In Brazil, a study of antimalarial 
activity performed with extracts from 295 plant species, 273 were tested by a randomized 
approach with only 0.7% of positive results, whereas for the 22 medicinal plants with 
indications for fever and malaria the positive results represented a total of 18% 
(CARVALHO & KRETTLI, 1991). In Belize, Central America, random collections of plants 
sent to the National Cancer Institute (NCI, USA) for anti-HIV activity resulted in 6% of 
active samples. However, with ethnopharmacologically selected samples, from a healer in a 
small village in Belize, an activity of 25% was obtained, showing a percentage four times 
higher (GUIRA & CUELLAR, 2008). 
 
BIOLOGICAL ACTIVITIES RANDOM (%) ETHNO (%) 
Antineoplasic 6 25 
Antihypertensive 31 44 
Anthelmintica 9.8 29.3 
Ichthyotoxicity 9.6 38.6 
Toxic/venoms 10.5 52.2 
Anti-HIV 8.5 71.4 
Antimicrobial 22 37 
Antiplasmodial 0.7 18 
Acetylcholinesterase inhibition 8 42.3 
Source: from Oliveira et al. 
Table 3. Comparison between the numbers of hits achieved by Ethnopharmacological x 
Random approaches in the search for different biological activities (OLIVEIRA et al. 2011). 
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Slish and colleagues (1999), when evaluating plant extracts obtained by the ethnoguided 
method (n = 31) for the relaxation effect in rat aortic smooth muscle, had a score of 12.9% 
active species, whereas by the random approach (n =32) no active species were observed. In 
an assessment with 80 traditional medicine plants from Reunion Islands for angiotensin-
converting enzyme inhibitory activity, which plays an important role in blood pressure 
regulation and diuresis, 44% of the species indicated by their antihypertensive or diuretic 
effect were active against 31% of the species without such indications (ADSERSEN & 
ADSERSEN, 1997). 
The selection of plants for use in primary health care should be based on the nosology of the 
region, referred to in the Brazilian Policy for Phytomedicine and Medicinal Plants (BRAZIL, 
2006), which is determined by an interview survey conducted among local experts in the 
communities . The nosological map obtained, defines the range of plants that are then 
selected according to technical criteria, considering their agronomic and pharmaceutical 
aspects. The list of the plants used to treat diseases that compose the nosological profile 
emerges from the treatment of the information provided by the respondents, applying the 
programming rule of the Pharmaceutical Assistance (BARBOSA, 2008). 
4. Possible innovations in phytomedicine development from the ethnoguided 
surveys  
The development of herbal medicines, as they need to generate specific parameters for each 
formulation, is more productive in terms of knowledge than in terms of the synthetic 
analogue, once the constitution of each species that gives rise to herbal medicines varies 
from one species to another. Compatibility studies of adjuvant in relation to the components 
of plant extracts, the need to characterize quality markers, pharmacologically active or not, 
all this set induces a creative process marked by strong innovative character. Some topics 
are presented below: 
 Regulation of pre-products and insumes; in the legal-administrative sphere, the 
phytomedicines bring and impose the need to develop regulatory frameworks that do 
not exist in many countries. 
 Documentation of traditional knowledge in the form of a regionalized National Plant 
Pharmacopoeia; in continental countries like Brazil, or which have microclimates with 
different biomes, this is a remarkable feature, and the existence of national human groups 
with appropriate cultural heritage, possessing their own herbal knowledge also influences. 
 Development of products to attend the national nosology; as a result of the ethno-
oriented surveys which, besides the list of plants can generate a regionalized 
nosological profile; this profile guides the development of therapeutical formulations to 
treat local diseases, often neglected by large laboratories . 
 Using the production of medicinal plants to recover degraded areas; to meet the national 
and local demands for plant material both for herbal medicines production as for use in 
primary health care, it is necessary to cultivate selected species, which can be intercropped 
and would not make sense to grow them in forested areas, but in areas that could be 
recovered.   
 Involving the communities in the production projects; since it is an ethno-oriented 
process, it involves communities per se; in the case of Ethnopharmacy, a social technology, 
the involvement of organized human groups is higher and can trigger initiatives. 
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 Applying new methods for development; the partnership of the academy in the 
development of phytomedicines, required due to the low participation of the 
pharmaceutical productive sector in this process, induces the application of modern 
techniques, as the academy, apart from contributing to the process still needs to 
produce knowledge in accordance to the regulatory sector. 
5. Medicinal plants in the basic health care from ethnoguided approach 
In Brazil the traditional use of medicinal plants was recognized by the public health 
administration and was integrated into the official health system through the National 
Policy of Complementary and Integrative Practices (BRASIL, 2006b). 
To support this therapeutical option available to the general population that uses the 
Integrated Brazilian Health System (SUS), regulatory documents were elaborated and 
promulgated which present a list of medicinal plant species of popular or traditional use, 
selected on basis of a set of information that indicates and supports the alleged use of these 
plants, its form of use and the cares to be taken in the preparation and the administration of 
the therapeutical product. 
The information that substantiates the inclusion of a given medicinal plant species into the 
primary health care is carefully conferred in the scientific literature. Data on botanical, 
agronomical, pharmacognostic and chemical characteristics are checked for the unequivocal 
description of the plant material to be considered as a potential source for an officialised 
phytotherapeutical. Results concerning the effectiveness and security of the herbal drug or 
its derivatives as well as information about toxicological, pre-clinical and clinical investigation 
of the plant species, herbal drug or preparations obtained from them,  complete the set of data. 
So, in this way, medicinal plant species are inserted into the list of phytotherapeutical for use 
in the basic health attention. Nowadays vegetal species and derivatives species are available 
as therapeutic resource in the basic pharmaceutical assistance program. 
Since information about a given medicinal plant species is still to be produced, the plant is 
inserted in the national Relation of Medicinal Plants of Interest for the Integrated Brazilian 
Health System (RENISUS), where the medicinal plants species that present good potential to 
generate products of interest to the SUS, or plant species that can be incorporated into the 
Live Pharmacies (an official program of medicinal herbal gardens cultivated in units of basic 
health assistance) or generate phytotherapeutical (teas, tinctures, pomades or other simple 
pharmaceutical forms) are inserted. 
The purpose of this list is to guide studies and research that can support the elaboration of a 
relation of available phytotherapeuticals for safe and effective use by the population, to treat 
some mild illnesses. Currently, “espinheira santa”and “guaco”phytotherapeutic derivatives 
are offered, respectively, for gastritis and ulcer, and for cough and influenza (BRAZIL, 
2009). 
In RENISUS there are 71 medicinal plant species with therapeutical potential to induce the 
development of research projects and to motivate organization of productive arrangements; 
which are disclosed by the National Programme of Medicinal Plants and Phytomedicines of 
the Health Ministry. Amongst these medicinal plant species Cynara scolymus (artichoke), 
Schinus terebenthifolius (aroeira da praia) and Uncaria tomentosa (cats claw) can be found, 
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which are used, according to the popular knowledge, to treat digestive disorder, vaginal 
inflammation and articulation pains, respectively, and whose indications are scientifically 
confirmed (BRAZIL, 2009). 
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1. Introduction 
The liver is the prime organ concerned with various states of metabolic and physiologic 
homeostasis of organism and is a key organ of metabolism and excretion  playing an 
important role in the maintenance of internal environment of the body through its multiple 
and diverse functions. It is continuously exposed to a variety of xenobiotics and therapeutic 
agents exposing the organ to numerous and varied disorders. There is a progressive increase 
in the incidence of hepatic damage mainly due to the viral infection, hepatotoxic chemicals 
(alcohol), toxin in food (especially aflotoxins), peroxides (particularly peroxidized edible 
oil), pharmaceuticals (antibiotics, chemotherapeutics, and CNS active agents), environment 
pollutants and xenobiotics (Hikino et al 1988). 
Though liver disease are among the most important disease affecting mankind , no 
remedy is available at present in the modern system of medicine which include 
corticosteroids and immunosuppressive agents which bring about symptomatic relief 
supporting only the process of healing of liver regeneration and in most cases have no 
influence on the disease process. Further, their use is associated with the risk of relapses 
and danger of side effects. An actual curative therapeutic agent has not yet been found 
and thus management of liver disease is still a challenge to the modern scientific 
community. Hence increasing attention is being given to plants recommended for the 
treatment of hepatic disorders in traditional system of medicine. A number of medicinal 
preparations have been advocated especially in Ayurvedic system of Indian medicine, for 
the treatment of liver disorders. Their usage is in vogue since centuries and are quite often 
claimed to offer significant relief. In addition, the use of many folklore remedies mainly 
plant products are also common throughout India.  
About 600 commercial preparations with claimed liver protecting activity are available all 
over the globe. In India about 33 patent herbal formulations are available for liver ailments 
and these preparations are a variety of combinations out of 100 Indian medicinal plants 
belonging to about 40 families (Handa et al 1986). Only a few scientific data with regard to 
their hepatoprotective action are on record. Phytoconstituents remains to be a major 
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contributor in the treatment of liver disorders. The growing concern for the identification of 
novel hepatoprotective agents from natural sources is evident from literature available on 
the same.  
1.1 Free radicals in hepatic disease 
The role of free radicals in the hepatic disorder is being suggested because of the fact that 
the detoxification of xenobiotics and toxic substances, an important function of liver,  
leads to the generation of large amounts of reactive oxygen intermediates. Though liver is 
one of the organs best supplied with antioxidant, chronic exposure to such substances 
overpowers the antioxidant defense system and cause hepatic damage. The role of 
lipid peroxidation (LPO) induced damage in the pathogenesis of chronic liver disease 
based on enzymatic studies (lysosomal enzyme in the serum), has been suggested. 
Pathological free radical reactions probably play a role in the hepatotoxicity of halothane, 
hydrazine, acetaminophen, carbon disulphide and α-methyl dopa. Free radical reactions 
participate secondarily in the development of organ damage in Wilson’s disease, 
haemochromatosis and secondary haemosiderosis. The majority of drugs used in the 
treatment of liver diseases are antioxidants (Vitamin E, lipoic acid, methionine etc.) (Feher, 
et al 1986) .The injurious roles played by the free radicals have brought in to use the 
antioxidants obtained from the plants for alleviating the severity of liver disorders (Meyer, 
et al 1990). Some plants which exhibit hepatoprotective and antioxidant activities are give 
belows:  
Silymarin (Silybum marianum) (Romellini, et al 1976); schizandrins wuweizischun 
(Schizandra chinensis) (Handa, et al 1986); Saikosaponin (Bupleurum falcatum) (Hikino, et al 
1988); glycyrrhizin , glycyrrhetic acid (Glycyrrhiza glabra) (Handa, et al 1986); catechin 
(Uncaria gambir)( Handa, et al 1986, Galvez, et al 1995 & Ubeda et al 1995); epicatechin (Acacia 
catechin) (Handa, et al 1986); andrographolide, andrographoside, neoandrographolides 
(Andrographis panicles) (Handa, et al 1986 & Kaul, et al 1994 );  picroside (Picrorrhiza kurrao) 
(Handa, et al 1986); acicubin (Plantago asiatica) (Handa, et al 1986); ginsenosides (Panax 
ginseng) (Handa, et al 1986);  piceid and resveratrol (Polygonum cuspidatum) (Handa, et al 
1986);  arcapallin (Artemisia capillaris) (Handa, et al 1986);  Sb-1 (Scutellaria baicabensis); α-
tocopherol (embryos of cereals, vegetable oil, fresh vegetables) (Handa, et al 1986); 
curcuminoid (Curcuma longa)(Ravishankar, et al 1993); oil (Bunium persicum); quercetin , 
kaempferol naringenin (Helichrysum arenarium) (Handa, et al 1986); kaempferol 3- 
rhamnoglucoside, quercetin 3- rhamnoglucoside, stepposide (Euphorbia palustris and E. 
stepposa) (Handa, et al 1986, Galvez, et al 1995 & Ubeda, et al 1995);  mixed flavonoids (Mentha 
arvensis, Stachy neglecta, Colinicum coggyria, Anemone hepatria, Convallaria majalis , 
Ononis arvensis) (Handa, et al 1986, Galvez, et al 1995 & Ubeda, et al 1995); brevifolin hyperin, 
ellagic acid (E. nematocypha) (Handa, et al 1986, Galvez, et al 1995 & Ubeda, et al 1995); Costus 
speciosus (Verma & Khosa 2009) and  Zanthoxylum armatum (Verma & Khosa 2010). 
2. Zanthoxylum armatum DC  
Synonyms: Zanthoxylum alatum Roxb. 
Family:  Rutaceae  
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2.1 Common (Indian) name 
Hindi – Darmar, nepali dhaniya, tejphal, tumuru 
Bengali – Gaira, tambul,  
Oriya – Tundopoda 
Sanskrit – Tumburu, dhiva, gandhalu 
2.2 Distribution 
A large genus of aromatic, prickly, dioecious or rarely monoecious tree or shrubs, mainly 
pantropical, through also distributed in the subtropics. The genus as dealt with in the article 
includes species of Fagara, through some authors treat them as two distinct genera. About 13 
species are recorded from India. 
Zanthoxylum armatum DC found in the hot valleys of the Himalayas from Jammu to Bhutan 
at altitudes of 1,000-2100 m and in Eastern Ghats in Orissa and Andhra Pradesh at 1,200 m., 




Fig. 1. Zanthoxylum armatum  
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Zanthoxylum armatum DC, is an armed  scandent or erect shrub or a small tree , 6 m tall or 
more with dense foliage, branches armed, the prickles flattened, up to 2 cm. long, bark pale 
brown, deep-furrowed, leaves imparipinnate or trifoliolate, 5-23 cm. long, often with 
flattened prickles , leaflets up to 5 pairs, opposite, ovate to lanceolate , entire to glandular 
crenate, acute to obtusely acuminate, flower green or yellow, in dense terminal, and 
occasionally axillary sparse panicles, follicles generally reddish, sub-globose, glabrous, seeds 
solitary in a fruit, globose, shining black. (Kirti & Basu 1975). 
2.4 Phytochemical review 
Several alkaloids have been isolated from the stem-bark and root-bark. The fruits of a number 
of species yielded essential oils. The oils from Z. acanthopodium, Z. armatum, and Z. nitidum are 
potential source of linalool, an important perfumery material; the first two species are also 
employed on a limited scale for the production of wartara oil. Z. americanum Mill. , a shrub of 
eastern North America, is used in its native country for toothache and rheumatism. 
The stems and roots contain β-amyrin, β- sitosterol, L-asarinin, L-planinin, and 
zanthobungeanine. 
The fruits contain 3.5% oil. The characteristics and constituents of the oil are summarized in 
Table. The fruit oil contains the rare monoterpine triol, 3, 7-dimethyl-1-octane-3, 6, 7-triol. It 
contains: limonene (I), linalool (II), methyl cinnamate (III), myrcene and α-thujene (IV) as 
the main constituents. The oil also contains 1, 8-cineol, p-cymene (V), cis-ocimene (VI), γ-
terpinene, camphor (VII), α-fenchol (VIII), carvone (IX), tagetonol and alloaromadendrene, 
besides α-terpeniol and β-caryophyllene. 
The seeds contains   6-hydroxynonadec-(4Z)-enoic acid (C19H36O3, m. p. 40-42°C) (X), 8-
hydroxy pentadec-(4Z)-enoic acid (C15H28O3) (viscous) (XI), 7-hydroxy-7-vinylhexadec-(4Z)-
enoic acid (C18H32O3) (XII) and hexadec-(4Z)-enoic acid (C16H30O2, m. p. 49-50°C) (XIII) 
along with cis-9-hexadecenoic, eicosenoic, palmitic acid (XIV), tambuletin and methyl 
cinnamate has been reported in seeds (Ahmad et al 1993). Further the chemical studies on the 
seeds of Zanthoxylum alatum Roxb. (Rutaceae) led to the isolation of two new phenolic 
constituents characterized as 3-methoxy-11-hydroxy-6,8-dimethylcarboxylate biphenyl (XV) 
and 3,5,6,7-tetrahydroxy-3',4'-dimethoxyflavone-5-β-d-xylopyranoside (XVI) along with the 
five known compounds, 1-methoxy-1,6,3-anthraquinone, 1-hydroxy-6,13-anthraquinone, 2-
hydroxybenzoic acid, 2-hydroxy-4-methoxy benzoic acid, and stigmasta-5-en-3β-d-
glucopyranoside, on the basis of spectral data and chemical analyse (Akhtar et al 2009).  
A number of alkaloids has been isolated and reported from the various parts of the 
Zanthoxylum armatum Dc. berberine (bark), dictamnine (stem-bark), magnofluorine(0.02% as 
picrate), xanthoplanine (0.01% as picrate) (wood and bark), magnofluorine (0.17% as 
picrate), xanthoplanine, skimmianine, dictamnine and γ-fagarine  (Wealth of India 2005). 
A new amide designated as armatamide along with two lignans, asarinin and fargesin, α- 
and β-amyrins, lupeol, and β-sitosterol-β-D-glucoside – has been isolated from the bark of 
Zanthoxylum armatum. The structure of the new compound was deduced by spectral and 
chemical analysis as N-(4‘-methoxyphenyl ethyl)-3, 4-methylenedioxy cinnamoyl amide 
(Kalia et al 1999). 
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2.5 Pharmacological review 
The bark, fruits, and seeds of Z. armatum are extensively used in indigenous system of 
medicine as a carminative, stomachic and anthelmintic. The stem has exhibited hypoglycemic 
activity in the preliminary trials. The bark is pungent and used to clean teeth. The fruits and 
seeds are employed as an aromatic tonic in fever and dyspepsia. An extract of the fruits is 
reported to be effective in expelling round worms. Because of their deodorant, disinfectant and 
antiseptic properties, the fruits are used in dental troubles, and their lotion for scabies. 
Zanthobungeanine, found in stems and roots shows inhibitory activity to platelet 
aggregation, L-plananin is the most active compound. 
The bark is used in India, for treating diarrhea and cholera. The fruits are analgesic and 
anodyne and used in tooth powder. 
The bark of several Indian species of Zanthoxylum is medicinally active and noted for 
febrifugal, sudorific and diuretic properties (Wealth of India 2005). 
The essential oil is said to possess antiseptic, disinfectant and deodorant properties. The 
freshly distilled essential oil from the seeds exhibited strong antibacterial activity against 
Escherichia coli, Vibro cholera, Micrococcus pyrogens var. aureus, Shigella dysenteriae and 
Salmonella typhi. The seed oil possesses ascaricidal, antibacterial, anthelmintic and antifungal 
properties. The oil on account of high percentage of linalool is highly fragrant and attractive 
and can be commercialized on this account. 
The oil obtained by steam-distillation of the fresh plant showed antifungal activity against a 
number of fungi. 
It is established that plants which having antioxidant property also exert hepatoprotective 
action (Fehar et al 1986). As Z. armatum has shown significant antioxidant activity (Verma et al 
2008) and also contain phenolic compounds, therefore, we have to investigate the 
hepatoprotective activity of ethanolic extract of Z. armatum in rats.  
3. Experimental 
3.1 Plant material 
 The Zanthoxylum armatum were procured from the Plant Physiology Division, Jawaharlal 
Nehru Krishi Vishwa Vidyalaya, Krishi Nagar, Jabalpur, M.P. (India) and authenticated by 
the taxonomic division, National Herbarium of Cultivated Plants, National Bureau of Plant 
Genetic and Resources, New Delhi. A voucher specimen (vide accession no. 
NHCP/NBPGR/2007/100/2225 dated 22/08/2007) was retained in our laboratory. The plant 
material was dried under shade at room temperature, reduced to moderately coarse powder 
and extracted successively with petroleum ether (60-80oC) and 95% ethanol using soxhlet 
apparatus. The ethanolic extract was dried under vacuum (yield, 6.67%). The defatted 
ethanolic extract of Zanthoxylum armatum (EEZA) was used for the preliminary 
phytochemical screening and hepatoprotective studies. 
3.2 Preliminary phytochemical screening 
A preliminary phytochemical screening was carried out for the extracts employing the 
standard procedure revealed the presence of various phytoconstituents viz. alkaloids, 
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steroids, terpenes, flavonoids, saponins, tannins, glycosides, carbohydrates and proteins 
(Harborne 1998). 
3.3 Chromatographic studies 
Thin layer chromatography (TLC) and High Performance Thin Layer Chromatography 
(HPTLC), of the alcoholic extract of Costus speciosus was done. 
3.4 Animals 
The Institutional Animal Ethics Committee, (IAEC) review the protocol and approved the 
use of animals for the studies, (Ethical clearance number: 711/02/a/CPCSEA). 
Wistar albino rats of both sexes (weighing 130–170 g) were used in the present study. They 
were housed in clean polypropylene cages (38X23X10 cm) with not more than three animals 
per cage and maintained under standard laboratory condition (temperature 25 ± 2°C) with 
dark and light cycle (12/12 h) and provided standard pellet diet (Hindustan Lever, Kolkata, 
India) and water ad libidum.  
3.5 Acute toxicity studies 
Acute toxicity study was performed for the extract according to the acute toxic classic 
methods as per OECD guidelines (OECD Guidelines 1996). Wister albino rats were used for 
acute toxicity study. The animals were kept fasting for overnight providing only water, after 
which the extract was administered orally 500 mg/kg b. w.  and observed for 14 days. The 
animals were observed If mortality was observed in 2 out of 3 animals, then the dose 
administered was assigned as toxic dose. If mortality was observed in 1 animal, then the 
dose administered was repeated again to confirm the toxic dose. If mortility was not 
observed, the procedure was repeated for further higher dose i.e. 2000 mg/kg.  
3.6 Assessment of hepatoprotective activity 
The rats were divided in to four groups of six rats each. The animals of group A and group 
B served as control and carbon tetrachloride (CCl4) control received vehicle (0.1% tween 80, 
10 ml/kg b. w.). Group C served as standard and received silymarin (100 mg/kg b. w. in 
0.1% tween 80), and group D was given EEZA (500 mg/kg b. w. in 0.1% tween 80). All 
administration of doses was made by gastric intubations once daily for 7 days.  
On the 8th day 1 h after the administration of last dose, the animals of group B; C and D were 
given an intraperitoneal injection of CCl4 with an equal quantity of liquid paraffin (0.5 
ml/kg b. w.). All the animals were then fasted for 24 h and anaesthetized and the blood was 
collected by cardiac puncture. The liver was quickly dissected, washed with ice-cold saline 
and stored in freezer. The blood samples were allowed to coagulate at room temperature for 
1 h. Serum was separated by centrifugation at 12,000 rpm at 40C for 5 min (Verma et al 2007). 
3.6.1 Biochemical estimation 
Serum was analyzed for various biochemical parameters, i.e. serum glutamyl oxalacetic acid 
transaminase (SGOT, AST), serum glutamyl pyruvate transaminases (SGPT, ALT)  (Reitman 
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et al 1957), alkaline phosphatase (ALKP) (Bessey et al 1946) and for serum bilurubin (SBLN) 
(Malloy et al 1937). 
3.6.2 Histopathological studies 
The hepatoprotective activity was confirmed through histopathological studies on liver of 
rats. Slices of liver were cut and washed in Ringer’s solution soaked with filter paper for 1.5 
min, then liver slices were fixed in Carnay’s fluid I (Ethanol: chloroform: Glacial acetic acid- 
6:3:1) and processed for paraffin embedding following the standard microtechniques. 
Sections of liver, stained with aqueous haematoxylein and alcoholic eosin were observed 
microscopically for histopathological changes (Galigher et al 1971). 
3.6.3 Statistical analysis 
The data represent M ± S.E.M. Results were analyzed statistically by one-way ANOVA, 
followed by Students‘t’ test. The minimum level of significance was set at P<0.001 compared 
to control. The entire statistics were estimated by using Sigma Stat 3.5™, statistical 
software.  
4. Result & discussion 
4.1 Phytochemical screening 
Phytochemical screening for the ethanolic extract of Zanthoxylum armatum revealed the 
presence of phytoconstituents like sterols, alkaloids, phenolic, flavonoids and reducing 
sugars. The ethanolic extract did not cause any mortality up to 2000 mg/kg and considered 
as safe. 
4.2 CCl4  induced Hepatotoxicity 
The results of CCl4-induced hepatotoxicity are represented in Table 1.  CCl4 intoxication in 
normal rats elevated the levels of SGOT, SGPT, ALKP, SBLN and liver inflammation were 
observed significantly indicating acute hepatocellular damage and billiary obstruction. The 
rats that received 500 mg/kg of EEZA showed a significant (P<0.001) decrease in all the 
SGOT, SGPT, ALKP, SBLN levels and liver inflammation, compared to induced control 
group.  
Normal histology of rat liver showed sinusoidal degeneration (Fig. 2a). The liver sections of 
the rats treated with CCl4 showed cellular degeneration hydropic changes which were more 
around the central vein and fatty changes with wide spread hepatocellular necrosis and 
centrolobular necrosis (Fig. 2b). The liver section of EEZA treated showed micro fatty 
changes with dense collection of lymphoid cells, suggesting evidence of very little necrosis 
or degeneration. There was no hepatocellular damage, except small arrears of focal 
degeneration and sinusoidal dilation in treated rat livers (Fig. 2c and d).  
CCl4 is biotransformed in to cytochrome P450 in the liver endoplasmic reticulum to the 
highly reactive trichloromethyl free radical which in turn reacts with oxygen to form a 
trichloromethyl peroxyradical, which may attack lipids on the membrane of endoplasmic 
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(a) Group I (control) - section shows central 
vein surrounded by hepatic cord of cells 
(normal architecture). 
(b) Group II (CCl4 treated) - section shows  
patches of liver cell necroses, inflammatory 
collections and accumulation of fatty lobules 
around central vein. 
(c) Group III (Standard silymarin treated) -  
almost near normal.  
(d) Group IV (treated with ethanolic extract 
of Z. armatum) - minimal inflammatory 
cellular infiltration. Almost  near normal 
liver architecture. Regeneration  of 
hepatocytes around central vein. 
Fig. 2. Histopathology of liver tissues at X 400 magnification 
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reticulum more readily than trichloromethyl free radical. The trichloromethylperoxy radical 
leads to elicit lipid peroxidation, the disruption of Ca2+ homeostasis, elevation of hepatic 
enzymes and finally results in cell death (Clawson et al 1989).  
The results obtained from the present study indicated that the EEZA exhibited 
hepatoprotective effect against CCl4-induced liver damage by normalizing the elevated 
levels of the hepatic enzymes. This suggested the possibility that EEZA is able to condition 
the hepatocytes, so as to cause accelerated regeneration of parenchyma cells, thus protecting 
against membrane fragility and decreases of leakage of the marker enzymes into the 
circulation as compared to silymarin, reported to have protective effect on the plasma 
membrane of hepatocytes (Ramellini et al 1976). The results supported the use of this plant 
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104±9.75* 438.00±7.0** 249.59±6.07* 1.82±0.38** 0.24±0.88* 3.32±0.10** 
Note: n= six animals in each group 
EEZA= Ethanolic extract of Zanthoxylum armatum 
Values are expressed as Mean ± SEM  
* p<0.05 compared to control.  
**p<0.02 compared to control.  
 ***p<0.001 compared to control. 
Table 1. Effect of Ethanolic Extract of Zanthoxylum armatum on CCl4 Induced Hepatotoxicity 
in Rats. 
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Flavonoids have been reported as active substances for the treatment of hepatitis induced by 
chemicals (Khalid et al 2002) and virus (Kang et al 2006) in vitro and in vivo. Ethanolic extract 
of Z. armatum showed positive results for the presence of phenolics and flavonoids during 
preliminary phytochemical screening. The possible mechanism may be that the antioxidant 
potentiality of flavonoids can scavenge free radicals and protect the cell membrane from 
destruction. Hence, the transaminases (ALT/AST) may not leak into blood from the necrotic 
hepatocytes.  
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reticulum more readily than trichloromethyl free radical. The trichloromethylperoxy radical 
leads to elicit lipid peroxidation, the disruption of Ca2+ homeostasis, elevation of hepatic 
enzymes and finally results in cell death (Clawson et al 1989).  
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104±9.75* 438.00±7.0** 249.59±6.07* 1.82±0.38** 0.24±0.88* 3.32±0.10** 
Note: n= six animals in each group 
EEZA= Ethanolic extract of Zanthoxylum armatum 
Values are expressed as Mean ± SEM  
* p<0.05 compared to control.  
**p<0.02 compared to control.  
 ***p<0.001 compared to control. 
Table 1. Effect of Ethanolic Extract of Zanthoxylum armatum on CCl4 Induced Hepatotoxicity 
in Rats. 
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Flavonoids have been reported as active substances for the treatment of hepatitis induced by 
chemicals (Khalid et al 2002) and virus (Kang et al 2006) in vitro and in vivo. Ethanolic extract 
of Z. armatum showed positive results for the presence of phenolics and flavonoids during 
preliminary phytochemical screening. The possible mechanism may be that the antioxidant 
potentiality of flavonoids can scavenge free radicals and protect the cell membrane from 
destruction. Hence, the transaminases (ALT/AST) may not leak into blood from the necrotic 
hepatocytes.  
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1. Introduction 
Plants have been used for thousand of year as a source of bioactive substances for 
therapeutic, agricultural and industrial purpose; in this regard the search for compounds 
active on these sources is an alternative for development of agrochemicals (Dayane et al., 
2009). The plans, their derivatives or extracts have been studied for different biological 
activities in economically important pests, assessing their toxic effects lethal, antifeedant, 
repellent, fumigant, growth regulation and deterrent to oviposition, among other (Isman, 
2006; Singh and Saratchandra, 2005).  
The ecological balance and the organisms of various ecosystems are vulnerable by excessive 
or careless use of pesticides in agricultural or urban system. In theory, through using these 
products is to provide enough food and pest control, in contrast, often cause undesirable 
and dangerous environmental situations. Therefore, before to take a decision on the use of 
any pesticide, you should be aware that if the use of these substances is performed under 
controlled conditions and with full knowledge of its adverse properties, the survival of 
living things and balance of nature can become seriously affected (SEMARNAT, 2011). 
The use of plants as a source of active compounds emerged as friendly alternative the 
indiscriminate use of synthetic products for pest control, which has causes toxicity to human 
health, biodiversity impoverishment, damage to beneficial organisms and favor the 
emergence of strains of pests resistant to these product, so it is common to increase the 
application rate risk to public health and the environment (Siqueira et al., 2000).  
The rescue of rudimentary practices used by farmers in pest management is one of the 
options to find alternatives to the frequent use of synthetic pesticides. This report compiles 
information about the use of Mexican medicinal plants, native and introduced in the pest 
control mainly of the system agriculture and livestock primarily, and report an analysis of 
current status and recommendations for use botanical insecticides.  
Currently investigations are conducted to determine the potential pesticide plant (used in 
herbal medicinal) , its derivatives or extracts, such as several spices of the family Asteraceae, 
Euphorbiaceae, Solanaceae, Meliaceae,Convolvulaceae, Lauraceae, Piperinaceae, and 
Anonaceae, among other (López-Olguín et al., 2002; Pereda-Miranda & Bah, 2003; Prakash & 
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Rao, 1997; Ramos, 2010; Rodríguez et al., 1982). For instance in the family Convolvulaceae, 
some species of the genus Ipomoea such as I. tricolor, I. batata and I. murucoides are 
traditionally used as nutricional, emetic, diuretic, diaphoretic, purgative (Pereda and Bah, 
2003) and pesticidal agents (nematodes, insects, and weeds) (Jackson & Peterson, 2000; Vera 
et al., 2009; Vyvyan, 2002). 
2. Botanic pesticide 
In ancient culture and in different parts of the world has existed for thousands of years 
(~1500 before J. C.) empirical knowledge of the use of plants for pest control, for example, 
the neem in India, rotenone in East Asia and South America, pyrethrin in Persia (Iran) and 
sabadilla in Central and South America later botanical insecticides were introduced in 
Europe and Unite States (Weinzierl, 2000). Since the late 1800s to the 1940s, these products 
were widely used to protect crops and stored products. It was in the early 1940s and the 
1950s which the development and commercial success of synthetic insecticides led to the 
abandonment of botanical insecticide in agriculture of the industrialized countries, as they 
won space on the market as products cheaper, effective, long-lasting and readily available. 
Only the botanical insecticides which remained in use in the Unite States after 1950, were 
pyrethrins (such aerosol spray and in home and industry) and nicotine (used primarily in 
the gardens). Already in the 1990s renewed interest stems from the use of botanical 
pesticides, because it is recognizes the impact on health and environmental that the 
synthetic insecticides cause, and their presence in food (Weinzierl, 2000).  
Botanical pesticides are formulations of organic solvents and aqueous based on different 
parts of plants (crude extracts) or derivatives thereof, are prepared in powder or liquid 
concentrates that can be incorporated into talc or clay for application either concentrated or 
diluted in a solvent such as water, ethanol and petroleum ether, among others (Isman, 2008). 
These products consist of a group of active ingredients of different chemical nature (Isman, 
1997). Preparations from plants such as pyrethroid, rotenone, neem, and citronella, 
commonly are formulated as liquid concentrates or extracts. The processed form of these 
products, are purified and isolated substances from plants through a series of extraction and 
distillation (Weinzierl, 2000).  
Through different studies have found that the biological activity of botanical extracts 
pesticides it is different significantly depending on the species of plants, plant parts used for 
the preparation of the extracts, the physiological state of the part used, of the solvent 
extraction, and the insect species under study (Shaalan et al., 2005). Although these products 
are of natural origin cannot be assumed to be completely safe, some plant-derived compounds, 
such as nicotine are extremely toxic to humans, or when used several times in continuous time, 
can affect the natural biotic control of pests by their natural enemies. Therefore, it is important 
to use correctly the technique and safety equipment when working on the preparation and 
application of botanical extracts, and recognize the appropriate dose formulation and its use in 
a program of integrated pest management, which will help efficiently to obtain the benefits of 
these products. Despite there are many plants and chemical constituents known to have 
insecticidal properties or insectistatic, few have been used for commercial production. Issue 
that has been reviewed by several researchers as Graiger and Amhed (1988) and Isman (2008). 
The Use large-scale commercial of the plant extracts as insecticides began in the 1950s with the 
introduction of nicotine from Nicotiana tabacum, rotenone from Lonchocarpus sp, derris from 
Derris elliptica, and pyrethrum from flowers of Chrysanthemum cinerariaefolium (Isman, 2008). 
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Gaugler (1997), mentioned concerning this that the inconvenient of these products are offset by 
its lower toxicity, higher levels of security and in addition to generally exhibit lower 
accumulation in the environment, characteristics that should be used to promote their sales 
(Silva et al., 2002). These products have the advantage of being generally compatible with 
other programs acceptable alternative integrated pest management, such as practices, 
cultivation of plants resistant to pests, pheromone oils, soaps, entomopathogenic, predators 
and parasitoids, among others (Brechelt, 2008). Botanical pesticides already registered and 
approved are promoted for organic crop production especially in industrialized countries and 
for production and postharvest food protection in developed countries (Rodriguez, 1997).  
Actually in the Unite States the registration of the botanical insecticides request few 
requirements, for that reason allows a wide range of these products, including pyretrins, 
neem, rotenone, sabadilla, ryania, and nicotine. Essential oils are also sold although several 
of them do not have a complete record (Isman, 2006). In Latin America, it is common that 
the production of oil and botanical extracts for pest control is done without regulatory 
system and small scale for local use in low-income populations. As in all developing 
countries, lack of training of relevant legislations to regulate these products has complicated 
the registration process, this is the case of Mexico with the insecticide Biocrack® (garlic 
extract) Berni Labs who have gave the record seven year after starting its activities (Silva et 
al., 2002). On the other hand, Mexico allows the use of many products sold in the Unite 
States as the PHCTM NEEEMTM (31.2 g i.a. L-1 azadirachtin) and NEEMIX® 4.5 (47.6 g i.a. L-1 
azadirachtin) and the insecticides approved for their use are pyrethrum, rotenone, nicotine, 
garlic and capsicum extract and powder the mixture of neem leaf and seed (Grain 
Protector®, Mexican Fitorganic) (Isman, 2006).  
In Mexico, Ultraquimia Group S.A. de C.V., manufactures organic and agrochemicals products 
used in the control of plant health problems and carry out coordinated studies with 
researchers from the National Research Institute Forestry, Agriculture and Livestock (INIFAP) 
to determine the biological effectiveness of botanical insecticides produced, such as BIODI®e, 
PROGRANIC® CinnAcar and PROGRANIC® Nimicide 80 among others, recommended for 
control of Diaforina (Diaphorina citri), mealybug (Planococcus citri), whitefly (Bemisia tabaci, 
Trialeurodes vaporariorum), aphids diver (Paratrioza cockerelli), bold (Phyllocoptruta oleivora), asian 
citrus psyllid (Diaphorina citri), diamond back moth (Plutella xylostella), worm looper 
(Trichoplusia ni), thrips (Thrips spp., Frankliniella spp., Caliothrips phaseoli, Heliothrips sp.) and 
aphids (Aphis spp, Myzus persicae, Brevicoryne brassicae, Toxoptera spp.). 
Isman (1999) indicated that within 10 to 15 years, specifically the botanical insecticides 
probably represent about 50% of the total insecticide market. However, the current 
availability of biopesticides market comprises a small portion of the total volume of 
pesticides available. According to FAO data, world consumption of bioinsecticides for 2009 
represented 0.2 % of the total consumption of insecticides (FAO, 2009). Nevertheless, these 
products remain important in the insect pest management for the reasons mentioned above. 
FAO (1999) indicated that little information exist about the use of botanical pesticide on the 
crop protection or stored food, also have been few evaluation of the effectiveness of these 
materials under real conditions of use on field. Currently plant species more recognized and 
evaluated under laboratory conditions belong to the genus Azadirachta, Piper, Chenopodium, 
Ipomoea, Mentha, Annona, and Tanacetum. However, the use of most of these plants has not 
been divulged due to lack of appropriate programs and properly established of outreach 
and training. Multinational corporations in western Mexico are implementing alternative 
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pest management in tobacco-growing areas, to try to reduce the amount of synthetic 
pesticides used; in this sense, botanists become an effective and attractive alternative (Isman, 
2008). Several traditionally used plant preparations have found local commercial markets, 
for example Ryania speciosa (Ryania) (Flacourtiaceae) which contains an insecticidal alkaloid, 
and Haplophyton spp. (Apocynaceae) have been used in the West Indies and Mexico for crop 
protection (FAO, 1999), situation depicted a growing and progressive interest in the use of 
this alternative in pest management, however the situation is confused, because sometimes 
ambiguous recommendations are made about the local use of these products without 
having been previously validated by field investigations and biosecurity. In Mexico and 
throughout Latin America, this is common, and is manifested in the publication of manuals 
that describe and encourage the use of botanical pesticides, which usually collect basis of 
partial observations and reviews established by the people that have empirically determined 
the effectiveness of certain plants and their formulated in the pest management.  
Undoubtedly, it is not strange that in the short term register new plants and compounds 
with potential usefulness pesticide or plaguistatic with novel modes and sites of action to 
ensure their gradual distinctiveness in the market and enabling to increase the range of low-
risk alternatives for pest management. 
3. Modes and sites of action 
In the current development of botanical insecticides has increased interest in the 
characterization of the active compounds. Secondary metabolites of plants with insecticidal 
or insectistatic properties cause alterations in biochemical and physiological insects 
(hormonal, neurological, nutritional or enzymatic) when operating with repellent, 
antifeedant, growth regulation, oviposition deterrent and lethal toxicity, among other 
activities (Isman, 2006; Singh & Saratchandra, 2005).  
Different modes of action are described for many active compounds, for example, when are 
applied on the crop to be protected, they can act systemically in the plant by penetrating 
through the stomata and transported through the vascular system, altering its enzymatic 
complex, transpiration and changes in the composition of sap; other phytocompounds 
increase plant’s energy, promote the synthesis of sucrose to help strengthen your 
metabolism and immune defense system. In many cases induce repellency and excitement 
of the nervous system from insect pests hindering the flight and oviposition therefore 
decrease the populations of insect pests.  
The mechanism of action and target sites of the active phytochemicals on insects is diverse. 
Some cause effects by contact or ingestion being generally difficult their detoxification. The 
extracts or phytocompounds that acting through contact can penetrate and dissolve the 
lipoprotein matrix of the cuticle and cell membranes of insects destroying the exoskeleton, 
disrupting permeability and cellular physiology, causing dehydration and consequently 
death or reduce the oxygen consumption of nymphs, larvae and adults killing them by 
asphyxiation, affect the peripheral and central nervous system causing hyperexcitation, 
hypersensitivity, to external stimuli, seizure, muscle tetanization, effect protein synthesis 
and cell membranes, causing further death. The hyperexcitation of the nervous system also 
cause the masking of pheromones responsible for the mating process. The phytochemicals 
that acting by ingestion alter the physiological rhythm of the digestive system, preventing 
the contraction of the muscles of the intestine, causing his paralysis and hemolysis. There 
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are components that act as repellents to block and inhibit the ability to search and locate 
food (antifeedant effect) reducing the amounts ingested and increased parasitism and 
predation by staying longer exposed to the environment and weak; repellency may be 
regarding the use of systems of chemical interaction between plant-insect chemical; the 
alomones, that plants synthesize when interacting with individuals of another species 
(insect pests, for example) induce them respond with physiological change or behavioral 
modifying which favors only the plant. The mechanism by which the repellent activity 
occurs could also be due to a mixed action for an unpleasant effect on the sensory endings as 
well as a chemical blocking of the perception that insect use for guidance. 
The phytochemicals that cause lethal toxicity against insects larvae affect on any of the 
following target sites: midgut epithelium, gastric caeca, malpighian tubules, and in the nerve 
axon because disruption of channel sodium whose result in the insect is hyperactivity and 
seizure. The mechanism of action involves disruption of metabolism both through inhibiting 
the transport of electrons and uncoupling the ATP transport system, depolarization of the 
membrane potential, effect on calcium channel with sustained muscle contraction and 
inhibition of acetylcholinesterase (Shaalan et al., 2005; Weinzierl, 2000). Other phytocompounds 
asset, have a high effect of “knockdown”, causing that the insect to stop feeding, become 
paralyzed and die of starvation soon after being in contact with the product or treated surfaces.  
In experimental tests with sublethal concentrations of the extracts or active compounds of 
plants, there is often an extension of the period of biological development of the insects under 
study, making it possible to determine the characteristics effects of botanical extracts classified 
as regulator of growth, which contain phytoecdysones, phytojuvenoids and juvenile hormone 
causing prolongation of the stages of development, affecting the size, adult emergence, the 
physiology of reproduction by disrupting the reproductive system, fertility and hatching of 
larvae, resulting in effective control (Shaalan et al., 2005). The effect of phytochemicals that 
cause growth inhibition in various stages of development of insect pests act through inhibiting 
larval and pupal molt, longer duration of larval and pupal stage, morphological abnormalities 
and mortality during the molt among other effects (Shaalan et al., 2005). 
Morphological abnormalities are observed in different development stage of insect, such as 
damage in the process of melanization in larvae and pupae, death in the intermediate stage 
of a larva and pupa (in this case can be observed organisms with the head of a pupa and the 
abdomen of a larva), death of adults with wings caught in the pupal exuviae and adult 
difficulties to fully emerge (Shaalan et al., 2005), these anomalies indicate an inhibitor effect 
on metamorphosis, probably due to disruption of hormonal control, and interference in the 
synthesis of chitin during the molting process (Pushpalatha & Muthukrishnan, 1999; Saxena 
& Sumithra, 1985). In the embryonic stage usually observe dehydration on eggs, bleeding, 
and death of embryo.  
The biological effects of the phytocompound mentioned above are manifested individually 
or in combination depending of the chemical enrichment of plant species with potential 
pesticide and interactions that exists between the compounds. Many of the botanicals 
products that exhibit combined effects, such as the simultaneous damage in the larval 
development time and adult emergence, occasionally extend to the progeny of the larvae 
exposed to these treatments (Shaalan et al., 2005).  
Boeke et al. (2004), validated the toxic and repellent effect of 33 plants used in Africa since 
the antique of empirical and traditional manner, for beetle Callosobruchus maculatus control. 
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The laboratory evaluation showed that the powders of Nicotiana tabacum, Tephrosia vogelii, 
and Securidaca longepedunculata significantly reduced the number of beetle progeny and the 
species Clausena anisata, Dracaena arborea, T. vogelii, Momordica charantia y Blumea aurita had 
repellent activity, as reported experimentally that the majority of species assessed, provided 
effective control against C. maculatus. 
Certain compounds are well known for their mechanisms of action, as quassin, a triterpene 
isolated from the wood of Quassia amara (Simaroubaceae). The quassin is an insecticide that 
show effects on the mosquito larval Culex quinquefasciatus through the inhibition of 
tyrosinase enzyme activity and consequently alter the development of the cuticle (Evans & 
Raj, 1991). This compound has also been tested successfully in cereal crops to control aphids 
(Sengonca & Brüggen 1991) by the mechanism of inhibition of enzymes of the insect.  
Species of the family Meliaceae are source of azadarachtin, a limonoid marketed and 
appreciated by their biological activities pesticides, such as the antifeedant effect, the 
regulation of growth, as ovicidal and larvicidal, among others. The main effect of 
azadirachtin is to inhibit development, especially affecting the molt, by inhibiting the 
hormone ecdysone. Scott et al. (1999), showed that azadirachtin caused inhibition of voltaje 
K+ channel in cultured rat neurons, this compounds has also shows antimitotic affect on Sf9 
insect cell line, resulting in prolongation of repolarization (Salehzadeh et al., 2003). 
Microscopic studies have indicated that azadirachtin interfere with the formation of the 
mitotic spindles and in the assembly of microtubules in the axoneme during 
microgametogenesis of Plasmodium berghei (Billker et al., 2002).  
The family Piperaceae has been used as sources of pesticides to contain piperamides, several 
lignans, and derivates of benzoic acid. The piperamides, are molecules with dual biological 
activity, the amide group is neurotoxic and secondly the group methylenedioxyphenyl 
(MPD) is an inhibitor of cytochrome P450 in the insect pest, which participates in the 
metabolism of fatty acids and steroids (Scott et al., 2003).  
Commercial botanical insecticide, rhodojaponin-III, islated from Rhododendron molle effect on 
more than 40 species of insect pests being antifeedant, oviposition, ovicidal, inhibitor of 
growth and change and toxic by ingestion and through contact. Previous studies indicate 
that this compound inhibits proliferation of Sf9 insect cell (isolated from pupal ovariantissue 
of Spodoptera frugiperda) dose-dependent effect. Besides interfering with cell division, the 
concentration of [Ca2+], and intracelular pH (Cheng et al., 2011). 
4. Pesticide compounds 
Plant extracts and their derivatives are a source of many chemical compounds with potential 
insecticide or insectistatic and processed forms of botanical insecticides are isolated and 
purified compounds through extractions and distillation. For instance, nicotine and 
limonoid are distilled from plant extracts (Weinzierl, 2000).  
Plants produce a vast and diverse reserve of secondary metabolites actives on different 
animals and plants of other species, allowing them to maintain relations of cohabitation 
(attractants) or defense (toxic or repellent substances) (Kutchan & Dixon, 2005). These 
secondary metabolites are not essential for growth and development of plants, but they are 
required for interaction with the environment and to respond to pressures such as scarcity 
of water and nutrients, extreme temperatures, to deter to the herbivores microorganisms 
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and viruses; also serve as signals to communicate with other organisms (Felton et al., 2008; 
Wink & Schimmer, 1999).  
The demand dynamic of biotic and abiotic environment gives the natural plasticity to the 
secondary metabolism and encourages the evolution of genetic diversification of the plant 
and thus generating a abundant group of natural products with variety of chemical 
structures (Kutchan & Dixon, 2005) many case bioactive (Macías et al., 2007).  
The biosynthesis of secondary metabolites and storage of these compounds is regulated in 
space and time, so the growing tissues are more vulnerable and more protected than the old 
or senescent tissues. For instance, is usually observed in seeds, latent and period of 
germination, flower buds and young tissues retain a certain amount of specific compounds 
or are actively synthesized. The organs that are important for the survival and 
multiplication, such as flowers, fruits and seeds, are almost always a rich source of chemical 
defenses (Wink, 1999). In addition, the metabolic profile usually varies between parts of a 
plant, including developmental stages, sometime during the day, the geographic location of 
the plant species and between plant species (Wink, 1999).  
Many secondary metabolites have biological activities such as insecticides, fungicides, and 
phytotoxic properties that can be employed in agriculture (Wink, 1999) either alone or in 
combination with other chemical and biological (Trysyono & Whalon, 1999; Weinzierl, 
2000). Particularly during the past 20 years, phytocompounds such as terpenes, alkaloids, 
rotenone and pyrethrum have gained commercial importance for the development of 
botanical insecticides (Isman, 2006). 
Macías et al. (2007), mention that it was until the twentieth century when the study of plant 
compounds and their mechanism of action is made relevant. The development of 
spectroscopic technique allowed the isolation and identification of pure active compounds 
such as (5E)-ocimenone from Tagetes minuta (1978), rotenone from Derris elliptica (1983), 
azadirachtin from Azadirachta indica (1981), capillin from Artemisia nilagirica (1990), quassin 
from Quassia amara (1991), neolignans from Piper decurrens (1996), arborine, a new bioactive 
compound related to quinazolone alkaloid, from Glycosmis pentaphylla (1999) and 
goniothalamin From Bryonopsis laciniosa (2003) (Shaalan et al., 2005). 
Kathuria and Kaushik (2005), determinedthe antifeedant effect of etanol extracts of leaves 
from Eucaliptus camaldulensis y Tylophora indica en Helicoverpa armigera (Hûbner) and found 
that the alkaloids identified in T. indica are responsible for this activity. In another study, 
extracts were evalued red maple (Arce rubrum) resulting assets over Malacosama disstria 
larvae, causing antifeedant affect. Gallates derivatives (1-O-galatoil-L-ramnosa) present in 
the plant were compounds responsible for this activity (Zaid & Nozzolillo, 2000).  
5. Mexican medicinal plants 
According to estimates published up to now, Mexico is the third country worldwide with a 
diversity of vascular plants. Of the 250 000 species located around the world, in the Mexico 
there are 22 411 (10%), not including nearly a thousand species (Villaseñor & Magaña, 2002; 
Vovides et al., 2010). Diversification, is back to geological times and have been possible by 
the variety of soil conditions, climate and topography of the country, as well as plant 
genetics and anthropogenic activities of conservation, introduction, selection and plant 
breeding.  
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In general terms, the biological, ecological and cultural diversity of Mexico has led to the 
generation of empirical and scientific knowledge, the first has its origins in ancient times 
with the practices of observation to the nature and experimentation through trial and error, 
inheritance transmitted from generation to generation through texts or stories. Through the 
inventory made under the empirical system made were possible the first classifications of 
plants with data on their ecology, biological importance and usefulness (Gómez-Pompa, 
2010). In Mexico the codices written by important pre-Hispanic groups are transcendental. 
With regard to the Azteca codex De la Cruz-Badiano is a record conceptual and illustrative 
of the medicinal plants used in New Spain of the Sixteenth Century, regarded worldwide as 
one of the best collections of Mexican folk medicine, this wealth of literature has fractured 
and disrupted on several occasions, however, has been rescued, preserved and expanded by 
the country’s ethnic groups and has now increased interest to validate through experimental 
science (Bye & Linares, 1999). Scientists from Mexico and other countries have used the 
codices, herbal, picked and general ethnobotanical practices for various purposes, among 
these, botanists have been interested in reviewing corroborated and enrich the etnoflora 
catalogs, describing the location, uses regional and popular names of plants and the 
phytochemical have used ethnobotanical studies as a reference for the location of plants 
with biological significance and the search for new phytocompounds useful in protecting, 
and preserving food un pre- and post-harvest either as pesticides and botanical repellents, 
as well as raw materials for pharmaceutical, cosmetic, chemical, beverage, food and 
bioprocesses. A current record, provides that Mexico has about 7 000 species of vascular 
plants with some use for various purposes (Caballero & Cortés, 2001).  
Importantly, there are still many regions of Mexico to explore thoroughly, to have an 
updated inventory of plants, a situation that reflects the potential in the many uses of these 
resources. In these sense, diversity and identification of endemic, native, and introduced 
strengthen several areas of research, local and foreign plant extracts or their derivatives. Of 
the plants with some kind of use, 3 300 species have medicinal use (Pérez, 2001); in addition 
to its therapeutic properties, many of these plants have the potential to be used in the 
management of pests and phytopathogens of agricultural and livestock importance, ancient 
practice that originated with the beginning of agricultural activities. The global ecological 
problem that exists in modern times, mankind has created demand for residue-free 
agricultural products and alternatives to reduce agrochemicals use, so that the development 
of conservation and sustainable agriculture was necessary and this favors the development 
and commercialization of these botanical pesticides. 
6. Ethnobotanical study of Mexican medicinal plants with insecticide potential 
Traditionally, the plants located in each geographic region of Mexico, are used for different 
purposes. Many have multiple applications and properties, the literature quotes are cite 
both for its medicinal properties as insecticides and antiparasitic properties. It is estimated 
that in Mexico there are about 7 000 useful plant species, representing 31% of vascular plants 
located in the country (Caballero & Cortés, 2001). 
Ethnobotany is considered as a source for research of phytopesticides of interest to the 
agricultural and livestock with production sustainable and alternative.  
This paper conducted a literature search and review of the publications on ethnobotanical 
studies in the country, plants that farmers and people in general routinely used to protect 
crops, stored grain, and ornamentals (Table 1). To confirm the medicinal use of plants  
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concerned are consulted databased of Plant Atlas of Traditional Mexican digital library of 
Mexican Traditional medicine of the National Autonomous University of Mexico with 
access at www.medicinatradicionalmexicana.unam.mx, as well as the book “The scientific 
investigation of the Mexican medicinal herbs” (Aguilar et al., 1993) and publications with 
information ethnobotany. 
7. Studies of insect pests of agricultural importance  
In Mexico and many parts of the world, people field for various decades have been 
consistently observed in their environment, and empirically they have selected plants that 
are not attacked by diseases and pests, many of which can be used as repellents and 
pesticides. Among the more promising botanical insecticides from the standpoint of its 
regulation, marketing and use, are products derived from plants that have already been 
validated by their pharmacological activity and insecticide, as the powdered of leaves and 
seed from neem (Grain Protector®) and garlic extract (Biocrack®) (Silva et al., 2002). 
According to Dev and Koul (1997) worldwide about 2 000 plant species have insecticidal 
active compounds with significant, mainly distributed in 61 families, of which we have 
identified for Mexico around 14 families of vascular plants by the number times cited in 
total publications consulted in this review, they are Asteraceae, Meliaceae, Convolvulaceae, 
Flacourtiaceae, Liliaceae, Solanaceae, Euphorbiaceae, Fabaceae, Lamiaceae, Rutaceae, 
Myrtaceae, Verbenaceae Burceraceae, Caricaceae (Table 2), despite diversity of resources 
with propierties worldwide, only a few of these species have commercial value in the 
market phytoinsecticides. Some authors like Isman (2006) mention that in modern times 
should restructure the search for new species with insecticidal or insectistatic activity and 
concentrate on the validation, regulation and marketing of phytoinsecticides already known 
for their potential. In developing countries like Mexico, is possible that the search of species 
with potential for pest control play an important role in food production (agricultural and 
livestock) and public health and livestock, because of empirical and traditional in several 
regions have been using some native species with this potential, either in the form of 
hedges, crude extracts, combustion products, powders, resins, latex, sap, poison baits or live 
plants interspersed throughout the orchards.  
Although Mexico exist isolated investigations on the search for plants with insecticidal 
activity (in some case having as antecedent pharmacological activity),there are well 
established research groups from different institutions of the country, for several years, have 
established this area as its research. A clear example is found in the Postgraduate College 
(Montecillo, Texcoco, State of Mexico) where Dr. Cesáreo Rodríguez Hernández, Dr. Laura 
D. Ortega Arenas and the group of contributors, since 1981 have worked consistently for the 
validation of plans that have traditionally been used since ancient times in rural 
communities across the country. About 30 rears, Dr. Rodríguez has collected and 
documented information from various parts of the country about the type local vegetation, 
plants with properties, uses, controlling pest species and forms of preparation. Generally, 
the information is recorded as prescription practices used among rural workers, agricultural 
technicians and promoters of organic farming, which details the use of local flora for the 
preparation of powders, baits or extracts, using materials available in the field. These 
research ranging from the intensive search for potential plant species present in a 
community insecticide and conducting toxicity tests on one or more species of insect pests of 
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worldwide importance such as Spodoptera frugiperda and the complex of while fly, or a local 
impact, such as Leptophobia aripa elodea (Table 3). The evaluations have been conducted in 
species of insect pests warehouse, public health and agricultural, using different parts of the 
candidate plants for preparations carrying out tests in laboratory and field level in several 
states. The information that Dr. Rodríguez and other working groups with whom he has 
worked, is recorded in different memories of the event “national and international 
symposium on plant and mineral substance in pest control” performed periodically in 
Mexico and is also published in scientific journals.  
In this sense, Villavicencio-Nieto and colleagues (2010), have determined that the State of 
Hidalgo there is much dependence on farmers for the local flora, the Autonomous 
University of Hidalgo State investigated the traditional use of 124 species of plants in the 
region, specifically for the pest control, only 97 of them being medicinal and 11 are used as 
insecticides. This research found that these plants have different uses in other regions of 
Mexico, including pharmacologic, as is the case Galphimia glauca, which have been used all 
its parts in different products (extracts, powders, essencial oils and resins) used in the 
management of pests of livestock agriculture, and health, such as human lice. Plant species 
most used in the communities of Hidalgo were Trichilia havanensis, Psidium guajava, Nicotiana 
tabacum, Tagetes erecta, Mentha rotundifolia, Ipomoea stans, Tagetes lucida, Parthenium 
hysterophorus, and Schinus molle. As a result of surveys conducted in this investigation, 
Villavicencio-Nieto and colleagues found that the plants with insecticide potential under 
study, are used to control 29 different pest species such as lice, fleas, weevils, ants, 
mosquitoes, cockroaches, among others, and are toxic to vertebrates such as dogs, squirrels, 
rats, snakes, and raccoons. This marks the importance of promoting the proper use of 
botanicals among communities.  
At the Center of Development of Biotic Products (CEPROBI) National Polytechnic Institute, 
Dr. Camino Lavín, developed his research on finding alternatives to the use of synthetic 
pesticides and in 1985 founded the department of plant-insect interactions, which among 
other line, encourages the development of phytoinsecticides. Currently, this line of research 
continues the group of collaborators and has evaluated Ficus goldmanii, Ficus petiolaris 
(Moraceae), Cochlospermun vitifolium (Bixaceae), Croton ciliatoglanduliferus (Euphorbiaceae), 
Crescentia alata (Bignoniaceae), Phitecellobium dulce, species of the genus Tagetes (Asteraceae) 
and also species in the Sierra Huautla, at the State of Morelos, as Prosopis laevigata (Fabaceae) 
and species of the genus Bursera (Burseraceae) and Lupinus (Fabaceae), which is known that 
several species have compounds with insecticidal and medicinal activity. They have also 
evaluated the biological activity of seeds of different varieties of Carica papaya (Caricaceae), 
which present effect insecticide e insectistatic against Spodoptera frugiperda (Franco et al., 
2006).  
In the Autonomous University of San Luis Potosi, have been assessed by laboratory tests, 
powdered of leaves and flowers from 81 plant species belonging to the Asteraceae family, 
the selection was made considering that this family includes many species with insecticidal 
activity or deterrent and also because they have pharmacological activities, the evaluations 
were conducted on Sitophilus zeamais. Of the 169 powder tested 50 were promising, 
highlighting the powder of leaves from Zinnia acerosa and Z. peruviana, in terms of 
insectistatic activity highlighted Bahia absintifolia, Stevia pilosa and Jefea brevifolia (Juárez-
Flores et al., 2010). 
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Trichilia havanensis (Meliaceae) is a species found from southern Tamaulipas to Tabasco and 
Chiapas, in considered native to Mexico and given its relationship with Azadirachta indica 
and Melia azaderach belonging to the same family, has been studied for over 15 years in the 
Benemerita Autonomous University of Puebla. The assessments are aimed at finding 
alternatives to control Ceratitis capitata, fruit pest species with cosmopolitan distribution and 
quarantine regulations in several countries, his control is restricted to the use of insecticidal 
organophosphates and pyrethroids. Other insects that have been used for the evaluations 
are Spodoptera exigua, especies del género Phyllophaga, Leptinotarsa decemlineata, Thrips tabaci, 
Helicoverpa armígera, Spodoptera litorali and Hypotenemus hampei. Actually, after years of 
experimentation and validation is likely to be patented and marketed a bioinsecticide 
obtained from the fruit species (López-Olguin et al., 1997; López-Olguin et al., 1998; López-
Olguin et al., 2002).  
The National Autonomous University of Mexico there is also consolidated groups of 
researchers in this area. The Department of Naural Products Chemistry Institute have 
among their line of validation of natural products with antifeedant and insecticidal activity, 
particularly plant species of the Labiatae, Burseraceae and Verbenaceae family. Have 
evaluated the activity of the purified active compounds are present in species such as Vitex 
hemsleyi. The tests were done in neonate larvae of S. frugiperda (Villegas et al., 2009). In the 
Faculty of Sciences, is studying the antifeedant activity of plant extracts from Acacia 
cornigera, Bursera species and some species of Solanaceae, the evaluations are performed on 
neonate larvae of S. frugiperda, and is also looking for alternatives to control Boophilus 
microplus.  
Northern Sierra of Oaxaca, community groups have received government support for 
production to tomatoes and other vegetables, have been advised by engineers and 
technician from the Institute of Technology in the Oaxaca Valley, the presence of whiteflies 
in the crop has been controlled with the use of extracts and infusions of garlic, onions, 
marigolds, basil, pepper, rue, chamomile, and others, the advantages are clear as reduces the 
investment cost and the food product developed under the organic system can be sold at 
higher prices.  
In the highlands of Chiapas cultivation of cabbage (Brassica oleracea) is of economic 
importance are usually affected mainly by the cabbage worm Leptophobia aripa elodia to 
control in these communities have used synthetic pesticides, to reduce costs, health 
problems and pollutation, El Colegio de la Frontera Sur has sought alternative biological 
control. This region has recorded around 1650 medicinal plant species, however, there are 
no studies on the effect of extracts of these species at different developmental stage of L. 
aripa elodia, a situation that prompted the selection of 15 wild species of insecticidal activity 
history ethnobotanical and medicinal use. The results showed no significant activity on L. 
aripa elodia although some of the species tested showed activity against Locussta migratoria 
and Trichoplusia ni, therefore should continue investigating the potential of these species in 
pest management (Ramírez-Moreno, et al., 2001). There has also been collecting traditional 
knowledge of indigenous Tzeltal farmers of Chiapas highlands, on the management of 
agricultural pests (ants, Phyllophaga spp., S. frugiperda, Doru taeniatum, Diphaulaca wagnerii y 
L. Aripa elodia) four of the most common crops in the region, this led to the evaluation of the 
sensitivity of these pest species and 64 medicinal wild plants belonging to the basic list of 
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useful plants from this ethnic group, the idea to promote local and regional control 
ecological these pests (Trujillo-Vázquez & García-Barrios, 2001).  
In the Biological Control Laboratory, Biotechnology Research Center, of the Autonomous 
University of Morelos State (UAEM), for 15 years under the initial coordination of Dr. 
Eduardo Aranda Escobar+, we have developed the research of plant extracts with biological 
activity on insect pests. Most plants have been collected in the State of Morelos, many of 
which have pharmacological properties (Table 4). Among the species tested include the 
genus Ipomoea (Convolvulaceae) bioassays have been done on S. frugiperda y Bemisia tabaci at 
different stages and we have observed different biological activities of the extracts, some 
Ipomoeas cause lethal toxicity against larvae and nymphs between 2-100% mortality (I. 
carnea, I. pauciflora, I. intrapilosa, I. cuernavacensis, I. murucoides), others cause decrease in 
weight of the larvae of S. frugiperda between 90-15% reduction (I. murucoides, I. carnea e I. 
pauciflora) and others affect the life cycle (I. carnea: cause malformation of pupae and adult 
difficulty to emerge, I. pauciflora: prolonged pupal development time). We also conducted 
tests on the establishment in vitro of Ipomoeas with potential, as an option to develop 
biotechnological technique for various purposes; one is to optimize the use of 
phytocompounds responsible for biological activity on insect pests (Toledo, 2001; Aguirre, 
2008; Gaona, 2009; Vera et al., 2009; Guzmán-Pantoja et al., 2010).  
Although they are abundant records of plants with insecticidal potential, before 
recommending its use should be tested for biosafety and formulation, it is important to the 
safety of these products in non-target species and the health of domestic animals and 
humans. Although most species with a history of drug use in communities has an apparent 
safety backup, remember the legacy of Paracelsus (1567) “the dose makes the poison”. 
Another factor to consider is the stock of plants because it could jeopardize the survival of 
these species in the ecological environment, in this regards is necessary to implement 
strategies for the compounds responsible for biological activity according to the 
phenological stage of the plant and seasonality is needed to establish the dates of collection 
and, if possible, establish community gardens for intensive planting of these plants with 
potential insecticide would have continuous availability of phytoinsecticides. 
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1. Introduction 
The development of herbal medicine requires a careful selection and unambiguous 
identification of plant species that will be the exclusive active principle, either as extract or 
as fraction, embedded in the product. An isolated substance, even if obtained from natural 
sources, does not give rise to a phytomedicine. 
The technical standardization of an intermediary of a phytomedicine is a decisive step for 
the quality standard that the product will show. After the validation of the alleged use, 
popular form of use, posology and agronomic certification of the plant material, for which 
phytochemical and pharmacognostic pattern will be developed to monitor the physical, 
chemical and physico-chemical characteristics of the plant, ensuring homogeneity of 
samples and the similarity to specimens tested in experimental stage. The plant material is 
then extracted and the obtained extract is used in the development of the formulation. This 
extract must be in accordance to the Brazilian Pharmacopoeia, respecting as far as possible 
the characteristics of the popular form of use. Before the next step, the pharmacotechnical 
handling, the extract will be phytochemically analysed, in order to determine the metabolic 
substance classes present in the sample. Then it must be pharmacologically investigated to 
assure that its activity, is similar to that originally alleged and experimentally tested; its 
physical and physico-chemical characteristics will be determined, and, subsequently, the 
extract undergoes chemical and chromatographic analysis to have identified substances that 
could characterize the plant and serve as chemical and, preferably, pharmacological quality 
markers. Substances which are chemically stable, responsible for the activity to be presented 
by the phytomedicine and able to be detectable and quantifiable by usual analytical 
methods, such as chromatography and ultraviolet spectroscopy or mass spectrometry, are 
potential candidates to be used as markers. 
To compose a pharmacopoeial monography of a medicinal plant it is recommended to 
describe the characteristics concerning the anatomy of organelle or tissues of the plant organ 
to be notified or from which a medicine will be developed. These structures of the herbal 
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drug can be observed in microscopic anatomical analysis and can be depicted as a 
micrography which is the document to be added to the monography. 
2. Microscopic anatomical description of leaves of Echinodorus macrophyllus 
The information produced from these analyses helps to standardize the raw material 
utilized in the production of a phytomedicine, this is illustrated by the anatomical 
description of leaves of Echinodorus macrophyllus which is used to produce several 
phytotherapeutical products in Brazil. To obtain the anatomical slices the dried plant 
material was rehydrated for 24h in distilled water and sectioned with stainless steel blade in 
different regions of the leaf and midrib. The sections were clarified in 20% NaClO and 
stained with Astra blue and basic fuchsin (MACHADO et al., 1988). 
Fractographs were obtained in light microscope Axiolab model ZEISS coupled to a Canon 
Power Shot model A640 digital camera for registration of anatomical characters. The 
electron micrographs of the material were prepared using the process of critical point and 
metallization with gold dust deposition and suitably organized in circular metal holders 
(stubs), the images were captured in the scanning electron microscope model LEO 1450 VP 
(KRAUS & ARDUIN, 1997). 
The following figures show the photographs of the cuts obtained by optical microscopy at 
the referred enlargement (10X or 40X). The leaf shows discrete epicuticular wax 
deposition of granulation aspect. In frontal view, the epidermal cells on both sides, 
adaxial and abaxial, are irregularly shaped, ranging from square and rectangular, with 
tiny and slightly sinuous walls. In transverse section the epidermis of both surfaces are 
uniseriate, with rectangular cells with flat anticlinal and periclinal walls; they are 
heterodimensional (Figure 1). 
 
 
Fig. 1. Transverse section of leaf showing the upper epidermis and palisade parenchyma 
(pp) in frontal view (40X). 
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The parenchyma is dorsiventral, consisting generally of two strata of homogeneous cells, 
slightly Sinuous anticlinal and smooth periclinal walls the first layer being more organized, 
with cells elongated, juxtaposed and perpendicular to the epidermis; the second layer 
palisade tissue consists of cells of the same format, but different in size, apparently less than 
the first. The cells of spongy parenchyma present thin walls, are heterodimensional showing 
different formats, in addition to well-developed intercellular spaces (Figure 2). 
 
 
Fig. 2. Transverse section of the leaf showing the lower epidermis with sinuous anticlinal 
walls and spongy parenchyma (sp) (40X). 
 
Fig. 3. Scanning electron microscopy showing paracytic stomata (ps). 
ps 
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In the parenchyma paracytic stomata can be observed, where stomatal complex is formed by 
a pair of lateral subsidiary cells connected to the guard cells, corroborating the description 
made by Tomlinson (1982). Picture obtained by electronic microscopy (Figure 3). 
The vascular bundles have xylem at the upper face and phloem occurring at the opposite 
side, in polar regions cells of sclerenchyma can be seen. This set appears enclosed in a sheath 
of parenchyma. 
 
Fig. 4. Transverse section of leaf showing vascular bundle (vb) (10X). 
The next figures show the transverse section of a petiole, which exhibits triangular to 
hexagonal shape, anatomically resembling the petiole of Sagittaria lancitolia, also an 
Alismataceae (TOMLINSON, 1982) (Figure 5). 
 
Fig. 5. Transverse section of petiole showing the hexagonal shape (10X). 
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Figure 6 displays a thin cuticle, showing a uniseriate epidermis, with polygonal shaped 
cells, and smooth walls. Reference to this format of petiole in this species has already been 
made by Matias (2007). 
 
Fig. 6. Transverse section of petiole showing the epidermis (40X). 
 
Fig. 7. Transverse section of the petiole highlighting the presence of secretory ducts (sd) 
(10X). 
The figure 7 shows that the petiole has two to three layers of compact parenchyma cells, in 
which secretory ducts are to see as well vascular bundles that have smaller diameter than 
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Fig. 6. Transverse section of petiole showing the epidermis (40X). 
 
Fig. 7. Transverse section of the petiole highlighting the presence of secretory ducts (sd) 
(10X). 
The figure 7 shows that the petiole has two to three layers of compact parenchyma cells, in 
which secretory ducts are to see as well vascular bundles that have smaller diameter than 
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the ones observed in the leaf’s parenchyma. This plant organ presents a great amount of 
parenchyma formed by a layer of isodiametric parenchyma cells, where bundles of different 
sizes are distributed, as seen in the figure. 
In the parenchyma of the petiole diaphragms can be observed (Figures 8 and 9). These 
structures are septate braciform cells that interrupt the existing intercellular spaces, 
preventing the collapse of the organ if there is an injury in the submerged part of the plant. 
Leite (2007) describes in less detail this structure. 
 
Fig. 8. Transverse section of petiole showing the presence of diaphragms. 40X. 
 
Fig. 9. Details of diaphragms in a higher enlargement (100X). 
The presence, in the analysed sample, of petioles with different sizes and shapes could also 
be observed. Figure 10 illustrates this observation since the shape of the organ differs from 
that showed in figure 5. The characteristic of the petiole here presented, according to Matias 
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(2007), seems closely similar to that from E. subalatus and E. palaefolius, indicating a possible 
introduction of parts of one of these species in the commercial sample, object of this study. 
 
Fig. 10. Transverse section of a petiole showing a shape different from that already 
described (10X). 
As a conclusion about the results here presented it could be assumed that the raw material 
to be used in the production of a phytomedicine must be analysed by microscopic 
anatomical techniques to ensure the identity of the species here in question. More 
specifically, although most of the fragments analysed can be attributed to Echinodorus 
macrophyllus, there is the possibility that fragments of petiole from E. subalutus and E. 
palaefolius were introduced in the material supplied for the work reported in this section. 
Anyway, it is important to note that for the production of herbal medicines based on E. 
macrophyllus, the part used is the leaf, where the chemical markers and the possible active 
principles are present, which this feature can threaten the credibility of the medicines 
prepared having a medicinal plant as active pharmaceutical matter. 
Once the raw material is anatomically characterized, in case of the development of a 
phytomedicine, a set of procedures is followed, which includes processing of plant material 
providing the herbal drug, that is used to obtain an extract, both drug and extract, are 
physically and physico-chemically analysed. Afterwards, or simultaneously, this extract 
undergoes the next steps in developing the proposed medicine, where chemical markers, or 
rather, pharmacological active markers, must be detected, characterized and quantified in 
the herbal drug derivative – a tincture, for instance. 
3. Characterization of potential markers for an Eleutherine species using 
TLC, LC-DAD e NMR 
The following case illustrates the characterisation of pro-oxidizing components found in an 
Eleutherine species (Iridaceae) that presents an excellent anti-protozoan activity in its extract. 
The substances belong to a class of metabolites which is easily detectable and quantifiable 
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by hyphenated techniques like LC-DAD. A tincture prepared from this medicinal plant was 
phytochemically investigated and provided two components which have been characterized 
by LC-DAD and by NMR. As the substances have this biochemical characteristic, induce 
oxidative stress, which allows combating microorganisms and protozoa, and can support 
the use of the plant as antiprotozoal agent, they can be used as markers for derivatives and 
products derived from this species. 
In attention to Brazilian regulation the marketing of herbal drugs for use in the form of tea, 
the phytochemical approach of an extract obtained from the medicinal plant in question and 
its chloroform fraction was performed and shows the presence of naphthoquinones. 
 
Metabolic class Crude extract Chloroform 
Steroids & Triterpenoids + + 
Azulen + + 
Reducer Sugars + - 
Anthraquinones + + 
Naphthoquinones + + 
Table 1. Metabolic classes detected by phytochemical analysis. 
The lyophilized chloroform fraction prepared from the tincture, was used in a sequence of 
chromatographic experiments performed using normal phase silica gel column 
chromatography and preparative Thin Layer Chromatography - TLC, with chloroform and 
acetone as mobile phase and with an 10% ethanolic solution of KOH for TLC monitoring of 
the separation and isolation of the naphthoquinones. The characterisation of the substances 
was achieved by comparison of the 1H e 13C NMR spectra of them with the spectra of 
substances already isolated from other species of Eleutherine 
Still in compliance with the Brazilian standards for herbal drugs (BRASIL, 2010), TLC 
analyses were conducted aiming to establish the chromatographic profile of the crude 
extract (EE), Hexan Fraction (HF) and the Chloroform Fraction (CF), and thus contribute to 
the quality control of drugs and their derivatives. Figure 10, observed under visible light, 
shows two zones of yellow color at Rfs 0.31 and 0.25, and pink areas at 0.44 pink Rf 0.62, 
both in EE and CF. 
When the chromatogram is observed under ultraviolet light at 254 nm, three absorption 
zones in EE and CF can be observed with the following retention factor (Rf) 0.25 and 0.31 
0.44, respectively. The chromatograms, after treatment with a 10% KOH methanolic 
solution, which is the spray reagent to detect quinones in the sample, show brownish 
coloured zones at Rf 0.25, 0.31 and 0.44 when observed under day light, this feature 
indicates the presence of naphthoquinones (WAGNER; BLAT .2001) in EE and CF. 
Naftoquinones are chemical compounds that present biological activities such as bactericide, 
fungicide, giardicide and amebicide and in recent years have aroused interest in the 
medicinal chemistry because they can induce oxidative stress, causing apoptosis (cell death) 
via topoisomerase inhibition (ANAZETTI; MELO, 2007). The isolated naftoquinones had 
their antioxidant capacity evaluated through the reaction with 2.2-diphenyl-1-picrilhidrazil 
(DPPH. +) a stable free radical. The reaction was monitored by colour change and the 
 




Fig. 11. Chromatograms obtained on normal sílica gel using as eluent Chloroform/Aceton 
99:1. From left: observed under visible light; b) ultraviolet light by 254 nm, and c) after 
treatment with 10% metanolic KOH. 
activity was measured by absorbance decrease of the sample measured at 517nm in relation 
to the corresponding blank (BLOIS, 1958). 
In order to verify the suitability of the substances to function as quality markers, the 
chromatographic profile of chloroform fraction and ethanolic extract was determined by 
High Performance Liquid Chromatography. To accomplish this task a Merck Hitachi® 
LaChrom7000 chromatographic system equipped with a diode array detector (DAD) was 
employed. The analysis were performed on a Agilent LiChrospher100 (250mmx 4.6 mm) 
column using ultra purified water (A) and acetonitrile (B) as mobile phase, which was 
pumped at 1.0mL/min., in gradient, starting with 15% of B during 10 minutes, followed by 
periods of 10 minutes by 30%, 50% and 80%. The detection range was set between 200nm 
and 400 nm, using the method developed by Paramapojn et al (2008), adapted to our sample 
conditions. 
The chromatogram of EE registered at 250nm presented two peaks (Ep1 and Ep2) of high 
intensity with Rt=18.93min. and 20.83min., areas of 45854675 and 60180902 and purity of 
99.97% and 99.72% (fig. 12). 
The chromatogram of the chloroform fraction presents as more intense peaks those with Rt 
of 19.12min. (Ep2) and 21.18min. (Ep1), areas of 1900571 and 7813739 and purity of 98.29% 
and 99.75, respectively, (Fig. 13). 
Substances Ep1 and Ep2 were analysed by HPLC under the same conditions as EE and CF, 
and showed peaks at Rt of 18.13min. and 21.71 min., areas of 3641711 and 24727851 and 
purity around 99.14% and 99.92% respectively. Using the reversed search function where 
recorded data are compared to others stored in the equipment library, it could be observed 
that peaks 01 in EE (fig. 12) and CF (fig. 13) present a similarity correlation of 97.40% and 
99.89%, respectively, to substance Ep2. The peaks 02 in EE (fig. 12) and CF (fig. 13) showed 
correlation of 99.84% and 99.98% to substance Ep1. 
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Fig. 12. CLAE - Chromatogram registered at 250nm from EE. 
 
Fig. 13. HPLC - Chromatogram obtained from the Chloroform Fraction, registered at 250nm. 
The detection of these substances by LC-DAD is based on diode arrangement and generates 
a diagram showing retention time, wavelength and absorbance as the three dimensions 
considered in the picture, which evidence the resolution of the chromatogram in the region 
where the two naphthoquinones are eluted (Figure 14). 
3.1 Characterization of substance Ep1 as isoeleutherol 
The Hydrogen Nuclear Magnetic Resonance spectrum obtained from Ep1 shows at δ= 
1.74ppm a duplet, due to a coupling with H-1, corresponding to three equivalents Hydrogen 



















































































































































Fig. 14. Chromatographic diagram showing the chemical constituents of EE. In detail the 
two isolated naphthoquinones and the absorbance scale. 
three Methyl Hydrogen atoms and produces a quadruplet. Furthermore four non equivalent 
aromatic Hydrogen atoms, e. g. H-4, H-6, H-7 and H-8 (Fig. 15) can also be observed. H-4 
appears as a singlet by δ= 7.86ppm, H-5 (δ= 6.93ppm) couples with H-6 (δ= 7.40ppm) giving 
rise to a duplet, H-6 besides the coupling with H-5 also couples with H-7 (δ= 7.54ppm) 
originating a signal like a superposed double duplet or false triplet, H-7 couples with H-6 and 
produces a duplet. The Hydrogen atoms from the Methoxyl group at C-8 (δ= 4.11ppm) 
appears as a singlet. Finally a phenolic Hydrogen atom generates a singlet at δ= 9.64. 
 
Fig. 15. 1HNMR spectrum of Isoeleutherol. 
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The 1HNMR data registered for Isoeleutherol isolated from Eleutherine americana MERR. et 
HEYNE by Hara et al (1997), agrees with that obtained from the substance here described as 
Ep1, in consequence we can affirm that Ep1 is Isoeleutherol and this is the first report of the 







δ(ppm) Multiplicity J (Hz) 
1-Me 1.74 1.73 d 6.5 
8-OMe 4.11 4.11 s  
H-1 5.72 5.70 dd 6.5 
H-5 6.93 6.93 d 7.7 
H-6 7.40 7.39 dd 7.7 
H-7 7.54 7.54 dd 7.7 
H-4 7.86 7.84 s  
9-OH 9.64 9.63 s  
From: Hara et al, 1997. 
Table 2. 1HNMR data Ep1, in comparison to Isoeleutherol. 
Because Isoeleutherol can show an adequate stability and seems to be one of the major 
chemical constituent of the tincture prepared from the bulbs of Eleutherine plicata EE, this 
substance can be used as a marker for the standardization of the herbal drug and its 
derivatives, probably linked to the antimoebian activity alleged to the plant.  
3.2 Structural characterization of Ep2 as isoeleutherine 
The substance Ep2 was analysed by 1HRMN, and the characterization of its structure was 
made by comparison of the obtained spectral data with that found in the literature. In table 
3 it can be seen that the Hydrogen atoms H-6, H-7 and H-8 in the aromatic ring, appear at 
δ=7.73, δ=7.64 and δ=7.27 respectively, with identical coupling constant J6H-8H= 6.7. The 
signal attributed to 6-H appears in the form of a duplet coupling with H-7, which in turn 
appears in the form of triplet due to the coupling with 6-H and h-8. The Hydrogen atoms of 
the Methyl group attached to C-1 and 1-H appear as duplet with δ= 1.33 and δ= 1.54, 
respectively and the Hydrogen atoms of Methyl group at C-3 appear as a duplet by δ= 1.34. 
 
Fig. 16. Chemical structure of isoeleutherine 
The bulbs of Eleutherine plicata Herb., vernacular “marupazinho”, are widely used in inland 
areas of the State of Pará, as a tea to treat diarrhoea possibly caused by Giardia and/or 
Entamoeba. The isolation of isoeleutherine from the Chloroform fraction of the tincture, 
suggests that the antiamoebian and antigiardian activity alleged by the population may be 
due to this chemical constituent, also found in the aqueous extract. Besides isoeleutherol,  
 








δ(ppm) Multiplicity J (Hz) 
3-ME 1.33 1.34 d 6.1 
1-ME 1.53 1.53 d 6.7 
4-βH 2.23 2.23 dd 11.0-19.0 
4-αH 2.69 2.68 dd 3.5-19.0 
3-H 3.95 3.96 m - - - 
9-OME 4.0 4.0 s - - - 
1-H 5.0 5.01 q 6.7 
8-H 7.27 7.27 d 6.7 
7-H 7.64 7.64 t 6.7 
6-H 7.73 7.74 d 6.7 
Based on Hara et al, 1997. 
Table 3. 1HNMR data from Ep2 in comparison to isoeleutherine. 
already known to inhibit HIV replication in H9 lymphocytes, these chemical constituents 
can be used as chemical markers for the quality control of the herbal drug and its 
derivatives. 
4. Characterization of Flavonoid glycosides as potential markers for a 
Vitaceae using LC-MS 
Another plant species widely recognized in Brazil, the Cissus species (Vitaceae) used in 
treating stroke sequels and to control diabetes, had its tincture analysed by LC-MS and is 
under evaluation for developing a phytomedicine. The tincture was obtained from dried 
leaves according to the methods described in the Brazilian Pharmacopoeia 5th edition (200g 
dried plant material macerated in 1 L ethanol 98oGL) (FARMACOPEIA BRASILEIRA, 2010). 
The analyses were performed in a HPLC system equipped with a diode-array detector. The 
compounds were separated on a RP-18 column using a mobile phase in linear gradient 
prepared with Acetonitrile, Methanol and Water (Table 4) containing HCOOH (pH 3.2); the 





































Table 4. Mobile phase composition and flow 
The tincture of C. verticillata was filtered on a PTFE membrane filter before analysis. The 
UV-Vis spectra were recorded at the range of 190-450nm, and chromatograms were 
acquired at 230, 254, 280, 330 and 350 nm. Typical chromatograms at 350 nm of Cissus (I) and 
Passionflower (II-reference) samples are reported in Figure 17. 
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Table 4. Mobile phase composition and flow 
The tincture of C. verticillata was filtered on a PTFE membrane filter before analysis. The 
UV-Vis spectra were recorded at the range of 190-450nm, and chromatograms were 
acquired at 230, 254, 280, 330 and 350 nm. Typical chromatograms at 350 nm of Cissus (I) and 
Passionflower (II-reference) samples are reported in Figure 17. 
 




Fig. 17. Chromatograms at 350 nm of Cissus (I) and Passionflower (II) (reference) tincture. 
The HPLC system described above was interfaced with atmospheric pressure chemical 
ionization (APCI)-electrospray mass-selective detector (MSD). The interface geometry with 
orthogonal positioning of the nebulizer relative to the capillary inlet, enabled the use of 
analytical conditions similar to those used for HPLC-DAD analysis. The conditions used for 
mass spectrometry (gas temperature 350oC at a flow rate of 10Lmin-1, nebulizer pressure 
30psi, quadrupole temperature of 30oC and capillary voltage 3500 V) were optimized to 
achieve the maximum sensitivity of ESI values. The column, time period, and flow rate used 
were the same as those described above, without appreciable variation of the 
chromatographic profile. Full scan spectra from m/z 100 to 800 were obtained in positive-
ion mode; the scan time was 1s. The volume of sample solution injected was 10µL. 
Identification of all constituents was performed by HPLC-MS analysis and/or by 
comparison of the retention times of peaks in the extracts with those of the authentic 
reference samples. Peak purity was checked by examination of the mass spectra and/or by 
use of HPLC with diode-array detection (UV spectra of the peaks were compared with those 
of authentic reference samples). 
Table 5 shows the comparison of LC-MS data obtained from Cissus verticillata tincture to 
those from Passiflora incarnata which allows the characterization of the compounds listed 
therein (BILIA et al, 2002). Peaks A, B, C, D, G and H show very similar retention time in 
both chromatograms (Figure 17).  
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Cissus verticillata Passiflora incarnata 
 [M+H]+ Rt Substance  Rt Substance 




B 565 16.94 Isoschaftoside  (apigenin 6-C-arabino-8-C glucoside) B’ 16.87 Isoschaftoside 
C 565 17.79 Schaftoside  (apigenin 6-C-glucosyl-8-C arabinoside) C’ 17.69 Schaftoside 
D - 18.65 Homoorientin (luteolin 8-C-glucoside) D’ 18.64 Homoorientin 
E 565 18.96 structural isomer of isoschaftoside E’ 18.97 Not reported 
F 565 19.32 structural isomer of schaftoside F’ 19.30 Not reported 
G 433 22.80 Vitexin (apigenin 8-C-glucoside) G’ 22.72 Vitexin 
H 433 23.06 Isovitexin (apigenin 6-C-glucoside) H’ 23.02 Isovitexin 
Table 5. LC-MS data of C. verticillata compared to P. Incarnata 
Comparing mass spectra of these substances to those obtained from P. incarnata and using 
the information available in the literature the flavonosides of C. verticillata could be 
characterized. The peaks A and A’ presented analogous mass spectra exhibiting [M+H]+ 
and [M+Na]+ ions at m/z 595 and 617. These data suggest the presence of an apigenin 
nucleus bounded to two glucose moieties, and thus it could be characterized as vicenin-2. 
Peaks B/B’ and C/C’ exhibited [M+H]+ and [M+Na]+ ions at m/z 565 and 587. These data 
suggest the presence of an apigenin nucleus plus a pentose and glucose. However, the 
absence for both peaks spectra of the fragment ions [M+H-162]+, [M+H-132]+ or [M+H-
(162+132)]+ at m/z 403, 433 and 271 (corresponding to the aglycone apigenin) suggest that 
peaks B, B’, C and C’ are 6,8-C-glycosides of apigenin. These suggestions were confirmed by 
the typical fragment ions [M+ H-H2O]+ and [M+H-2H2O]+ that were evidenced at m/z 547 
and 529. 
Another characteristic fragment ions [M+H- 2H2O-CH2O]+, [M+H-5H2O-CH2O]+ and 
[M+H- 6H2O-CH2O]+ were also evidenced at m/z 499, 445 and 427. From these data, peak 
B was identified as 6-C-arabinosyl-8-C-glucosylapigenin (isoschaftoside) and the peak C 
was identified as 6-C-glucosyl-8-C-arabinosylapigenin (schaftoside). Peaks D (minor 
constituent) and D’ were identified as homoorientin, by comparison of chromatographic and 
spectroscopic data with authentic samples.  
Peaks E (minor constituent) and F (minor constituent) exhibited [M+H]+ and [M+Na]+ ions 
at m/z 565 and 587. These data suggested the presence of an apigenin nucleus plus a 
pentose and glucose. However, the absence for both peaks spectra of the fragment ions 
[M+H-162]+, [M+H-132]+ or [M+H-(162+132)]+ at m/z 403, 433 and 271 (corresponding to 
the aglycone apigenin) suggested that peaks E and E’ were 6,8-C-glycosides of apigenin. 
These suggestions were confirmed by the typical fragment ions [M+ H-H2O]+ and [M+H-
2H2O]+ that were evidenced at m/z 547 and 529. 
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The fragment ions [M+H- 2H2O-CH2O]+ and [M+H-5H2O-CH2O]+ were also evidenced at 
m/z 499 and 445. No differentiation was found between mass spectra of isoschaftoside and 
compound E and between mass spectra of schaftoside and compound F. From these data, 
the minor constituents, peaks E and F, were identified as apigenin-6,8-di-C-glycoside 
(probably structural isomers of isoschaftoside and schaftoside respectively). 
The peaks at 23,06min and 22,80 min in the LC-DAD chromatograms of Cissus, suggest the 
presence of isomers vitexin and isovitexin when compared with the respective standards, 
therefore the mass spectra shows the fragmentation pattern. These mass spectra show 
important fragmentations that help to differentiate the position of the pyranose unit in the 
ring of flavone apigenin characterizing the detection of vitexin and isovitexin in the 
analyzed samples.  
The signal registered at 22.8 min in the Cissus chromatogram was characterized by 
comparison to that observed for commercial Passiflora incarnata. The mass spectra showed 
the same fragmentation pattern. Base peak coincided with molecular ion (433 [M+H]), the 
spectra also showed fragmentation of the pyranose ([M+H-120]+) and the loss of two 
molecules of water ([M+H-18]+, [M+H-36]+), characterizing the structure of the vitexin. 
Similarly, the signal at 23,06 min, corresponds to a mass spectrum which shows the loss of 
120 amu ([M+H-120]+), that can be attributed to the fragmentation of part of the glucose 
molecule; the spectrum also showed three typical peaks of losses of three molecules of water 
from the glucose unit ([M+H-18]+, [M+H-36]+ e [M+H-54]+, indicating to be due to 
isovitexin. 
Peaks G and G’ exhibit [M+H]+ and [M+Na]+ ions at m/z 433 and 455. Peak G and H were 
identified as vitexin and isovitexin respectively also by comparing their chromatographic 
and spectroscopic data with that provided by authentic samples.  
On basis of these results it can be stated that the ethanol tincture at 98oGL of Cissus 
verticillata (L) Nicolson & C. E. Jarvis) contains at least eight flavonoid glycosides which can 
be used as markers to monitor the quality of plant material, its derivatives and products. 
The detection and characterization of these substances in pharmacopoeial preparations, 
using LC-DAD and LC-MS, can be very useful in developing phytomedicines, once the 
isolation and characterization of these substances by chromatographic and spectrometric 
usual methods are expensive and demand more time. 
5. Characterization of a metabolic class as potential marker by UV-
spectroscopy: Validation of a new quantification method according to 
Brazilian regulation 
The standardization of plant extracts, which contain chemical substances without the 
necessary chemical characteristics to be used as quality markers, can be accomplished using 
chemical groups, or metabolic classes, found in the intermediary as active pharmaceutical 
constituent. This is the case, for example, of an Apocynaceae that composes a phytomedicine 
widely used in Brazil and has as its active principle, alkaloids. The complexity of the 
alkaloid fraction present in the intermediate and the instability of the substances when 
isolated indicated that the development of a method based on the alkaloid fraction, using 
ultraviolet spectroscopy to standardize this extract would be the best solution. 
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A species from the genus Himatanthus, popularly known as "agoniada", has its bark 
commonly used in the form of decoction to produce a phytomedicine indicated to treat 
uterine congestion; irregular, difficult and painful periods and uterine cramps, besides other 
associated symptoms (CRUZ, 1985). 
The aqueous extract prepared with the barks of the plant, after concentration and drying, 
was treated with 1% aqueous HCl and filtered, then the solution was made alkaline with 
concentrated ammonium hydroxide to pH 10. The alkalinised solution was partitioned with 
chloroform. The chloroform fraction filtered through anhydrous sodium sulphate and 
concentrated without heating under reduced pressure, was used to prepare a methanol 
solution at 30 mg/mL which was used to quantify the total alkaloids fraction. 
The observation of an absorption maximum at 281nm by the UV analysis of the alkaloid 
fraction allowed to choose Yohimbine as external standard for the quantification process, 
because of its absorption maxima at 281nm (OLIVEIRA, 1994). In addition the substance is 
an indole alkaloid, which is also present in Apocynacee species (SOUZA, 2008), and is able 
to be acquired in the market as chemical reference substance (CRS). This substance was also 
utilized to produce a series of dilutions in methanol, which could be utilized to determine 
linearity of the method and to compose the calibration curve. 
5.1 Brazilian guidelines to define validation procedures 
Despite of the technique used to characterize markers, and the fact that they are isolated or 
in the form of a chemical group - metabolic class, the method developed for their 
quantification must be validated in order to ensure that this analytical method generates 
reliable information about the analysed sample (RIBANI, et al. 2004). Analytical method 
validation is the confirmation by examination and provision of objective evidence that the 
specific requirements for an intended specific use are met (NBR ISO/IEC/17025, 2001). 
Validation is intended to demonstrate that the method is appropriate for qualitative, semi-
quantitative and/or quantitative determination of drugs and other substances in 
pharmaceuticals (BRASIL, 2003). 
All regulatory agencies in Brazil and in other countries require the validation of the 
analytical methodology for the registration of new products (RIBANI, et al. 2004). In Brazil, 
there are two certification agencies, ANVISA (National Agency for Sanitary Surveillance) 
and INMETRO (National Institute of Metrology, Standardization and Industrial Quality) 
which verify the competence of analytical laboratories. These bureau provide guidelines to 
define the validation procedures of new analytical methods, respectively, the resolution No. 
899, from 5/29/2003 (BRASIL, 2003) and the document INMETRO DOQ-CGCRE-008, June 
2007, which aims at guiding the validation of analytical methods. 
Here we adopted the criteria described by the resolution No. 899 of ANVISA, as the basis for 
the development of a quality control method for the aqueous extract prepared from 
Himatanthus sp. According to this resolution there are four set of tests for validation of a new 
method, as follows: 
1. Quantitative assays for the determination of an active ingredient in pharmaceuticals or 
raw materials; 
2. Quantitative tests or limit test for the determination of impurities and degradation 
products in pharmaceuticals and raw materials;  
 
Bioactive Compounds in Phytomedicine 
 
84
The fragment ions [M+H- 2H2O-CH2O]+ and [M+H-5H2O-CH2O]+ were also evidenced at 
m/z 499 and 445. No differentiation was found between mass spectra of isoschaftoside and 
compound E and between mass spectra of schaftoside and compound F. From these data, 
the minor constituents, peaks E and F, were identified as apigenin-6,8-di-C-glycoside 
(probably structural isomers of isoschaftoside and schaftoside respectively). 
The peaks at 23,06min and 22,80 min in the LC-DAD chromatograms of Cissus, suggest the 
presence of isomers vitexin and isovitexin when compared with the respective standards, 
therefore the mass spectra shows the fragmentation pattern. These mass spectra show 
important fragmentations that help to differentiate the position of the pyranose unit in the 
ring of flavone apigenin characterizing the detection of vitexin and isovitexin in the 
analyzed samples.  
The signal registered at 22.8 min in the Cissus chromatogram was characterized by 
comparison to that observed for commercial Passiflora incarnata. The mass spectra showed 
the same fragmentation pattern. Base peak coincided with molecular ion (433 [M+H]), the 
spectra also showed fragmentation of the pyranose ([M+H-120]+) and the loss of two 
molecules of water ([M+H-18]+, [M+H-36]+), characterizing the structure of the vitexin. 
Similarly, the signal at 23,06 min, corresponds to a mass spectrum which shows the loss of 
120 amu ([M+H-120]+), that can be attributed to the fragmentation of part of the glucose 
molecule; the spectrum also showed three typical peaks of losses of three molecules of water 
from the glucose unit ([M+H-18]+, [M+H-36]+ e [M+H-54]+, indicating to be due to 
isovitexin. 
Peaks G and G’ exhibit [M+H]+ and [M+Na]+ ions at m/z 433 and 455. Peak G and H were 
identified as vitexin and isovitexin respectively also by comparing their chromatographic 
and spectroscopic data with that provided by authentic samples.  
On basis of these results it can be stated that the ethanol tincture at 98oGL of Cissus 
verticillata (L) Nicolson & C. E. Jarvis) contains at least eight flavonoid glycosides which can 
be used as markers to monitor the quality of plant material, its derivatives and products. 
The detection and characterization of these substances in pharmacopoeial preparations, 
using LC-DAD and LC-MS, can be very useful in developing phytomedicines, once the 
isolation and characterization of these substances by chromatographic and spectrometric 
usual methods are expensive and demand more time. 
5. Characterization of a metabolic class as potential marker by UV-
spectroscopy: Validation of a new quantification method according to 
Brazilian regulation 
The standardization of plant extracts, which contain chemical substances without the 
necessary chemical characteristics to be used as quality markers, can be accomplished using 
chemical groups, or metabolic classes, found in the intermediary as active pharmaceutical 
constituent. This is the case, for example, of an Apocynaceae that composes a phytomedicine 
widely used in Brazil and has as its active principle, alkaloids. The complexity of the 
alkaloid fraction present in the intermediate and the instability of the substances when 
isolated indicated that the development of a method based on the alkaloid fraction, using 
ultraviolet spectroscopy to standardize this extract would be the best solution. 
 
Standardization of Herbal Drugs Derivatives with Special Reference to Brazilian Regulations 
 
85 
A species from the genus Himatanthus, popularly known as "agoniada", has its bark 
commonly used in the form of decoction to produce a phytomedicine indicated to treat 
uterine congestion; irregular, difficult and painful periods and uterine cramps, besides other 
associated symptoms (CRUZ, 1985). 
The aqueous extract prepared with the barks of the plant, after concentration and drying, 
was treated with 1% aqueous HCl and filtered, then the solution was made alkaline with 
concentrated ammonium hydroxide to pH 10. The alkalinised solution was partitioned with 
chloroform. The chloroform fraction filtered through anhydrous sodium sulphate and 
concentrated without heating under reduced pressure, was used to prepare a methanol 
solution at 30 mg/mL which was used to quantify the total alkaloids fraction. 
The observation of an absorption maximum at 281nm by the UV analysis of the alkaloid 
fraction allowed to choose Yohimbine as external standard for the quantification process, 
because of its absorption maxima at 281nm (OLIVEIRA, 1994). In addition the substance is 
an indole alkaloid, which is also present in Apocynacee species (SOUZA, 2008), and is able 
to be acquired in the market as chemical reference substance (CRS). This substance was also 
utilized to produce a series of dilutions in methanol, which could be utilized to determine 
linearity of the method and to compose the calibration curve. 
5.1 Brazilian guidelines to define validation procedures 
Despite of the technique used to characterize markers, and the fact that they are isolated or 
in the form of a chemical group - metabolic class, the method developed for their 
quantification must be validated in order to ensure that this analytical method generates 
reliable information about the analysed sample (RIBANI, et al. 2004). Analytical method 
validation is the confirmation by examination and provision of objective evidence that the 
specific requirements for an intended specific use are met (NBR ISO/IEC/17025, 2001). 
Validation is intended to demonstrate that the method is appropriate for qualitative, semi-
quantitative and/or quantitative determination of drugs and other substances in 
pharmaceuticals (BRASIL, 2003). 
All regulatory agencies in Brazil and in other countries require the validation of the 
analytical methodology for the registration of new products (RIBANI, et al. 2004). In Brazil, 
there are two certification agencies, ANVISA (National Agency for Sanitary Surveillance) 
and INMETRO (National Institute of Metrology, Standardization and Industrial Quality) 
which verify the competence of analytical laboratories. These bureau provide guidelines to 
define the validation procedures of new analytical methods, respectively, the resolution No. 
899, from 5/29/2003 (BRASIL, 2003) and the document INMETRO DOQ-CGCRE-008, June 
2007, which aims at guiding the validation of analytical methods. 
Here we adopted the criteria described by the resolution No. 899 of ANVISA, as the basis for 
the development of a quality control method for the aqueous extract prepared from 
Himatanthus sp. According to this resolution there are four set of tests for validation of a new 
method, as follows: 
1. Quantitative assays for the determination of an active ingredient in pharmaceuticals or 
raw materials; 
2. Quantitative tests or limit test for the determination of impurities and degradation 
products in pharmaceuticals and raw materials;  
 
Bioactive Compounds in Phytomedicine 
 
86
3. Performance tests (e.g. dissolution, active substance release); 
4. Identification tests 
A method that aims at the quantification of a marker in a phytomedicine fits category I and 
can be considered validated when the following parameters: selectivity/specificity, 
linearity, interval, precision, limit of detection (sensitivity), accuracy, robustness are 
determined and verified. 
5.1.1 Selectivity/specificity 
A segment of the UV spectrum obtained from the alkaloid fraction of Himatanthus sp 
aqueous extract (30 µg/mL), the Yohimbine hydrochloride (22 µg/mL) and methanol 
solvent in the range between 200nm and 400nm is shown in Figure 18 and discloses the 
absorption maximum at 281nm just to Yohimbine and the alkaloid fraction. Herewith, it 
could be confirmed that at this wavelength it is selectively possible to quantify the reference 
substance and the alkaloid fraction even in the presence of other components. 
 
Fig. 18. Segment of UV spectra of Yohimbine (Y) and the alkaloid fraction of the aqueous 
extract of Himatanthus sp. (H), in comparison to the methanol solvent (M) showing the 
selectivity of the developed method. 
5.1.2 Linearity 
The spectrophotometric method presented linearity at 281nm for the concentrations tested. 
The linearity of the method, the coefficient of determination (R2) and correlation (r) to 
Yohimbine are expressed in Figure 19. 
The value of the correlation coefficient itself is not sufficient to ensure the adequacy of the 
linear adjustment to the calibration curve, because calibration models with high residue in 
the analytic signal, or unevenly distributed points along the calibration range can 
nevertheless offer a good correlation coefficient (RIBEIRO, et al., 2008). For that reason the 
analysis of residue of the data used for the determination of the method linearity was 
performed and could demonstrate a uniform data distribution, constant variance 
(homocedastity), average zero and absence of atypical samples (Figure 20) observed in 
homogeneous distribution of points along the axis of the chart indicating that the curve is 
well adjusted. 
 




Fig. 19. Graphical representation of the linearity method for the series dilution of Yohimbine 
in methanol at 281nm, in detail, the used concentrations and their absorbance. 
 
Fig. 20. Graphical representation of the residues of method’s linearity data using the dilution 
series of Yohimbine. 
5.1.3 Interval 
Interval means the range between the maximal and minimal limits of quantification of an 
analytical method. Typically, it is derived from the study of linearity and depends on the 
intended application of the method (BRASIL, 2003). Thus, the range employed for the 
standardization of the aqueous extract of Himatanthus sp (16 to 28 µg/mL) was established 
in accordance with the average of absorptions found for Yohimbine (range of 80% to 120%). 
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5.1.4 Calibration curve 
The analytical curve, with the respective line equation and Pearson correlation coefficient (r) 
for Yohimbine is demonstrated in Figure 21.  
 
Fig. 21. Graphical representation of the calibration curve obtained using the dilution series 
with Yohimbine. 
5.1.5 Precision and accuracy 
Data of repeatability (intra-run), intermediate precision (inter-run) and accuracy are 
demonstrated in Table 6 where it can be seen that the relative standard deviation values found 
vary from 0.19% to 2.09% and that the accuracy values found oscillate between 98% and 
102.90%. ANVISA establishes that the precision variation may not exceed 5% and that the 
accuracy should not be less than 95% (BRASIL, 2003). These data confirm that the proposed 
method for the quantification of total alkaloids of aqueous extract of Himatanthus sp. by UV 
spectrophotometry is in accordance with current legislation and provides reliable results. 
5.1.6 Detection limit 
It is the lowest amount of analyte present in a sample which can be detected, but not 
necessarily quantified, under the established experimental conditions. In the case of 




Where: SDa is the standard deviation of the y-intercept of at least 3 calibration curves built 
containing concentrations of the drug near the supposed limits of quantification and IC is 
the inclination of the calibration curve. The value of the detection limit estimated by the 
equation for the here proposed method is 4.59 µg/mL. 
x
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Test Calculated Concentration. (µg/ml) N 
C 




16 3 15.698 0.030 0.19 98.00 
20 3 19.864 0.181 0.90 99.32 
28 3 27.724 0.392 1.41 99.01 
Intermediate 
precision Day 1 
16 3 16.448 0.205 1.25 102.80 
20 3 20.580 0.257 1.25 102.90 
28 3 28.373 0.245 0.86 101.33 
Intermediate 
precision Day 2 
16 3 16.213 0.339 2.09 101.33 
20 3 20.345 0.054 0.27 101.72 
28 3 28.391 0.271 0.96 101.39 
(C) average concentration of (N) determinations; (SD) standard deviation; (RSD %) Relative Standard 
Deviation. 
Table 6. Results of repeatability, intermediate precision and accuracy of the developed UV-
Spectrophotometric method to determine the total alkaloids fraction contained in the 
aqueous extract of Himatanthus sp. 
5.1.7 Quantification limit 
It is the lowest amount of analyte in a sample, which can be determined with acceptable 
accuracy and precision under the established experimental conditions and can be expressed 




Where: SDa is the standard deviation of the y-intercept of at least 3 calibration curves built 
containing concentrations of the drug near the supposed limits of quantification and IC is 
the inclination of the calibration curve. The quantification limit of the reported method is 
15.31μg/mL. 
5.1.8 Robustness  
The robustness of the proposed method was evaluated by changing the supplier of the 
solvent used to prepare the sample (Table 7). Three determinations were made in low (16 
µg/mL), middle (20 µg/mL) and high (28 µg/mL) concentrations, with three replicates 
each. The absorption maxima at 281nm obtained for these Yohimbine solutions prepared 
with solvents from two different suppliers were compared and no variation in the obtained 
spectra could be observed. The data are shown in table 7 and were submitted to a statistical 
variance analysis, which provided a p value of 0.5694, evidencing no significant statistical 
difference, because p > 0.05, thus demonstrating a robust method. 
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5.1.4 Calibration curve 
The analytical curve, with the respective line equation and Pearson correlation coefficient (r) 
for Yohimbine is demonstrated in Figure 21.  
 
Fig. 21. Graphical representation of the calibration curve obtained using the dilution series 
with Yohimbine. 
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containing concentrations of the drug near the supposed limits of quantification and IC is 
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16 3 16.448 0.293 
20 3 20.580 0.373 
28 3 28.373 0.523 
2 
16 3 16.217 0.261 
20 3 19.651 0.315 
28 3 28.141 0.449 
(C) average concentration of (N) determinations 
Table 7. Results of the evaluation of robustness of the developed UV-Spectrophotometric 
method for the determination of total alkaloids contained in the aqueous extract of 
Himatanthus sp. 
5.2 Quantification of total alkaloids fraction present in the aqueous extract of a 
Himatanthus sp. 
The analysis of a methanolic solution at 30µg/mL of an alkaloid fraction obtained from the 
aqueous extract of a Himatanthus species barks; performed in triplicate, in a 
spectrophotometer, at 281nm, provided an average absorption of 0.462. Using the equation 
deduced from the calibration curve (y = 0.0046 + 0.0196x), it is possible to calculate the 
amount of total alkaloids present in the sample; the results are condensed in Table 8. 
 
Material Herbal Drug Dry aq. extract Alkaloid Fraction  Total Alkaloid  
Weight 25000mg 9549mg 26.74mg 20.80mg 
I 100%  ....................................................................... 0.0832% (832ppm) 
II  100% ................................................. 0.218% 
III   100% ..........  77.79% 
Table 8. Amount of total alkaloids on the powdered bark of Himatanthus sp employed for 
the preparation of dried herbal drug (I), in relation to dried aqueous extract (II) and in 
relation to total alkaloid fraction obtained (III). 
The proposed quantification method could be validated, since it shows selectivity at 281nm 
for the alkaloid fraction from the Himatanthus species aqueous extract, giving reliability to 
the quantification of total alkaloids fraction in the plant material. In addition it is a robust 
method, according to the parameters established by the legislation in use in Brazil. The 
correlation between absorbance and concentration, according to the equation obtained, is 
linear, at a given wavelength; the quantification method is also exact and precise, as well as 
accessible and easy to be applied. 
In Brazil, the National Health Surveillance Agency – ANVISA – responsible for regulating 
the use of medicinal plants and their derivatives, protects and promotes the health of the 
population, ensuring the safety of health products and services. This control seeks to 
deconstruct the idea that herbal medicines are products of less quality or without toxic 
potential risk, because it evaluates various parameters as quality, safety and efficacy, 
demanding requirements similar to those required for synthetic medicines. The Collegiate 
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Direction Resolution (RDC) No. 14/2010 from ANVISA regulates the registration of 
phytomedicines in Brazil and defines how to achieve standardization of intermediates used 
in the galenic development of herbaceous medicines. The developed methods, in this 
process, shall be validated according to the rules described in the Special Resolution (RE) 
No. 899/2003, also from ANVISA, which indicates as validation parameters for herbal 
extracts: selectivity of the method to detect the marker, calibration curve and linearity by the 
quantification of the marker, precision by the calculation of the content of the marker, limits 
of detection and quantification of the marker in the sample, and robustness of the method 
regarding modifications in its routine. 
6. Quantification of isolated substances using HPLC 
The method for the quantification of marker compounds isolated from active 
pharmaceutical ingredients (APhI) that will give rise to phytomedicines must have the same 
validation criteria presented in section 5.1. These substances should be ideally associated to 
the alleged activity of the medicinal plant although for the registration of the product, 
according to the Brazilian legislation, this fact is not decisive. 
The presence of the marker shall be characterized in the matrix (extract from which the 
phytomedicne will be developed) as demonstrated in section 3, by thin-layer 
chromatography (TLC) and high performance liquid chromatography (HPLC) data. The 
structure of the substance must be elucidated or characterized by spectroscopic techniques 
such as UV, infrared and nuclear magnetic resonance (NMR) as in 3.1 and 3.2 and by mass 
spectrometry as described in section 4, where the technique was applied hyphenated to 
HPLC. Once the structural characteristics of the candidate substance to be used as a marker 
are described and the analytical conditions by HPLC defined, a calibration curve using this 
technique and a dilution series containing the potential marker can be drawn, by correlating 
the peak area of the substance registered on the chromatogram, to the concentration of the 
solution employed to register it. Once the area of the substance in the chromatogram of the 
APhI is registered, this value shall be applied to the straight line equation defined by the 
calibration curve (as in section 5.1.4). 
The validation of a quantification method based on isolated markers demands the same 
criteria previously described and exemplified in section 5.1. HPLC methods for the 
standardization of herbal extracts used to develop phytomedicine produces more accurate 
results, since the most common source of error, in this technique, is the preparation of 
samples and components of the eluent, steps prepared by human operators. These possible 
deviations can be minimized by obtaining data in replicate. 
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1.1 General background 
The Maltese archipelago is composed of a small number of islands with a total surface area 
of approximately 457 km2. Albeit this small size the Maltese islands host a vast number of 
plant and animal species. Plant biodiversity, with its 1264 vascular species, is mainly 
attributed to the strategic position of Malta within the Mediterranean, in which throughout 
the years several conquerors and civilisations sought to possess Malta particularly for 
military purposes.  In part, the plant diversity of Malta is attributed to introductions brought 
about by various military forces, as an aid during injury and sickness. Naturally, the 
phytodiversity has an inclination towards the Mediterranean type of flora with an 
approximately 66% of the Maltese flora pertaining to this region (E. Attard, 2004). Typical 
Mediterranean medicinal plants include conifers (Pinus halepensis and Cupressus 
sempervirens), broad-leaved trees (Laurus nobilis, Morus nigra and Tamarix gallica), fruit trees 
(Ceratonia siliqua, Citrus trees, Nerium oleander, Olea europaea and Punica granatum), and 
others (Allium sativum, Aloe ferox, Capparis spinosa, Opuntia ficus-indica, Origanum vulgare, 
Papaver somniferum, Phytolacca decandra and Pistacia lentiscus). The other portion (34%) is 
attributed to plants originating from the warm North African (Cynomorium coccineum, Ficus 
carica and Myrtus communis) and the colder South Europaean regions (Crataegus monogyna, 
Populus alba and Salix species).  
There are approximately 458 medicinal taxa, used in the past to treat one or more ailments 
(Lanfranco 1993; Lanfranco 1975). Most popular treatments were for the gastrointestinal 
system, nervous system, cardiovascular system and dermatological conditions. The most 
predominating plant family within this group is the Asteraceae family, followed by the 
Lamiaceae and Fabaceae families (Attard, 2004). In spite of their use, these medicinal plants 
were administered on a trial and error basis. Today, with the advent of modern scientific 
techniques, the ethnobotanical attributes of a medicinal plant can be challenged by 
phytochemical and pharmacological testing. 
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1.2 Scientific evaluation of local medicinal and aromatic plants in relation to 
pharmacology 
Locally, only 8 % out of the 458 taxa have been studied scientifically. However, the studies 
conducted were rather fragmented and covering one or two extracts from a specific plant. 
Plants include Ecballium elaterium (E. Attard et al., 2005; E. Attard & H. Attard, 2008), Crataegus 
monogyna (E. Attard & H. Attard, 2006), Olea eurpoaea (Mangion Randon & E. Attard, 2007), 
Ephedra fragilis (E. Attard & Vella, 2009) Urtica dubia (Rossi & E. Attard, 2011), Tetraclinis 
articulata (Buhagiar et al., 1999) and Ricinus communis (Darmanin, 2003) amongst others.  
1.3 Technical approaches  
The evaluation of plant species using different solvent systems has been widely exploited in 
previous studies (Rodriguez-Lopez et al., 2003; Kumarasamy et al., 2002; Calderon et al., 
2003; Konning et al., 2004). A wide spectrum of solvents may be employed when a small 
number of plants (1-15) are investigated, but when investigating larger numbers or a new 
group of plants for the first time, the solvents used in ethno-medicine are preferentially 
selected (Punjani and Kumar, 2003; Guarrera, 2003).  
Phytochemical analysis for major classes of metabolites is an important first step in 
pharmacological evaluation of plant extracts.  Some journals require that pharmacological 
studies be accompanied by a comprehensive phytochemical analysis. Details of such 
analysis are found in several text books (Harborne, 1984; Evans, 2009). The main secondary 
metabolite classes include flavonoids, terpenoids and alkaloids, which have been widely 
tested by the acidified vanillin test, the Salkowski test and the Dragendorff’s test, 
respectively.  
Bench top bioassays have been devised to facilitate screening of a large number of samples 
(Meyer et al., 1982; Carballo et al., 2002). They are based on the principle that pharmacology 
is simply toxicology at low doses, while toxicology is pharmacology at high doses.  Several 
researchers have used these bioassays for primary pharmacological screening of medicinal 
plants (Franssen et al., 1997; Kanegusuku et al., 2001; Javidnia et al., 2003). The brine shrimp 
lethality test (BST), which involves the exposure of brine shrimps to different extract 
concentrations, is considered as a useful tool for preliminary assessment of cytotoxicity (Jaki 
et al., 1999). It is a rapid (24 hours), inexpensive and simple technique. A positive correlation 
has been found between the brine shrimp test and cytotoxicity of the 9KB human 
nasopharyngeal carcinoma, and other cell lines (Meyer et al., 1982; Kim et al., 2000).   
The DNA methyl green bioassay is a simple and comprehensive technique with a high 
throughput. Methyl green, binds quantitatively to DNA forming a DNA-methyl green 
complex, hence identifying agents with a high affinity for the DNA. This affinity determines 
the displacement of methyl green, hence leading to a colourless carbinol (N. Kurnick, 1950; 
B. Kurnick and Foster, 1950; Krey and Hahn, 1975).  
1.4 Aims of study 
We believe that Maltese medicinal and aromatic plants have a great pharmacological 
potential. This is based on the concept that, in the past, these plants had important medicinal 
uses. Therefore, we aimed our study at ethnobotanical research by:  
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1. Identifying plants cited in ethnobotanical research as active medicinal plants 
2. Preparing five extracts using different solvents from each medicinal plant, and the 
subsequent determination of  the classes of metabolites present in the different 
extracts. 
3. Determining whether or not, the extracts obtained eventually possess pharmacological 
activity employing a primary screening programme. 
4. Identifying plant extracts that possess DNA binding. 
2. Materials and methods 
2.1 Plant materials 
Fifty-five authenticated plant specimens were collected locally during different seasons of 
the year. The plants were selected on their relative abundance, and collected during their 
flowering period. The plants were further identified at the Rural Sciences and Food Systems 
Division, Institute of Earth Systems. Voucher specimens are stored within the Institute. The 
botanical and ethnobotanical details of the medicinal plants and their voucher specimen 
code numbers are listed in Table 1. 
2.2 Preparation of plant extracts 
Fresh plants were cut and oven-dried for 48 hours at 35-40°C in a hot air convection oven. 
Five 300g samples of the dried plants were ground in a heavy duty blender for 20 minutes.  
500 ml of solvent (distilled water, distilled water and ethanol (1:1) mixture, ethanol or 
chloroform or petroleum ether) were added to the respective sample, shaken for 48 hours at 
210 rpm, and filtered through a Buchner funnel. Each filtered extract was concentrated at 38 
C under reduced pressure, and finally dried in an oven at 38 C. 
2.3 Phytochemical analysis: quantitative colorimetric assays 
Although most phytochemical analysis carried out may have a qualitative importance, the 
methods were modified according to other authors to read aborbance values at a 
wavelength of 405 nm rather than visual examination. The MTP reader gave more concrete 
results, in the form of absorbance values. Therefore semi-quantification is possible through 
this process. 
Four colorimetric tests were quantitatively used to determine the presence or absence of 
metabolites:  
1. The Salkowski test for terpenoids. After the addition of chloroform and concentrated 
sulphuric acid, a reddish brown colouration at the interface forms, hence showing a 
positive result for the presence of terpenoids (Edeoga et al., 2005); 
2. The Dragendorff’s test for alkaloids (Steinberg et al., 1997) gives a brown coloration;   
3. The Acidified Vanillin test for flavonoids. Under acidic conditions, vanillaldehyde 
condenses to flavan-3,4-diols,  flavan-3-ol monomers and proanthocyanidins to give a 
cherry-red product (Deshpande et al., 1986); 
4. The ninhydrin test was used for proteins (Delhaye & Landry, 1992). The α-amino acids 
typically give a blue-purple product. 
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Sonchus oleraceus L., 
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Table 1. Botanical, ethnobotanical and voucher specimen code numbers for the fifty-five 
plants studied. 
2.4 Brine Shrimp Test (BST) 
In a set of 12-well plates, each well contained 10 nauplii, 1 ml sea water and 1 ml of extract 
diluted to  final concentrations of 1%, 0.1%, 0.01%, 0.001% and 0.0001% respectively. The 
tests were set out in triplicate so that a total of fifteen wells per extract were used. numbers 
of living nauplii were counted after 24 hours. The LC50 values and 95 % confidence intervals 
were determined in μg/ml, using the Finney probit analysis computer program. A median 
lethal concentration (LC50) smaller than 1000 μg/ml (Alkofahi et al., 1997) indicates 
pharmacological activity.  
2.5 DNA-methyl green (intercalation) tests 
DNA intercalation assay for DNA activity.  Samples were incubated with 200 µl of DNA-
methyl green in the dark at 25 °C for 24 h. The decrease in absorbance at 650 nm was 
calculated as a percentage of the untreated DNA-methyl green absorbance value. The 
median inhibitory concentration (IC50) was calculated (Desmarchelier et al., 1996) through 
regression analysis. Cucurbitacin E and Dexamethasone were used as potent and moderate 
positive controls, respectively. Data was analyzed using Student's t-test. 
3. Results and discussion 
In this study, 55 plant species from 31 plant families were studied. The plant families ranked 
in the following order: Asteraceae (15 species), Apiaceae (3 species), Liliaceae, 
Scrophulariaceae, Mimosaceae, Brassicaceae, Fumariaceae, Euphorbiaceae, Lamiaceae and 
Anacardiaceae (2 species), Acanthaceae, Primulaceae, Boraginaceae, Iridaceae, Araliaceae, 
Solanaceae, Guttiferae, Lauracea, Malvaceae, Apocynaceae, Cactaceae, Oleaceae, Oxaliaceae, 
Papaveraceae, Urticaceae, Pinaceae, Plantaginaceae, Resedaceae, Verbenaceae, Myrtaceae 
and Cyperaceae (1 species). The distribution of plants within families was as broad as 
possible. However, the most abundant plant family of the Maltese flora (Attard, 2004) was 
given more importance than the other families. 
3.1 Phytochemical analysis 
The results for the four phytochemical classes are illustrated in table 2 and a generalised 
picture of the number of extracts, containing phytochemicals for each solvent system used, 
is illustrated in figure 1.  
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PLANT NAME P. N° Aqueous Aqueous-
ethanol  
Ethanol Chloroform Petroleum 
ether 
Acanthus mollis 002 TP TP TFP TP T 
Aloe vera 015 - - TF AF - 
Anagallis arvensis 028 P P P FP P 
Antirrhinum siculum 037 P TP TP TP T 
Antirrhinum tortuosum 036 TFP TFP TFP T TP 
Arum italicum 046 TFP TFP TFP T T 
Asparagus aphyllus 049 TFP TFP TFP TFP TAFP 
Aster squamatus 453 FP AFP P - F 
Calendula arvensis 068 TAP TFP AFP - F 
Calendula suffruticosa 073 F TFP TFP - P 
Carlina gummifera 081 TAFP FP A - TF 
Ceratonia siliqua 091 AF F FP TAF AF 
Cynoglossum creticum 145 FP TFP TFP - TP 
Diplotaxis erucoides 153 P P T - - 
Diplotaxis tenuifolia 463 TF FP FP TF T 
Dittrichia viscosa 223 TFP FP TF FP AFP 
Eucalyptus globulus 460 TFP TFP TFP TFP - 
Ferula communis 459 TP TP TP - FP 
Foeniculum vulgare 185 T TP TP - F 
Fumaria capreolata 191 TP TFP TFP TF TP 
Fumaria officinalis 190 TP TP TP F P 
Galactites tomentosa 454 TFP TFP AP - TFP 
Gladiolus italicus 197 - - TAF - TF 
Glebionis coronaria  101 TFP T TAFP - TF 
Hedera helix 202 - TP T - TF 
Holoschoenus vulgaris 461 TFP FP F F T 
Hyoscyamus albus 213 P A TP - TP 
Hypericum aegyptiacum  217 FP F - F TP 
Inula crithmoides 450 TFP TFP TFP F TF 
Lactuca sativa 462 T T P P F 
Lactuca virosa 236 - P - TP F 
Laurus nobilis 234 F T T - TAF 
Leontodon tuberosus 238 TFP TFP TF F F 
Malva sylvestris 254 T TP T - - 
Mercurialis annua 268 TF TF F TFP TF 
Nerium oleander 285 TF TFP TFP P TF 
Olea europaea 290 TFP TFP TF TF TFP 
Opuntia ficus- indica 286 T TP TFP P TP 
Oxalis pes-caprae 291 TF TFP TF TF A 
Palaeocyanus crassifolius 90 TFP TP TP TP TFP 
Papaver somniferum  294 FP TP TP FP TF 
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PLANT NAME P. N° Aqueous Aqueous-
ethanol  
Ethanol Chloroform Petroleum 
ether 
Parietaria judaica 296 F FP TFP FP AP 
Phlomis fruticosa 304 TP TFP TFP T TFP 
Pinus halepensis 317 P - TF F AF 
Pistacia lentiscus 319 TFP TF P - - 
Plantago lagopus 318 - FP AFP TP AP 
Prasium majus 331 TFP TFP TFP TP P 
Psoralea bituminosa 345 TP TFP T T P 
Reichardia picroides 308 TFP TFP TP F TFP 
Ricinus communis 360 TFP TP TFP TF - 
Schinus terebinthifolius 374 TFP TP TP P TF 
Smyrnium olusatrum 388 TFP P TFP F P 
Sonchus oleraceus 393 TF TF TF - TF 
Verbena officinalis 443 P TP TP - P 
Table 2. The phytochemical analysis of the extracts under investigation for the main 
phytochemical classes: Flavonoids (F), Terpenoids (T), Alkaloids (A) and Proteins (P) 
 
Fig. 1. A generalised profile of the number of extracts containing terpenoids, alkaloids, 
flavonoids and proteins for each solvent system used (n=280). 
The predominating compound classes were terpenoids (56.07 %), followed by proteins 
(53.57 %) and flavonoids (48.93 %). Alkaloids were limited to a smaller number of extracts 
(7.50 %). The majority of the polar solvents, aqueous, aqueous-ethanol and ethanol 
contained terpenoids and proteins (p<0.05, n=4). The chloroform extract contained mainly 
flavonoids (p<0.05, n=4), while the petroleum ether extracts contained predominantly 
flavonoids and terpenoids.  
The highest terpenoid contents were found in the ethanol and aqueous-ethanol extracts. In 
fact, it was observed that 70.70 % of the positive extracts were polar extracts, i.e. using 
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Aster squamatus 453 FP AFP P - F 
Calendula arvensis 068 TAP TFP AFP - F 
Calendula suffruticosa 073 F TFP TFP - P 
Carlina gummifera 081 TAFP FP A - TF 
Ceratonia siliqua 091 AF F FP TAF AF 
Cynoglossum creticum 145 FP TFP TFP - TP 
Diplotaxis erucoides 153 P P T - - 
Diplotaxis tenuifolia 463 TF FP FP TF T 
Dittrichia viscosa 223 TFP FP TF FP AFP 
Eucalyptus globulus 460 TFP TFP TFP TFP - 
Ferula communis 459 TP TP TP - FP 
Foeniculum vulgare 185 T TP TP - F 
Fumaria capreolata 191 TP TFP TFP TF TP 
Fumaria officinalis 190 TP TP TP F P 
Galactites tomentosa 454 TFP TFP AP - TFP 
Gladiolus italicus 197 - - TAF - TF 
Glebionis coronaria  101 TFP T TAFP - TF 
Hedera helix 202 - TP T - TF 
Holoschoenus vulgaris 461 TFP FP F F T 
Hyoscyamus albus 213 P A TP - TP 
Hypericum aegyptiacum  217 FP F - F TP 
Inula crithmoides 450 TFP TFP TFP F TF 
Lactuca sativa 462 T T P P F 
Lactuca virosa 236 - P - TP F 
Laurus nobilis 234 F T T - TAF 
Leontodon tuberosus 238 TFP TFP TF F F 
Malva sylvestris 254 T TP T - - 
Mercurialis annua 268 TF TF F TFP TF 
Nerium oleander 285 TF TFP TFP P TF 
Olea europaea 290 TFP TFP TF TF TFP 
Opuntia ficus- indica 286 T TP TFP P TP 
Oxalis pes-caprae 291 TF TFP TF TF A 
Palaeocyanus crassifolius 90 TFP TP TP TP TFP 
Papaver somniferum  294 FP TP TP FP TF 
 
The Phytochemical and In Vitro Pharmacological Testing of Maltese Medicinal Plants 101 
PLANT NAME P. N° Aqueous Aqueous-
ethanol  
Ethanol Chloroform Petroleum 
ether 
Parietaria judaica 296 F FP TFP FP AP 
Phlomis fruticosa 304 TP TFP TFP T TFP 
Pinus halepensis 317 P - TF F AF 
Pistacia lentiscus 319 TFP TF P - - 
Plantago lagopus 318 - FP AFP TP AP 
Prasium majus 331 TFP TFP TFP TP P 
Psoralea bituminosa 345 TP TFP T T P 
Reichardia picroides 308 TFP TFP TP F TFP 
Ricinus communis 360 TFP TP TFP TF - 
Schinus terebinthifolius 374 TFP TP TP P TF 
Smyrnium olusatrum 388 TFP P TFP F P 
Sonchus oleraceus 393 TF TF TF - TF 
Verbena officinalis 443 P TP TP - P 
Table 2. The phytochemical analysis of the extracts under investigation for the main 
phytochemical classes: Flavonoids (F), Terpenoids (T), Alkaloids (A) and Proteins (P) 
 
Fig. 1. A generalised profile of the number of extracts containing terpenoids, alkaloids, 
flavonoids and proteins for each solvent system used (n=280). 
The predominating compound classes were terpenoids (56.07 %), followed by proteins 
(53.57 %) and flavonoids (48.93 %). Alkaloids were limited to a smaller number of extracts 
(7.50 %). The majority of the polar solvents, aqueous, aqueous-ethanol and ethanol 
contained terpenoids and proteins (p<0.05, n=4). The chloroform extract contained mainly 
flavonoids (p<0.05, n=4), while the petroleum ether extracts contained predominantly 
flavonoids and terpenoids.  
The highest terpenoid contents were found in the ethanol and aqueous-ethanol extracts. In 
fact, it was observed that 70.70 % of the positive extracts were polar extracts, i.e. using 
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water, water-ethanol and ethanol as extracting solvents. This is due to the fact that most 
terpenoids are present in the glycosidic form rather than the non-polar or low polarity 
terpene aglycone form. Some plants exhibited the presence of terpenes and related 
compounds in all solvent systems. Typical examples included Acanthus mollis, which mainly 
contains β-sitosterol as the triterpene-like compound (Loukis & Philianos, 1980), 
Antirrhinum tortuosum, with mono and sesquiterpene volatile derivatives (Nagegowda et al., 
2008), Arum italicum, with the tetraterpene carotenoids  (Bonora et al., 2000), Asparagus 
aphyllus with saponins and sapogenins (Shao et al., 1996), Olea europaea containing mainly 
triterpenoids (Caputo et al., 1974; Elamrani, 2011), Palaeocyanus crassifolius containing 
sesquiterpene lactones (Koukoulitsa et al., 2002) and Phlomis fruticosa, mainly containing 
mono- and sesquiterpenes (Amor et al., 2009). In the case of Fumaria capreolata the main 
constituents mentioned in previous studies were the alkaloids (Soušek et al., 1999; Maiza-
Benabdesselam et al., 2007). In this present study, there was the strong presence of 
terpenoids. 
The distribution of alkaloids in polar and non-polar solvents was almost equal (52.38 % and 
47.62 %, respectively). Alkaloids may be present either as the non-polar organic form or as the 
polar ionised alkaloid salt. The highest content was recorded in the ethanol extract of Gladiolus 
italicus and in the chloroform extract of Aloe vera. For Gladiolus, this result goes in accordance 
with that obtained by Ameh and coworkers (2011) and for Aloe, a similar result was obtained 
by Waller and coworkers (1978). Other plants with an alkaloidal content include Asparagus 
aphyllus (Negi et al., 2010), Calendula arvensis (Shamsa et al., 2008), Glactites tomentosa, Glebionis 
coronaria, Oxalis pes-caprae, Parietaria judaica, Carlina gummifera, Hyoscyamus albus (Doerk-
Schmitz et al., 1993), Laurus nobilis (Nayak et al., 2006), Pinus halepensis (Tawara et al., 1993) and 
Plantago lagopus (Hultin & Torssell, 1965). Fumaria species are known to contain alkaloids 
(Soušek et al., 1999; Maiza-Benabdesselam et al., 2007). However, no alkaloids were detected 
for Fumaria officinalis and Fumaria capreolata in this present study. Although Ceratonia siliqua is 
claimed to contain no alkaloids (El Hajaji et al., 2011), in this present study, alkaloids were 
detected in the aqueous, chloroform and petroleum ether extracts. It was also observed that for 
Papaver somniferum no alkaloids were detected in the leaves. This depends on several factors. 
Primarily, the wild variety might have a low potential for the production of morphinan 
alkaloids, and other plant parts such as the stem, roots and capsules, tend to accumulate more 
alkaloids than the leaves (Williams & Ellis, 1989). 
For the flavonoid group, out of the positive responses, 65.69 % were polar extracts while the 
rest (34.41 %) were extracts derived from non-polar solvents. Typically, flavonoids are 
polyphenolic compounds that are highly soluble in aqueous and aqueous-alcohol solvents. 
However, flavonoids have been reported to be also extracted by chloroform and petroleum 
ether (Gudej & Czapski, 2009; Rajendran & Krishnakumar, 2010). Plants containing 
flavonoids in all extracts, consistent with other studies, include Asparagus aphyllus (Sun et 
al., 2007), Ceratonia siliqua (Papagiannopoulos et al., 2004; Vaya & Mahmood, 2006), 
Dittrichia viscosa (M.J. Martin et al., 1988), Leontodon tuberosus (Zidorn & Stuppner, 2001), 
Mercurialis annua (Aquino et al., 1987) and Olea europaea (Benavente-García et al., 2000). 
Almost all plant species exhibited the presence of flavonoids in one or more extracts, except 
for four plants, namely, Antirrhinum siculum, Diplotaxis erucoides, Malva sylvestris and Verbena 
officinalis. Other studies report the presence of flavonoids in Diplotaxis erucoides (Bennett et 
al., 2006), Malva sylvestris (Billeter et al., 1991) and Verbena officinalis (Rehecho et al., 2011). 
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The absence of flavonoids in these species for the current study may be due to several 
factors that include a different chemotype, different environmental conditions and the 
presence of these compounds below the detection limit, amongst others. Antirrhinum siculum 
is palely pigmented and this may contribute to the insignificant content of flavonoids (C. 
Martin et al., 2010). 
Proteins prevail in many plants. Within the positive response group, 74.67 % were polar 
extracts while 25.33 % were non-polar extracts. This indicated that three-forths of the 
detected proteins were functional proteins including enzymes. Anagallis arvensis, Asparagus 
aphyllus, Palaeocyanus crassifolius and Prasium majus exhibited the presence of proteins in all 
their extracts. This goes in accordance with previous studies carried out on these plants 
(Alignier et al., 2008; King et al., 1990). Plants that were devoid of proteins in all their 
extracts include Aloe vera, Gladiolus italicus, Laurus nobilis and Sonchus oleraceus. In previous 
studies, Aloe vera revealed the presence of glutathione peroxidase (Sabeh et al., 1993), 
Gladiolus italicus contained arabinogalactan-protein (Gleeson & Clarke, 1979) and Laurus 
nobilis contained lipase (Isbilir et al., 2008). Although most plant material was collected at 
flowering time, the inclusion of seed protein in the extract would have been possible in cases 
where fruit were harvested alongside the flowers. 
3.2 The Brine Shrimp Test 
The results for the tested extracts are given in Table 3. Primary screening involves the use of 
bench-top bioassays. Extracts exhibiting LC50 values above 1000 μg/ml are generally 
regarded as ineffective extracts. In this study, 42.26 % of the extracts were therefore inactive 
(Table 4). The most inactive were the petroleum ether extracts, while the most active were 
the ethanolic extracts. Correlating the BST lethal concentrations to phytochemical classes, it 
was observed that inactive extracts contained several phytochemicals. The reason may be 
due to the low concentration or possible antagonistic activity between the phytochemicals 
from the different classes. 55.68 % of the extracts exhibited LC50 values below 1000 μg/ml. 
The most active were the ethanolic extracts (72.97 %), while the least active were the 
petroleum ether extracts (35.14 %). Four plants exhibited activity for all their five extracts. 
These were Nerium oleander, Olea europaea, Opuntia ficus-indica and Pinus halepensis, all 
exhibiting LC50 values below 0.01 μg/ml. These four plant species are amongst the most 
popular Maltese traditional medicinal plants. It was also observed that some extracts with 
non-detectable phytochemicals exhibited significant LC50 values. Typical examples include 
the aqueous extract of Lactuca virosa, the aqueous-ethanol extract of Pinus halepensis, the 
ethanolic extracts of Hypericum aegypticum and Lactuca virosa, and the chloroform extracts of 
Ferula communis, Foeniculum vulgare and Pistacia lentiscus. On the other hand, there were 
extracts that exhibited significant LC50 values as opposed to other studies. For example, for 
Fumaria officinalis aqueous-ethanol and ethanol extracts, in the present study, exhibited 
significant effects on brine shrimps as opposed to the ethanol extract reported in the study 
by Erdoğan (2009). 
3.3 The DNA-methyl green assay 
Table 5 shows the IC50 values obtained for the DNA-methyl green assay. Although low IC50 
values have been reported for pure compounds (Burres et al., 1992) , such as rubiflavin and 
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water, water-ethanol and ethanol as extracting solvents. This is due to the fact that most 
terpenoids are present in the glycosidic form rather than the non-polar or low polarity 
terpene aglycone form. Some plants exhibited the presence of terpenes and related 
compounds in all solvent systems. Typical examples included Acanthus mollis, which mainly 
contains β-sitosterol as the triterpene-like compound (Loukis & Philianos, 1980), 
Antirrhinum tortuosum, with mono and sesquiterpene volatile derivatives (Nagegowda et al., 
2008), Arum italicum, with the tetraterpene carotenoids  (Bonora et al., 2000), Asparagus 
aphyllus with saponins and sapogenins (Shao et al., 1996), Olea europaea containing mainly 
triterpenoids (Caputo et al., 1974; Elamrani, 2011), Palaeocyanus crassifolius containing 
sesquiterpene lactones (Koukoulitsa et al., 2002) and Phlomis fruticosa, mainly containing 
mono- and sesquiterpenes (Amor et al., 2009). In the case of Fumaria capreolata the main 
constituents mentioned in previous studies were the alkaloids (Soušek et al., 1999; Maiza-
Benabdesselam et al., 2007). In this present study, there was the strong presence of 
terpenoids. 
The distribution of alkaloids in polar and non-polar solvents was almost equal (52.38 % and 
47.62 %, respectively). Alkaloids may be present either as the non-polar organic form or as the 
polar ionised alkaloid salt. The highest content was recorded in the ethanol extract of Gladiolus 
italicus and in the chloroform extract of Aloe vera. For Gladiolus, this result goes in accordance 
with that obtained by Ameh and coworkers (2011) and for Aloe, a similar result was obtained 
by Waller and coworkers (1978). Other plants with an alkaloidal content include Asparagus 
aphyllus (Negi et al., 2010), Calendula arvensis (Shamsa et al., 2008), Glactites tomentosa, Glebionis 
coronaria, Oxalis pes-caprae, Parietaria judaica, Carlina gummifera, Hyoscyamus albus (Doerk-
Schmitz et al., 1993), Laurus nobilis (Nayak et al., 2006), Pinus halepensis (Tawara et al., 1993) and 
Plantago lagopus (Hultin & Torssell, 1965). Fumaria species are known to contain alkaloids 
(Soušek et al., 1999; Maiza-Benabdesselam et al., 2007). However, no alkaloids were detected 
for Fumaria officinalis and Fumaria capreolata in this present study. Although Ceratonia siliqua is 
claimed to contain no alkaloids (El Hajaji et al., 2011), in this present study, alkaloids were 
detected in the aqueous, chloroform and petroleum ether extracts. It was also observed that for 
Papaver somniferum no alkaloids were detected in the leaves. This depends on several factors. 
Primarily, the wild variety might have a low potential for the production of morphinan 
alkaloids, and other plant parts such as the stem, roots and capsules, tend to accumulate more 
alkaloids than the leaves (Williams & Ellis, 1989). 
For the flavonoid group, out of the positive responses, 65.69 % were polar extracts while the 
rest (34.41 %) were extracts derived from non-polar solvents. Typically, flavonoids are 
polyphenolic compounds that are highly soluble in aqueous and aqueous-alcohol solvents. 
However, flavonoids have been reported to be also extracted by chloroform and petroleum 
ether (Gudej & Czapski, 2009; Rajendran & Krishnakumar, 2010). Plants containing 
flavonoids in all extracts, consistent with other studies, include Asparagus aphyllus (Sun et 
al., 2007), Ceratonia siliqua (Papagiannopoulos et al., 2004; Vaya & Mahmood, 2006), 
Dittrichia viscosa (M.J. Martin et al., 1988), Leontodon tuberosus (Zidorn & Stuppner, 2001), 
Mercurialis annua (Aquino et al., 1987) and Olea europaea (Benavente-García et al., 2000). 
Almost all plant species exhibited the presence of flavonoids in one or more extracts, except 
for four plants, namely, Antirrhinum siculum, Diplotaxis erucoides, Malva sylvestris and Verbena 
officinalis. Other studies report the presence of flavonoids in Diplotaxis erucoides (Bennett et 
al., 2006), Malva sylvestris (Billeter et al., 1991) and Verbena officinalis (Rehecho et al., 2011). 
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The absence of flavonoids in these species for the current study may be due to several 
factors that include a different chemotype, different environmental conditions and the 
presence of these compounds below the detection limit, amongst others. Antirrhinum siculum 
is palely pigmented and this may contribute to the insignificant content of flavonoids (C. 
Martin et al., 2010). 
Proteins prevail in many plants. Within the positive response group, 74.67 % were polar 
extracts while 25.33 % were non-polar extracts. This indicated that three-forths of the 
detected proteins were functional proteins including enzymes. Anagallis arvensis, Asparagus 
aphyllus, Palaeocyanus crassifolius and Prasium majus exhibited the presence of proteins in all 
their extracts. This goes in accordance with previous studies carried out on these plants 
(Alignier et al., 2008; King et al., 1990). Plants that were devoid of proteins in all their 
extracts include Aloe vera, Gladiolus italicus, Laurus nobilis and Sonchus oleraceus. In previous 
studies, Aloe vera revealed the presence of glutathione peroxidase (Sabeh et al., 1993), 
Gladiolus italicus contained arabinogalactan-protein (Gleeson & Clarke, 1979) and Laurus 
nobilis contained lipase (Isbilir et al., 2008). Although most plant material was collected at 
flowering time, the inclusion of seed protein in the extract would have been possible in cases 
where fruit were harvested alongside the flowers. 
3.2 The Brine Shrimp Test 
The results for the tested extracts are given in Table 3. Primary screening involves the use of 
bench-top bioassays. Extracts exhibiting LC50 values above 1000 μg/ml are generally 
regarded as ineffective extracts. In this study, 42.26 % of the extracts were therefore inactive 
(Table 4). The most inactive were the petroleum ether extracts, while the most active were 
the ethanolic extracts. Correlating the BST lethal concentrations to phytochemical classes, it 
was observed that inactive extracts contained several phytochemicals. The reason may be 
due to the low concentration or possible antagonistic activity between the phytochemicals 
from the different classes. 55.68 % of the extracts exhibited LC50 values below 1000 μg/ml. 
The most active were the ethanolic extracts (72.97 %), while the least active were the 
petroleum ether extracts (35.14 %). Four plants exhibited activity for all their five extracts. 
These were Nerium oleander, Olea europaea, Opuntia ficus-indica and Pinus halepensis, all 
exhibiting LC50 values below 0.01 μg/ml. These four plant species are amongst the most 
popular Maltese traditional medicinal plants. It was also observed that some extracts with 
non-detectable phytochemicals exhibited significant LC50 values. Typical examples include 
the aqueous extract of Lactuca virosa, the aqueous-ethanol extract of Pinus halepensis, the 
ethanolic extracts of Hypericum aegypticum and Lactuca virosa, and the chloroform extracts of 
Ferula communis, Foeniculum vulgare and Pistacia lentiscus. On the other hand, there were 
extracts that exhibited significant LC50 values as opposed to other studies. For example, for 
Fumaria officinalis aqueous-ethanol and ethanol extracts, in the present study, exhibited 
significant effects on brine shrimps as opposed to the ethanol extract reported in the study 
by Erdoğan (2009). 
3.3 The DNA-methyl green assay 
Table 5 shows the IC50 values obtained for the DNA-methyl green assay. Although low IC50 
values have been reported for pure compounds (Burres et al., 1992) , such as rubiflavin and 
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distamycin A (17 and 18 μg/ml, respectively), it is reasonable that in the case of extracts 
higher IC50 values are acceptable as for pyrido[2,3-d]pyrimidin-4(1H)-one and pyrido[2,3-
d]triazolo[3,4-b]pyrimidine analogs (40 – 53 μg/ml) (Goda & Badria, 2005). Since plant 
extracts are complex matrices with several phytochemicals, IC50 values are expected to be 
higher than for pure compounds. Therefore, extracts with IC50 values below 70 μg/ml were 
considered as active (Figure 2). Only 15 % of the extracts displaced methyl green from the 
methyl green DNA complex. It is likely that these compounds act as intercalating agents at 
the DNA level. 86.67 % were active polar extracts with proteins predominating in these 
extracts. The other extracts either exhibited an IC50 value higher than 70 μg/ml or else a 50 
% activity was never achieved. From the remaining 85 %, only one-third of the extracts 
exhibited values above 70 μg/ml. Alkaloids only featured in one active aqueous extract of 
Ceratonia siliqua. Terpenoids, flavonoids and proteins predominated mainly in aqueous and 
aqueous-ethanol extracts. For a few extracts, there was no correlation between the 
phytochemical class and DNA-methyl green activity. These include the aqueous-ethanol 
extract of Gladiolus italicus, the aqueous extract of Hedera helix and the ethanolic extract of 
Hypericum aegyptiacum. For example H. aegyptiacum contains hypericin that can inhibit DNA 







Fig. 2. The number of extracts classified as (a) below 70 μg/ml, (b) above 70 μg/ml range 
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PLANT NAME  P. N° Aqueous Aqueous-
ethanol  
Ethanol Chloroform Petroleum 
ether 
Acanthus mollis 002 <0.01 <0.01 <0.01 <0.01 >1000 
Anagallis arvensis 028 460 <0.01 <0.01 >1000 >1000 
Antirrhinum tortuosum 036 <0.01 >1000 <0.01 >1000 <0.01 
Antirrhinum siculum 037 10 <0.01 <0.01 >1000 <0.01 
Asparagus aphyllus 049 >1000 <0.01 <0.01 <0.01 >1000 
Aster squamatus 453 >1000 >1000 >1000 >1000 >1000 
Calendula arvensis 068 >1000 63 >1000 >1000 796 
Carlina gummifera 081 >1000 >1000 >1000 >1000 >1000 
Dittrichia viscosa 223 >1000 >1000 >1000 <0.01 >1000 
Ferula communis 459 <0.01 <0.01 <0.01 <0.01 >1000 
Foeniculum vulgare 185 >1000 <0.01 <0.01 <0.01 >1000 
Fumaria officinalis 190 >1000 <0.01 <0.01 >1000 <0.01 
Fumaria capreolata 191 >1000 >1000 <0.01 <0.01 >1000 
Galactites tomentosa 454 >1000 >1000 >1000 >1000 >1000 
Glebionis coronaria 101 >1000 >1000 93 131 >1000 
Hyoscyamus albus 213 >1000 ND <0.01 >1000 >1000 
Hypericum aegyptiacum spreng 217 <0.01 <0.01 <0.01 >1000 >1000 
Inula crithmoides 450 >1000 344 >1000 >1000 562 
Lactuca sativa 462 <0.01 <0.01 <0.01 >1000 <0.01 
Lactuca virosa 236 <0.01 <0.01 <0.01 >1000 >1000 
Leontodon tuberosus 238 >1000 >1000 >1000 >1000 >1000 
Nerium oleander 285 <0.01 <0.01 <0.01 <0.01 <0.01 
Opuntia ficus- indica 286 <0.01 <0.01 <0.01 <0.01 <0.01 
Olea europaea 290 <0.01 <0.01 <0.01 <0.01 <0.01 
Oxalis pes-caprae 291 <0.01 <0.01 <0.01 <0.01 >1000 
Palaeocyanus crassifolius 090 >1000 <0.01 <0.01 >1000 10 
Papaver somniferum  294 <0.01 <0.01 <0.01 <0.01 >1000 
Pinus halepensis 317 <0.01 <0.01 <0.01 <0.01 <0.01 
Plantago lagopus 318 >1000 10 <0.01 >1000 0.07 
Pistacia lentiscus 319 <0.01 <0.01 <0.01 <0.01 ND 
Prasium majus 331 <0.01 <0.01 <0.01 <0.01 >1000 
Psoralea bituminosa 345 <0.01 <0.01 <0.01 10 <0.01 
Reichardia picroides 308 >1000 >1000 >1000 >1000 >1000 
Reseda alba 348 >1000 <0.01 ND 10 >1000 
Ricinus communis 360 >1000 <0.01 <0.01 <0.01 >1000 
Schinus terebinthifolius 374 <0.01 <0.01 <0.01 <0.01 >1000 
Sonchus oleraceus 393 >1000 >1000 >1000 >1000 >1000 
Table 3. The result for the effect of extracts on the Brine Shrimp Test 
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distamycin A (17 and 18 μg/ml, respectively), it is reasonable that in the case of extracts 
higher IC50 values are acceptable as for pyrido[2,3-d]pyrimidin-4(1H)-one and pyrido[2,3-
d]triazolo[3,4-b]pyrimidine analogs (40 – 53 μg/ml) (Goda & Badria, 2005). Since plant 
extracts are complex matrices with several phytochemicals, IC50 values are expected to be 
higher than for pure compounds. Therefore, extracts with IC50 values below 70 μg/ml were 
considered as active (Figure 2). Only 15 % of the extracts displaced methyl green from the 
methyl green DNA complex. It is likely that these compounds act as intercalating agents at 
the DNA level. 86.67 % were active polar extracts with proteins predominating in these 
extracts. The other extracts either exhibited an IC50 value higher than 70 μg/ml or else a 50 
% activity was never achieved. From the remaining 85 %, only one-third of the extracts 
exhibited values above 70 μg/ml. Alkaloids only featured in one active aqueous extract of 
Ceratonia siliqua. Terpenoids, flavonoids and proteins predominated mainly in aqueous and 
aqueous-ethanol extracts. For a few extracts, there was no correlation between the 
phytochemical class and DNA-methyl green activity. These include the aqueous-ethanol 
extract of Gladiolus italicus, the aqueous extract of Hedera helix and the ethanolic extract of 
Hypericum aegyptiacum. For example H. aegyptiacum contains hypericin that can inhibit DNA 
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PLANT NAME  P. N° Aqueous Aqueous-
ethanol  
Ethanol Chloroform Petroleum 
ether 
Acanthus mollis 002 <0.01 <0.01 <0.01 <0.01 >1000 
Anagallis arvensis 028 460 <0.01 <0.01 >1000 >1000 
Antirrhinum tortuosum 036 <0.01 >1000 <0.01 >1000 <0.01 
Antirrhinum siculum 037 10 <0.01 <0.01 >1000 <0.01 
Asparagus aphyllus 049 >1000 <0.01 <0.01 <0.01 >1000 
Aster squamatus 453 >1000 >1000 >1000 >1000 >1000 
Calendula arvensis 068 >1000 63 >1000 >1000 796 
Carlina gummifera 081 >1000 >1000 >1000 >1000 >1000 
Dittrichia viscosa 223 >1000 >1000 >1000 <0.01 >1000 
Ferula communis 459 <0.01 <0.01 <0.01 <0.01 >1000 
Foeniculum vulgare 185 >1000 <0.01 <0.01 <0.01 >1000 
Fumaria officinalis 190 >1000 <0.01 <0.01 >1000 <0.01 
Fumaria capreolata 191 >1000 >1000 <0.01 <0.01 >1000 
Galactites tomentosa 454 >1000 >1000 >1000 >1000 >1000 
Glebionis coronaria 101 >1000 >1000 93 131 >1000 
Hyoscyamus albus 213 >1000 ND <0.01 >1000 >1000 
Hypericum aegyptiacum spreng 217 <0.01 <0.01 <0.01 >1000 >1000 
Inula crithmoides 450 >1000 344 >1000 >1000 562 
Lactuca sativa 462 <0.01 <0.01 <0.01 >1000 <0.01 
Lactuca virosa 236 <0.01 <0.01 <0.01 >1000 >1000 
Leontodon tuberosus 238 >1000 >1000 >1000 >1000 >1000 
Nerium oleander 285 <0.01 <0.01 <0.01 <0.01 <0.01 
Opuntia ficus- indica 286 <0.01 <0.01 <0.01 <0.01 <0.01 
Olea europaea 290 <0.01 <0.01 <0.01 <0.01 <0.01 
Oxalis pes-caprae 291 <0.01 <0.01 <0.01 <0.01 >1000 
Palaeocyanus crassifolius 090 >1000 <0.01 <0.01 >1000 10 
Papaver somniferum  294 <0.01 <0.01 <0.01 <0.01 >1000 
Pinus halepensis 317 <0.01 <0.01 <0.01 <0.01 <0.01 
Plantago lagopus 318 >1000 10 <0.01 >1000 0.07 
Pistacia lentiscus 319 <0.01 <0.01 <0.01 <0.01 ND 
Prasium majus 331 <0.01 <0.01 <0.01 <0.01 >1000 
Psoralea bituminosa 345 <0.01 <0.01 <0.01 10 <0.01 
Reichardia picroides 308 >1000 >1000 >1000 >1000 >1000 
Reseda alba 348 >1000 <0.01 ND 10 >1000 
Ricinus communis 360 >1000 <0.01 <0.01 <0.01 >1000 
Schinus terebinthifolius 374 <0.01 <0.01 <0.01 <0.01 >1000 
Sonchus oleraceus 393 >1000 >1000 >1000 >1000 >1000 
Table 3. The result for the effect of extracts on the Brine Shrimp Test 
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 Percentage per extract type Percentage of Total 
Extracts BST result Aqueous Aqueous-ethanol Ethanol Chloroform Petroleum
ether 
>1000 51.35 27.03 24.32 48.65 59.46 42.16 % 
0.01-1000 5.41 8.11 2.70 8.11 10.81 7.03 % 
0.01 43.24 62.16 70.27 43.24 24.32 48.65 % 
ND 0.00 2.70 2.70 0.00 5.41 2.16 % 
Table 4. The percentage of results classified as (a) above 1000 μg/ml, (b) 0.01 – 1000 μg/ml 
range, (c) less than 0.01 μg/ml and (d) not determined (ND) with the different solvent types 
for the brine shrimp test. 
 
PLANT NAME  P. N° Aqueous Aqueous-
ethanol  
Ethanol Chloroform Petroleum 
ether 
Acanthus mollis 2 30.399 34.102 NA 131.005 34.354 
Aloe vera 15 NA 278.589 270.983 NA NA 
Anagallis arvensis 28 28.658 43.534 NA NA NA 
Antirrhinum tortuosum 36 63.354 156.171 314.838 38.065 354.278 
Antirrhinum siculum 37 NA NA NA NA NA 
Asparagus aphyllus 49 NA 52.985 NA 305.865 NA 
Calendula suffruticosa 73 70.296 144.921 350.003 261.826 364.324 
Ceratonia siliqua 91 23.230 NA NA 134.563 NA 
Cynoglossum creticum 145 45.941 50.063 NA NA NA 
Eucalyptus globulus 460 NA NA NA NA NA 
Ferula communis 459 NA NA NA 71.158 92.264 
Foeniculum vulgare 185 NA NA NA NA NA 
Fumaria capreolata 191 133.655 77.458 NA 596.272 NA 
Fumaria officinalis 190 NA 346.108 NA NA 79.496 
Gladiolus italicus 197 NA 54.931 NA 143.109 251.228 
Hedera helix 202 60.086 231.921 NA NA NA 
Holoschoenus vulgaris 461 NA 91.229 NA NA NA 
Hyoscyamus albus 213 NA NA 195.094 NA NA 
Hypericum aegyptiacum 217 NA NA 66.803 NA 443.799 
Diplotaxis tenuifolia 463 NA 30.688 NA NA NA 
Dittrichia viscosa 223 26.945 NA 108.418 171.989 NA 
Laurus nobilis 234 50.835 NA 324.334 189.539 NA 
Lactuca sativa 462 NA 166.722 326.359 NA NA 
Lactuca virosa 236 NA NA NA NA 57.791 
Malva sylvestris 254 NA 31.530 NA NA 54.922 
Mercurialis annua 268 NA 165.974 NA NA NA 
Nerium oleander 285 NA 62.957 NA 105.401 163.761 
Opuntia ficus- indica 286 41.899 85.339 NA 115.870 NA 
Olea europaea 290 53.908 95.687 80.988 227.594 NA 
Oxalis pes-caprae 291 NA NA 64.089 223.200 171.288 
Palaeocyanus crassifolius 90 122.931 NA NA NA NA 
Papaver somniferum 294 147.538 NA NA NA 131.727 
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Parietaria judaica 296 NA NA 89.115 NA NA 
Phlomis fruticosa 304 137.404 NA 159.786 130.591 171.195 
Pinus halepensis 317 NA NA NA NA NA 
Plantago lagopus 318 NA 49.252 338.260 NA NA 
Pistacia lentiscus 319 NA NA NA NA NA 
Prasium majus 331 48.142 103.372 273.826 92.489 279.194 
Psoralea bituminosa 345 NA 59.332 NA NA 177.895 
Reseda alba 348 193.473 NA NA NA NA 
Ricinus communis 360 48.912 NA NA 103.224 NA 
Schinus terebinthifolius 374 NA NA NA NA 181.849 
Smyrnium olusatrum 388 104.605 NA NA NA NA 
Silybum marianum 392 NA 46.528 NA NA NA 
Verbena officinalis 443 67.656 104.453 145.529 158.008 NA 
Cucurbitacin E - 19.12 
Dexamethasone - 32.74 
Table 5. The median inhibitory concentration (IC50 in μg/ml) values obtained for the DNA-
methyl green assay (NA no activity – 50% effect was never reached). 
4. Conclusions 
This study has confirmed the presence of useful phytochemicals and biological activities of 
several extracts from selected Mediterranean plants. It is expected that these results will 
serve as a stimulus for further investigations into the active phytochemicals. 
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1. Introduction 
Phytochemicals in plant material have raised interest among scientists, food manufacturing 
and pharmaceutical industry, as well as consumers for their roles in the maintenance of 
human health. Phytochemicals are the bioactive, non-nutrient, and naturally occurring plant 
compounds found in fruits, vegetables, and whole grains. They can be categorized into 
various groups, i.e., polyphenols, organosulfur compounds, carotenoids, alkaloids, and 
nitrogen-containing compounds (Lampe & Chang, 2007). 
Many phytochemicals are potent effectors of biologic processes and have the capacity to 
influence disease risk via several complementary and overlapping mechanisms (Lampe 
2007).Further some phytochemicals undergo bacterial modification to produce metabolites 
that are more biologically active than the parent compounds (Lampe & Chang, 2007). 
At present, one of the main objectives of the industry is to identify plant matrices rich in 
these compounds. 
The goal of this chapter is devoted to the description of four classes of phytochemical 
compounds founded in oil-seeds such as: Sterols, Aliphatic alcohols (e.g. Policosanol), 
Squalene, Phenolic acids (e.g. resveratrol) and their content in oil-seeds. We will also evoke 
the physiological impact of these nutraceuticals on human health. 
2. The main phytochemical compounds: structures and sources  
The chemical compounds of oilseeds can be divided into two groups: the saponifiable 
fraction, which accounts for almost the entire weight of the oil (98–99% of total weight) and 
the nonsaponifiable fraction, which represents 0.5–2.0% of the total weight and is 
constituted of diverse components that are of great importance in terms of its biological 
value (Samaniego-Sanchez, 2010). 
This fraction is used when we wish to study the characteristics and authenticity of oil or fat, 
due to its varied composition, including phytosterols, policosanol, hydrocarbons, 
polyphenols, tocopherols, triterpenics alcohol and volatile products. 
 
Bioactive Compounds in Phytomedicine 112 
Rossi, B. & Attard, E. (2011). The Haemagglutination potential of extracts from Urtica dubia 
plant parts. Journal of Natural Remedies, Vol. 11, No. 1, pp. 76-78, ISSN 0972-5547 
Sabeh, F., Wright, T. & Norton, S.J. (1993). Purification and characterization of a glutathione 
peroxidase from the Aloe vera plant. Enzyme & Protein, Vol. 47, No. 2, pp. 92-98, 
ISSN 1019-6773 
Shamsa, F., Monsef, H., Ghamooshi, R. & Verdian-rizi, M. (2008). Spectrophotometric 
determination of total alkaloids in some Iranian medicinal plants. Thai J. Pharm. 
Sci. Vol. 32, pp. 17-20, ISSN 0125-4685 
Shao, Y., Chin, C.K., Ho, C.T., Ma, W., Garrison, S.A. & Huang, M.T. (1996). Anti-tumor 
activity of the crude saponins obtained from asparagus. Cancer Letters, Vol. 104, No. 
1, pp. 31-36, ISSN 0304-3835 
Soušek, J.,  Guédon, D.,  Adam, T.,  Bochořáková H.,  Táborská E.,  Válka I. &  Šimánek V. 
(1999). Alkaloids and organic acids content of eight Fumaria species. Phytochemical 
Analysis. Vol. 10, No. 1, pp. 6–11,  ISSN 0958-0344 
Steinberg, D.M., Sokoll, L.J., Bowles, K.C., Nichols, J.H., Roberts, R., Schultheis, S.K. & 
O’Donnell, C.M. (1997). Clinical evaluation of Toxi-Prep™: A semiautomated solid-
phase extraction system for screening of drugs in urine. Clinical Chemistry, Vol. 43, 
pp. 2099-2105, ISSN 0009-9147 
Sun, T.,  Powers, J.R. & Tang, J. (2007). Evaluation of the antioxidant activity of asparagus, 
broccoli and their juices. Food Chemistry. Vol. 105, No. 1, pp. 101-106, ISSN  0308-
8146  
Tawara, J.N., Blokhin, A., Foderaro, T. A., Stermitz, F. R. & Hope, H. (1993). Toxic piperidine 
alkaloids from pine (Pinus) and spruce (Picea) trees. New structures and a 
biosynthetic hypothesis. Journal of Organic Chemistry, Vol. 58, No. 18, pp. 4813–4818, 
ISSN 0022-3263 
Vaya, J. & Mahmood, S. (2006). Flavonoid content in leaf extracts of the fig (Ficus carica L.), 
carob (Ceratonia siliqua L.) and pistachio (Pistacia lentiscus L.). BioFactors, Vol. 28, 
No. 3-4, pp. 169-175, ISSN 0951-6433 
Waller, G.R., Mangiafico, S. & Ritchey, C.R. (1978). A Chemical Investigation of Aloe 
barbadensis Miller. Proceedings of the Oklahoma Academy of Science, Vol. 58, pp. 69-76, 
ISSN: 0078-4303. 
Williams, R.D. & Ellis, B.E. (1989). Age and tissue distribution of alkaloids in Papaver 
somniferum. Phytochemistry, Vol. 28, No. 8, pp. 2085-2088, ISSN 0031-9422 
Zidorn, C. & Stuppner, H. (2001). Evaluation of chemosystematic characters in the genus 
Leontodon (Asteraceae). Taxon, Vol. 50, pp. 115-133, ISSN 0040-0262  
6 
Phytochemicals Components 
as Bioactive Foods 
Aicha Olfa Cherif 
Laboratoire de Biochimie, des Lipides et des Protéines, 
Département de Biologie, 
Faculté des Sciences de Tunis, Tunis,  
Tunisia 
1. Introduction 
Phytochemicals in plant material have raised interest among scientists, food manufacturing 
and pharmaceutical industry, as well as consumers for their roles in the maintenance of 
human health. Phytochemicals are the bioactive, non-nutrient, and naturally occurring plant 
compounds found in fruits, vegetables, and whole grains. They can be categorized into 
various groups, i.e., polyphenols, organosulfur compounds, carotenoids, alkaloids, and 
nitrogen-containing compounds (Lampe & Chang, 2007). 
Many phytochemicals are potent effectors of biologic processes and have the capacity to 
influence disease risk via several complementary and overlapping mechanisms (Lampe 
2007).Further some phytochemicals undergo bacterial modification to produce metabolites 
that are more biologically active than the parent compounds (Lampe & Chang, 2007). 
At present, one of the main objectives of the industry is to identify plant matrices rich in 
these compounds. 
The goal of this chapter is devoted to the description of four classes of phytochemical 
compounds founded in oil-seeds such as: Sterols, Aliphatic alcohols (e.g. Policosanol), 
Squalene, Phenolic acids (e.g. resveratrol) and their content in oil-seeds. We will also evoke 
the physiological impact of these nutraceuticals on human health. 
2. The main phytochemical compounds: structures and sources  
The chemical compounds of oilseeds can be divided into two groups: the saponifiable 
fraction, which accounts for almost the entire weight of the oil (98–99% of total weight) and 
the nonsaponifiable fraction, which represents 0.5–2.0% of the total weight and is 
constituted of diverse components that are of great importance in terms of its biological 
value (Samaniego-Sanchez, 2010). 
This fraction is used when we wish to study the characteristics and authenticity of oil or fat, 
due to its varied composition, including phytosterols, policosanol, hydrocarbons, 
polyphenols, tocopherols, triterpenics alcohol and volatile products. 
 
Bioactive Compounds in Phytomedicine 114 
2.1 Phytosterols  
Structure 
Phytosterols (plants sterols) are a group of naturally substances occurring in plants as 
bioactive minor constituents (up to 5%). They are derived from 3-hydroxylated polycyclic 
isopentanoids which have a 1,2-cyclopentanophenthrene structure with a 5,6- double 
bond (Fig. 1) (Abidi, 2004, 2001). These compounds contain a total of  27-30 carbon atoms 
(the number of carbon atoms in the biosynthetic precursor squalene oxide) and that of the 
side chain attached at the carbon-17 position can be equal to or greater than seven (Abidi, 
2004).In addition to the free form (FS), phytosterols occur as four types of “conjugates” in 
which the 3β-OH group is esterified to a fatty acid (SE) or a hydroxycinnamic acid (HSE), 
or glycosylated with a hexose (SG) or a 6-fatty-acyl hexose (ASG) (Moreau et al., 2002). In 
free phytosterols (FS), the 3β-OH group on the A-ring is underivatized, whereas in the 
four conjugates the OH is covalently bound with another constituent. In the case of SE, 
the OH group is ester-linked with a fatty acid and linked with a 1-O - β-glycosidic bond 
with a hexose (most commonly glucose). In ASG, there is an addition of a fatty acid 
esterified to the 6-OH of the hexose moiety. In the fourth group the sterol 3β-OH group is 
esterifid to ferulic or p-coumaric acid especially in rice and corn seeds (Moreau et al., 
2002). 
 
Fig. 1. Structure of a steroid numbered. 
Phytosterols have been recognized into three subclasses (Fig 2); on the basis of the number 
of methyl groups at the C4 position: none (4-desmethylsterols or sterols), one (4α-
monomethylsterols) and two (4,4’-dimetylsterols or triterpenes alcohols (Cherif, 2011a; 
Moreau, 2002; Benveniste, 2002) (Fig. 2.). These later two groups are metabolic intermediates 
in the biosynthetic pathway leading to the end-product, 4-desmethylsterols, but they are 
usually present at lower levels than 4-desmethylsterols in most plant tissues (Cherif, 2011a; 
Moreau, 2002; Grunnwald, 1975). According to the position of the double bond at C5 or C7 in 
A ring (Fig. 1.); 4-desmethylsterols are present in two groups which are ∆5-desmethylsterols 
and ∆7-desmethylsterols. The most proportion of 4-desmethylsterol is ∆5-desmethylsterol 
which contained mainly β-sitosterol, ∆5- avenasterol, campesterol and stigmasterol (Pardo, 
2007). 
 




Fig. 2. The sterol pathway for higher plants. 
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Indeed, 250 types of phytosterols are actually reported in the literature, nutrition research 
has focused mostly upon the unsaturated β -sitosterol (24α-ethylcholest-5en-3β-ol), 
campesterol (24α-methyl-5-cholesten-3β-ol), stigmasterol (5,22-cholestadien-24α-ethyl-3β-ol) 
and ∆5- avenasterol (24-ethyl-cholesta-5,24 (28)Z-dien-3β-ol) (Kochar, 1983). 
 
Compounds 4-DEMS MW Mains fragmentation ions (M/Z) and others 
Campesterol 472 382, 343, 255, 129 
Stigmasterol 484 394, 255, 175, 129, 83 
β-sitosterol 486 396, 381, 357, 255, 129, 73 
Δ5-avenasterol 484 469, 386, 379, 355,296, 129, 55 
Fucosterol 484 469, 386, 296, 129, 55 
Δ7-sitosterol 486 303, 255, 229, 213 
Δ7-avenasterol 486 386, 343, 255, 213 
MW: Molecular Weight (g/mol) 
Table 1. Retention time and mass spectrometric data for trimethylsilyl derivatives of 4-
desmethylsterols identified by GC-MS (Cherif, 2011a) 
 
Compounds 4-DIMS and 4-MMS MW  Mains fragmentation ions (M/Z) and others 
Obtusifoliol 498 .498 ; 483 ; 393 ; 109 
β-amyrin 498 483 ; 408 ; 393 ; 218 ; 203. 
α-amyrin 498 483 ; 408 ; 393 ; 218 ; 203. 
Gramisterol 484 469 ; 393 ; 357 ; 254 ; 206 ; 83 ; 41. 
Cycloartenol 498 483 ; 408 ; 393 ; 365 ; 271 ; 189 ; 69 
28-methyleneobtusifoliol 512 497 ; 407 ; 309 ; 295 ; 281 ; 255 ; 55 
24-methylenecycloartanol 512 497 ; 422 ; 407 ; 379 ; 353 ; 255 ;73. 
Citrostadienol 498 400 ; 357 ; 264 ; 250 ; 83 ; 47. 
MW: Molecular Weight (g/mol) 
Table 2. Retention time and mass spectrometric data for trimethylsilyl derivatives of 4,4’-
dimethyl and 4-monomethylsterols identified by GC-MS (Cherif, 2011a) 
Effects 
Phytosterols exist in all foods of plant origin and are known to have several bioactive 
properties with possible benefits for human health (Cherif et al.,2010a).They contribute to 
lowering serum cholesterol levels (Cherif, 2010a), and are also considered to have anti-
inflammatory, anti-bacterial, anti-artherosclerotic, anti-oxidative, anti-ulcerative, anti-tumor 
properties in humans (Lagarda, 2006; Moreau, 2002; Beveridgs, 2002), as well as contributing 
to the oxidative and thermal stability and shelf-life of vegetable oils  (Przybylski, 2006). 
Additional, they are useful emulsifiers for cosmetic manufacturers and supply the majority of 
steroidal intermediates and precursors for the production of hormone pharmaceuticals 
(Grunnwald, 1975). Phytosterols might also prevent the development of colon cancer and 
benign prostatic hyperplasia (Awad, 2000). Among different plant sterols, β-sitosterol has been 
most intensively investigated and has been shown to exhibit anti-inflammatory; antineoplastic, 
antipyretic, and immunomodulating activities (Careri, 2006). Also, β-sitosterol, campesterol 
and stigmasterol exert antioxidant effects. Indeed, ∆5- avenasterol has an essential 
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antipolymerization effect, which could protect oils from oxidation during heating, exposure to 
ionizing radiation, light, chemical catalysts, or enzymatic processes (Nasar, 2007).  
Titerpenes compounds and 4α-monomethylsterols are also important bioactive secondary 
metabolites, due to the wide range of their biological activities. They show mainly 
antimicrobial, cytotoxic, antitumoral, antiviral, anti-inflammatory, hepatoprotective, 
antifeedant and insecticidal activities ( Alvarenga, 2005). These methylsterols have been used 
as markers to characterize and to detect admixture of vegetable oils (Cert, 1997; Jimenez, 1996). 
It is noteworthy that the compositional distributions of phytosterols in certain vegetable oils 
have been used for their identification (Abidi, 2001). Hence, phytosterols and other non-
saponifiable compounds in oils are often used as markers for the assessment of adulterated 
oils (Abidi, 2001). Recently, plant sterols have been added to margarine and vegetable oils as 
examples of successful functional foods and used as food ingredients in modern formulations 
(Fernandes, 2007). Reported phytosterols data for some oilseeds have shown that (Lin, 2004)  
 
Vegetable oils PS totaux ß-sitosterol Campesterol Stigmasterol Δ5avénasterol 
peanut 315 203 52 28 22,8 
Linseed  471 226 120 38 70,7 
Olive  177 141 9 4 22,9 
corn 843 519 184 56 41,4 
grapes 215 169 24 24 nd 
nd : not detected 
Table 3. The major phytosterols components content in selected vegetable oils (mg/100g of 
oil) (Lin, 2004) 
 
Fig. 3. Mass spectrum of Docosanol (Cherif, 2011b) 
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2.2 Aliphatic alcohols (e.g. Policosanol) 
Structure 
POLICOSANOL (PC) is a trivial name of a mixture of high molecular weight (HMW) 
aliphatic primary alcohols (C20 to C36), originally isolated from sugar cane (Saccharum 
officinarum L.) (Cherif, 2010b). 
It is also found from a diversity of other natural substances, such as bee wax, rice bran and 
wheat germ (Lin, 2004). These plants represent good sources of PC with its health-enhancing 
components. PC is present also in the fruits, leaves, and surfaces of plants and whole seeds 
(peanut seeds) (Cherif, 2010b). It is containing mainly docosanol (C22), tetracosanol (C24), 
hexacosanol (C26), octacosanol (C28) and triacontanol (C30) (Irmak, 2006). 
The analysis of individual policosanol components required mass spectrometric for 
tentative identification of the chromatographic peaks (Cherif, 2010b). Several components 
have been identified in the literature.The majorities of them are saturated n-alcohols, but we 
also note the presence of some unsaturated alcohols as in the case of peanut (Cherif, 2010b). 
 
Mb [M-15]+ (m/z) Alcohol1 
286 271 Tetradecan-1-ol 
300 285 Pentadecan-1-ol 
314 299 Hexadecan-1-ol 
328 313 Heptadecan-1-ol 
340 325 (Z) Octadec-9-en-1-ol 
342 327 Octadecan-1-ol 
356 341 Nonadacan-1-ol 
368 353 Eicosen-1-ol 
370 355 Eicosan-1-ol 
382 367 Heneicosen-1-ol 
384 369 Heneicosan-1-ol 
396 381 Docosen-1-ol 
398 383 Docosan-1-ol 
412 397 Tricosan-1-ol 
424 409 Tetracosen-1-ol 
426 411 Tetracosan-1-ol 
440 425 Pentacosan-1-ol 
454 439 Hexacosan-1-ol 
468 453 Heptacosan-1-ol 
482 467 Octacosan-1-ol 
510 495 Triacontan-1-ol 
bMass of the trimethylsilylated alcohol. In all cases the mass spectrum exihibited a major peak due to 
CH3 loss, [M-15], and a peak characteristic of the Trimethylsilyl group on a terminal ether site, m/z 
=103 [(CH3)3SiOCH2]+ 
1Compounds tentatively identified. 
Table 4. Retention indices and mass spectrometric data for trimethylsilyl derivatives of 
aliphatic alcohols identified by GC-MS  (Cherif, 2010b). 
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Beneficial effects of policosanol 
Several researchers have reported the biological effects of active compounds extracted from 
sugar cane crude wax (CW) such as long chain n-alcohols, fatty acids or ethanolic extracts, 
which have application to artherosclerotic vascular, coronary heart diseases, and 
dermatologic diseases (Lucas, 2007).  
In fact, policosanol has been shown to decrease platelet aggregation, endothelial damage, 
and foam cell formation. The effectiveness of policosanol as a lipid-lowering agent, in 
several different populations has been extensively (Irmak, 2006). PC is supposed to 
downregulate the cellular expression of hydroxymethylglutamyl coenzyme Z (HMG-CoA) 
reductase; the rate-limiting enzyme in the cholesterol synthesis, rather inhibit the enzyme 
activity (Lin, 2004). So inhibiting cholesterol biosynthesis and enhancing low-density 
lipoprotein (LDL) decatabolism (Menendez, 1994). Similarly, PD improves protection of 
lipoproteins against lipid peroxidation, both in the lipid and the protein moieties 
(Menendez, 1999).However, Franci-Pesenti et al (Francini-Pesenti, 2008) have reported that 
the mechanisms by which PC improves plasma lipid profile are unclear, and there is a 
continuing debate about the exact effect of PC. Nevertheless, PC was successful worldwide, 
and it is sold as a lipid-lowering supplement in more than 40 countries (Cherif, 2010b). The 
majority of these supplements are prepared from bees wax or sugar cane extracts.   
Marcelleti et al. reported that docosanol inhibits replication of herpes viruses in vitro and in 
vivo. While, octacosanol might be oxidized and degraded to fatty acids via β-oxidation in 
mammals (Menendez, 2005). 
 
Samples C22 C24 C26 C28 C30 PC 
Wheat germ 
(mg/kg) 
2,8 1,4 nd 2,9 2,5 10,0 
Beeswax 
(g/kg) 
0,06 2,6 1,7 2,0 5,7 12,0 
Sugar cane 
(mg/kg) 
0,92 1,68 0,9 10,0 1,0 17,4 
Policosanol TM 
(mg/comprimé) 
7,1 14,8 8,5 8,8 8,3 53,6 
Policosanol TM : commercial dietary supplement; nd : non détecté. 
Table 5. Policosanol content of some natural sources rich in PC in compared with that PC 
supplement (Cherif, 2011b) 
2.3 Squalene 
Structure 
In virgin oil, the major hydrocarbon is the squalene (2,6,10,15,19,23-hexamethyl-
2,6,10,14,18,20-tetracosahexaene) (C30H50),  a terpenoid hydrocarbon occurring in high 
concentrations (800-12000 mg/kg which can constitute up to 90% of the hydrocarbon 
fraction of olive oil and pumpkin oils (Fig .4) (Tuberoso, 2007). It is also present in all plant 
oils and fats except flaxseed, grapeseed, and soybean oils (Tuberoso, 2007). It is 
accompanied by n-alkanes in the range of C8-C35, being the more abundant the 
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comprehended between C21 and C35, in which alkanes with an odd number of carbon atoms 
predominated over those of even numbers (Cert, 2000). 
 
Fig. 4. Mass spectrum of squalene 
Squalene is built up from a universal C5 building block isopentenyl diphosphate (IDP or 
IPP). The IPP in the classical Bloch-Lynen pathway; is formed from three molecules of 
acetyl-CoA via the mevalonate (MVA pathway). Then the squalene epoxidase catalyzes the 
epoxidation of squalene to 2,3-oxidosqualene, which is the substrate for formation of sterols 
and a wide range of triterpenoids (Volkman, 2005). 
In humans, squalene is synthesized in the liver and the skin, transported in the blood by 
very low density lipoproteins (VLDL) and low density lipoproteins (LDL), and secreted in 
large quantities by the sebaceous glands (Reddy, 2009). 
Beneficial effects of squalene 
Squalene is also regarded as one of the compounds responsible for the beneficial effects 
against certain type of cancers (Tuberoso,  2007).Antioxidant activity of squalene is 
demonstrated against polyunsaturated fatty acid (PUFA), and it is secondary to that of 
phenols and tocopherols (Tuberoso, 2007). Its antioxidant activity can reinforce the 
endogenous antioxidant system against oxidative damage (Tuberoso, 2007). Together with 
other components of the non-saponifiable fraction, it prevents also the autooxidation process 
and thus contributes to the stability of the oil and its aroma and flavor characteristics 
(Tuberoso, 2007). It is normally used in its natural or hydrogenated form (squalene) as a 
moisturizing or emollient agent in cosmetic preparations (Moreda, 2001). Squalene is 
widespread in nature, especially among olives, liver oil, wheat germ and rice bran. 
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Structure 
Trans-Resveratrol or Res (trans-3,5,4’-trihydroxystilbene) (Fig.5) (Lin 2007) and its many 
derivatives (pterostilbene, piceatannol) are naturally occurring phytoalexins; a class of 
antibiotic compounds, produced in a select number of plant species as part of the plant’s 
defense system (Bolivar, 2007).The terminal enzyme in the production of resveratrol is 
resveratrol synthase, which condenses p-coumaroyl-coenzyme A and three malonyl-
coenzyme A molecules to form resveratrol (Bolivar, 2007).This enzyme is highly regulated 
by elicitors and general plant defense compounds in an effort to protect the plant. 
Resveratrol exist as both the trans- and cis-isomers but the most active for is the trans one. 
 
Fig. 5. The chemical structure of trans-resveratrol and trans-piceatannol (Lin, 2007) 
Resveratrol and effects 
Res and its derivatives like piceatannol, has similar structure (Fig Lin, 2007), but piceatannol 
has much potent biological activities than resveratrol. Piceatannol is more efficient inducer 
of apoptosis (Lin, 2007). Other reports, suggested that both piceatannol and resveratrol are 
able to induce apoptosis in many cancer cell lines, but to different extent (Lin 2007).Lin et al. 
reported that piceatannol is more effective in cancer prevention and could be an anticancer 
compound while resveratrol is a chemoprotective one. In fact, resveratrol and piceatannol 
become promising natural compounds in cancer treatments (Lin, 2007), they blocks the 
carcinogenesis stages of initiation, promotion and progression (Lu, 2009).  
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In plants, the amount of piceatannol is much lower than that of Res. Lu et al reported that 
roots can produce higher levels of phytoalexins in response to environmental stimulations 
like injury or fungal attack (Lu, 2009). 
Besides, its strong anitcarcinogenic effect, Res decreased coronary heart diseases mortality 
(Lu, 2009), modulates lipid metabolism, protects low-density lipoproteins against oxidative 
and free radical damage (Lu, 2009), and inhibits platelets activation and aggregation (Lu, 
2009), and anti-aging benefits (Bolivar, 2007) 
A number of taxonomically unrelated plant families (72 plant species) have been reported to 
produce marked levels of resveratrol including: peanuts, several types of berries, some pine 
trees and most recently tomato fruit skin (Ragab, 2006). 
The highest level of piceatannol and resveratrol was detected in roots due to their consistent 
exposure to the micoorganisms in soil.  
3. Conclusion 
Phytochemicals in plant material have raised interest among scientist, producers, and 
consumers for their roles in the maintenance of human health and in assessing the protective 
status of people from chronic degenerative disorders. Given the importance of dietary habit 
and food components to health, the provision of phytochemical information of a range of 
foods is vital to support the future work in assessing the protective status of people from 
chronic degenerative disorders. Food-based approaches would be essential for sustainable 
solutions to combat the alarming prevalence of chronic cancer, coronary heart diseases and 
diabetes. The health benefits of these foods may prompt research onto the assessment and 
determination of potential rich sources of phytochemicals compounds in agricultural produce. 
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1. Introduction 
Phytochemicals found in foods and spices are progressively gaining popularity over 
conventional synthetic drugs mainly because they act via multiple molecular targets that 
synergize to efficiently prevent or treat chronic illnesses. Phytochemicals are also safe (with 
minimal or no toxic or side effects) with better bioavailability. Food saponins have been used 
in complimentary and traditional medicine against a variety of diseases including several 
cancers. Diosgenin, a naturally-occurring steroid saponin is found abundantly in legumes 
(Trigonella sp.) and yams (Dioscorea sp.). Diosgenin is a precursor of various synthetic steroidal 
drugs that are extensively used in the pharmaceutical industry. Over the past two decades, a 
series of pre-clinical and mechanistic studies have been independently conducted to 
understand the beneficial role of diosgenin against metabolic diseases (hypercholesterolemia, 
dyslipidemia, diabetes and obesity), inflammation and cancer. In experimental models of 
obesity, diosgenin decreases plasma and hepatic triglycerides and improves glucose 
homeostasis plausibly by promoting adipocyte differentiation and inhibiting inflammation in 
adipose tissues. A limited number of experiments have been conducted to understand the pre-
clinical efficacy of diosgenin as a chemopreventive/therapeutic agent against cancers of 
several organ sites. Mechanistic studies using in vitro models suggest that diosgenin 
suppresses cancer cell growth through multiple cell signaling events associated with 
proliferation, differentiation, apoptosis, inflammation and oncogenesis. This chapter 
provides a comprehensive review of the biological activity of diosgenin that contributes to 
several diseases in its role as a health beneficial phytochemical by citing new studies. In 
addition, diosgenin’s safety with regards to its potential toxicity is also critically discussed. 
Altogether, the findings from pre-clinical and mechanistic studies strongly implicate the use 
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1. Introduction 
Phytochemicals found in foods and spices are progressively gaining popularity over 
conventional synthetic drugs mainly because they act via multiple molecular targets that 
synergize to efficiently prevent or treat chronic illnesses. Phytochemicals are also safe (with 
minimal or no toxic or side effects) with better bioavailability. Food saponins have been used 
in complimentary and traditional medicine against a variety of diseases including several 
cancers. Diosgenin, a naturally-occurring steroid saponin is found abundantly in legumes 
(Trigonella sp.) and yams (Dioscorea sp.). Diosgenin is a precursor of various synthetic steroidal 
drugs that are extensively used in the pharmaceutical industry. Over the past two decades, a 
series of pre-clinical and mechanistic studies have been independently conducted to 
understand the beneficial role of diosgenin against metabolic diseases (hypercholesterolemia, 
dyslipidemia, diabetes and obesity), inflammation and cancer. In experimental models of 
obesity, diosgenin decreases plasma and hepatic triglycerides and improves glucose 
homeostasis plausibly by promoting adipocyte differentiation and inhibiting inflammation in 
adipose tissues. A limited number of experiments have been conducted to understand the pre-
clinical efficacy of diosgenin as a chemopreventive/therapeutic agent against cancers of 
several organ sites. Mechanistic studies using in vitro models suggest that diosgenin 
suppresses cancer cell growth through multiple cell signaling events associated with 
proliferation, differentiation, apoptosis, inflammation and oncogenesis. This chapter 
provides a comprehensive review of the biological activity of diosgenin that contributes to 
several diseases in its role as a health beneficial phytochemical by citing new studies. In 
addition, diosgenin’s safety with regards to its potential toxicity is also critically discussed. 
Altogether, the findings from pre-clinical and mechanistic studies strongly implicate the use 
of diosgenin as a novel multi-target based chemopreventive or therapeutic agent against 
several chronic diseases. 
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1.1 Background of origin 
Diosgenin is a major bioactive constituent of various edible pulses and roots, well 
characterized in the seeds of fenugreek (Trigonella foenum graecum Linn) as well as in the root 
tubers of wild yams (Dioscorea villosa Linn) (No authors listed, 2004; Taylor et al., 2000). 
Reference to the ethnobotanical use of fenugreek seeds appears in the Egyptian Ebers 
papyrus (c. 1500 BC) as a medicine to induce childbirth. Fenugreek seeds were referred as a 
“soothing herb” by the Greek physician Hippocrates (5th century BC) and Dioscorides (1st 
century AD) suggested its use in the treatment of gynaecological inflammation (Chevalier, 
2000). Wild yam tubers on the other hand have been used traditionally as a pain reliever by 
the ancient Aztec and Mayan people in the Americas (Chevalier, 2000). Data available from 
various traditional medical practices indicate that fenugreek seeds and wild yam tubers 
have been purported to be used as a preventive or therapeutic medicine against several 
ailments including arthritis, cancer, diabetes, gastrointestinal disorders, high cholesterol, 
and inflammation suggesting a variety in its use (Memorial Sloan-Kettering Cancer 
Center). 
1.2 Chemistry, structure-function and bioavailability 
Structurally, diosgenin [(25R)-spirost-5-en-3b-ol] is a spirostanol saponin consisting of a 
hydrophilic sugar moiety linked to a hydrophobic steroid aglycone (Figure 1). Diosgenin is 
structurally similar to cholesterol and other steroids. Since its discovery, diosgenin is the 
single main precursor in the manufacture of synthetic steroids in the pharmaceutical 
industry (Djerassi et al., 1952). In a recent study it was shown that spirostanol compounds, 
especially diosgenin glycosides exhibited inducible or inhibitory activity in rat uterine 
contraction based on (a) the number, length and position of sugar side chains attached by a 
glycoside, and (b) related to the structure of the aglycone (Yu et al., 2010). The structure-
related functions of diosgenin have been extensively tested using cancer cells in vitro. In 
comparison to two-structurally-related saponins, hecogenin and tigogenin, only diosgenin 
caused a cell cycle arrest associated with strong apoptosis in vitro (Corbiere et al., 2003).) The 
biological activities of diosgenin and other structurally-related steroid saponins and 
alkaloids were tested in vitro (Trouillas et al., 2005). By using molecular modelling, the 
spatial conformation and electron transfer capacity were calculated in relation to the 
structural characteristics of diosgenin necessary to elicit its effect on proliferation rate, cell 
cycle distribution and apoptosis; and the anti-cancer bioactivity of diosgenin was shown to 
be related to the presence of a hetero-sugar moiety and the 5,6-double bond in its structure 
(Trouillas et al., 2005). Moreover, structural conformation at C-5 and C-25 carbon atoms was 
shown to be important for diosgenin’s biological activity (Trouillas et al., 2005). Further 
studies are warranted to assess the structure-function relationship of diosgenin and to 
understand whether and how synthetic changes brought about could augment its biological 
activity in favour of its role as a therapeutic agent. Rodent studies on the disposition of 
diosgenin revealed that diosgenin was poorly absorbed and underwent extreme 
biotransformation (Cayen et al., 1979). In the same study, 1 μg/mL of diosgenin was 
recovered from the serum of human subjects receiving an oral dose of 3 g diosgenin per day 
for 4 weeks suggesting poor absorption and possibly active biotranformation (Cayen et al., 
1979). 
Diosgenin, a Steroid Saponin Constituent 




Fig. 1. Structure of diosgenin: Diosgenin (a) and its analogue protodioscin (b) are steroid 
saponins consisting of a hydrophilic sugar moiety linked to a hydrophobic steroid aglycone 
2. Metabolic diseases 
Fenugreek seeds and Dioscorea sp. yam tubers together with their constituent diosgenin 
have been shown to have biological activity against several metabolic diseases (Ulbricht et 
al., 2007; Raju & Rao, 2009). In the following sections, studies that have used the active 
constituent diosgenin in both experimental models of metabolic diseases and human clinical 
studies are reviewed. A list of studies evaluating the effects of diosgenin against different 
metabolic diseases is summarised in Table 1. 
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Table 1. Effect of diosgenin (purified) on metabolic and related diseases 
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2.1 Dyslipidemia and obesity 
The lipid-lowering potential of diosgenin has been demonstrated by several experimental 
studies (Sauvaire et al., 2000). Diosgenin decreased the elevated cholesterol in serum LDL 
and HDL fractions in cholesterol-fed rats, and had no effect on serum cholesterol in 
normocholesterolemic rats. In addition, diosgenin inhibited cholesterol absorption, and 
suppressed its uptake in serum and liver, and its accumulation in the liver (Cayen and 
Dvornik, 1979). Diosgenin lowered plasma cholesterol in diet-induced hypercholesterolemic 
rats, chicken and rabbits when administered orally or parenterally (Juarez-Oropeza et al., 
1987). Recently, it was shown that diosgenin ( at a oral dose of 0.1% or 0.5% in the diet for 
6 weeks) decreased total cholesterol levels and increased the plasma high-density 
lipoprotein (HDL) cholesterol level in both plasma and livers of diet-induced 
hypercholesterolemic rats (Son et al., 2007). In a study that evaluated the anti-obesity role 
of diosgenin-rich Dioscorea nipponica Makino, a related species to Dioscorea villosa, 
Sprague-Dawley rats fed a diet containing 40% beef tallow and 5% freeze-dried extract of 
the yam gained less body weight and adipose tissue than those that received only the 40% 
beef tallow diet (Kwon et al., 2003). In the same study it was shown that diosgenin 
suppressed the time-dependent increase of blood triacylglycerol levels when orally 
administered with corn oil to ICR mice, suggesting an inhibitory potential against fat 
absorption (Kwon et al., 2003). 
An evidence-based systemic review clearly suggests that fenugreek seeds (rich in diosgenin 
content) have an important role in the control of metabolic diseases such as diabetes and 
obesity (Ulbricht et al., 2007). Fenugreek decreased the size of adipocytes in diabetic obese 
KK-Ay mice suggesting an increased differentiation of adipocytes leading to decreased 
adipocyte lipid accumulation (Uemura et al., 2010). These results were further validated 
with molecular data that showed that fenugreek increased the mRNA expression levels of 
differentiation-related genes in adipose tissues (Uemura et al., 2010). Furthermore, in vitro 
experiments using 3T3-L1 adipocytes showed that diosgenin, the major saponin in 
fenugreek, promoted 3T3-L1 adipocyte differentiation to enhance insulin-dependent glucose 
uptake (Uemura et al., 2010). Two clinical studies were recently published showing the anti-
obesity properties of fenugreek seeds. First, a double-blind randomized placebo-controlled 
three-period (14 days) cross-over trial with twelve healthy male volunteers, demonstrated 
that fenugreek seed extract selectively reduced spontaneous fat consumption compared to 
placebo controls (Chevassus et al., 2009). However, there was no effect on body weight, 
normal and fasting glucose levels, insulin and lipid profile, and visual analogue scale scores 
of appetite/satiety in subjects receiving the fenugreek seed extract (Chevassus et al., 2009). 
In the second study, a 6-week double-blind randomized placebo-controlled parallel trial 
with thirty-nine healthy overweight male volunteers, showed decreased dietary fat 
consumption in subjects that received a fixed dose of a fenugreek seed extract compared to 
those that received the placebo (Chevassus et al., 2010). In addition, subjects that received 
the fenugreek seed extract also demonstrated a decrease in the insulin/glucose ratio in the 
serum of fasted subjects (Chevassus et al., 2010). Put together, these two clinical studies 
provided evidence to support that fenugreek seeds may potentially regulate fat 
consumption in humans. Whether diosgenin per se can mimic these results at appreciable 
doses in human subjects need to be addressed. 
Diosgenin, a Steroid Saponin Constituent 




There are several reports suggesting that diosgenin-rich food sources such as fenugreek seeds 
and yam tubers contribute to anti-diabetic effects in experimental models (Basch et al., 2003; 
Omoruyi, 2008). Evidence from human clinical trials clearly suggests that fenugreek seeds 
improve blood glucose and other metabolic parameters leading to treatment of diabetes (Basch 
et al., 2003).) Diosgenin significantly decreased plasma glucose in streptozotocin-induced 
diabetic rats by comparison to the diabetic controls suggesting its anti-diabetic properties 
(McAnuff et al., 2005). These results were further strengthened by the fact that several hepatic 
rate-limiting enzymes commonly involved in glucose metabolism altered in the diabetic state 
were normalized by treatment with diosgenin (McAnuff et al., 2005).  While there is ample 
evidence (including clinical trials) suggesting that fenugreek seeds may be used as an 
alternative medicine to treat diabetes and associated complications, more experimental studies 
are warranted to address if diosgenin can be efficaciously used in the control of diabetes and to 
understand the mechanism(s) of action. 
2.3 Liver function, liver disease and bile secretion 
There is a plethora of information that suggests that both fenugreek seeds and yam tubers 
influence several metabolic diseases directly affecting a number of molecular targets 
involved in enzyme metabolism as well as signal transduction pathways in the liver 
suggesting that their active compounds such as diosgenin may plausibly modulate liver 
function and may aid in the therapeutic control of liver diseases. A lyophilized fraction of 
Dioscorea sp. yam tubers attenuated CCl4-induced hepatic fibrosis in rats in a dose-
dependent manner (Chan et al., 2010). On the other hand, aqueous extract of fenugreek 
seeds contributed to a significant histopathological protection against ethanol-induced liver 
toxicity in rats (Thirunavukkarasu et al., 2003). Furthermore, the authors reported that this 
protection against ethanol-induced toxicity was by modulating lipid peroxidation and the 
antioxidant status (Thirunavukkarasu et al., 2003). Powdered fenugreek seeds administered 
in the diet at a dose of 5% (wt/wt) reduced the liver weight and alleviated hepatic steatosis 
in Zucker obese (fa/fa) rats (Raju and Bird, 2006).  The main mechanism of fenugreek seeds in 
controlling hepatic steatosis was through lowering plasma tumor necrosis factor (TNF)-α, a 
proinflammatory cytokine and by decreasing total fat and triglycerides in the liver (Raju and 
Bird, 2006). Specifically, there are no reports demonstrating the therapeutic potency of 
diosgenin against liver disease. It is postulated that diosgenin feeding causes cholesterol 
excretion in the stool of experimental animals, mainly by cholesterol secretion from the bile 
(Cayen and Dvornik, 1979). Diosgenin has been shown to increase cholesterol secretion five- 
to seven-fold in the bile of rats without altering the output of bile salts and phospholipids 
(Kosters et al., 2005; Nervi et al., 1988; Nibbering et al., 2001). Recently, it was shown that the 
bilary cholesterol secretion stimulated by diosgenin and leading to fecal cholesterol 
excretion is independent of intestinal cholesterol absorption (Temel et al., 2009). 
3. Cancer 
3.1 In vivo studies 
There are limited experimental studies addressing the in vivo tumor modulating potential of 
diosgenin (summarised in Table 2). Diosgenin inhibited the formation of colon aberrant 
crypt foci (ACF), putative precancerous lesions induced by azoxymethane (AOM) in F344 
 
Bioactive Compounds in Phytomedicine 
 
128 
2.1 Dyslipidemia and obesity 
The lipid-lowering potential of diosgenin has been demonstrated by several experimental 
studies (Sauvaire et al., 2000). Diosgenin decreased the elevated cholesterol in serum LDL 
and HDL fractions in cholesterol-fed rats, and had no effect on serum cholesterol in 
normocholesterolemic rats. In addition, diosgenin inhibited cholesterol absorption, and 
suppressed its uptake in serum and liver, and its accumulation in the liver (Cayen and 
Dvornik, 1979). Diosgenin lowered plasma cholesterol in diet-induced hypercholesterolemic 
rats, chicken and rabbits when administered orally or parenterally (Juarez-Oropeza et al., 
1987). Recently, it was shown that diosgenin ( at a oral dose of 0.1% or 0.5% in the diet for 
6 weeks) decreased total cholesterol levels and increased the plasma high-density 
lipoprotein (HDL) cholesterol level in both plasma and livers of diet-induced 
hypercholesterolemic rats (Son et al., 2007). In a study that evaluated the anti-obesity role 
of diosgenin-rich Dioscorea nipponica Makino, a related species to Dioscorea villosa, 
Sprague-Dawley rats fed a diet containing 40% beef tallow and 5% freeze-dried extract of 
the yam gained less body weight and adipose tissue than those that received only the 40% 
beef tallow diet (Kwon et al., 2003). In the same study it was shown that diosgenin 
suppressed the time-dependent increase of blood triacylglycerol levels when orally 
administered with corn oil to ICR mice, suggesting an inhibitory potential against fat 
absorption (Kwon et al., 2003). 
An evidence-based systemic review clearly suggests that fenugreek seeds (rich in diosgenin 
content) have an important role in the control of metabolic diseases such as diabetes and 
obesity (Ulbricht et al., 2007). Fenugreek decreased the size of adipocytes in diabetic obese 
KK-Ay mice suggesting an increased differentiation of adipocytes leading to decreased 
adipocyte lipid accumulation (Uemura et al., 2010). These results were further validated 
with molecular data that showed that fenugreek increased the mRNA expression levels of 
differentiation-related genes in adipose tissues (Uemura et al., 2010). Furthermore, in vitro 
experiments using 3T3-L1 adipocytes showed that diosgenin, the major saponin in 
fenugreek, promoted 3T3-L1 adipocyte differentiation to enhance insulin-dependent glucose 
uptake (Uemura et al., 2010). Two clinical studies were recently published showing the anti-
obesity properties of fenugreek seeds. First, a double-blind randomized placebo-controlled 
three-period (14 days) cross-over trial with twelve healthy male volunteers, demonstrated 
that fenugreek seed extract selectively reduced spontaneous fat consumption compared to 
placebo controls (Chevassus et al., 2009). However, there was no effect on body weight, 
normal and fasting glucose levels, insulin and lipid profile, and visual analogue scale scores 
of appetite/satiety in subjects receiving the fenugreek seed extract (Chevassus et al., 2009). 
In the second study, a 6-week double-blind randomized placebo-controlled parallel trial 
with thirty-nine healthy overweight male volunteers, showed decreased dietary fat 
consumption in subjects that received a fixed dose of a fenugreek seed extract compared to 
those that received the placebo (Chevassus et al., 2010). In addition, subjects that received 
the fenugreek seed extract also demonstrated a decrease in the insulin/glucose ratio in the 
serum of fasted subjects (Chevassus et al., 2010). Put together, these two clinical studies 
provided evidence to support that fenugreek seeds may potentially regulate fat 
consumption in humans. Whether diosgenin per se can mimic these results at appreciable 
doses in human subjects need to be addressed. 
Diosgenin, a Steroid Saponin Constituent 




There are several reports suggesting that diosgenin-rich food sources such as fenugreek seeds 
and yam tubers contribute to anti-diabetic effects in experimental models (Basch et al., 2003; 
Omoruyi, 2008). Evidence from human clinical trials clearly suggests that fenugreek seeds 
improve blood glucose and other metabolic parameters leading to treatment of diabetes (Basch 
et al., 2003).) Diosgenin significantly decreased plasma glucose in streptozotocin-induced 
diabetic rats by comparison to the diabetic controls suggesting its anti-diabetic properties 
(McAnuff et al., 2005). These results were further strengthened by the fact that several hepatic 
rate-limiting enzymes commonly involved in glucose metabolism altered in the diabetic state 
were normalized by treatment with diosgenin (McAnuff et al., 2005).  While there is ample 
evidence (including clinical trials) suggesting that fenugreek seeds may be used as an 
alternative medicine to treat diabetes and associated complications, more experimental studies 
are warranted to address if diosgenin can be efficaciously used in the control of diabetes and to 
understand the mechanism(s) of action. 
2.3 Liver function, liver disease and bile secretion 
There is a plethora of information that suggests that both fenugreek seeds and yam tubers 
influence several metabolic diseases directly affecting a number of molecular targets 
involved in enzyme metabolism as well as signal transduction pathways in the liver 
suggesting that their active compounds such as diosgenin may plausibly modulate liver 
function and may aid in the therapeutic control of liver diseases. A lyophilized fraction of 
Dioscorea sp. yam tubers attenuated CCl4-induced hepatic fibrosis in rats in a dose-
dependent manner (Chan et al., 2010). On the other hand, aqueous extract of fenugreek 
seeds contributed to a significant histopathological protection against ethanol-induced liver 
toxicity in rats (Thirunavukkarasu et al., 2003). Furthermore, the authors reported that this 
protection against ethanol-induced toxicity was by modulating lipid peroxidation and the 
antioxidant status (Thirunavukkarasu et al., 2003). Powdered fenugreek seeds administered 
in the diet at a dose of 5% (wt/wt) reduced the liver weight and alleviated hepatic steatosis 
in Zucker obese (fa/fa) rats (Raju and Bird, 2006).  The main mechanism of fenugreek seeds in 
controlling hepatic steatosis was through lowering plasma tumor necrosis factor (TNF)-α, a 
proinflammatory cytokine and by decreasing total fat and triglycerides in the liver (Raju and 
Bird, 2006). Specifically, there are no reports demonstrating the therapeutic potency of 
diosgenin against liver disease. It is postulated that diosgenin feeding causes cholesterol 
excretion in the stool of experimental animals, mainly by cholesterol secretion from the bile 
(Cayen and Dvornik, 1979). Diosgenin has been shown to increase cholesterol secretion five- 
to seven-fold in the bile of rats without altering the output of bile salts and phospholipids 
(Kosters et al., 2005; Nervi et al., 1988; Nibbering et al., 2001). Recently, it was shown that the 
bilary cholesterol secretion stimulated by diosgenin and leading to fecal cholesterol 
excretion is independent of intestinal cholesterol absorption (Temel et al., 2009). 
3. Cancer 
3.1 In vivo studies 
There are limited experimental studies addressing the in vivo tumor modulating potential of 
diosgenin (summarised in Table 2). Diosgenin inhibited the formation of colon aberrant 
crypt foci (ACF), putative precancerous lesions induced by azoxymethane (AOM) in F344 
 
Bioactive Compounds in Phytomedicine 
 
130 
rats. In this study, administration of diosgenin in the diet at a dose of 0.1% and 0.05% 
(wt/wt) either during initiation/post-initiation or promotion stages significantly suppressed 
AOM-induced colon ACF (Raju et al., 2004). The demonstrated ability of diosgenin to inhibit 
both the total number of ACF and large ACF (those with crypt multiplicity of four or more) 
suggests that it could effectively prevent, retard and cease the appearance and growth of 
precancerous lesions in the colon (Raju et al., 2004). Furthermore the lower dose of 0.05% 
was as effective as the higher dose of 0.1% in blocking ACF formation (Raju et al., 2004). In a 
double-blind study designed to assess the tumor-modulating potential of diosgenin using 
the AOM-injected F344 rats, Malisetty et al. (2005) reported that 0.1% of diosgenin 
suppressed the incidence of both invasive and non-invasive colon adenocarcinomas by up to 
60% (Malisetty et al., 2005). In addition, diosgenin decreased colon tumor multiplicity 
(adenocarcinomas/rat) compared to Controls. In part, these in vivo effects were shown to be 
related to a lower proliferating cell nuclear antigen (PCNA) index in colon tumors 
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Raju et al., 2004 
Malisetty et al., 2005 
Miyoshi et al., 2011 
Breast    
MCF-7 tumor xenografts 
MDA 231 tumor xenografts 
Nude (nu/nu) mice 
Nude (nu/nu) mice 
Y 
Y 
Srinivasan et al., 2009 
Srinivasan et al., 2009 
Lung    
LA795 ectopic tumors T739 mice Y Yan et al., 2009 
*Inhibition of either (a) tumor incidence [number of tumor-bearing animals], (b) tumor multiplicity 
[number of tumors per tumor-bearing rats], or (c) tumor size. 
Table 2. In vivo anticancer effects of diosgenin (purified) 
Diosgenin has been shown to attenuate inflammatory process in relevant animal models. 
For instance, diosgenin dose-dependently attenuated sub-acute intestinal inflammation and 
normalized bile secretion in indomethacin-induced intestinal inflammation in rats (Yamada 
et al., 1997). The role of chronic inflammation on carcinogenesis is vital (Dinarello, 2006); 
thus the study by Yamada et al. (1997) demonstrating the ability of diosgenin to effectively 
treat inflammation could be extrapolated to its prospective chemopreventive action against 
cancers. Recently, the efficacy of diosgenin against AOM/dextran sodium sulphate (DSS)-
induced inflammation-associated colon carcinogenesis in ICR mice was reported (Miyoshi N 
et al., 2011). Diosgenin at doses of 20, 100 and 500 mg/kg (wt/wt) in the diet reduced 
AOM/DSS induced ulcers to 53%, 46% and 40%, respectively in comparison to control 
(Miyoshi et al, 2011). While diosgenin did not alter the incidence of colon tumors (adenoma 
+ adenocarcinoma), it reduced the tumor multiplicity significantly at all the three tested 
doses (Miyoshi N et al., 2011). Furthermore, it was shown that diosgenin’s potency against 
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experimentally-induced inflammation-associated colon carcinogenesis was in part mediated 
by the alteration of lipid metabolism (reduced serum triglyceride levels by up-regulation of 
lipoprotein lipase), and the modulation of genes associated with inflammation and multiple 
signaling pathways (Miyoshi N et al., 2011). 
With regards to breast cancer, the effect of diosgenin on the ectopic growth of human breast 
cancer MCF-7 and MDA 231 tumor xenografts was studied in nude mice (Srinivasan et al., 
2009). It was reported that diosgenin (10 mg/kg body weight administered intra-tumorally) 
significantly inhibited the growth of tumor xenografts of both MCF-7 and MDA 231 
compared to vehicle-treated controls, with no toxicity to any of the vital organs in the 
experimental mice (Srinivasan et al., 2009). To test the anti-aging properties of diosgenin in 
relation to hormonal-effects in vivo, Tada et al. (2009) assessed the effect of diosgenin-rich 
Dioscorea Sp. yam tuber extract on the ectopic growth of estradiol-dependent human breast 
cancer (MCF-7) in ovarectomized nude mice for 12 weeks. Diosgenin containing extracts 
was shown to repress the size of the tumors compared to sham controls (Tada et al., 2009). 
Yan et al. (2009) reported that oral administration of diosgenin at a dose of 200 ppm (p.o.) 
significantly inhibited the growth mouse LA795 lung adenocarcinoma tumors by 33.94% in 
T739 inbred mice. 
3.2 In vitro studies 
The anti-cancer effects of diosgenin in vitro through different mechanisms are discussed in 
the following sub-sections. Many molecular candidates critical to tumorigenesis are affected 
by diosgenin (Raju and Mehta, 2009; Raju and Rao, 2009). The in vitro anticancer effects of 
diosgenin and its cellular/molecular effects is summarised in Table 3. 
3.2.1 Colon cancer 
Diosgenin inhibited the growth of HT-29 and HCT-116 human colon adenocarcinoma cells 
(Lepage et al., 2010; Raju and Bird, 2007; Raju et al., 2004). Diosgenin induced apoptosis in 
HT-29 cells, in part by inhibition of bcl-2 and by induction of caspase-3 protein expression 
(Raju et al., 2004). Lepage et al. (2010) reported that in HT-29 cells, diosgenin at 40 µM 
caused delayed apoptosis together with an increase in cyclooxygenase (COX)-2 expression 
and activity, higher 5-lipooxygenase (LOX) expression and enhanced leukotriene B4 
production. COX-2 inhibition by NS-398 strongly sensitized HT-29 cells to diosgenin-
induced apoptosis (Lepage et al., 2010). Furthermore, diosgenin was shown to sensitize HT-
29 cells to TRAIL-induced apoptosis (Lepage et al., 2011). In HCT-116 cells, diosgenin was 
shown to induce apoptosis by the cleavage of the 116 kDa poly (ADP-ribose) polymerase 
(PARP) protein to the 85kDa fragment (Raju and Bird, 2007). In addition, it was shown that 
diosgenin significantly lowered the expression of HMG-CoA reductase at both mRNA and 
protein levels, suggesting the involvement of the cholesterol biosynthetic pathway in 
diosgenin’s efficacy as an anti-cancer agent (Raju and Bird, 2007). 
3.2.2 Breast cancer 
Diosgenin arrested the growth of HER2 oncoprotein-overexpressing AU565 human breast 
adenocarcinoma cells at sub-G1 phase (Chiang et al., 2007). Selective apoptosis induced by 
diosgenin in these cells was found to be through PARP cleavage involving the down- 
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experimentally-induced inflammation-associated colon carcinogenesis was in part mediated 
by the alteration of lipid metabolism (reduced serum triglyceride levels by up-regulation of 
lipoprotein lipase), and the modulation of genes associated with inflammation and multiple 
signaling pathways (Miyoshi N et al., 2011). 
With regards to breast cancer, the effect of diosgenin on the ectopic growth of human breast 
cancer MCF-7 and MDA 231 tumor xenografts was studied in nude mice (Srinivasan et al., 
2009). It was reported that diosgenin (10 mg/kg body weight administered intra-tumorally) 
significantly inhibited the growth of tumor xenografts of both MCF-7 and MDA 231 
compared to vehicle-treated controls, with no toxicity to any of the vital organs in the 
experimental mice (Srinivasan et al., 2009). To test the anti-aging properties of diosgenin in 
relation to hormonal-effects in vivo, Tada et al. (2009) assessed the effect of diosgenin-rich 
Dioscorea Sp. yam tuber extract on the ectopic growth of estradiol-dependent human breast 
cancer (MCF-7) in ovarectomized nude mice for 12 weeks. Diosgenin containing extracts 
was shown to repress the size of the tumors compared to sham controls (Tada et al., 2009). 
Yan et al. (2009) reported that oral administration of diosgenin at a dose of 200 ppm (p.o.) 
significantly inhibited the growth mouse LA795 lung adenocarcinoma tumors by 33.94% in 
T739 inbred mice. 
3.2 In vitro studies 
The anti-cancer effects of diosgenin in vitro through different mechanisms are discussed in 
the following sub-sections. Many molecular candidates critical to tumorigenesis are affected 
by diosgenin (Raju and Mehta, 2009; Raju and Rao, 2009). The in vitro anticancer effects of 
diosgenin and its cellular/molecular effects is summarised in Table 3. 
3.2.1 Colon cancer 
Diosgenin inhibited the growth of HT-29 and HCT-116 human colon adenocarcinoma cells 
(Lepage et al., 2010; Raju and Bird, 2007; Raju et al., 2004). Diosgenin induced apoptosis in 
HT-29 cells, in part by inhibition of bcl-2 and by induction of caspase-3 protein expression 
(Raju et al., 2004). Lepage et al. (2010) reported that in HT-29 cells, diosgenin at 40 µM 
caused delayed apoptosis together with an increase in cyclooxygenase (COX)-2 expression 
and activity, higher 5-lipooxygenase (LOX) expression and enhanced leukotriene B4 
production. COX-2 inhibition by NS-398 strongly sensitized HT-29 cells to diosgenin-
induced apoptosis (Lepage et al., 2010). Furthermore, diosgenin was shown to sensitize HT-
29 cells to TRAIL-induced apoptosis (Lepage et al., 2011). In HCT-116 cells, diosgenin was 
shown to induce apoptosis by the cleavage of the 116 kDa poly (ADP-ribose) polymerase 
(PARP) protein to the 85kDa fragment (Raju and Bird, 2007). In addition, it was shown that 
diosgenin significantly lowered the expression of HMG-CoA reductase at both mRNA and 
protein levels, suggesting the involvement of the cholesterol biosynthetic pathway in 
diosgenin’s efficacy as an anti-cancer agent (Raju and Bird, 2007). 
3.2.2 Breast cancer 
Diosgenin arrested the growth of HER2 oncoprotein-overexpressing AU565 human breast 
adenocarcinoma cells at sub-G1 phase (Chiang et al., 2007). Selective apoptosis induced by 
diosgenin in these cells was found to be through PARP cleavage involving the down- 
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Organ site Cancer cell 
type 
Cellular/molecular targets References 
Colon HT-29 Apoptosis/ bcl-2, caspase-3, 
COX-2, 5-LOX 
Raju et al., 2004 
Lepage et al., 2010; 2011 
 HCT-116 Apoptosis/ PARP, COX-2, 5-LOX
Lipid metabolism/ HMG-CoA 
reductase 
Raju et al., 2007 
Lepage et al., 2010; 2011 
Raju et al., 2007 
Breast AU565 Apoptosis/ PARP, mTOR, JNK 
Lipid metabolism/FAS 
Chiang et al., 2007 
 MCF-7 Growth-proliferation/ Akt, p53 
Apoptosis/ NF-κB, Bcl-2, 
survivin 
Srinivasan et al., 2009 
 MDA 231 Growth-proliferation/ ERK 
Apoptosis/caspase-3, NF-κB, Bcl-
2, survivin 
Srinivasan et al., 2009 
Prostate PC-3 Growth-proliferation/ PI3K, Akt, 
ERK, JNK, NF-κB 
Angiogenesis/ VEGF 
Chen et al., 2011 
 DU145 Growth-invasion/ HGF, mdm2, 
vimentin, Akt, mTOR 
Chang et al., 2011 
Cervix CaSki Growth-proliferation Fernández-Herrera et al., 
2010 
Liver HCC Apoptosis/caspase-3, PARP 
Transcription/ STAT3, cSrc  
Li et al., 2010 
Bone/blood 1547 
osteosarcoma
Apoptosis/ NF-κB, p53, PPAR-γ, 
COX-2 
Corbiere et al., 2003; 2004a 
Moalic et al., 2001 
 RAW-264.7 Growth-proliferation/ NF-κB, 
RANK-L 
Shishodia and Aggarwal, 
2006 
 KBM-5 Growth-proliferation/ NF-κB, 
IκBα, cyclin-D1,  
Shishodia and Aggarwal, 
2006 
 HEL Apoptosis/ PARP, caspase-3, p21
Eicosanoid biosynthesis/ COX-2, 
5-LOX/cPLA2 
Leger et al., 2004a; 2006 
Leger et al., 2004b; Napez 
et al., 1995 
 K562 Apoptosis/ PARP, caspase-3, NF-
κB, COX-2, p38 MAPK 
Liagre et al., 2005 
Larynx HEp-2 Apoptosis/ p53 Corbiere et al., 2004b 
Skin M4Beu Apoptosis/ p53 Corbiere et al., 2004b 
Table 3. In vitro anticancer activities of diosgenin (purified) 
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regulation of phospho-Akt and phospho- mammalian target of rapamycin (mTOR), and up-
regulation of phospho- c-Jun N-terminal kinase (JNK) independent of p38 and extracellular 
signal regulating kinase (ERK) phosphorylations (Chiang et al., 2007). In the same cell-line 
(AU565 cells), diosgenin inhibited the expression of fatty acid synthase (Chiang et al., 2007). 
The anti-cancer mechanism of diosgenin was shown to be different in human breast cancer 
cells based on the status of estrogen receptor (ER) expression (Srinivasan et al., 2009). In ER-
positive MCF-7 human breast cancer cells, diosgenin induced p53 tumor suppressor protein; 
while the pro-apoptotic mechanism of diosgenin in ER-negative MDA human breast 
carcinoma cells involved the activation of caspase-3 and down-regulation of bcl-2 
(Srinivasan et al., 2009). 
3.2.3 Prostate cancer 
Diosgenin inhibited proliferation of PC-3 human prostate cancer cells in a dose-dependent 
manner (Chen et al., 2011). At non-toxic doses, diosgenin suppressed cell migration and 
invasion by reducing the activities and mRNA expression of matrix metalloproteinase (MMP) 
-2 and MMP-9 (Chen et al., 2011). Diosgenin abolished the expression of vascular endothelial 
growth factor (VEGF) in PC-3 cells and tube formation of endothelial cells (Chen et al., 2011). 
In addition, diosgenin downregulated the phosphorylation of phosphatidylinositide-3 kinase 
(PI3K), Akt, ERK and JNK proteins and significantly decreased the nuclear level of nuclear 
factor (NF)-κB, suggesting that diosgenin inhibited NF-κB activity (Chen et al., 2011). Another 
study using DU145 human prostate cancer cells found that diosgenin abrogated hepatocyte 
growth factor (HGF)-induced cell scattering and invasion, together with inhibition of Mdm2 
and vimentin through down-regulation of phosphorylated Akt and mTOR (Chang et al., 2011). 
3.2.4 Cervical cancer 
Recently, Fernández-Herrera et al. (2010) reported the synthesis of a novel 26-hydroxy-22-
oxocholestanic steroid from diosgenin and its anticancer activity against human cervical 
cancer CaSki cells. Mainly this diosgenin-derivative caused apoptosis at non-cytotoxic doses 
activation of caspase-3 along. Furthermore, they report that antiproliferative doses of this 
compound observed in cancer cells did not affect the proliferative potential of normal 
fibroblasts from cervix and peripheral blood lymphocytes (Fernández-Herrera et al., 2010). 
3.2.5 Liver cancer 
Diosgenin was shown to inhibit the proliferation of hepatocellular carcinoma (HCC) cells in 
a dose and time-dependent manner (Liu et al., 2005). Diosgenin caused arrest of HCC cells 
at the G1 phase of the cell cycle and induced apoptosis through caspase-3 activation leading 
to PARP cleavage (Li et al., 2010). In these cells, diosgenin inhibited both constitutive and 
inducible activation of signal transducers and activators of transcription (STAT)3 with no 
effect on STAT5, and suppressed the activation of c-Src, Janus-family tyrosine kinases 
(JAK)1 and JAK2 implicated in STAT3 activation (Li et al., 2010). 
3.2.6 Other cancers 
Cytotoxic effects of diosgenin were reported in human cancer cell lines of various other 
organ types: osteosarcoma (Corbiere et al., 2003, Moalic et al., 2001), leukemia (Liu et al., 
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regulation of phospho-Akt and phospho- mammalian target of rapamycin (mTOR), and up-
regulation of phospho- c-Jun N-terminal kinase (JNK) independent of p38 and extracellular 
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(AU565 cells), diosgenin inhibited the expression of fatty acid synthase (Chiang et al., 2007). 
The anti-cancer mechanism of diosgenin was shown to be different in human breast cancer 
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positive MCF-7 human breast cancer cells, diosgenin induced p53 tumor suppressor protein; 
while the pro-apoptotic mechanism of diosgenin in ER-negative MDA human breast 
carcinoma cells involved the activation of caspase-3 and down-regulation of bcl-2 
(Srinivasan et al., 2009). 
3.2.3 Prostate cancer 
Diosgenin inhibited proliferation of PC-3 human prostate cancer cells in a dose-dependent 
manner (Chen et al., 2011). At non-toxic doses, diosgenin suppressed cell migration and 
invasion by reducing the activities and mRNA expression of matrix metalloproteinase (MMP) 
-2 and MMP-9 (Chen et al., 2011). Diosgenin abolished the expression of vascular endothelial 
growth factor (VEGF) in PC-3 cells and tube formation of endothelial cells (Chen et al., 2011). 
In addition, diosgenin downregulated the phosphorylation of phosphatidylinositide-3 kinase 
(PI3K), Akt, ERK and JNK proteins and significantly decreased the nuclear level of nuclear 
factor (NF)-κB, suggesting that diosgenin inhibited NF-κB activity (Chen et al., 2011). Another 
study using DU145 human prostate cancer cells found that diosgenin abrogated hepatocyte 
growth factor (HGF)-induced cell scattering and invasion, together with inhibition of Mdm2 
and vimentin through down-regulation of phosphorylated Akt and mTOR (Chang et al., 2011). 
3.2.4 Cervical cancer 
Recently, Fernández-Herrera et al. (2010) reported the synthesis of a novel 26-hydroxy-22-
oxocholestanic steroid from diosgenin and its anticancer activity against human cervical 
cancer CaSki cells. Mainly this diosgenin-derivative caused apoptosis at non-cytotoxic doses 
activation of caspase-3 along. Furthermore, they report that antiproliferative doses of this 
compound observed in cancer cells did not affect the proliferative potential of normal 
fibroblasts from cervix and peripheral blood lymphocytes (Fernández-Herrera et al., 2010). 
3.2.5 Liver cancer 
Diosgenin was shown to inhibit the proliferation of hepatocellular carcinoma (HCC) cells in 
a dose and time-dependent manner (Liu et al., 2005). Diosgenin caused arrest of HCC cells 
at the G1 phase of the cell cycle and induced apoptosis through caspase-3 activation leading 
to PARP cleavage (Li et al., 2010). In these cells, diosgenin inhibited both constitutive and 
inducible activation of signal transducers and activators of transcription (STAT)3 with no 
effect on STAT5, and suppressed the activation of c-Src, Janus-family tyrosine kinases 
(JAK)1 and JAK2 implicated in STAT3 activation (Li et al., 2010). 
3.2.6 Other cancers 
Cytotoxic effects of diosgenin were reported in human cancer cell lines of various other 
organ types: osteosarcoma (Corbiere et al., 2003, Moalic et al., 2001), leukemia (Liu et al., 
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2005) and erythroleukemia (Leger et al., 2004a). The growth of 1547 human osteosarcoma 
cells was inhibited through G1 phase cell cycle arrest and induction of apoptotic demise; and 
the main the mechanism involved the activation of p53 and binding of NFB to DNA 
independent of PPAR- (Corbiere et al., 2003, 2004a). Interestingly, diosgenin’s effect in 
suppressing osteoclastogenesis in RAW-264.7 cells was reported to follow a pro-apoptotic 
mechanism through receptor activated NFB ligand (RANK-L) induction (Shishodia and 
Aggarwal, 2006). Moalic et al. (2001) demonstrated that diosgenin inhibited COX-2 activity 
and expression in human osteosarcoma 1547 cells. 
Diosgenin arrested chronic myelogenous leukemia KBM-5 cells of human origin at sub-G1 
phase of cell cycle arrest (Shishodia and Aggarwal, 2006). This cell cycle arrest was 
correlated to the inhibition of tumor necrosis factor (TNF)-dependent NF-B activation and 
TNF-induced degradation and phosphorylation of IB (the inhibitory subunit of NF-B) 
(Shishodia and Aggarwal, 2006). Diosgenin downregulated TNF-induced cyclin D1 in KBM-
5 cells (Shishodia and Aggarwal, 2006). Furthermore it abolished both basal and TNF-
induced COX-2 gene products in a time-dependent manner (Shishodia and Aggarwal, 2006).  
Diosgenin controlled the growth of human erythroleukemia TIB-180 (HEL) cells by arresting 
cells at G2/M cell cycle and inducing apoptosis through PARP cleavage, activation of 
caspase-3 and up-regulation of p53-independent p21 (Leger et al., 2004a, 2004b, 2006). 
Diosgenin treatment to HEL cells induced cytosolic phospholipase (cPL)A2 activation 
through translocation to the cellular membrane together with an increase in COX-2 
expression (Leger 2004b).  In a study by Nappez et al. (1995), it was reported that diosgenin 
treatment in HEL cells did not affect 5-LOX mRNA or 5-LOX activating protein (FLAP) 
mRNA at the transcriptional level. However, when HEL cells undergoing differentiation 
were incubated with diosgenin in the presence of indomethacin (a COX inhibitor), the 
growth inhibitory effect of diosgenin was reversed and an exponential growth kinetic of 
undifferentiated cells was observed (Nappez et al., 1995). Taken together, these studies 
provide an insight into the role of 5-LOX in diosgenin’s modulation of growth and 
differentiation in HEL cells. Leger et al. (2004b) demonstrated that diosgenin increased the 
synthesis of arachidonic acid in HEL cells leading to COX-2 overexpression, which was 
accompanied by apoptosis induction. The anticancer activity of diosgenin was also shown in 
human erythroleukemia K562 cells through caspase-3-activation dependent PARP-mediated 
pro-apoptotic effects (Liagre et al., 2005). Diosgenin induced COX-2-independent apoptosis 
through activation of the p38 MAP kinase signalling pathway and inhibition of NFB 
binding in COX-2 deficient K562 cells (Liagre et al., 2005). The anticancer mechanism of 
diosgenin was also shown in laryngocarcinoma HEp-2 and melanoma M4Beu cells through 
a p53-dependent cell death meachnism (Corbiere et al., 2004b). 
4. Other diseases and ailments 
A clinical study by Turchan-Cholewo et al. (2006) reported that diosgenin may have 
therapeutic potential against an increased risk of developing dementia in opiate abusers 
with HIV infection. Recently, the effect of diosgenin on hepatitis C virus (HCV) replication 
was reported (Wang et al., 2011). Based on a reporter-based HCV subgenomic replicon 
system, diosgenin was found to inhibit HCV replication at low µM concentrations in vitro 
(Wang et al., 2011). Furthermore, a combination of diosgenin and interferon-α exerted an 
additive effect on the resultant anti-HCV activity (Wang et al., 2011). The neuroprotective 
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effect of diosgenin against d-galactose-induced senescence in mice by improving cognitive 
abilities as assessed through the Morris water maze test and mediated by enhancing 
endogenous antioxidant enzyme activities (Chiu et al., 2011). Diosgenin induced apoptosis 
in non-cancerous human rheumatoid arthritis synoviocytes (RAS) through the 
overexpression of COX-2 protein and concomitant increase in the level of prostaglandin 
(PG)-E2 (Liagre et al., 2004, 2007). Diosgenin may be an effective inhibitor of 
hyperpigmentation, commonly seen in skin disorders and inhibits melanogenesis by 
activating the PI3K pathway and (Lee et al., 2007). A novel effect of diosgenin in restoration 
of keratinocyte proliferation in aged skin in an animal model suggests that diosgenin may 
have a potential in slowing the aging process in the skin commonly associated with 
climacteric (Tada et al., 2009). Recent data support the possibility that some diosgenin-
glycoside derivatives may represent a new type of contractile agonist for the uterus and 
their synergism may be responsible for their therapeutic effect against abnormal uterine 
bleeding (Yu et al., 2010). 
5. Safety 
There is a claim that diosgenin has an endocrine effect (estrogen-like or progesterone-like 
activity) in humans, however there is no scientific evidence to its validation (Djerassi et al., 
1952; No authors listed, 2004). Diosgenin is neither synthesized nor metabolically converted 
into steroid by-products in the mammalian body. Toxicology studies using relevant 
experimental models have established that even at an upper concentration of 3.5% (wt/wt), 
diosgenin was safe and failed to cause systemic toxicity, genotoxicity, or estrogenic activity 
(63). Qin et al. (2009) reported that ethanol extracts of Dioscorea sp. containing 28.34% 
(wt/wt of lyophilized powder) did not cause any signs of acute toxicity in mice at an upper 
tested dose of 562.5 mg/kg/d, and did not significantly change toxicological parameters up 
to a dose of 255 mg/kg/d. No acute renal or hepatic toxicity associated with the 
administration of extracts of Dioscorea villosa at an oral dose of 0.79 g/kg/d (Wojcikowski et 
al., 2008). However, an increase in fibrosis in the kidneys and in inflammation in livers when 
rats were on the dose for 28 days was reported in the same study (Wojcikowski et al., 2008). 
Thus it was concluded that these toxicology effects be considered when consuming these 
extracts on a long-term basis, especially in people with compromised renal or hepatic 
function (Wojcikowski et al., 2008). On the other hand, in a 90-day subchronic study, rats fed 
fenugreek seeds, at doses between 1% and 10% in pure diet, had no toxic effects 
(Muralidhara et al., 1999). Typically, fenugreek seeds are known to contain ∼0.42% to 0.75% 
diosgenin depending on the cultivars and seed quality (Taylor et al., 2000). Fenugreek seed 
extract evaluated using the standard battery of tests (reverse mutation assay, mouse 
lymphoma forward mutation assay and mouse micronucleus assay) recommended by US 
Food and Drug Administration (FDA) for food ingredients came negative and thus rendered 
safe for consumption at the therapeutic doses tested (Flammang et al., 2004). A recent study 
using human sera indicated that fenugreek seed powder contains several proteins that 
potentially act as allergens (Faeste et al., 2009); however, it remains unclear if diosgenin in 
interaction with any proteins would test positive in these allergen tests. More studies are 
warranted to understand the toxicological effects of diosgenin at both levels present in 
common foods as well as therapeutic doses. Although there is toxicology data with regards 
to diosgenin-rich botanicals such as Dioscorea sp. yam tubers and fenugreek seeds, there is a 
clear lack of data studying the safety of diosgenin per se. Some of the important aspects for 
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future studies assessing the toxicology of diosgenin include those related to developmental 
toxicity, neurotoxicity and allergenicity. 
6. Conclusions 
With changing lifestyle patterns such as diet and physical activity combined with factors 
such as genetic predispositions and smoking, the incidences of metabolic diseases including 
diabetes and obesity and certain kinds of cancers are increasing worldwide and hence are a 
public health concern with major economic impacts. While the pathogenesis of these 
diseases is different, there appears to be one or more molecular candidates that are 
commonly up- or down-regulated leading to the notion that these could be common 
molecular targets in prevention or therapeutic interventions of diseases. Ethnomedicine has 
been instrumental in providing important clues as to the role herbs and foods and their 
bioactive constituents in disease prevention and therapy; however, rigorous experimental-
based evidence in support of ethnomedicine-derived notions would lead to the 
development of products relevant to and drug development. Several naturally-occurring 
compounds such as those in edible plants or spices are known to target multiple molecular 
pathways of signalling, thus bestowing them a broad preventive/therapeutic potential 
against several diseases. For example, curcumin from turmeric, resveratrol from grapes and 
epigallocatechin gallate (EGCG) from green tea have shown excellent pre-clinical potency 
against a wide range of diseases (reviewed in Epstein et al., 2010; Marques et al., 2009; Saito 
et al., 2009). These natural compounds have also been tested in clinical trials as potential 
therapeutics against several diseases. One emerging natural compound of interest with 
similar potency as curcumin, resveratrol and EGCG is diosgenin. In the above sub-sections, 
we have discussed in detail, the health promoting effects of diosgenin and diosgenin-rich  
 
Fig. 2. Schematic representation depicting the molecularmode of action of diosgenin in the 
control of metabolic pathway. Diosgenin plausibly regulates signaling molecules in fatty 
acid metabolism and inflammatory pathway. Insulin and IGF-1 mediated signalling 
pathways may also be regulated by diosgenin and are thus candidates for future studies 
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sources: (a) Dioscorea sp. yam tubers and (b) Trigonella sp. (fenugreek) seeds. In addition, we 
have summarised the toxicology data pertaining to the safe use of diosgenin either in a pure 
form (where data was available) or in extracts. The health promoting effects of diosgenin 
can be broadly divided according to the differential molecular mechanisms it elicits. First, 
there is a growing body of experimental evidence suggesting the use of diosgenin in the 
treatment of metabolic diseases. Much of this is rendered through diosgenin’s capacity to 
lower lipids in the blood and perhaps in tissues such as liver and adipose tissue. To date, 
there is some evidence that implicates both inflammatory pathway-associated NFκB and 
fatty acid metabolism-associated HMG-CoA reductase and FAS as potential molecular 
targets of diosgenin (Chiang et al., 2007; Raju and Bird, 2007), and these may be extended to 
its role as a therapeutic against metabolic diseases (Figure 2). Pathways associated with 
insulin and insulin-like growth factor (IGF)-1 may be of relevance in understanding the 
molecular mechanism of diosgenin’s action in the control of metabolic diseases (Figure 2). 
Second, the role of diosgenin in modulating cancers has been substantially addressed; most 
of these data are related to the growth and proliferation of human cancer cell types and its 
potential mechanism(s) of action in vitro. Several molecular candidates associated with fatty 
acid metabolism (Chiang et al., 2007; Raju and Bird, 2007), inflammatory pathway (Leger et 
al., 2006; Liagre et al., 2005; Shishodia and Aggarwal, 2006), eicosanoid biosynthesis (Leger 
et al., 2004; Lepage et al., 2010; 2011; Moalic et al., 2001; Napez et al., 1995), cell proliferation 
and growth (Chiang et al., 2007; Leger et al., 2006; Srinivasan et al., 2009), apoptosis 
(Corbiere et al., 2004; Leger et al., 2006; Lepage et al., 2010; 2011; Raju and Bird, 2007; Raju et 
al., 2004), and regulation of transcription (Chiang et al., 2007; Li et al., 2010) are affected (up- 
or down-regulated) by diosgenin leading to tumor cell death (Figure 3). 
 
Fig. 3. Schematic representation of plausible mechanism of action(s) of diosgenin at the 
cellular level as a cancer chemopreventivel/therapeutic agent. Diosgenin up- or down-
regulates several molecular candidates associated with cell proliferation and growth, 
apoptosis, regulation of transcription, fatty acid metabolism, inflammatory pathway and 
eicosanoid biosynthesis leading to tumor cell death. 
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While there are ample in vivo studies available to implicate the beneficial effects of diosgenin 
against metabolic disease, more studies to understand the specific modes of action at the 
molecular level are warranted. On the contrary, substantial in vitro evidence exists to 
understand the molecular mechanism of action of diosgenin against several cancers. More in 
vivo studies are thus essential to understand the physiological relevance of such data in 
controlling cancers. Moreover, there is excellent opportunity to address whether diosgenin 
plays a role in chemoprevention versus therapy, or both, in cancers of various organ sites 
using relevant models. The health beneficial effects of diosgenin are further extended to its 
potential role to treat other ailments such as HIV and hepatitis-C infections as well as liver 
diseases. There is little information regarding the bioavailability, pharmacokinetics and 
pharmacodynamics of diosgenin in relation to its health beneficial effects. Diosgenin and 
diosgenin-containing products are emerging in the market and are being promoted as 
natural health products. The scientific knowledge in this area is limited and hence extensive 
pre-clinical and clinical research should be carried out prior to advocating the safe and 
efficacious use of diosgenin and diosgenin-rich plant extracts against the prevention and 
control of diseases. Furthermore, such research will assist in the development of evidence-
based regulation of diosgenin and disogenin-containing products as they become 
increasingly popular and enter the market. 
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1. Introduction 
It is well-established from numerous population-based observational studies, that 
consumption of polyphenol-rich foods, principally fruits and vegetables is beneficial to 
health, reducing mortality rates and the incidence of the major diseases of modern 
civilisation, cancer and cardiovascular disease (Stevenson & Hurst, 2007). Until relatively 
recently, it was widely believed that these health benefits were mediated by free radical-
scavenging antioxidants, i.e., vitamins C and E and polyphenols, all compounds with high 
antioxidant capacity when measured by in vitro chemical tests such as “ORAC”. A large 
body of research, however, has not found a conclusive link between the apparent health 
benefits of polyphenols and their antioxidant capacity. In addition, supplementation with 
vitamins C and E, which are thought to operate in the body by radical scavenging, has been 
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2.1 Mitochondria generate metabolic energy and ROS 
Mitochondria are responsible for the bulk of cellular energy production (Scheffler, 2008), 
with only a small proportion being accounted for by the glycolytic pathway. The “electron 
transport chain” (ETC – Figure 1) oxidises NADH, one output from the TCA acid cycle 
(Brookes, 2005). This generates electrons, which are transferred through the various 
components of the ETC, ultimately reducing oxygen to water. In the process, a membrane 
potential (or proton gradient) is generated by the five ETC complexes pumping protons 
across the mitochondrial membrane. The return flow of protons through ATP synthase 
drives ATP synthesis from ADP. The ATP produced during this process is the main energy 
source used by cells and tissues.  
 
Fig. 1. Schematic summarising the main features of mitochondrial metabolism (Brookes, 
2005). Electrons (e_) from the NADH to NAD+ transition are transferred between electron 
donors and acceptors, in the process generating energy to pump protons outside the inner 
membrane. The resulting proton gradient can leak back through the membrane or through 
uncoupling proteins, but most flow through Complex V (ATP synthase) and power ATP 
synthesis. Complex I (Cx I, NADH dehydrogenase) passes electrons to Complex III (Cx III, 
cytochrome bc1) via Q (ubiquinone). Complex II (Cx II, succinate dehydrogenase) delivers 
more electrons via Q, while Complex IV (Cx IV, cytochrome C oxidase) accepts electrons 
from Cx III, carried by cytochrome C and uses them to reduce oxygen to water. 
The ETC is not 100% efficient and some oxygen molecules are incompletely reduced into the 
free radical (or reactive oxygen species – ROS) superoxide (Scheffler, 2008; Dorta et al., 
2006). Superoxide can in turn generate other ROS species. The production of ROS by muscle 
cells is greatest during exercise, and the condition arising when ROS increase to damaging 
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levels, is termed “oxidative stress” (Powers & Jackson, 2008). Mitochondria are the major 
source (approx. 90%, the remainder coming from immune system action and the 
environment) of ROS in the body (Ristow et al., 2009), but in healthy and especially, 
physically fit individuals, the mitochondria are also well-equipped with antioxidant 
enzymes to inactivate ROS before they can do more than minor damage to DNA or other 
vital cellular components (Hu et al., 2007).  
The mitochondrial form of the antioxidant enzyme superoxide dismutase (SOD), 
Manganese , or MnSOD, converts superoxide into hydrogen peroxide, which is not in itself a 
radical, but easily forms one (Hu et al., 2007). This is, in turn, reduced to water by a 
mitochondrial form of another enzyme, glutathione peroxidase (GPX) (Dorta et al., 2006). 
The cell cytosol has a different form of SOD (Copper Zinc, or CuZnSOD) and a different 
enzyme, catalase, is primarily responsible for removing hydrogen peroxide (Dinkova-
Kostova & Talalay, 2008). Under most circumstances, mitochondria in healthy cells leak only 
a tiny proportion of ROS into the cytoplasm. ROS generation and leakage increase markedly 
in unhealthy cells during e.g., exhaustive exercise, because the ETC becomes much less 
efficient when working close to its maximum capacity. 
2.2 Mitochondrial adaptation to oxidative stress 
It is well established that exercise increases the mitochondrial content of muscle fibres 
(known as mitochondrial biogenesis or MB) and consequently their respiratory capacity 
(Holloszy & Coyle, 1984; Hood et al., 2006; Huang & Hood, 2009). More recently, the 
increase in ROS generation during exercise has been found to be the primary signal for this 
adaptive effect of exercise (Ji et al., 2008). The benefit to the organism of MB is greater 
energy generation capacity and reduced ROS generation for a given energy output. 
Although it might be expected that increases in mitochondrial/ETC density would lead to 
increased respiration and ROS production, the opposite actually appears to be the reality. 
ROS are primarily produced when the flow of electrons through the ETC is limited later in 
the chain (Barros et al., 2004; Kushnareva et al., 2002). Under these conditions, electrons back 
up and start to leak out of the complexes earlier in the chain, thereby generating ROS. Under 
conditions of rigorous exercise, for example, oxygen, the final electron acceptor, would be in 
limited supply, thus flow of electrons from Complex IV to oxygen would be limited and 
leakage would occur, primarily from Complex I (Brookes, 2005). There is strong supporting 
evidence for the link between limited electron flow and ROS generation. Compounds that 
inhibit any of the ETC complexes cause backing-up of electrons and increased ROS 
production (Cadenas & Boveris, 1980). The Complex III inhibitor antimycin A increased 
superoxide production in an in vitro cell model (Dairaku et al., 2004). Inhibition slows the 
flow of electrons through the ETC and increases the probability of incomplete reduction of 
oxygen, thereby making superoxide generation more likely. 
Moderate regular exercise is reported to induce a low level of ROS, which is thought to up-
regulate antioxidant/repair enzymes and consequently to reduce ROS-associated diseases 
(heart disease, type 2 diabetes, rheumatic arthritis, Alzheimer’s and Parkinson’s diseases, 
and certain cancers) (Radak et al., 2008; Ji et al., 2008; Jackson, 2008). Another 
complementary benefit is that increased mitochondrial respiration capacity and/or MB 
should reduce resting ROS generation and reduce the effects of aging (Lopez-Lluch et al., 
2006). This comes about because ROS generation is highest when the flow of electrons 
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through the ETC is limited. Increased respiratory capacity permits faster electron flow and 
lowers basal ROS generation. High basal ROS generation is thought to be the main factor 
causing aging (Cadenas & Davies, 2000), through damage to mitochondrial DNA. Whereas 
nuclear DNA is heavily protected from damage by ROS, mitochondrial DNA is located in 
the inner mitochondrial membrane, close to the ETC complexes and very exposed to 
damage from ROS. It is thought that damage to mitochondrial DNA leads to synthesis of 
defective ETC protein subunits and thereby, defective ETCs, which generate less energy and 
more ROS. A negative feedback loop then results in further increase in ROS generation and 
DNA damage, to both mitochondrial and nuclear DNA (Huang & Hood, 2009; Droge, 2002).  
2.3 Mitochondrial adaptation - a new mechanism of antioxidant action? 
It is reasonable to assume that, if exercise-induced oxidative stress is the primary signal 
leading to mitochondrial adaptation and consequently, increased respiratory capacity and 
decreased basal ROS production, then other sources of oxidative stress could generate 
similar adaptations. This is an excellent example of the principle of hormesis (Calabrese, 
2008), i.e., a non-linear, adaptive, dose response to a toxin. High doses of ROS are clearly 
harmful, but low doses appear to be essential to initiate the signalling pathways that lead to 
beneficial adaptive responses. A hypothesis has been proposed recently to explain how 
oxidative stress induces mitochondrial adaptation to improve efficiency of energy 
generation, thereby improving physical fitness and general health, ameliorating health 
issues such as metabolic syndrome and diabetes and above all, increasing life span (Nunn et 
al., 2009, 2010). Oxidative stressors that are proposed to induce mitochondrial adaptation 
include exercise, calorie restriction, ionising radiation and most relevant to this discussion, 
phytochemical “pro-oxidants” (Nunn et al., 2009; Ristow & Zarse, 2010). The ways in which 
exercise and polyphenols generate oxidative stress are discussed below. Ionising radiation 
generates ROS directly, from any molecule encountered (Harman, 1956), thereby causing 
oxidative stress. Calorie restriction stimulates increased respiration that also leads to 
oxidative stress (Guarente, 2008; Tapia, 2006).  
2.4 Signalling pathways that control mitochondrial adaptation 
It is thought that mitochondrial adaptation to exercise is primarily brought about by a 
complex signalling cascade, which is initiated by increased generation of ROS (Droge, 2002) 
generated by the mitochondria during exercise. The most important aspect of this 
adaptation is MB i.e., an increase in the number and mass of mitochondria and/or an 
increase in the density of ETC complexes (Hoppeler et al., 1973; Baar et al., 2002; Holloszy & 
Coyle, 1984). Most mitochondrial proteins, including those that make up the ETC, are 
actually encoded by nuclear genes (Scheffler, 2008) and these are regulated by nuclear 
respiratory factors (Nrf) including Nrf-1 and Nrf-2 (Hawley & Holloszy, 2009). These Nrfs 
activate genes that encode mitochondrial respiratory chain proteins. Nrf-1 also up-regulates 
expression of mitochondrial transcription factor A (TFAM), which is transported into the 
mitochondria and regulates transcription of the mitochondrial genome (Hawley & Holloszy, 
2009). Expression of mitochondrial fatty acid oxidation enzymes is regulated by peroxisome-
proliferator coactivator 1- (PGC1-) (Baar et al., 2002; Lopez-Lluch et al., 2006; Poderoso et 
al., 2000). Sirtuin1 (a regulatory protein deacetylase, is discussed further in Section 5.1) is 
thought to be involved in deacetylating and thus activating PGC-1, which, in turn, co-
activates peroxisome-proliferator activated receptor- (PPAR-).  
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PPAR- is primarily a receptor for fatty acids, which regulates fatty acid oxidation, but it can 
apparently also be activated by a number of natural products, including some polyphenols 
(Huang et al., 2005). The anti-diabetic drugs “glitazones” are known to activate PPAR- and 
have also been shown in vitro to induce MB and reduce mitochondrial ROS production 
(Fujisawa et al., 2009). Polyphenols isolated from red wine, particularly ellagic acid and 
epicatechin gallate (ECG), were able to activate PPAR in vitro with similar affinity to the 
reference pharmaceutical compound rosiglitazone (Zoechling et al., 2011). A number of 
studies on resveratrol, another polyphenol found in red wine, suggest that many of its 
purported beneficial effects are mediated by its stimulation of PGC1- signalling (Tan et al., 
2008). Interactions with PPAR therefore appear to be a possible means for polyphenols to 
influence mitochondrial adaptation. These interactions may be mediated through direct 
binding to and activation of PPAR, or indirectly through its co-activator PGC1-. 
2.5 How do ROS interact with signalling pathways? 
One uncertainty in our knowledge of the MB signalling pathway is how an increase in ROS 
generation initiates signalling. One possible mechanism involves oxidised lipids and the 
Electrophile (or Antioxidant) Response Element (ERE, or ARE). Mitochondria are primarily 
composed of membranes into which the ETC complexes are embedded. The lipids in these 
membranes should be highly susceptible to peroxidation by superoxide generated in their 
immediate vicinity. One species of breakdown products known to arise from lipid 
peroxidation is a number of conjugated aldehydes such as 4-hydroxy-2-nonenal (HNE) 
(Uchida et al., 1999). Conjugated aldehydes and ketones are also potent activators of the ERE 
(Dinkova-Kostova & Talalay, 2008). The ERE itself is a regulatory region in nuclear DNA 
that controls the expression of a series of cytoprotective proteins, including a number of 
antioxidant enzymes, cytochrome P-450 xenobiotic hydroxylases and xenobiotic conjugative 
enzymes (Dinkova-Kostova & Talalay, 2008). The transcription factor that controls the ERE 
is Nrf2, which is normally bound to the sensory protein Keap1. Binding of an inducer, such 
as HNE, or phytochemicals such as curcumin, some polyphenols or sulphoraphane releases 
Nrf2, which activates the ERE and the proteins it regulates (Dinkova-Kostova & Talalay, 
2008). It is possible that the ERE and Nrfs are a link between lipid peroxidation by ROS and 
the signalling pathway for MB. It appears from this discussion that one of the potential 
mechanisms for the adaptive effects of polyphenols and other phytochemicals is direct 
interaction with the MB signalling pathway, through direct activation of either PPAR 
receptors or the ERE, through interaction with its regulatory protein Keap1. 
3. Effect of exercise on mitochondria 
This area of science has been subjected to intensive research for at least two decades and is 
now well understood. The mechanisms of action of exercise in mitochondrial adaptation 
would reasonably be expected to be very similar to those of other adaptogens, such as 
polyphenols, if they work through generation of oxidative stress. Evidence that polyphenols 
can have a hormetic effect through generation of oxidative stress is discussed below. 
Exercise science should, therefore, be a good source of insights into the mechanistic details 
of how polyphenols should interact with mitochondria, as well as providing validated 
assays to monitor these effects both in vitro and in vivo.  
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(Uchida et al., 1999). Conjugated aldehydes and ketones are also potent activators of the ERE 
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3.1 Macroscopic effects of exercise 
The well-known benefits of exercise in weight management have been explored by a 
comparison of mitochondrial metabolism between trained athletes and sedentary 
individuals (Befroy et al., 2008). The athletes had a 53% higher resting TCA cycle flux, but 
the same ATP synthesis rate as the sedentary individuals. Essentially, the athletes appeared 
to have much higher mitochondrial respiration capacity, which “wasted” energy in the 
resting state, thereby raising their metabolic rate. As discussed above (Section 3.2), it would 
be reasonable to expect that the athletes’ mitochondria would generate less ROS than the 
sedentary controls in a resting state, because of greater mitochondrial capacity and 
efficiency, in spite of their higher metabolic rate.  
3.2 Antioxidants may inhibit exercise-induced mitochondrial adaptation 
If the mechanism underlying the adaptive effects of exercise is initiated by increased 
oxidative stress, i.e., ROS production, then logically, radical-scavenging antioxidants may be 
expected to at best have no effect, or at worst hinder adaptations. A number of studies on 
the use of radical-scavenging antioxidants, i.e., vitamins C and E, appear to support this 
hypothesis. In a comparison between “Ironman” triathletes and untrained controls, the 
triathletes had higher resting plasma levels of glutathione peroxidase (GPX), catalase, and 
superoxide dismutase (SOD), plus lower malondialdehyde (MDA, a biomarker of lipid 
peroxidation). Participation in the Ironman event then lowered the athletes’ antioxidant 
enzymes and raised MDA. Triathletes who took antioxidant supplements had greater 
increases in MDA than those that did not (Knez et al., 2007). This suggests that training-level 
exercise up-regulates antioxidant defences, but competition-level exercise suppresses them. 
Antioxidant supplements taken during training may cause further suppression of 
endogenous antioxidant defences. Supplementation of both trained and untrained subjects 
during a one-month training programme revealed that the supplements suppressed several 
early biomarkers of mitochondrial adaptation, including expression of PGC1-, PPAR-, 
SOD2 and GPX1 (Ristow et al., 2009). It appears, however, that there is no overall inhibition 
of exercise adaptation resulting from antioxidant supplementation because no effect on 
markers of oxidative stress or on increases in training-induced muscle performance was 
identified (Theodorou et al., 2011).  
It appears reasonable to suggest that exercise is an antioxidant in itself, because it leads to 
significant up-regulation of antioxidant enzymes in humans (Gomez-Cabrera et al., 2006; 
Gomez-Cabrera et al., 2008). Similarly, SOD2, the specific mitochondrial form of the 
enzyme, was induced in rodents by exercise (Higuchi et al., 1985). Although antioxidant 
supplementation appears to be of no benefit to most sports training, it may be useful if 
applied in a well-planned and timely manner, to protect untrained individuals from the 
most damaging effects of high ROS production at the start of a fitness programme (Vincent 
et al., 2006). These findings are consistent with the hormetic hypothesis of polyphenol-
stimulated mitochondrial adaptation. It seems reasonable to conclude that if radical-
scavenging antioxidants inhibit the signalling of mitochondrial adaptive effects, but 
polyphenols promote them, then polyphenols are not primarily acting as radical-scavenging 
antioxidants in vivo. 
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4. Evidence that polyphenols can induce mitochondrial adaptation 
4.1 Polyphenols may be able to regulate Sirtuins 
“Sirtuins” are a family of regulatory protein deacetylases, coded by SIRT genes. Sirtuin1 is 
thought to play a role in regulation of MB (see above). SIRT1 activation by a synthetic 
activator was found to up-regulate lipid oxidation (a pathway located in the mitochondria), 
suggesting potential in treatment of obesity, diabetes and metabolic disorders (Feige et al., 
2008). Mice over-expressing SIRT1 showed a phenotype resembling calorie restriction, 
supporting the involvement of the SIRT1 pathway (and by implication, MB) in adaptations 










































Fig. 2. Chemical structures of the compounds most often referred to in the text. 
It has been demonstrated in vitro, that polyphenolics, particularly resveratrol, can enhance 
the activity of the recombinant human sirtuin coded by SIRT1, apparently by a 
conformational change to the enzyme. Resveratrol at 10 M also extended the lifespan of 
yeast from ~23 to ~37 generations (Howitz et al., 2003). Chemical derivatives of resveratrol 
appear to be even more effective (Yang et al., 2007), suggesting that these compounds in 
some way decrease the DNA damage associated with aging. These enzyme-activation 
results have been questioned by subsequent studies (Grubisha et al., 2005; Kaeberlein et al., 
2005) on the grounds that resveratrol required highly supra-physiological concentrations (a 
3-fold activation at 20 M) and a non-physiological substrate to have a measurable effect. 
Observations that the plasma concentration of resveratrol from a realistic dose is in the 
nanomolar range and that it exists in vivo almost entirely as conjugates, rather than as free 
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resveratrol (Goldberg et al., 2003) cast further doubt on sirtuin activation as a key 
mechanism in vivo. It appears more likely that direct sirtuin activation is only a very minor 
mechanism of MB stimulation by polyphenols in vivo.  
4.2 Inhibition of the ETC by polyphenols 
It is well-established that inhibitors of the ETC increase ROS generation (Cadenas & Boveris, 
1980). It has been shown, in vitro, that flavonoids can inhibit specific mitochondrial 
functions, including NADH oxidase (Hodnick et al., 1986), F1-ATPase (Gledhill et al., 2007) 
and the membrane permeability transition (Santos et al., 1998). Other in vitro studies found 
that polyphenols inhibited overall mitochondrial respiration (Hodnick et al., 1987) and the 
closely related rate of ATP generation (Dorta et al., 2005). The former study also detected a 
burst of ROS generation associated with the inhibition of respiration. A wide range of 
compounds was tested in these studies, to the extent that structure-activity relationships 
were established. The two best classes of compound appeared to be stilbenes (e.g., 
resveratrol) and flavonols (e.g., quercetin). These findings suggest that polyphenols, if they 
were able to access the mitochondria in vivo, could directly but transiently increase ROS 
generation, thereby inducing beneficial adaptations in a similar way to exercise.  
4.3 Can polyphenols access mitochondria to exert biological effects? 
The ability of a compound to inhibit mitochondrial metabolism strongly suggests, but does 
not prove, that it can access the interior of the mitochondria. Several in vitro studies, 
however, have provided indirect evidence to support the potential of polyphenols to access 
the interior of mitochondria in vivo. In a study of the effects of treatment with EGCG on rat 
neuronal cells in vitro, in which the cells were fractionated to isolate the mitochondria, 90-
95% of the detectable EGCG was present in the mitochondrial fraction (Schroeder et al., 
2009). Similarly, quercetin was rapidly and extensively absorbed by Jurkat cells and their 
isolated mitochondria, as well as by the mitochondria of preloaded cells (Fiorani et al., 2010). 
When isolated rat kidney mitochondria were treated with quercetin, various changes 
consistent with access of quercetin to the interior of the mitochondria were observed, 
including increased mitochondrial membrane permeability and oxygen consumption, but 
decreased membrane potential and oxidative phosphorylation (Ortega & Garcia, 2009). It 
thus appears that mitochondria would be easily able to absorb significant concentrations of 
polyphenols, provided the intracellular concentrations around them were high enough. 
4.4 Bioavailability and access of polyphenols to mitochondria in vivo 
Studies in vitro can only indicate potential for in vivo effects; to date there is very little 
direct evidence to support “mitochondrial bioavailability” in vivo. The many hundreds of 
polyphenol bioavailability studies done in vivo have only measured concentrations of 
polyphenols and their metabolites in plasma and/or urine; this proves only that the 
compound or compounds got as far as the circulatory system (Stevenson et al., 2008). A 
radioactive tracer approach is also unable to resolve the intracellular location of the 
radioactivity or the specific chemical compound involved. Studies on animals find 
radioactivity in all tissues in the body, but cannot distinguish between the original 
polyphenol, a conjugate or some much simpler breakdown product (Stevenson et al., 2008). 
This approach is also unable to resolve the intracellular location of the radioactivity. 
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Polyphenol feeding studies on pigs have found polyphenols at micromolar concentrations 
in a variety of tissues and organs (Bieger et al., 2008; Kalt et al., 2008; Kalt et al., 2007), but 
one concern with these studies is that entrained blood may not have been completely 
removed, thus casting doubt on the actual concentrations in the tissues. On balance, it seems 
probable that polyphenols can access tissues and therefore cells in vivo, but probably in the 
form of conjugated metabolites or breakdown products, rather than the unconjugated forms 
tested in vitro. We therefore have no solid evidence of the mitochondrial bioavailability in 
vivo of the polyphenols tested in vitro. A number of in vivo trials (discussed in later 
sections) have successfully detected physiological changes consistent with mitochondrial 
adaptation, linked to dosing with polyphenols, suggesting that polyphenols or their 
metabolites can in some way stimulate mitochondrial adaptation, but these trials give little 
information on how these effects could be mediated. 
4.5 In vitro evidence for mitochondrial adaptation by polyphenols 
The in vitro studies reported to date have nearly all been carried out on the polyphenols 
resveratrol and hydroxytyrosol. Resveratrol, at a supra-physiological concentration of 50 
µM, was found to induce MB significantly and greatly up-regulate antioxidant enzyme 
synthesis including MnSOD in both mouse and human cell cultures (Robb et al., 2008). The 
critical importance of MnSOD to health and life itself has been demonstrated by several 
studies. Genetically modified mice that over-express this enzyme have a modestly extended 
lifetime (Hu et al., 2007), whereas MnSOD-knockout mice die within a few days of birth (Y. 
Li et al., 1995). Recombinant lactobacilli over-expressing the antioxidant enzymes SOD and 
CAT demonstrated greatly enhanced resistance to oxidative stress and significantly 
increased longevity compared with normal bacteria (An et al., 2011).  
Resveratrol treatment of isolated human vascular endothelial cells up-regulated many 
biomarkers of mitochondrial adaptation, including PPAR-, Nrf1, TFAM, mitochondrial 
DNA, ETC proteins and MB. Endothelial nitric oxide synthase (eNOS) was also up-
regulated, but if NO synthesis was blocked, MB and the other adaptations were also blocked 
(Csiszar et al., 2009). These findings support the regulatory effects of eNOS/NO on 
mitochondria, at least in vascular cells. NO itself is well-established as an important factor in 
mitochondrial regulation (Cadenas et al., 2000).  
Hydroxytyrosol (HT), a polyphenol found in olives and olive oil, at concentrations as low as 
1 M significantly stimulated MB and ETC complex synthesis, concomitant with up-
regulation of the MB-signalling molecules PGC1- and Nrf-1 and-2 (Hao et al., 2010). Very 
similar results were obtained from ARPE-19 cells, a human retinal pigment epithelial line, 
challenged with acrolein and in addition, HT increased expression of ERE-regulated phase II 
detoxifying enzymes (Lu et al., 2010). These in vitro studies provide considerable evidence 
that polyphenols could stimulate adaptive effects in vivo, provided they could accumulate 
in the cell or mitochondria at sufficient concentrations. Adaptations mediated by eNOS/NO 
would only require access to the vascular system, which is well-proven by numerous 
plasma bioavailability studies. 
4.6 Other potential adaptogenic effects of polyphenols 
Other adaptive effects, not necessarily related to mitochondria, have been associated with 
polyphenols. Quercetin glycosides stimulated glucose uptake in C2C12 mouse muscle cells 
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in vitro (Eid et al., 2010), an effect that should be beneficial in treating type 1 diabetes, a 
condition thought to involve mitochondrial dysfunction (Fujisawa et al., 2009). The 
glycolytic pathway for ATP generation in the cytosol converts glucose to lactate (Scheffler, 
2008). Lactate is converted to pyruvate, which is a major input into the TCA cycle in the 
mitochondria (Figure 1). Treatment with elevated concentrations of pyruvate stimulates MB 
in both L6E9 myoblasts and C2C12 cells (Duguez et al., 2004; Wilson et al., 2007). Induction 
of MB by increased pyruvate supply in vitro suggests that there could be a similar effect in 
vivo. Stimulation of glucose uptake by muscle cells may increase glycolysis and indirectly 
stimulate MB and other mitochondrial adaptations. In other words, this may be an 
additional mechanism for stimulation of mitochondrial adaptation by polyphenols. 
4.7 Animal trials linking polyphenols with mitochondrial adaptation 
Support for the in vivo effects of polyphenolics being closely related to those of exercise on 
mitochondria has been provided by two trials in mice, which found that high doses of 
dietary resveratrol (400 and 20 mg/kg/day respectively) reversed all the harmful biological 
changes (in particular, a shortened lifespan) induced by a high calorie diet, apart from 
weight gain (Lagouge et al., 2006; Baur et al., 2006). Both trials found increased activity of 
the mitochondrial signalling molecules SIRT1 and PGC1-, as well as increased insulin 
sensitivity. Although 400 mg/kg/day is far from a practical intake for humans, the absence 
of any ill-effects to the test animals strongly suggests that this compound should have no 
toxicity in humans at any realistic dietary intake. A subsequent trial found significant 
increases in the major antioxidant enzymes in mice dosed with resveratrol as part of a high 
fat diet (Robb et al., 2008). Of particular interest was a doubling of the activity of MnSOD in 
brain and kidney tissue, in agreement with the observations from in vitro trials of 
resveratrol.  
Resveratrol and its methylated analogues were found to be effective in an in vitro cellular 
model of oxidative stress. One of these analogues, the naturally-occurring dimethylated 
derivative of resveratrol, pterostilbene, was subsequently found to reduce neuro-
degeneration, a major contributor to age-related cognitive decline, in a long-term rat trial 
(Joseph et al., 2008). Mitochondrial dysfunction has been implicated in and may be a 
primary cause of most common neurodegenerative conditions, including those related to 
aging (Scheffler, 2008). Although these trials do not provide a definitive link between the 
observed health benefits and resveratrol-induced MB, the results are consistent with such a 
link and certainly lend support to the link between polyphenols and human health benefits. 
4.8 In vivo evidence for mitochondrial adaptation by polyphenols 
Highly significant augmentation of exercise performance resulted from dietary 
supplementation with quercetin in a mouse model (Davis et al., 2009). Groups of mice were 
fed 0, 12.5 or 25 mg/kg/day of quercetin (approximately equivalent to a realistic dose of 1 
or 2 g/day for an 80 kg human) for 7 days. Increases (relative to placebo) were observed in 
gene expression of PCG-1 and SIRT1 by up to 2 fold in muscle and brain, whilst levels of 
cytochrome C (a marker of mitochondrial mass) increased by 23% in muscle and 18% in 
brain. Mitochondrial DNA also increased up to 2 fold (Davis et al., 2009). This suggests that 
the numbers of mitochondria approximately doubled and their overall respiration capacity 
increased by around 20%. The importance of these results is the clear link between quercetin 
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consumption, increases in biomarkers for mitochondrial adaptation, and MB itself. This trial 
is therefore, the first to demonstrate unequivocally mitochondrial adaptive effects of a 
common polyphenol, administered orally. Exercise trials were done on other, similarly 
dosed mice, in the same study. Forced treadmill running time to exhaustion increased by 
37% at both doses of quercetin. Voluntary wheel running activity also increased, both in 
speed and in time spent. Total distance covered increased by ~45% by the end of the 7-day 
treatment period and was sustained for the following 7 days (Davis et al., 2009).  
Although these performance improvements appear spectacular, they are not unexpected. 
Laboratory animals are over-fed, chronically under-exercised and lack social interaction and 
environmental stimulation, being confined to single cages for most of their lives (Cressey, 
2010). Although such animals may be poor models of human responses in most cases, they 
would be expected to be excellent models of obese, unfit and depressed humans who could 
benefit most from exercise and a healthy, high-polyphenol diet. In this light, the physical 
performance improvements observed in the trial undertaken by Davis and colleagues would 
not be expected to be reproduced in humans; much smaller changes in human fitness would 
be expected from the same treatment. The salient point here is that the performance-
enhancing effects of the quercetin are of minor relevance to human health, compared with 
the clear demonstration of its adaptive effects on mitochondria. In another study, resveratrol 
supplementation (0.2% w/w) for 12 weeks increased exercise performance in a mouse 
model of senescence, whereas performance declined in the control group (Murase et al., 
2009). Polyphenols therefore, may have potential to ameliorate age-related physical decline 
in humans. 
One aspect of the Davis et al. (2009) study that cannot be easily explained by mitochondrial 
adaptation is the large increase in voluntary wheel running. Davis and colleagues suggested 
that this resulted from an entirely different property of quercetin, namely that, in vitro, it is 
an adenosine A1 receptor antagonist, as are caffeine and some other common flavonoids 
(Alexander, 2006). Caffeine is both psycho-stimulatory and ergogenic and this may explain 
the apparently increased motivation for the mice to exercise. 
There is also solid evidence from human trials for adaptive effects of quercetin. A 
supplementary combination of quercetin (1 g), isoquercetin, EGCG and polyunsaturated 
fatty acids was tested on trained cyclists undergoing 3 hours of cycling on each of 3 days 
(Nieman et al., 2009). Significant decreases in inflammatory biomarkers were detected 
relative to the control (placebo), but no change was observed in performance, or any marker 
of exercise or mitochondrial adaptation. The latter finding is not unexpected in trained 
athletes, who would be expected to have minimal capacity for increased performance or 
additional exercise-induced adaptation. In a further trial, 1 g/day of quercetin for two 
weeks was tested on untrained male test subjects (Nieman et al., 2010). Distance travelled in 
12 minutes on a treadmill was determined. Relative to placebo, a small but significant 
increase in distance was observed, accompanied by slight increases in RNA coding for the 
MB biomarkers PGC-1, sirtuin 1, citrate synthase and cytochrome C oxidase (Complex IV) 
(Nieman et al., 2010). Similar results were obtained when Davis et al. (2009) undertook a 
human trial to examine whether they could replicate the effects previously observed in 
mice. Twelve untrained volunteers were given 500 mg of quercetin twice daily for 7 days, 
dissolved in a drink. After treatment, both VO2max and ride time to fatigue on an exercise 
bike were determined. The observed increases in VO2max and ride time to fatigue were 
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in vitro (Eid et al., 2010), an effect that should be beneficial in treating type 1 diabetes, a 
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consumption, increases in biomarkers for mitochondrial adaptation, and MB itself. This trial 
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treatment period and was sustained for the following 7 days (Davis et al., 2009).  
Although these performance improvements appear spectacular, they are not unexpected. 
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the clear demonstration of its adaptive effects on mitochondria. In another study, resveratrol 
supplementation (0.2% w/w) for 12 weeks increased exercise performance in a mouse 
model of senescence, whereas performance declined in the control group (Murase et al., 
2009). Polyphenols therefore, may have potential to ameliorate age-related physical decline 
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an adenosine A1 receptor antagonist, as are caffeine and some other common flavonoids 
(Alexander, 2006). Caffeine is both psycho-stimulatory and ergogenic and this may explain 
the apparently increased motivation for the mice to exercise. 
There is also solid evidence from human trials for adaptive effects of quercetin. A 
supplementary combination of quercetin (1 g), isoquercetin, EGCG and polyunsaturated 
fatty acids was tested on trained cyclists undergoing 3 hours of cycling on each of 3 days 
(Nieman et al., 2009). Significant decreases in inflammatory biomarkers were detected 
relative to the control (placebo), but no change was observed in performance, or any marker 
of exercise or mitochondrial adaptation. The latter finding is not unexpected in trained 
athletes, who would be expected to have minimal capacity for increased performance or 
additional exercise-induced adaptation. In a further trial, 1 g/day of quercetin for two 
weeks was tested on untrained male test subjects (Nieman et al., 2010). Distance travelled in 
12 minutes on a treadmill was determined. Relative to placebo, a small but significant 
increase in distance was observed, accompanied by slight increases in RNA coding for the 
MB biomarkers PGC-1, sirtuin 1, citrate synthase and cytochrome C oxidase (Complex IV) 
(Nieman et al., 2010). Similar results were obtained when Davis et al. (2009) undertook a 
human trial to examine whether they could replicate the effects previously observed in 
mice. Twelve untrained volunteers were given 500 mg of quercetin twice daily for 7 days, 
dissolved in a drink. After treatment, both VO2max and ride time to fatigue on an exercise 
bike were determined. The observed increases in VO2max and ride time to fatigue were 
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3.9% and 13.2%, respectively, compared with the control (placebo). Whilst no mitochondrial 
biomarkers were measured in this trial, the enhancement of endurance capacity observed, in 
the absence of any physical training, is entirely consistent with mitochondrial adaptation. 
One should bear in mind that the physical performance aspects of polyphenol-stimulated 
mitochondrial adaptation are of minor importance in the context of human health. In this 
respect, mitochondrial dysfunction is of much higher importance, given that it is implicated 
in some way in both the major diseases of modern civilisation (CVD, cancer and neuro-
degeneration) and the aging process (Huang & Hood, 2009). Mitochondrial adaptation, 
rather than antioxidant capacity, is emerging as the primary mode of action of the health 
benefits of dietary polyphenols. Whilst there is, to date, no evidence that polyphenol 
consumption can increase human lifespan, there is good evidence from animal trials (Baur et 
al., 2006; Lagouge et al., 2006). This suggests that humans may benefit similarly, even if only 
through reduction in the incidence of life-threatening diseases. It is unlikely that dietary 
polyphenols could have a major effect on the maximum life-span of humans, but they do 
appear to have great potential to increase the proportion of people who attain all or most of 
the maximum lifespan. 
4.9 Polyphenolics, mitochondria and apoptosis 
Mitochondria are the instigators of programmed cell death, or apoptosis (Dorta et al., 2006). 
If mitochondria are sufficiently damaged by oxidative stress and DNA damage to become 
dysfunctional and lose their capacity to adapt to oxidative stress, they initiate a signalling 
pathway leading to apoptosis, or programmed death, of the host cell and thus the demise of 
the defective mitochondria. This mechanism has been proposed to explain the “chemo-
preventive” effects of polyphenolics (Roy et al., 2009; Juan et al., 2008), based on the 
observation that cancer cells in vitro are more sensitive to mitochondrial-induced apoptosis 
than normal cells. Therefore, polyphenols may promote apoptosis of cancerous cells in vivo. 
The ability to induce apoptosis was demonstrated in vitro for pterostilbene, a natural 
methylated derivative of resveratrol (Pan et al., 2007), resveratrol itself (Shakibaei et al., 
2009), kaempherol, a flavonol similar to quercetin (Marfe et al., 2009), EGC (W. Li et al., 
2009) and catechin (Iwasaki et al., 2009). This property of polyphenols may explain at least 
part of the putative anti-cancer effect of polyphenol-rich foods (see Introduction).  
4.10 Does the antioxidant capacity of polyphenols have any role in health? 
Polyphenol concentrations achieved in plasma from a realistic dietary intake are both 
transient and at most, ~2-4% of the small-molecule antioxidants normally present in the 
plasma; antioxidant enzymes contribute a large additional endogenous antioxidant capacity 
(Clifford, 2004; Stevenson & Lowe, 2009; Stevenson et al., 2009). In comparison, polyphenols 
are clearly insignificant in the overall context of resistance to oxidative stress. They could 
make a contribution at sites within the body where localised concentrations are much higher 
than the average. One example of this may be in the gastrointestinal (GI) tract, where 
polyphenol concentrations have been demonstrated to be many times that achieved in 
plasma (Stevenson et al., 2009), a consequence of the low proportions of most polyphenols 
that are absorbed from the GI tract. The cells of the GI tract are thus exposed to 
concentrations that should be more than sufficient for a significant radical-scavenging 
antioxidant effect. Another possible example is in cell membranes, where in vitro studies 
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found that up to 75% of polyphenols spiked into blood samples can end up bound to the 
membranes of the blood cells (Biasutto et al., 2010; Koren et al., 2010). This may allow them 
a significant and direct role in prevention of lipid peroxidation. If this membrane-binding 
phenomenon translates to the in vivo environment and is common to other cells (and to 
mitochondria) in the body, polyphenols may have a significant whole-body protective effect 
from lipid peroxidation. 
5. The role of homeostasis in polyphenol action in the body 
A good question to ask is why so many trials of antioxidants have failed to demonstrate any 
benefit and why polyphenol-induced mitochondrial adaptation appears only to be readily 
detected and manifested as an augmentation of exercise-induced adaptation. The answer 
may lie in the principle of homeostasis (van Ommen et al., 2009). Homeostasis is the normal 
state of a healthy cell or organism, where all biochemicals and enzymes are regulated to 
their optimal concentrations. When an organism is in homeostasis, dietary or 
pharmaceutical intervention has no particular benefit, because there is no “problem” to 
rectify. This may go some way towards explaining the apparent ‘failure’ of intervention 
trials with antioxidants. If the concentrations of endogenous antioxidants are tightly 
regulated, then addition of large amounts of exogenous antioxidants would result in down-
regulation of endogenous synthesis to restore homeostasis. Van Ommen and colleagues 
propose that any search for biomarkers of the effects of interventions must be undertaken 
with simultaneous perturbation of homeostasis, so the intervention can assist its restoration. 
This is not a major consideration for pharmaceutical interventions, which are typically 
designed to treat disease, in which homeostasis has already been perturbed. Dietary 
interventions, in contrast, are usually aimed at optimisation of health, rather than treatment 
of disease. The search for health benefits of either dietary antioxidants or adaptogens will 
almost inevitably fail unless tested on subjects with pre-existing or applied oxidative stress. 
Oxidative stress may be applied to animals by treatment with toxins, enforced exercise, or 
the use of animal models of suitable disease states. For humans, the options are restricted to 
the use of test subjects with pre-existing conditions that elevate oxidative stress, such as 
metabolic syndrome, or the performance of endurance exercise by healthy subjects. If 
oxidative stress is applied during a trial, appropriate intervention reduces the magnitude of 
the perturbation (i.e., the stress) and accelerates the restoration of homeostasis. 
6. Conclusion 
A large body of evidence has now been accumulated to support the concept that 
polyphenols are primarily adaptogens rather than radical-scavenging antioxidants. This 
does not negate their potent capacity to reduce oxidative stress; rather it indicates that the 
mechanism is far more complex and subtle than previously realised. Several in vivo trials 
have clearly linked polyphenol interventions with actual mitochondrial adaptation, or 
macroscopic effects consistent with adaptation, specifically mitochondrial biogenesis (MB) 
and up-regulation of MB-signalling molecules and antioxidant enzymes as the main 
biomarkers established for detection of mitochondrial adaptation. In vitro trials have been 
entirely consistent in demonstrating up-regulation of the same biomarkers that provide 
clues to possible mechanisms of action for polyphenols. These are direct activation of the 
components of the MB signalling pathway (e.g., sirtuin 1 and PPAR); direct activation of 
 
Bioactive Compounds in Phytomedicine 154 
3.9% and 13.2%, respectively, compared with the control (placebo). Whilst no mitochondrial 
biomarkers were measured in this trial, the enhancement of endurance capacity observed, in 
the absence of any physical training, is entirely consistent with mitochondrial adaptation. 
One should bear in mind that the physical performance aspects of polyphenol-stimulated 
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al., 2006; Lagouge et al., 2006). This suggests that humans may benefit similarly, even if only 
through reduction in the incidence of life-threatening diseases. It is unlikely that dietary 
polyphenols could have a major effect on the maximum life-span of humans, but they do 
appear to have great potential to increase the proportion of people who attain all or most of 
the maximum lifespan. 
4.9 Polyphenolics, mitochondria and apoptosis 
Mitochondria are the instigators of programmed cell death, or apoptosis (Dorta et al., 2006). 
If mitochondria are sufficiently damaged by oxidative stress and DNA damage to become 
dysfunctional and lose their capacity to adapt to oxidative stress, they initiate a signalling 
pathway leading to apoptosis, or programmed death, of the host cell and thus the demise of 
the defective mitochondria. This mechanism has been proposed to explain the “chemo-
preventive” effects of polyphenolics (Roy et al., 2009; Juan et al., 2008), based on the 
observation that cancer cells in vitro are more sensitive to mitochondrial-induced apoptosis 
than normal cells. Therefore, polyphenols may promote apoptosis of cancerous cells in vivo. 
The ability to induce apoptosis was demonstrated in vitro for pterostilbene, a natural 
methylated derivative of resveratrol (Pan et al., 2007), resveratrol itself (Shakibaei et al., 
2009), kaempherol, a flavonol similar to quercetin (Marfe et al., 2009), EGC (W. Li et al., 
2009) and catechin (Iwasaki et al., 2009). This property of polyphenols may explain at least 
part of the putative anti-cancer effect of polyphenol-rich foods (see Introduction).  
4.10 Does the antioxidant capacity of polyphenols have any role in health? 
Polyphenol concentrations achieved in plasma from a realistic dietary intake are both 
transient and at most, ~2-4% of the small-molecule antioxidants normally present in the 
plasma; antioxidant enzymes contribute a large additional endogenous antioxidant capacity 
(Clifford, 2004; Stevenson & Lowe, 2009; Stevenson et al., 2009). In comparison, polyphenols 
are clearly insignificant in the overall context of resistance to oxidative stress. They could 
make a contribution at sites within the body where localised concentrations are much higher 
than the average. One example of this may be in the gastrointestinal (GI) tract, where 
polyphenol concentrations have been demonstrated to be many times that achieved in 
plasma (Stevenson et al., 2009), a consequence of the low proportions of most polyphenols 
that are absorbed from the GI tract. The cells of the GI tract are thus exposed to 
concentrations that should be more than sufficient for a significant radical-scavenging 
antioxidant effect. Another possible example is in cell membranes, where in vitro studies 
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found that up to 75% of polyphenols spiked into blood samples can end up bound to the 
membranes of the blood cells (Biasutto et al., 2010; Koren et al., 2010). This may allow them 
a significant and direct role in prevention of lipid peroxidation. If this membrane-binding 
phenomenon translates to the in vivo environment and is common to other cells (and to 
mitochondria) in the body, polyphenols may have a significant whole-body protective effect 
from lipid peroxidation. 
5. The role of homeostasis in polyphenol action in the body 
A good question to ask is why so many trials of antioxidants have failed to demonstrate any 
benefit and why polyphenol-induced mitochondrial adaptation appears only to be readily 
detected and manifested as an augmentation of exercise-induced adaptation. The answer 
may lie in the principle of homeostasis (van Ommen et al., 2009). Homeostasis is the normal 
state of a healthy cell or organism, where all biochemicals and enzymes are regulated to 
their optimal concentrations. When an organism is in homeostasis, dietary or 
pharmaceutical intervention has no particular benefit, because there is no “problem” to 
rectify. This may go some way towards explaining the apparent ‘failure’ of intervention 
trials with antioxidants. If the concentrations of endogenous antioxidants are tightly 
regulated, then addition of large amounts of exogenous antioxidants would result in down-
regulation of endogenous synthesis to restore homeostasis. Van Ommen and colleagues 
propose that any search for biomarkers of the effects of interventions must be undertaken 
with simultaneous perturbation of homeostasis, so the intervention can assist its restoration. 
This is not a major consideration for pharmaceutical interventions, which are typically 
designed to treat disease, in which homeostasis has already been perturbed. Dietary 
interventions, in contrast, are usually aimed at optimisation of health, rather than treatment 
of disease. The search for health benefits of either dietary antioxidants or adaptogens will 
almost inevitably fail unless tested on subjects with pre-existing or applied oxidative stress. 
Oxidative stress may be applied to animals by treatment with toxins, enforced exercise, or 
the use of animal models of suitable disease states. For humans, the options are restricted to 
the use of test subjects with pre-existing conditions that elevate oxidative stress, such as 
metabolic syndrome, or the performance of endurance exercise by healthy subjects. If 
oxidative stress is applied during a trial, appropriate intervention reduces the magnitude of 
the perturbation (i.e., the stress) and accelerates the restoration of homeostasis. 
6. Conclusion 
A large body of evidence has now been accumulated to support the concept that 
polyphenols are primarily adaptogens rather than radical-scavenging antioxidants. This 
does not negate their potent capacity to reduce oxidative stress; rather it indicates that the 
mechanism is far more complex and subtle than previously realised. Several in vivo trials 
have clearly linked polyphenol interventions with actual mitochondrial adaptation, or 
macroscopic effects consistent with adaptation, specifically mitochondrial biogenesis (MB) 
and up-regulation of MB-signalling molecules and antioxidant enzymes as the main 
biomarkers established for detection of mitochondrial adaptation. In vitro trials have been 
entirely consistent in demonstrating up-regulation of the same biomarkers that provide 
clues to possible mechanisms of action for polyphenols. These are direct activation of the 
components of the MB signalling pathway (e.g., sirtuin 1 and PPAR); direct activation of 
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the ERE via binding to its regulatory protein Keap1; stimulation of glycolysis and glucose 
uptake, which increases the supply of nutrients to the mitochondria; stimulation of NO 
synthesis, which is a known signal for MB; and generation of a mild oxidative stress in the 
mitochondria through inhibition of the ETC or other mechanisms. 
Since mitochondrial dysfunction is implicated in aging and major diseases such as cancer, 
CVD and neuro-degeneration, any means of improving mitochondrial function, or inducing 
destruction of the most dysfunctional mitochondria, should be highly beneficial to healthy 
aging and maintenance of good health. Dietary polyphenols are almost certainly a good 
means of achieving these ends.  
7. List of abbreviations and definitions 
ORAC : Oxygen radical absorbance capacity; an in vitro measure of relative antioxidant 
power. ROS: Reactive oxygen species; another term for free radicals. ETC: Electron 
transport chain; a group of mitochondrial proteins that generates ATP (adenosine 
triphosphate) by reduction of oxygen to water. NADH: Nicotinamide adenine dinucleotide; 
a biochemical reducing agent. MnSOD or SOD2: Mitochondrial form of the antioxidant 
enzyme, manganese superoxide dismutase. CuZnSOD or SOD1: Cytosolic form of 
superoxide dismutase. MB: Mitochondrial biogenesis; the increase of mitochondrial 
numbers within cells. Complex III: One of the five components of the mitochondrial 
electron transport chain (ETC). Nrf-1 and Nrf-2: Nuclear respiratory factors; transcription 
factors involved in control of adaptive responses. TFAM: Mitochondrial transcription factor 
A; transcription factor involved in control of adaptive responses. PGC-1: Peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha. PPAR-: Peroxisome-proliferator 
activated receptor-; receptor involved in control of adaptive responses. ERE/ARE: 
Electrophile (or Antioxidant) Response Element; gene promoter controlling antioxidant 
enzyme gene expression. HNE: 4-hydroxy-2-nonenal; product of lipid peroxidation and 
likely activator of the ERE. Keap1: Kelch-like ECH-associated protein 1; a sensing protein 
linked to the ERE. TCA cycle: Tricarboxylic acid cycle; ATP-generating metabolic pathway 
in mitochondria. eNOS: Endothelial nitric oxide (NO) synthase enzyme. GPX: glutathione 
peroxidase; antioxidant enzyme. MDA: malondialdehyde; a commonly used plasma 
biomarker of lipid peroxidation. SIRT: silent mating type information regulation 2 homolog; 
gene coding for a sirtuin, or regulatory protein deacetylase. EGCG: epigallocatechin gallate; 
a flavonoid polyphenol mainly found in green tea. 
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A; transcription factor involved in control of adaptive responses. PGC-1: Peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha. PPAR-: Peroxisome-proliferator 
activated receptor-; receptor involved in control of adaptive responses. ERE/ARE: 
Electrophile (or Antioxidant) Response Element; gene promoter controlling antioxidant 
enzyme gene expression. HNE: 4-hydroxy-2-nonenal; product of lipid peroxidation and 
likely activator of the ERE. Keap1: Kelch-like ECH-associated protein 1; a sensing protein 
linked to the ERE. TCA cycle: Tricarboxylic acid cycle; ATP-generating metabolic pathway 
in mitochondria. eNOS: Endothelial nitric oxide (NO) synthase enzyme. GPX: glutathione 
peroxidase; antioxidant enzyme. MDA: malondialdehyde; a commonly used plasma 
biomarker of lipid peroxidation. SIRT: silent mating type information regulation 2 homolog; 
gene coding for a sirtuin, or regulatory protein deacetylase. EGCG: epigallocatechin gallate; 
a flavonoid polyphenol mainly found in green tea. 
8. References 
Alexander, S.P.H. (2006). Flavonoids as antagonists at A(1) adenosine receptors. Phytotherapy 
Research, Vol. 20, Issue 11, pp. 1009-1012, ISSN 0951-418X. 
An, H.; Zhai, Z.; Yin, S. et al. (2011). Coexpression of the Superoxide Dismutase and the 
Catalase Provides Remarkable Oxidative Stress Resistance in Lactobacillus 
rhamnosus. Journal of Agricultural and Food Chemistry, Vol. 59, Issue 8, pp. 3851-
3856, ISSN 0021-8561. 
Baar, K.; Wende, A.R.; Jones, T.E. et al. (2002). Adaptations of skeletal muscle to exercise: 
rapid increase in the transcriptional coactivator PGC-1. FASEB J., Vol. 16, Issue 14, 
pp. 1879-1886. 
 
Polyphenols as Adaptogens – The Real Mechanism of the Antioxidant Effect? 157 
Barros, M.H.; Bandy, B.; Tahara, E.B. et al. (2004). Higher respiratory activity decreases 
mitochondrial reactive oxygen release and increases life span in Saccharomyces 
cerevisiae. Journal of Biological Chemistry, Vol. 279, Issue 48, pp. 49883-49888, ISSN 
0021-9258. 
Baur, J.A.; Pearson, K.J.; Price, N.L. et al. (2006). Resveratrol improves health and survival of 
mice on a high-calorie diet. Nature, Vol. 444, Issue 7117, pp. 337-342, ISSN 0028-0836. 
Befroy, D.E.; Petersen, K.F.; Dufour, S. et al. (2008). Increased substrate oxidation and 
mitochondrial uncoupling in skeletal muscle of endurance-trained individuals. 
Proceedings of the National Academy of Sciences, Vol. 105, Issue 43, pp. 16701-16706. 
Biasutto, L.; Marotta, E.; Garbisa, S. et al. (2010). Determination of Quercetin and Resveratrol 
in Whole Blood—Implications for Bioavailability Studies. Molecules, Vol. 15, Issue 9, 
pp. 6570-6579, ISSN 1420-3049. 
Bieger, J.; Cermak, R.; Blank, R. et al. (2008). Tissue Distribution of Quercetin in Pigs after 
Long-Term Dietary Supplementation. J. Nutr., Vol. 138, Issue 8, pp. 1417-1420. 
Bjelakovic, G.; Nikolova, D.; Ll, G. et al. (2008). Antioxidant supplements for prevention of 
mortality in healthy participants and patients with various diseases. Cochrane 
Database of Systematic Reviews, Vol. 2, Issue 2, pp. 1-252, ISSN 1469-493X. 
Bordone, L.; Cohen, D.; Robinson, A. et al. (2007). SIRT1 transgenic mice show phenotypes 
resembling calorie restriction. Aging Cell, Vol. 6, Issue 6, pp. 759-767, ISSN 1474-9718. 
Brookes, P.S. (2005). Mitochondrial H+ leak and ROS generation: An odd couple. Free 
Radical Biology and Medicine, Vol. 38, Issue 1, pp. 12-23, ISSN 0891-5849. 
Cadenas, E. & Boveris, A. (1980). Enhancement of hydrogen peroxide formation by 
protophores and ionophores in antimycin-supplemented mitochondria. Biochem. J., 
Vol. 188, Issue 1, pp. 31-37. 
Cadenas, E. & Davies, K.J.A. (2000). Mitochondrial free radical generation, oxidative stress, and 
aging. Free Radical Biology and Medicine, Vol. 29, Issue 3-4, pp. 222-230, ISSN 0891-5849. 
Cadenas, E.; Poderoso, J.J.; Antunes, F. et al. (2000). Analysis of the pathways of nitric oxide 
utilization in mitochondria. Free Radical Research, Vol. 33, Issue 6, pp. 747-756, ISSN 
1071-5762. 
Calabrese, E.J. (2008). Hormesis: Why it is important to toxicology and toxicologists. 
Environmental Toxicology and Chemistry, Vol. 27, Issue 7, pp. 1451-1474, ISSN 0730-7268. 
Clifford, M.N. (2004). Diet-derived Phenols in plasma and tissues and their implications for 
health. Planta Medica, Vol. 70, Issue 12, pp. 1103-1114. 
Cressey, D. (2010). Fat rats skew research results; Overfed lab animals make poor subjects 
for experiments. Nature, Vol. 464, 19. 
Csiszar, A.; Labinskyy, N.; Pinto, J.T. et al. (2009). Resveratrol induces mitochondrial 
biogenesis in endothelial cells. American Journal of Physiology-Heart and Circulatory 
Physiology, Vol. 297, Issue 1, pp. H13-H20, ISSN 0363-6135. 
Dairaku, N.; Kato, K.; Honda, K. et al. (2004). Oligomycin and antimycin A prevent nitric 
oxide-induced opoptosis by blocking cytochrome C leakage. Journal of Laboratory 
and Clinical Medicine, Vol. 143, Issue 3, pp. 143-151, ISSN 0022-2143. 
Davis, J.M.; Murphy, E.A.; Carmichael, M.D. et al. (2009). Quercetin increases brain and 
muscle mitochondrial biogenesis and exercise tolerance. American Journal of 
Physiology-Regulatory Integrative and Comparative Physiology, Vol. 296, Issue 4, pp. 
R1071-R1077, ISSN 0363-6119. 
 
Bioactive Compounds in Phytomedicine 158 
Dinkova-Kostova, A.T. & Talalay, P. (2008). Direct and indirect antioxidant properties of 
inducers of cytoprotective proteins. Molecular Nutrition & Food Research, Vol. 52, 
S128-S138, ISSN 1613-4125. 
Dorta, D.J.; Curti, C. & Rodrigues, T. (2006). Effects of flavonoids on mitochondria: An 
overview on pharmacological and toxicological aspects. In Moreno, A.; Oliveira, P. 
& Palmeira, C., eds, Mitochondrial Phamacology and Toxicology, pp. 147-161, ISBN 
Transworld Research Network, Kerala, India. 
Dorta, D.J.; Pigoso, A.; Mingatto, F. et al. (2005). The interaction of flavonoids with 
mitochondria: effects on energetic processes. Chemico-Biological Interactions, Vol. 
152, Issue 2-3, pp. 67-78. 
Droge, W. (2002). Free radicals in the physiological control of cell function. Physiological 
Reviews, Vol. 82, Issue 1, pp. 47-95, ISSN 0031-9333. 
Duguez, S.; Sabido, O. & Freyssenet, D. (2004). Mitochondrial-dependent regulation of 
myoblast proliferation. Experimental Cell Research, Vol. 299, Issue 1, pp. 27-35, ISSN 
0014-4827. 
Eid, H.M.; Martineau, L.C.; Saleem, A. et al. (2010). Stimulation of AMP-activated protein 
kinase and enhancement of basal glucose uptake in muscle cells by quercetin and 
quercetin glycosides, active principles of the antidiabetic medicinal plant 
Vaccinium vitis-idaea. Molecular Nutrition & Food Research, Vol. 54, Issue 7, pp. 991-
1003, ISSN 1613-4125. 
Feige, J.N.; Lagouge, M.; Canto, C. et al. (2008). Specific SIRT1 Activation Mimics Low Energy 
Levels and Protects against Diet-induced Metabolic Disorders by Enhancing Fat 
Oxidation. Cell Metabolism, Vol. 8, Issue 5, pp. 347-358, ISSN 1550-4131. 
Fiorani, M.; Guidarelli, A.; Blasa, M. et al. (2010). Mitochondria accumulate large amounts of 
quercetin: prevention of mitochondrial damage and release upon oxidation of the 
extramitochondrial fraction of the flavonoid. The Journal of Nutritional Biochemistry, 
Vol. 21, Issue 5, pp. 397-404. 
Fujisawa, K.; Nishikawa, T.; Kukidome, D. et al. (2009). TZDs reduce mitochondrial ROS 
production and enhance mitochondrial biogenesis. Biochemical and Biophysical 
Research Communications, Vol. 379, Issue 1, pp. 43-48. 
Gledhill, J.R.; Montgomery, M.G.; Leslie, A.G.W. et al. (2007). Mechanism of inhibition of 
bovine F1-ATPase by resveratrol and related polyphenols. Proceedings of the 
National Academy of Sciences, Vol. 104, Issue 34, pp. 13632-13637. 
Goldberg, D.A.; Yan, J. & Soleas, G.J. (2003). Absorption of three wine-related polyphenols 
in three different matrices by healthy subjects. Clinical Biochemistry, Vol. 36, Issue 1, 
pp. 79-87. 
Gomez-Cabrera, M.C.; Domenech, E.; Ji, L.L. et al. (2006). Exercise as an antioxidant: it up-
regulates important enzymes for cell adaptations to exercise. Science & Sports, Vol. 
21, Issue 2, pp. 85-89, ISSN 0765-1597. 
Gomez-Cabrera, M.C.; Domenech, E. & Vina, J. (2008). Moderate exercise is an antioxidant: 
Upregulation of antioxidant genes by training. Free Radical Biology and Medicine, 
Vol. 44, Issue 2, pp. 126-131. 
Grubisha, O.; Smith, B.C. & Denu, J.M. (2005). Small molecule regulation of Sir2 protein 
deacetylases. Febs Journal, Vol. 272, Issue 18, pp. 4607-4616, ISSN 1742-464X. 
Guarente, L. (2008). Mitochondria - A nexus for aging, calorie restriction, and sirtuins? Cell, 
Vol. 132, Issue 2, pp. 171-176, ISSN 0092-8674. 
 
Polyphenols as Adaptogens – The Real Mechanism of the Antioxidant Effect? 159 
Hao, J.; Shen, W.; Yu, G. et al. (2010). Hydroxytyrosol promotes mitochondrial biogenesis 
and mitochondrial function in 3T3-L1 adipocytes. The Journal of Nutritional 
Biochemistry, Vol. 21, Issue 7, pp. 634-644, ISSN 0955-2863. 
Harman, D. (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol, 
Vol. 11, Issue 3, pp. 298-300, ISSN 0022-1422. 
Hawley, J.A. & Holloszy, J.O. (2009). Exercise: it's the real thing! Nutrition Reviews, Vol. 67, 
Issue 3, pp. 172-178, ISSN 0029-6643. 
Higuchi, M.; Cartier, L.J.; Chen, M. et al. (1985). SUPEROXIDE-DISMUTASE AND 
CATALASE IN SKELETAL-MUSCLE - ADAPTIVE RESPONSE TO EXERCISE. 
Journals of Gerontology, Vol. 40, Issue 3, pp. 281-286, ISSN 0022-1422. 
Hodnick, W.F.; Bohmont, C.W.; Capps, C. et al. (1987). Inhibition of the mitochondrial NADH-
oxidase (NADH-Coenzyme Q oxido-reductase) enzyme system by flavonoids: a 
structure-activity study. Biochemical Pharmacology, Vol. 36, Issue 17, pp. 2873-2874. 
Hodnick, W.F.; Kung, F.S.; Roettger, W.J. et al. (1986). Inhibition of mitochondrial 
respiration and production of toxic oxygen radicals by flavonoids: A structure-
activity study. Biochemical Pharmacology, Vol. 35, Issue 14, pp. 2345-2357. 
Holloszy, J.O. & Coyle, E.F. (1984). Adaptations of skeletal muscle to endurance exercise and 
their metabolic consequences. J Appl Physiol, Vol. 56, Issue 4, pp. 831-838. 
Hood, D.A.; Irrcher, I.; Ljubicic, V. et al. (2006). Coordination of metabolic plasticity in 
skeletal muscle. Journal of Experimental Biology, Vol. 209, Issue 12, pp. 2265-2275, 
ISSN 0022-0949. 
Hoppeler, H.; Lüthi, P.; Claassen, H. et al. (1973). The ultrastructure of the normal human skeletal 
muscle. Pflügers Archiv European Journal of Physiology, Vol. 344, Issue 3, pp. 217-232. 
Howitz, K.T.; Bitterman, K.J.; Cohen, H.Y. et al. (2003). Small molecule activators of sirtuins 
extend Saccharomyces cerevisiae lifespan. Nature, Vol. 425, Issue 6954, pp. 191-196, 
ISSN 0028-0836. 
Hsun-Wei Huang, T.; Prasad, B.; Valentina Razmovski, K. et al. (2005). Herbal or Natural 
Medicines as Modulators of Peroxisome Proliferator-Activated Receptors and 
Related Nuclear Receptors for Therapy of Metabolic Syndrome. Basic & Clinical 
Pharmacology & Toxicology, Vol. 96, Issue 1, pp. 3-14, ISSN 1742-7843. 
Hu, D.; Cao, P.; Thiels, E. et al. (2007). Hippocampal long-term potentiation, memory, and 
longevity in mice that overexpress mitochondrial superoxide dismutase. 
Neurobiology of Learning and Memory, Vol. 87, Issue 3, pp. 372-384. 
Huang, J.H. & Hood, D.A. (2009). Age-associated Mitochondrial Dysfunction in Skeletal 
Muscle: Contributing Factors and Suggestions for Long-term Interventions. Iubmb 
Life, Vol. 61, Issue 3, pp. 201-214, ISSN 1521-6543. 
Institute of Medicine (1998). Panel on dietary antioxidants and related compounds report: 
Dietary Reference Intakes. Proposed definition and plan for review of dietary 
antioxidants and related compounds. In Standing comittee on the scientific 
evaluation of dietary reference intakes, F.a.N.B., Institute of Medicine, ed. National 
Academy Press, Washington DC. 
Iwasaki, R.; Ito, K.; Ishida, T. et al. (2009). Catechin, green tea component, causes caspase-
independent necrosis-like cell death in chronic myelogenous leukemia. Cancer 
Science, Vol. 100, Issue 2, pp. 349-356, ISSN 1347-9032. 
Jackson, M.J. (2008). Free radicals generated contracting muscle: By-products of metabolism 
or key regulators of muscle function? Free Radical Biology and Medicine, Vol. 44, 
Issue 2, pp. 132-141. 
 
Bioactive Compounds in Phytomedicine 158 
Dinkova-Kostova, A.T. & Talalay, P. (2008). Direct and indirect antioxidant properties of 
inducers of cytoprotective proteins. Molecular Nutrition & Food Research, Vol. 52, 
S128-S138, ISSN 1613-4125. 
Dorta, D.J.; Curti, C. & Rodrigues, T. (2006). Effects of flavonoids on mitochondria: An 
overview on pharmacological and toxicological aspects. In Moreno, A.; Oliveira, P. 
& Palmeira, C., eds, Mitochondrial Phamacology and Toxicology, pp. 147-161, ISBN 
Transworld Research Network, Kerala, India. 
Dorta, D.J.; Pigoso, A.; Mingatto, F. et al. (2005). The interaction of flavonoids with 
mitochondria: effects on energetic processes. Chemico-Biological Interactions, Vol. 
152, Issue 2-3, pp. 67-78. 
Droge, W. (2002). Free radicals in the physiological control of cell function. Physiological 
Reviews, Vol. 82, Issue 1, pp. 47-95, ISSN 0031-9333. 
Duguez, S.; Sabido, O. & Freyssenet, D. (2004). Mitochondrial-dependent regulation of 
myoblast proliferation. Experimental Cell Research, Vol. 299, Issue 1, pp. 27-35, ISSN 
0014-4827. 
Eid, H.M.; Martineau, L.C.; Saleem, A. et al. (2010). Stimulation of AMP-activated protein 
kinase and enhancement of basal glucose uptake in muscle cells by quercetin and 
quercetin glycosides, active principles of the antidiabetic medicinal plant 
Vaccinium vitis-idaea. Molecular Nutrition & Food Research, Vol. 54, Issue 7, pp. 991-
1003, ISSN 1613-4125. 
Feige, J.N.; Lagouge, M.; Canto, C. et al. (2008). Specific SIRT1 Activation Mimics Low Energy 
Levels and Protects against Diet-induced Metabolic Disorders by Enhancing Fat 
Oxidation. Cell Metabolism, Vol. 8, Issue 5, pp. 347-358, ISSN 1550-4131. 
Fiorani, M.; Guidarelli, A.; Blasa, M. et al. (2010). Mitochondria accumulate large amounts of 
quercetin: prevention of mitochondrial damage and release upon oxidation of the 
extramitochondrial fraction of the flavonoid. The Journal of Nutritional Biochemistry, 
Vol. 21, Issue 5, pp. 397-404. 
Fujisawa, K.; Nishikawa, T.; Kukidome, D. et al. (2009). TZDs reduce mitochondrial ROS 
production and enhance mitochondrial biogenesis. Biochemical and Biophysical 
Research Communications, Vol. 379, Issue 1, pp. 43-48. 
Gledhill, J.R.; Montgomery, M.G.; Leslie, A.G.W. et al. (2007). Mechanism of inhibition of 
bovine F1-ATPase by resveratrol and related polyphenols. Proceedings of the 
National Academy of Sciences, Vol. 104, Issue 34, pp. 13632-13637. 
Goldberg, D.A.; Yan, J. & Soleas, G.J. (2003). Absorption of three wine-related polyphenols 
in three different matrices by healthy subjects. Clinical Biochemistry, Vol. 36, Issue 1, 
pp. 79-87. 
Gomez-Cabrera, M.C.; Domenech, E.; Ji, L.L. et al. (2006). Exercise as an antioxidant: it up-
regulates important enzymes for cell adaptations to exercise. Science & Sports, Vol. 
21, Issue 2, pp. 85-89, ISSN 0765-1597. 
Gomez-Cabrera, M.C.; Domenech, E. & Vina, J. (2008). Moderate exercise is an antioxidant: 
Upregulation of antioxidant genes by training. Free Radical Biology and Medicine, 
Vol. 44, Issue 2, pp. 126-131. 
Grubisha, O.; Smith, B.C. & Denu, J.M. (2005). Small molecule regulation of Sir2 protein 
deacetylases. Febs Journal, Vol. 272, Issue 18, pp. 4607-4616, ISSN 1742-464X. 
Guarente, L. (2008). Mitochondria - A nexus for aging, calorie restriction, and sirtuins? Cell, 
Vol. 132, Issue 2, pp. 171-176, ISSN 0092-8674. 
 
Polyphenols as Adaptogens – The Real Mechanism of the Antioxidant Effect? 159 
Hao, J.; Shen, W.; Yu, G. et al. (2010). Hydroxytyrosol promotes mitochondrial biogenesis 
and mitochondrial function in 3T3-L1 adipocytes. The Journal of Nutritional 
Biochemistry, Vol. 21, Issue 7, pp. 634-644, ISSN 0955-2863. 
Harman, D. (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol, 
Vol. 11, Issue 3, pp. 298-300, ISSN 0022-1422. 
Hawley, J.A. & Holloszy, J.O. (2009). Exercise: it's the real thing! Nutrition Reviews, Vol. 67, 
Issue 3, pp. 172-178, ISSN 0029-6643. 
Higuchi, M.; Cartier, L.J.; Chen, M. et al. (1985). SUPEROXIDE-DISMUTASE AND 
CATALASE IN SKELETAL-MUSCLE - ADAPTIVE RESPONSE TO EXERCISE. 
Journals of Gerontology, Vol. 40, Issue 3, pp. 281-286, ISSN 0022-1422. 
Hodnick, W.F.; Bohmont, C.W.; Capps, C. et al. (1987). Inhibition of the mitochondrial NADH-
oxidase (NADH-Coenzyme Q oxido-reductase) enzyme system by flavonoids: a 
structure-activity study. Biochemical Pharmacology, Vol. 36, Issue 17, pp. 2873-2874. 
Hodnick, W.F.; Kung, F.S.; Roettger, W.J. et al. (1986). Inhibition of mitochondrial 
respiration and production of toxic oxygen radicals by flavonoids: A structure-
activity study. Biochemical Pharmacology, Vol. 35, Issue 14, pp. 2345-2357. 
Holloszy, J.O. & Coyle, E.F. (1984). Adaptations of skeletal muscle to endurance exercise and 
their metabolic consequences. J Appl Physiol, Vol. 56, Issue 4, pp. 831-838. 
Hood, D.A.; Irrcher, I.; Ljubicic, V. et al. (2006). Coordination of metabolic plasticity in 
skeletal muscle. Journal of Experimental Biology, Vol. 209, Issue 12, pp. 2265-2275, 
ISSN 0022-0949. 
Hoppeler, H.; Lüthi, P.; Claassen, H. et al. (1973). The ultrastructure of the normal human skeletal 
muscle. Pflügers Archiv European Journal of Physiology, Vol. 344, Issue 3, pp. 217-232. 
Howitz, K.T.; Bitterman, K.J.; Cohen, H.Y. et al. (2003). Small molecule activators of sirtuins 
extend Saccharomyces cerevisiae lifespan. Nature, Vol. 425, Issue 6954, pp. 191-196, 
ISSN 0028-0836. 
Hsun-Wei Huang, T.; Prasad, B.; Valentina Razmovski, K. et al. (2005). Herbal or Natural 
Medicines as Modulators of Peroxisome Proliferator-Activated Receptors and 
Related Nuclear Receptors for Therapy of Metabolic Syndrome. Basic & Clinical 
Pharmacology & Toxicology, Vol. 96, Issue 1, pp. 3-14, ISSN 1742-7843. 
Hu, D.; Cao, P.; Thiels, E. et al. (2007). Hippocampal long-term potentiation, memory, and 
longevity in mice that overexpress mitochondrial superoxide dismutase. 
Neurobiology of Learning and Memory, Vol. 87, Issue 3, pp. 372-384. 
Huang, J.H. & Hood, D.A. (2009). Age-associated Mitochondrial Dysfunction in Skeletal 
Muscle: Contributing Factors and Suggestions for Long-term Interventions. Iubmb 
Life, Vol. 61, Issue 3, pp. 201-214, ISSN 1521-6543. 
Institute of Medicine (1998). Panel on dietary antioxidants and related compounds report: 
Dietary Reference Intakes. Proposed definition and plan for review of dietary 
antioxidants and related compounds. In Standing comittee on the scientific 
evaluation of dietary reference intakes, F.a.N.B., Institute of Medicine, ed. National 
Academy Press, Washington DC. 
Iwasaki, R.; Ito, K.; Ishida, T. et al. (2009). Catechin, green tea component, causes caspase-
independent necrosis-like cell death in chronic myelogenous leukemia. Cancer 
Science, Vol. 100, Issue 2, pp. 349-356, ISSN 1347-9032. 
Jackson, M.J. (2008). Free radicals generated contracting muscle: By-products of metabolism 
or key regulators of muscle function? Free Radical Biology and Medicine, Vol. 44, 
Issue 2, pp. 132-141. 
 
Bioactive Compounds in Phytomedicine 160 
Ji, L.L.; Radak, Z. & Goto, S. (2008). Hormesis and Exercise: How the Cell Copes with Oxidative 
Stress. American Journal of Pharmacology and Toxicology, Vol. 3, Issue 1, pp. 44-58. 
Joseph, J.A.; Fisher, D.R.; Cheng, V. et al. (2008). Cellular and Behavioral Effects of Stilbene 
Resveratrol Analogues: Implications for Reducing the Deleterious Effects of Aging. 
Journal of Agricultural and Food Chemistry, Vol. 56, Issue 22, pp. 10544-10551, ISSN 
0021-8561. 
Juan, M.E.; Wenzel, U.; Daniel, H. et al. (2008). Resveratrol induces apoptosis through ROS-
dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. Journal 
of Agricultural and Food Chemistry, Vol. 56, Issue 12, pp. 4813-4818, ISSN 0021-8561. 
Kaeberlein, M.; McDonagh, T.; Heltweg, B. et al. (2005). Substrate-specific activation of 
sirtuins by resveratrol. Journal of Biological Chemistry, Vol. 280, Issue 17, pp. 17038-
17045, ISSN 0021-9258. 
Kalt, W.; Blumberg, J.B.; McDonald, J.E. et al. (2008). Identification of anthocyanins in the 
liver, eye, and brain of blueberry-fed pigs. Journal of Agricultural and Food Chemistry, 
Vol. 56, 705-712, ISSN 0021-8561. 
Kalt, W.; Foote, K.; Fillmore, S.A.E. et al. (2007). Effect of blueberry feeding on plasma lipids 
in pigs. British Journal of Nutrition, Vol. 100, Issue 01, pp. 70-78, ISSN 0007-1145. 
Knez, W.; Jenkins, D. & Coombes, J. (2007). Does antioxidant supplementation prevent 
favorable adaptations to exercise training? - Response. Medicine and Science in Sports 
and Exercise, Vol. 39, Issue 10, pp. 1888-1888. 
Koren, E.; Kohen, R. & Ginsburg, I. (2010). Polyphenols enhance total oxidant-scavenging 
capacities of human blood by binding to red blood cells. Experimental Biology and 
Medicine, Vol. 235, Issue 6, pp. 689-699, ISSN 1535-3702. 
Kushnareva, Y.; Murphy, A.N. & Andreyev, A. (2002). Complex I-mediated reactive oxygen 
species generation: modulation by cytochrome c and NAD(P)(+) oxidation-
reduction state. Biochemical Journal, Vol. 368, 545-553, ISSN 0264-6021. 
Lagouge, M.; Argmann, C.; Gerhart-Hines, Z. et al. (2006). Resveratrol improves 
mitochondrial function and protects against metabolic disease by activating SIRT1 
and PGC-1 alpha. Cell, Vol. 127, Issue 6, pp. 1109-1122, ISSN 0092-8674. 
Li, W.; Nie, S.; Yu, Q. et al. (2009). Epigallocatechin-3-gallate Induces Apoptosis of Human 
Hepatoma Cells by Mitochondrial Pathways Related to Reactive Oxygen Species. 
Journal of Agricultural and Food Chemistry, Vol. 57, Issue 15, pp. 6685-6691. 
Li, Y.; Huang, T.-T.; Carlson, E.J. et al. (1995). Dilated cardiomyopathy and neonatal lethality 
in mutant mice lacking manganese superoxide dismutase. Nat Genet, Vol. 11, Issue 
4, pp. 376-381. 
Lopez-Lluch, G.; Hunt, N.; Jones, B. et al. (2006). Calorie restriction induces mitochondrial 
biogenesis and bioenergetic efficiency. Proceedings of the National Academy of Sciences 
of the United States of America, Vol. 103, Issue 6, pp. 1768-1773, ISSN 0027-8424. 
Lu, Z.; Zhongbo, L.; Zhihui, F. et al. (2010). Hydroxytyrosol protects against oxidative 
damage by simultaneous activation of mitochondrial biogenesis and phase II 
detoxifying enzyme systems in retinal pigment epithelial cells. Journal of Nutritional 
Biochemistry, Vol. 21, Issue 11, pp. 1089-1098, ISSN 0955-2863. 
Marfe, G.; Tafani, M.; Indelicato, M. et al. (2009). Kaempferol Induces Apoptosis in Two 
Different Cell Lines Via Akt Inactivation, Bax and SIRT3 Activation, and 
Mitochondrial Dysfunction. Journal of Cellular Biochemistry, Vol. 106, Issue 4, pp. 
643-650, ISSN 0730-2312. 
 
Polyphenols as Adaptogens – The Real Mechanism of the Antioxidant Effect? 161 
Murase, T.; Haramizu, S.; Ota, N. et al. (2009). Suppression of the aging-associated decline in 
physical performance by a combination of resveratrol intake and habitual exercise 
in senescence-accelerated mice. Biogerontology, Vol. 10, Issue 4, pp. 423-434, ISSN 
1389-5729. 
Nieman, D.C.; Henson, D.A.; Maxwell, K.R. et al. (2009). Effects of Quercetin and EGCG on 
Mitochondrial Biogenesis and Immunity. Medicine and Science in Sports and Exercise, 
Vol. 41, Issue 7, pp. 1467-1475, ISSN 0195-9131. 
Nieman, D.C.; Williams, A.S.; Shanely, R.A. et al. (2010). Quercetin's Influence on Exercise 
Performance and Muscle Mitochondrial Biogenesis. Medicine and Science in Sports 
and Exercise, Vol. 42, Issue 2, pp. 338-345, ISSN 0195-9131. 
Nunn, A.V.W.; Bell, J.D. & Guy, G.W. (2009). Lifestyle-induced metabolic inflexibility and 
accelerated ageing syndrome: insulin resistance, friend or foe? Nutrition & 
Metabolism, Vol. 6, ISSN 1743-7075. 
Nunn, A.V.W.; Guy, G.W. & Bell, J.D. (2010). Endocannabinoids, FOXO and the metabolic 
syndrome: Redox, function and tipping point - The view from two systems. 
Immunobiology, Vol. 215, Issue 8, pp. 617-628, ISSN 0171-2985. 
Ortega, R. & Garcia, N. (2009). The flavonoid quercetin induces changes in mitochondrial 
permeability by inhibiting adenine nucleotide translocase. Journal of Bioenergetics 
and Biomembranes, Vol. 41, Issue 1, pp. 41-47, ISSN 0145-479X. 
Pan, M.H.; Chang, Y.H.; Badmaev, V. et al. (2007). Pterostilbene induces apoptosis and cell 
cycle arrest in human gastric carcinoma cells. Journal of Agricultural and Food 
Chemistry, Vol. 55, Issue 19, pp. 7777-7785, ISSN 0021-8561. 
Poderoso, J.J.; Boveris, A. & Cadenas, E. (2000). Mitochondrial oxidative stress: A self-
propagating process with implications for signaling cascades. BioFactors, Vol. 11, 
Issue 1-2, pp. 43-45, ISSN 0951-6433. 
Powers, S.K. & Jackson, M.J. (2008). Exercise-induced oxidative stress: Cellular mechanisms 
and impact on muscle force production. Physiological Reviews, Vol. 88, Issue 4, pp. 
1243-1276, ISSN 0031-9333. 
Radak, Z.; Chung, H.Y. & Goto, S. (2008). Systemic adaptation to oxidative challenge induced by 
regular exercise. Free Radical Biology and Medicine, Vol. 44, Issue 2, pp. 153-159. 
Ristow, M. & Zarse, K. (2010). How increased oxidative stress promotes longevity and 
metabolic health: The concept of mitochondrial hormesis (mitohormesis). 
Experimental Gerontology, Vol. 45, Issue 6, pp. 410-418, ISSN 0531-5565. 
Ristow, M.; Zarse, K.; Oberbach, A. et al. (2009). Antioxidants prevent health-promoting 
effects of physical exercise in humans. Proceedings of the National Academy of 
Sciences, Vol. 106, Issue 21, pp. 8665-8670. 
Robb, E.L.; Winkelmolen, L.; Visanji, N. et al. (2008). Resveratrol Affects Mitochondrial 
Reactive Oxygen Species Metabolism. Free Radical Biology and Medicine, Vol. 45, S90-
S90, ISSN 0891-5849. 
Roy, P.; Kalra, N.; Prasad, S. et al. (2009). Chemopreventive Potential of Resveratrol in 
Mouse Skin Tumors Through Regulation of Mitochondrial and PI3K/AKT 
Signaling Pathways. Pharmaceutical Research (Dordrecht), Vol. 26, Issue 1, pp. 211-
217, ISSN 0724-8741. 
Santos, A.C.; Uyemura, S.A.; Lopes, J.L.C. et al. (1998). Effect of naturally occurring flavonoids 
on lipid peroxidation and membrane permeability transition in mitochondria. Free 
Radical Biology and Medicine, Vol. 24, Issue 9, pp. 1455-1461, ISSN 0891-5849. 
Scheffler, I.E. (2008). Mitochondria. In, Ed Second. Wiley, Hoboken, p 462pp. 
 
Bioactive Compounds in Phytomedicine 160 
Ji, L.L.; Radak, Z. & Goto, S. (2008). Hormesis and Exercise: How the Cell Copes with Oxidative 
Stress. American Journal of Pharmacology and Toxicology, Vol. 3, Issue 1, pp. 44-58. 
Joseph, J.A.; Fisher, D.R.; Cheng, V. et al. (2008). Cellular and Behavioral Effects of Stilbene 
Resveratrol Analogues: Implications for Reducing the Deleterious Effects of Aging. 
Journal of Agricultural and Food Chemistry, Vol. 56, Issue 22, pp. 10544-10551, ISSN 
0021-8561. 
Juan, M.E.; Wenzel, U.; Daniel, H. et al. (2008). Resveratrol induces apoptosis through ROS-
dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. Journal 
of Agricultural and Food Chemistry, Vol. 56, Issue 12, pp. 4813-4818, ISSN 0021-8561. 
Kaeberlein, M.; McDonagh, T.; Heltweg, B. et al. (2005). Substrate-specific activation of 
sirtuins by resveratrol. Journal of Biological Chemistry, Vol. 280, Issue 17, pp. 17038-
17045, ISSN 0021-9258. 
Kalt, W.; Blumberg, J.B.; McDonald, J.E. et al. (2008). Identification of anthocyanins in the 
liver, eye, and brain of blueberry-fed pigs. Journal of Agricultural and Food Chemistry, 
Vol. 56, 705-712, ISSN 0021-8561. 
Kalt, W.; Foote, K.; Fillmore, S.A.E. et al. (2007). Effect of blueberry feeding on plasma lipids 
in pigs. British Journal of Nutrition, Vol. 100, Issue 01, pp. 70-78, ISSN 0007-1145. 
Knez, W.; Jenkins, D. & Coombes, J. (2007). Does antioxidant supplementation prevent 
favorable adaptations to exercise training? - Response. Medicine and Science in Sports 
and Exercise, Vol. 39, Issue 10, pp. 1888-1888. 
Koren, E.; Kohen, R. & Ginsburg, I. (2010). Polyphenols enhance total oxidant-scavenging 
capacities of human blood by binding to red blood cells. Experimental Biology and 
Medicine, Vol. 235, Issue 6, pp. 689-699, ISSN 1535-3702. 
Kushnareva, Y.; Murphy, A.N. & Andreyev, A. (2002). Complex I-mediated reactive oxygen 
species generation: modulation by cytochrome c and NAD(P)(+) oxidation-
reduction state. Biochemical Journal, Vol. 368, 545-553, ISSN 0264-6021. 
Lagouge, M.; Argmann, C.; Gerhart-Hines, Z. et al. (2006). Resveratrol improves 
mitochondrial function and protects against metabolic disease by activating SIRT1 
and PGC-1 alpha. Cell, Vol. 127, Issue 6, pp. 1109-1122, ISSN 0092-8674. 
Li, W.; Nie, S.; Yu, Q. et al. (2009). Epigallocatechin-3-gallate Induces Apoptosis of Human 
Hepatoma Cells by Mitochondrial Pathways Related to Reactive Oxygen Species. 
Journal of Agricultural and Food Chemistry, Vol. 57, Issue 15, pp. 6685-6691. 
Li, Y.; Huang, T.-T.; Carlson, E.J. et al. (1995). Dilated cardiomyopathy and neonatal lethality 
in mutant mice lacking manganese superoxide dismutase. Nat Genet, Vol. 11, Issue 
4, pp. 376-381. 
Lopez-Lluch, G.; Hunt, N.; Jones, B. et al. (2006). Calorie restriction induces mitochondrial 
biogenesis and bioenergetic efficiency. Proceedings of the National Academy of Sciences 
of the United States of America, Vol. 103, Issue 6, pp. 1768-1773, ISSN 0027-8424. 
Lu, Z.; Zhongbo, L.; Zhihui, F. et al. (2010). Hydroxytyrosol protects against oxidative 
damage by simultaneous activation of mitochondrial biogenesis and phase II 
detoxifying enzyme systems in retinal pigment epithelial cells. Journal of Nutritional 
Biochemistry, Vol. 21, Issue 11, pp. 1089-1098, ISSN 0955-2863. 
Marfe, G.; Tafani, M.; Indelicato, M. et al. (2009). Kaempferol Induces Apoptosis in Two 
Different Cell Lines Via Akt Inactivation, Bax and SIRT3 Activation, and 
Mitochondrial Dysfunction. Journal of Cellular Biochemistry, Vol. 106, Issue 4, pp. 
643-650, ISSN 0730-2312. 
 
Polyphenols as Adaptogens – The Real Mechanism of the Antioxidant Effect? 161 
Murase, T.; Haramizu, S.; Ota, N. et al. (2009). Suppression of the aging-associated decline in 
physical performance by a combination of resveratrol intake and habitual exercise 
in senescence-accelerated mice. Biogerontology, Vol. 10, Issue 4, pp. 423-434, ISSN 
1389-5729. 
Nieman, D.C.; Henson, D.A.; Maxwell, K.R. et al. (2009). Effects of Quercetin and EGCG on 
Mitochondrial Biogenesis and Immunity. Medicine and Science in Sports and Exercise, 
Vol. 41, Issue 7, pp. 1467-1475, ISSN 0195-9131. 
Nieman, D.C.; Williams, A.S.; Shanely, R.A. et al. (2010). Quercetin's Influence on Exercise 
Performance and Muscle Mitochondrial Biogenesis. Medicine and Science in Sports 
and Exercise, Vol. 42, Issue 2, pp. 338-345, ISSN 0195-9131. 
Nunn, A.V.W.; Bell, J.D. & Guy, G.W. (2009). Lifestyle-induced metabolic inflexibility and 
accelerated ageing syndrome: insulin resistance, friend or foe? Nutrition & 
Metabolism, Vol. 6, ISSN 1743-7075. 
Nunn, A.V.W.; Guy, G.W. & Bell, J.D. (2010). Endocannabinoids, FOXO and the metabolic 
syndrome: Redox, function and tipping point - The view from two systems. 
Immunobiology, Vol. 215, Issue 8, pp. 617-628, ISSN 0171-2985. 
Ortega, R. & Garcia, N. (2009). The flavonoid quercetin induces changes in mitochondrial 
permeability by inhibiting adenine nucleotide translocase. Journal of Bioenergetics 
and Biomembranes, Vol. 41, Issue 1, pp. 41-47, ISSN 0145-479X. 
Pan, M.H.; Chang, Y.H.; Badmaev, V. et al. (2007). Pterostilbene induces apoptosis and cell 
cycle arrest in human gastric carcinoma cells. Journal of Agricultural and Food 
Chemistry, Vol. 55, Issue 19, pp. 7777-7785, ISSN 0021-8561. 
Poderoso, J.J.; Boveris, A. & Cadenas, E. (2000). Mitochondrial oxidative stress: A self-
propagating process with implications for signaling cascades. BioFactors, Vol. 11, 
Issue 1-2, pp. 43-45, ISSN 0951-6433. 
Powers, S.K. & Jackson, M.J. (2008). Exercise-induced oxidative stress: Cellular mechanisms 
and impact on muscle force production. Physiological Reviews, Vol. 88, Issue 4, pp. 
1243-1276, ISSN 0031-9333. 
Radak, Z.; Chung, H.Y. & Goto, S. (2008). Systemic adaptation to oxidative challenge induced by 
regular exercise. Free Radical Biology and Medicine, Vol. 44, Issue 2, pp. 153-159. 
Ristow, M. & Zarse, K. (2010). How increased oxidative stress promotes longevity and 
metabolic health: The concept of mitochondrial hormesis (mitohormesis). 
Experimental Gerontology, Vol. 45, Issue 6, pp. 410-418, ISSN 0531-5565. 
Ristow, M.; Zarse, K.; Oberbach, A. et al. (2009). Antioxidants prevent health-promoting 
effects of physical exercise in humans. Proceedings of the National Academy of 
Sciences, Vol. 106, Issue 21, pp. 8665-8670. 
Robb, E.L.; Winkelmolen, L.; Visanji, N. et al. (2008). Resveratrol Affects Mitochondrial 
Reactive Oxygen Species Metabolism. Free Radical Biology and Medicine, Vol. 45, S90-
S90, ISSN 0891-5849. 
Roy, P.; Kalra, N.; Prasad, S. et al. (2009). Chemopreventive Potential of Resveratrol in 
Mouse Skin Tumors Through Regulation of Mitochondrial and PI3K/AKT 
Signaling Pathways. Pharmaceutical Research (Dordrecht), Vol. 26, Issue 1, pp. 211-
217, ISSN 0724-8741. 
Santos, A.C.; Uyemura, S.A.; Lopes, J.L.C. et al. (1998). Effect of naturally occurring flavonoids 
on lipid peroxidation and membrane permeability transition in mitochondria. Free 
Radical Biology and Medicine, Vol. 24, Issue 9, pp. 1455-1461, ISSN 0891-5849. 
Scheffler, I.E. (2008). Mitochondria. In, Ed Second. Wiley, Hoboken, p 462pp. 
 
Bioactive Compounds in Phytomedicine 162 
Schroeder, E.K.; Kelsey, N.A.; Doyle, J. et al. (2009). Green Tea Epigallocatechin 3-Gallate 
Accumulates in Mitochondria and Displays a Selective Antiapoptotic Effect 
Against Inducers of Mitochondrial Oxidative Stress in Neurons. Antioxidants & 
Redox Signaling, Vol. 11, Issue 3, pp. 469-480, ISSN 1523-0864. 
Shakibaei, M.; Harikumar, K.B. & Aggarwal, B.B. (2009). Resveratrol addiction: To die or not to 
die. Molecular Nutrition & Food Research, Vol. 53, Issue 1, pp. 115-128, ISSN 1613-4125. 
Stevenson, D. & Lowe, T. (2009). Plant-derived compounds as antioxidants for health – are 
they all really antioxidants? Functional Plant Science and Biotechnology, Vol. 3(S1), 1-12. 
Stevenson, D.E.; Scheepens, A. & Hurst, R.D. (2009). Bioavailability and metabolism of dietary 
flavonoids - much known - much more to discover. In Keller, R.B., ed, Flavonoids: 
biosynthesis, biological effects and dietary sources, Nova Science Publishers Inc. 
Stevenson, D.E.; Cooney, J.M.; Jensen, D.J. et al. (2008). Comparison of enzymically 
glucuronidated flavonoids with flavonoid aglycones in an in vitro cellular model of 
oxidative stress protection. In Vitro Cellular & Developmental Biology-Animal, Vol. 44, 
Issue 3-4, pp. 73-80. 
Stevenson, D.E. & Hurst, R.D. (2007). Polyphenolic phytochemicals - just antioxidants or 
much more? Cellular and Molecular Life Sciences, Vol. 64, 2900-2916. 
Tan, L.; Yu, J.T. & Guan, H.S. (2008). Resveratrol exerts pharmacological preconditioning by 
activating PGC-1 alpha. Medical Hypotheses, Vol. 71, Issue 5, pp. 664-667, ISSN 0306-
9877. 
Tapia, P.C. (2006). Sublethal mitochondrial stress with an attendant stoichiometric 
augmentation of reactive oxygen species may precipitate many of the beneficial 
alterations in cellular physiology produced by caloric restriction, intermittent 
fasting, exercise and dietary phytonutrients: "Mitohormesis" for health and vitality. 
Medical Hypotheses, Vol. 66, Issue 4, pp. 832-843. 
Theodorou, A.A.; Nikolaidis, M.G.; Paschalis, V. et al. (2011). No effect of antioxidant 
supplementation on muscle performance and blood redox status adaptations to 
eccentric training. The American Journal of Clinical Nutrition, Vol. 93, Issue 6, pp. 
1373-1383. 
Uchida, K.; Shiraishi, M.; Naito, Y. et al. (1999). Activation of stress signaling pathways by 
the end product of lipid peroxidation - 4-hydroxy-2-nonenal is a potential inducer 
of intracellular peroxide production. Journal of Biological Chemistry, Vol. 274, Issue 4, 
pp. 2234-2242, ISSN 0021-9258. 
van Ommen, B.; Keijer, J.; Heil, S.G. et al. (2009). Challenging homeostasis to define 
biomarkers for nutrition related health. Molecular Nutrition and Food Research, Vol. 
53, Issue 7, pp. 53 (57) 795-804, ISSN 1613-4125. 
Vincent, H.K.; Bourguignon, C.M.; Vincent, K.R. et al. (2006). Antioxidant supplementation 
lowers exercise-induced oxidative stress in young overweight adults. Obesity, Vol. 
14, Issue 12, pp. 2224-2235. 
Wilson, L.; Yang, Q.; Szustakowski, J.D. et al. (2007). Pyruvate induces mitochondrial 
biogenesis by a PGC-1alpha-independent mechanism. American Journal of 
Physiology-Cell Physiology, Vol. 292, Issue 5, pp. C1599-C1605, ISSN 0363-6143. 
Yang, H.Y.; Baur, J.A.; Chen, A. et al. (2007). Design and synthesis of compounds that extend 
yeast replicative lifespan. Aging Cell, Vol. 6, Issue 1, pp. 35-43, ISSN 1474-9718. 
Zoechling, A.; Liebner, F. & Jungbauer, A. (2011). Red wine: A source of potent ligands for 
peroxisome proliferator-activated receptor [gamma]. Food & Function, Vol. 2, Issue 
1, pp. 28-38, ISSN 2042-6496. 
9 
Erythrina, a Potential Source 
of Chemicals from the Neotropics 
R. Marcos Soto-Hernández, Rosario García-Mateos, 
Rubén San Miguel-Chávez, Geoffrey Kite, 
Mariano Martínez-Vázquez and Ana C. Ramos-Valdivia 
1Colegio de Postgraduados, Campus Montecillo Mexico, Universidad 
Autónoma Chapingo, Preparatoria Agrícola, Mexico, 
2Royal Botanic Gardens, Kew Richmond, 
3Universidad Nacional Autónoma de México, Instituto de Química Mexico, 





The history of Erythrina research begins at the end of the nineteen century. During the last 
two decades of that time extracts from species of Erythrina have been found to exhibit 
curare-like neuro muscular blocking activities which are caused by alkaloids occurring there 
in (Rey, 1883; Altamirano, 1888; Greshoff, 1890; Folkers & Unna, 1938). 
It was Altamirano (1888), who obtained a silky shining, crystalline compound as well as 
Greshoff (1890) who already isolated several basic unspecified compounds. Because of their 
remarkable biological activity he suggested a systematic phytochemical examination of the 
genus Erythrina. But it still has taken at most half a century before this has been realized for 
the first time by Folkers. He has shown that more than fifty Erythrina species e.g. Erythrina 
americana (Fig. 1) are containing the typical alkaloids exhibiting the same curare-like activity 
reported before (Folkers & Unna, 1939; Folkers & Major, 1937). Moreover, his group 
succeeded in isolation the first erythrinane alkaloid named erythroidine (14, Fig. 3) (Folkers 
& Koniouszy, 1939). Soon after numerous alkaloids have been isolated, e.g. erythramine (8) 
(Folkers & Koniouszy, 1940a), erythraline (3) (Folkers & Koniouszy, 1940b), erythratine (9) 
(Folkers & Koniouszy, 1940c), erysodine (6), erysopine (4) and erysovine (5) (Carmag, et al. 
1951). 
Another decade later the fundamentals investigations of Prelog (Kenner, et al., 1951; Tsuda 
& Sano, 1996) and Boekelheide (Boekelheide, et al. 1953) have finally led to the correct 
structural framework of the erythrinane alkaloids (Parent compounds 1, Fig. 2) 
Due to the increasing attraction and rapid extension in this field the Erythrina alkaloids have 
been regularly reviewed concerning occurrence, structure, analytical, spectral properties, 
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Fig. 1. Erythrina americana Mill (Colorin) 
biosynthesis, total synthesis and biological activities covering the literature up to date. 
Besides compounds as flavonoids, isoflavonoids, lectins, saponins have received special 
attention mainly by their biological activity or toxicity. 
This review has the aim to show the evolution in the knowledge of these ubiquitous 
compounds that remark the Erythrina genus and emphasize their importance and interest in 
different areas. 
2. Structural classification of Erythrina alkaloids 
The alkaloids of Erythrina type are characterized by their unique skeleton of a tetracyclic 
spiroamine. They are classified in two main groups: alkaloids possesses a skeleton of a 
6,5,6,6 indoloisoquinoline called erythrinanes and those with a skeleton of 6,5,7-6 
indolobenzazepine called schelhammerans or homoerythrinane alkaloids (Fig. 2). 
 
      (3R,5S,6S/3S,5R,6R)-Erythrinane (1)                     (5S,6S / 5R,6R)-Schelhammerane (2) 
                                                                                                (homoerytrinane alkaloids) 
Depending of the nature of D ring both groups can be subdivide in aromatic and non 
aromatic. In this last group that include in the D ring oxa compounds, are those called 
lactonic alkaloids. Besides, in both series have been isolated alkaloids with a pyridinium 
group instead of a phenyl group, for example the erymelanthine (11) and the holidine 
(12). 
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R1-R2=CH2;n=1: Erythraline (3) 
R1=H;R2=H;n=1 Erysopine (4) R=H; n=1: Erythramine (8) 
R1= CH3;R2=H;n=1 Erysovine (5) R= β-OH;n=1 Erythratine (9) 
R1=H;R2=CH3;n=1 Erysodine (6) R=H;n=2:Schelhammericine (10) 









                              Erythroidine (14)                                    Cocculolidine (15) 
 
Fig. 2. General classification of Erythrina alkaloids: Dienoid and alkenoid  type alkaloids and 
D ring modifications.  
 
Bioactive Compounds in Phytomedicine 164 
 
 
Fig. 1. Erythrina americana Mill (Colorin) 
biosynthesis, total synthesis and biological activities covering the literature up to date. 
Besides compounds as flavonoids, isoflavonoids, lectins, saponins have received special 
attention mainly by their biological activity or toxicity. 
This review has the aim to show the evolution in the knowledge of these ubiquitous 
compounds that remark the Erythrina genus and emphasize their importance and interest in 
different areas. 
2. Structural classification of Erythrina alkaloids 
The alkaloids of Erythrina type are characterized by their unique skeleton of a tetracyclic 
spiroamine. They are classified in two main groups: alkaloids possesses a skeleton of a 
6,5,6,6 indoloisoquinoline called erythrinanes and those with a skeleton of 6,5,7-6 
indolobenzazepine called schelhammerans or homoerythrinane alkaloids (Fig. 2). 
 
      (3R,5S,6S/3S,5R,6R)-Erythrinane (1)                     (5S,6S / 5R,6R)-Schelhammerane (2) 
                                                                                                (homoerytrinane alkaloids) 
Depending of the nature of D ring both groups can be subdivide in aromatic and non 
aromatic. In this last group that include in the D ring oxa compounds, are those called 
lactonic alkaloids. Besides, in both series have been isolated alkaloids with a pyridinium 
group instead of a phenyl group, for example the erymelanthine (11) and the holidine 
(12). 
 
Erythrina, a Potential Source of Chemicals from the Neotropics 165 




R1-R2=CH2;n=1: Erythraline (3) 
R1=H;R2=H;n=1 Erysopine (4) R=H; n=1: Erythramine (8) 
R1= CH3;R2=H;n=1 Erysovine (5) R= β-OH;n=1 Erythratine (9) 
R1=H;R2=CH3;n=1 Erysodine (6) R=H;n=2:Schelhammericine (10) 









                              Erythroidine (14)                                    Cocculolidine (15) 
 
Fig. 2. General classification of Erythrina alkaloids: Dienoid and alkenoid  type alkaloids and 
D ring modifications.  
 
Bioactive Compounds in Phytomedicine 166 
Besides, the specific position and number of double bonds in the A and B rings have taken 
to another alkaloid sub division: dienoid and alkenoid  in both series. The first ones are 
characterized by a conjugated diene in the 1,2,6 and 7 carbons whereas the last ones 
possesses only one a double bond in the position 1,6 (8,9). 
As aromatic erythrinane alkaloids and homoerythrinanes as well show a substitution 
characteristics pattern, e.g. present oxygenated substituents in the 3,15 and 16 carbons 
mainly and besides there is a group of alkaloids deoxygenated in C-16,the saturated 
compounds in both series of alkaloids have cis configuration in the fussion A/B  
independently that had obtained by transformation of natural alkaloids or by synthesis 
(Mondon, et al., 1970;  Reiman & Ettmayr, 2004). 
Generally these alkaloids are dextrorotatory and their absolute configuration in the carbon 5 
is (S) to respect to basic skeleton (Amer, et al., 1991), although is observed some exceptions 
as the wilsonine (49) has configuration (R) in the carbon 5. 
The carbon 3 of the erythrinanes always have the configuration R. 
3. Biosynthesis of the erythrinane alkaloids  
A series of experiment in vivo and in vitro done by Barton and coworkers (Barton & Cohen, 
1957; Barton et al.,1970) demonstrated that a derivative of an isoquinoline, the (5)-
norprotosinomenine (Bencyl-tetrahydroisoquinoline (34) is the main precursor to which is 
cyclized through a phenolic coupling p-p to a derivative of a neoproaphorfine (35). 
In this is effected a rearrangement to form a dibenzazonine (36). Its hydrogenation product 
(37) is oxydized to the corresponding diphenoquinone 38. To the end occurs an 
intramolecular addition type Michael to form the erysodienone (39) which already has  
the skeleton of an erythrinane (Barton & Cohen, 1957; Barton, et al., 1970; Barton, et al., 
1974). Both precursors 34 and 37 are compounds of natural origin (Scheme 1). Later on this 
route was reinvestigated by Maier & coworkers (Maier & Zenk 1997; Maier, et al., 1999) 
because was observed only occurred a small rate of relative incorporation of non 
protosinomenine (34) in the erythraline (3) (0.1 – 0.25%) someone not usual to the group of 
alkaloids with isoquinoline skeleton derivated of (S) reticuline (40: NCH3 instead of NH) 
e.g. aporphines, protoberberine, bisbencylisoquinolines, morphinones, pavines and 
benzophenanthridines. 
 
S-Norprotosinomenine (34)         Neoproaporphine (35)                          (36) 
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   Dibenzazonine (37)                   Dibenzazonine dione (38)                         Erysodienone (39) 
Scheme 1. 
It was observed by this way that the (S)- non reticuline (40) is the biosynthetic precursor 
more important to the erythrinane alkaloids and that the rate of incorporation  surpassed by 
for that of (S) norprotosinomenine(34) previously found (7.9%) against 0.25% in the case of 
erythraline and this last one did not transform in another alkaloids. This can suggest a new 
route and mechanism to the biosynthesis of the alkaloids (Scheme 2) 
In this model, the p-p coupling of the (S) nor reticuline should take to the derivative of the 
morphinanedienone, the norisosalutanidine (41) and not to the neoproaporphine derivative 
(35). 
The last one, after formation the function benzo [1,3]dioxol forms the noramurine (42), 
which can rearrange via the ion neoespirinic (43) to the unsymmetrical dibenzazonine 
oxidation of the free phenolic residue proceeds through a SET mechanism to form diallylic 
cation (45), the last one is supposed that reacts with the nitrogen atom to get  
Δ3erythratinone (46). 
The subsequent steps leading to erythraline (3) are similar to those already established 
(Maier, et al., 1999 ). 
4. Syntheses of Erythrina alkaloids and compounds type Erythrine 
Since some time ago had interest in the total synthesis of the Erythrina alkaloids because 
their unique structure and biological activity. In this way has been developed to date 
numerous synthetic approaches to the tetracyclic skeleton. Considering that three of the 
rings A,B and C can be joint in a final step,have been developed two synthetic strategies to 
this type of compounds: the formation of one of the mentioned rings (route A, B, or C) or the 
simultaneous or sequential formation of more than one cycle for example A/B, A/C, B/C or 
A/B/C in one step (called routes A/B, B/C, etc. schemes 3,4). 
Various subtypes of the synthesis result depending of the bond formed (Schemes 3,4): for 
example the formation of the C ring can be attain through the method (a) or (b) = route C (a) 
or C (b). 
According to this can be generate two different subdivisions to the simultaneous 
construction of the B and C  rings ( = route B/C (a) or B/C (b) (Kawasaki, 2001) 
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Scheme 2. Biosynthetic pathway of Erythrina alkaloids suggested by Maier, et al. (1999) 
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Scheme 3. Synthetic strategies to the aromatic erythrinane alkaloids. Generation of an 
alicyclic ring in the final step 
 
 
Scheme 4. Strategies to the synthesis of aromatic erythrinane alkaloids. Generation of more 
than one alicyclic ring for tandem sequential cyclization in the final step or in one step. 
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In the case of the non aromatic  Erythrine  alkaloids, only has described one total synthesis so 
far. Thus the synthesis of the (±) coculolidine (15) has been completed in 0.42% total yield 
through 21 steps (Kawasaki, et al., 2001). Also has been described several synthetic 
approaches to the D ring of the oxaerythrinane skeleton (Studa & Sano, 1996). 
5. Spectroscopic characteristics of the Erythrina alkaloids 
In the structural determination of these alkaloids have been used widely the common 
spectroscopic techniques e.g. UV, IR, and 1H NMR 13CNMR, besides of mass spectrometry 
and X ray crystallography. 
The aromatic alkaloids show IR absorption to 1610 cm-1 and in the UV in the range of 285-
290 nm (aromatic deoxygenated ring) and 235-240 nm (of the diene residue). The alkenoid 
alkaloids absorb in the UV about of 225 nm, whereas the enone residue shows absorption to 
230 nm and in IR between 1675-1698  cm-1. The lactonic alkaloids absorb in the IR to 1720 
cm-1  (carbonyl of the lactone) whereas in the UV its absorption is about 224 and 238 nm. 
The 1H- NMR easily distinguish to the dienoid alkaloids by the presence of a ABX system 
comes from the three olefinic protons pattern does not presented the alkenoid  alkaloids or 
the lactonic alkaloids. 
The 13C spectra of various erythrinane alkaloids has been assigned by comparison with 
series of related compounds or well through the case of model compounds, the spirocenter 
at C-5  usually absorb at δ 63-68. The tertiary aromatic carbons of those of C-14 present a 
chemical shift to high field (δ 108-112) whereas that at C-17 is observed about δ 111-117. 
The mass spectrometry had an important role in the structural identification of these alkaloids 
particularly when is combined with gas chromatography or liquid chromatography. An 
analysis of a mass spectrum to those alkaloids shows in the case of those aromatic or lactonic 
that occurs a main fragmentation of the methyl or methoxy group in C-3 (Fig. 3) In the series 
of the alkenoid alkaloids also is observed this type of fragmentation, but is observed another 
peak at M+-58 which corresponds to a retro Diels-Alder fragmentation. Loss of C-3, C-4 and 
methoxy group at C-3 also is observed in this series (Fig. 4). 
 
Fig. 3. Fragmentation of dienoid alkaloids 
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Fig. 4. Fragmentation of the alkenoid alkaloids 
Following MS/MS analysis in an ion trap analyser, Erythrina alkaloids methoxylated at C3 
show the neutral loss of methanol from the protonated molecule but few other abundant 
fragments. Thus MS3 analysis of the [(M+H)-CH3OH]+ is necessary to obtain a greater array 
of fragments, which is necessary to confirm identities against standards of for library spectra 
(Fig. 5). Several product ions generated from the [(M+H)-CH3OH]+  fragment appear to be 
produced by radical losses of methyl or hydroxyl groups. Glycosylated forms of Erythrina 
alkaloids are also evident in some species when crude extracts are analysed by LC-MS, and 
they may be the most abundant types present. Fragmentation of the glycosides proceeds via 
neutral loss of the glycosyl unit to yield a protonated aglycone ion that fragments in the 
same manner at the free protonated alkaloid. Undoubtedly, systematic surveys of native 
Erythrinane alkaloids in Erythrina species by LC-MS will reveal a greater variety of 
glycosilated or other conjugated forms than have presently been isolated. 
In this sense all parts of Erythrina plants have been screened to describe new compounds, for 
instance Wanjala & Majinda (2000) described the structures of two novel alkaloids from E. 
latissima seeds; from the wood of E. poeppigiana Tanaka et al, (2001) isolated a new erythrina 
alkaloid, 8-oxo-α-erythroidine. From the flowers of E. speciosa two alkaloids were isolated, 
erysotrine and erythartine and the leaves furnished one alkaloid, nororientaline, Faria, et al 
(2007.) Three new alkaloids, 10,11-dioxo-erythrartine, 10,11-dioxoepierythratidine and 10,11-
dioxo erythratidinone and a new pterocarpan 1-methoxyerythrabissin were isolated from the 
bark of E. subumbrans (Rukachaisirikul, et al., 2008). A new Erythrina alkaloid, 10-hydroxy-11-
oxo-erysotrine has been isolated from the flowers of E. herbacea (Tanaka & Hattori, 2008). From 
the bark of E. crista-galli two new alkaloids, cristanines A and B  were isolated ( Ozawa, et al., 
2010) and from the seeds of  E. velutina were isolated four new alkaloids, three of them were 
found to be novel sulfated erythrinane alkaloids (Ozawa, et al., 2011).  
It is interesting to note that in the 2000 decade the literature described not only the isolation 
of new structures but also related them with biological activity, for instance Juma & Majinda 
(2004) described the isolation of fourteen different Erythrina alkaloids from the flowers and 
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pods of E. lysistemon and tested their DPPH radical scavenging  properties against stable 2,2-
diphenyl-1-picrylhydrazyl (DPPH) radical. The antifeedant activities of the Erythrina 
alkaloids from the seeds, seed pods and flowers of E. latissima were investigated in 
laboratory dual-choice bioassays using third –instar Spodoptera littoralis (Boisduval) larvae 
(Wanjala, et al., 2009) and they found  a dependant activity at concentrations between 100-
500 ppm. The seed pods of E. latissima were studied by Wanjala  & coworkers (Wanjala, et 
al., 2002), they found in this tissue the known alkaloids,  erysotrine and erysodine and a new 
alkaloid, 10,11-dioxoerysotrine, which was lethal to brine shrimp and a 2-(5´-hydroxy-3´-
methoxy phenyl)-6-hydroxy-5-methoxybenzofuran, which showed strong antimicrobial 
activity against the yeast spores, Gram-positive and Gram-negative bacteria. 
 
Fig. 5. MS (m/z 313 [MH]+ →268) spectrum of erysodine recorded on a Thermo-Scientific 
I.CQ Classic quadrupole ion trap mass spectrometer. 
6. Analysis of Erythrina alkaloids by liquid chromatography 
These alkaloids has been analyzed traditionally by gas chromatography coupled to mass 
spectrometry (GC-MS). Although is possible analyze some of these alkaloids directly by this 
technique (Mantle, 1995)  the method is improved with chemical derivatization, for example 
with trimethyl silylation the volatility of the compounds in increased (Jackson, et al., 1982). 
The glycosylated compounds are hydrolyzed to release the aglycone and facilitate the 
analysis. By this way the technique has been valuable in the analysis of several species of 
Erythrina (Soto-Hernandez & Jackson, 1994) also to compare hydrolyzed form with non 
hydrolyzed the levels of conjugated alkaloids can be deducted. 
Besides, the high resolution of the hyphenated technique helps in the distinction of isomers,  
but the derivatization could complicate the analysis to form artifacts or  could be incomplete 
and the method is consuming time.These observation made to look another technique with 
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lesser inconveniences e.g. the coupling of HPLC with mass spectrometry referred as HPLC-
MS. As these alkaloids easily accept protons, are ionized efficiently in positive mode with 
ionic sources as electrospray (ESI) or chemical ionization at atmospheric pressure (APCL). 
This last ionization mode is obtained higher sensitivity to the aglucones. Being basic 
compounds is low probable that their ionization is depleted in positive mode by other 
compounds, allowing that is detected easily by direct injection of a crude extract of 
alkaloids. However when is presented isomeric forms should be separated them before their 
analysis by mass spectrometry. 
In one first step, the analysis of these alkaloids by HPLC with UV detection has been done 
with a normal phase column (Soto-Hernandez & Jackson, 1994). Later on was used the 
columns in reverse phase C-18 which at the beginning had low  resolution and presented 
adverse effects to occur interactions between the charged alkaloids and negative residue 
charge from the stationary phase of the column. Also these compounds have been 
analyzed in the ionic pair mode. To diminish the positive charge of them, this mode 
(Fabre, et al. 2000) took to propose a method of analysis with the combination HPLC-MS, 
but the use of the present C-18 columns can remove the participation of the ionic volatile 
reagent (Verpoorte & Niesse, 1994).With them are managed in basic pH to increase the 
retention of the alkaloids and suppress the ionization of the OH groups in the stationary 
phase, this criteria helped in the analysis of the alkaloids of Erythrina herbacea that allowed 
a good separation and detection of the alkaloids, starting from a crude extract of the plant 
in which was used a programmed gradient of 0.1% ammonium acetate (at pH 7.4) and 
methanol (Garin-Aguilar, et al., 2005). However, with the recent incorporation of C-18 
column with phenyl group linked to ethers, designed specifically to retain polar aromatic 
compounds, results suitable to the analysis of these alkaloids using simply a gradient of 
aqueous methanol and the method is still acceptable in acidic methanol (Fig. 5) by this 
way the acidic mobile phase promote the protonation of the alkaloids and improve their 
sensitivity. 
7. Pharmacology 
The biological activity of extracts of Erythrina species is known since long time ago. Thus, 
the natives of  South America used concentrated extracts of these species as arrow poisons 
as antidote against strychnine or as an hypnotic and antiepileptic (Folkers & Unna, 1938). 
Also was observed that when is applied to dogs at different doses an alcoholic extract of 
seeds of E. americana provoked a similar  activity to that of tubocurarine, this action was 
confirmed later on (Lozoya & Lozoya, 1982) 
The first crystalline alkaloid pharmacologically active was isolated from E. americana 
(Folkers & Major, 1937) called erythroidine. Altamirano used this name but he related it as a 
unknown constituent of the plant. The subsequent analysis showed that this material was a 
mixture of isomeric alkaloids to which were called α- and β- erythroidines(47, 48) 
Between 1940 and 1950 the systematic review of more than 50 species of Erythrina showed 
that all the isolated alkaloids produced similar effects to those of the curare alkaloids ( 
Pick & Unna, 1945) used before as adjuvants in surgical anaesthesia, this stimulated the 
systematic investigation of the Erythrina species related to the biological properties of 
their extracts. 
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way the acidic mobile phase promote the protonation of the alkaloids and improve their 
sensitivity. 
7. Pharmacology 
The biological activity of extracts of Erythrina species is known since long time ago. Thus, 
the natives of  South America used concentrated extracts of these species as arrow poisons 
as antidote against strychnine or as an hypnotic and antiepileptic (Folkers & Unna, 1938). 
Also was observed that when is applied to dogs at different doses an alcoholic extract of 
seeds of E. americana provoked a similar  activity to that of tubocurarine, this action was 
confirmed later on (Lozoya & Lozoya, 1982) 
The first crystalline alkaloid pharmacologically active was isolated from E. americana 
(Folkers & Major, 1937) called erythroidine. Altamirano used this name but he related it as a 
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Fig. 6. Chromatogram of a LC-MS analysis of a methanol crude extract of E. americana seeds. 
The analysis was done in a phenomenex RP polar column of 150 x 46 mm, using a gradient 
of 0-10% methanol in the mobile phase (acidified with 1% acetic acid).  Detection with APCI. 
The figures near to the peaks are the values of [M+H]. 
 
β-erythroidine (47)                       Dihydro-β-erythroidine (48)                        Wilsonine (49) 
Fig. 7.  Structure of various Erythrina alkaloids with special  pharmacological properties. 
Several species have been used in the indigenous medicine as eyewashes or wounds, for 
pain relief of arthritis or as calm and relaxants agents (Garin-Aguilar, et al., 2000). Interesting 
also has been described the hypoglycemic activity of E. variegata leaf in streptozotocin-
induced diabetic rats (Kumar, et al., 2011) and the authors conclude that leaf of  this plant 
has promising hypoglycemic action in STZ-induced diabetic rats substantiating in this way 
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the ethnomedical use. The study of the antidiarrhoeal effects of ethanolic leaf extract of E. 
indica L. in experimental animals done by Sonia and coworkers (Sonia, et al., 2011) showed 
that this extract elicit potential antidiarrhoeal effects and thus substantiated its traditional 
claim as an antidiarrohoeal agent, also their findings suggest that the main constituents of 
the extracts were alkaloids 
Also they have been related with antiasthmatic, diuretic or hypnotics properties. The 
alkaloidal extracts of E.  variegata besides of its smooth properties as muscular relaxant has 
found depressed activity of the CNS and anticonvulsant, also increase the hypnosis 
provoked by pentobarbital and inhibit the acetyl choline induced spasm. Extracts of E. 
velutina and E.suberosa have spasmolytic and antineoplastic activity (Ghosal, et al., 1972; 
Craig, 1955). In recent researches crude extracts of E. americana as well their pure 
constituents: β-erythroidine and dihydro-β-erythroidine (Fig. 7) diminished the aggressive 
behavior in rats when is used diazepam as control. These effects are attributed to an 
interaction between the cholinergic and GABAergic receptors. Besides was determined the 
LD50 of the extracts as well to the pure alkaloids.  From all the pure alkaloids tested the α- 
and β-erythroidine showed the highest activity (Garin-Aguilar, et al., 2000). It is considered 
that they are responsible of the hypnotic activity of the extracts of the flowers of E. americana 
(Tsuda & Sano, 1996). The β-erythroidine and its more potent derivative (2,7-dihydro) (48) 
have been used as muscular relaxants in numerous clinical applications (Lozoya & Lozoya, 
1982). This activity is attributed to a antagonistic action of the dihydro β-erythroidine with 
the nicotinic receptors of acetyl choline (Tsuda & Sano, 1996; Cheeta, et al., 2001; 
Schoffelmer, et al., 2002). 
 Subsequently the group of Iturriaga-Vasquez and coworkers (Iturriaga-Vasquez, et al., 
2010)  studied the molecular determinants for competitive inhibition of  α4β2 nicotinic 
acetylcholine receptors provoked by the dihydro-β-erythroidine (DHβE). They addressed 
this issue by examining the effects of DHβE and a range of aromatic Erythrina alkaloids on 
[3H] cytisine binding and receptor function in conjunction with homology models of the 
α4β2 nAChR, mutagenesis and functional assays. They found that the lactone group of 
DHβE and a hydroxyl group at position C-16 in aromatic Erythrina alkaloids were identified 
as major determinants of potency, which was decreased when the conserved residue Tyr 126 
in loop A of the  α4 subunit was substituted by alanine. 
Erysodine (6) has found as competitive reversible antagonist of nicotine and the induced 
release of dopamine. It is equipotent with the dihydro-β-erythroidine (48) and can be used 
as  tool to characterize neuronal nicotinic receptors of acetyl choline. 
The anxiolytic effects of the E. velutina aqueous alcoholic crude extract and  the purified 
alkaloids of the flowers of this plant  were evaluated using the elevated T-maze test, and the 
light dark transition model( Flausino, et al., 2007a; Flausino, et al., 2007b). They observed a 
moderate activity but explain the use of the plant as calm agitation and other disorders of 
the nervous system. Subsequently, Carvalho, et al., (2009) showed an evidence of the 
mechanism of action of the leaves aqueous extract of this plant and they found that this 
extract  provokes a GABAA receptor activation, acetylcholine release, muscarinic receptor 
activation, augmentation of Ca2+ entry though L-type calcium channels, and calcium release 
from the intracellular stores and they mention that their findings provide further support for 
E. velutina traditional uses. 
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as major determinants of potency, which was decreased when the conserved residue Tyr 126 
in loop A of the  α4 subunit was substituted by alanine. 
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However the study of Silva and coworkers (Silva et al., 2011) put in attention the use of this 
plant because through genotoxicity and cytotoxicity experiments on the root meristem cells 
of Allium cepa showed that the decoction of the leaves can have genotoxic effects at some 
doses and they recommend caution when using this plant for the preparation of teas and 
other medicinal products. 
The group of Atsarno & coworkers (Atsarno, et al., 2011) evaluated the potential toxicity of 
the decoction of the stem bark of E. senegalensis which is used traditionally  in Cameroon 
against liver disorders. Their results demonstrated that there is a wide margin of safety for 
the therapeutic use of this decoction and further corroborated the traditional use of this 
extract as hepatoprotective agent. 
 The analgesic properties of extracts and fractions from E. crista-galli leaves were tested by 
Fischer, et al., (2007) and they found that one of the fractions was the most active, being 
about 7-fold more active than the reference drugs(acetyl salicylic acid and acetaminophen) 
It is important to mention that the curare alkaloids as quaternary salts and by their potent 
solubility in water are administered parentally. In contrast the Erythrina alkaloids are 
tertiary amines and they are able to develop their pharmacologic effects by oral via. 
8. Chemotaxonomy 
The alkaloids has been proposed as possible taxonomic markers is several species of 
angiosperms and this has helped to the resolution of some taxonomic problems, their 
limited distribution make that they can not be employed in the higher level of taxonomic 
classification only in those orders and classes where they are represented. 
In this way the chemotaxonomy of alkaloids is found well documented but only to certain 
families of angiosperms (Hegnauer, 1963).  In the case of Erythrina plants has been studied 
the alkaloid content in approximately half of the known species and the relationship of them 
is reflected in the presence of a series of alkaloids with isoquinoline skeleton. 
Although the pattern of alkaloids of this genus is characteristic, their concentration varies. 
Hargreaves & coworkers mentioned that in the American species the proportion of alkaloids 
differs widely. The results indicate that in the genus, the dienoid alkaloids  erysodine, 
erysovine and erysopine are the most abundant and widely distributed. In the American 
species the alkaloids generally do not contain oxygenated functions in C-11 may be by the 
enzymatic lack to hydroxylate this position (Hargreaves, et al., 1974).  Aguilar & coworkers 
pointed out that in E. americana is typical to find lactonic alkaloids as main compounds 
(Aguilar, et al., 1981). 
In E. folkersii has been found alkaloids of the type 1,6-diene and in E. salviflora those of 
alkenoid type. Ghosal & coworkers mentioned that erysotrine is the most abundant alkaloid 
in bark of E. variegata var. orientalis but also has been identified  the erysodine in a lesser 
amounts (Ghosal, et al., 1972), whereas Dyke & Quessy mentioned that only is found 
erysodine in the bark of the same species (Dyke & Quessy, 1981). In some species is frequent 
to find alkaloids to contain oxygenated functions in the C-8 and C-11 position of the 
erythrinane skeleton,  still exist doubts respect if one species is synonym to other. As the 
case of E. americana which some authors mention is synonym of E. coralloides. To prove that 
they are different species San Miguel-Chavez & coworkers found that the plantlets of one 
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month age of E. americana synthetize erysosalvine, erythraline, N-oxide, erythratine and 8-
oxo-α-erythroidine, whereas those of E. coralloides presented only erythraline and erysopine. 
These observations together  with those of the morphology of the plantlets gives the idea of 
both species are different (San Miguel-Chavez et al., 2006). 
9. Biotechnology in the production of Erythrinane alkaloids 
Is well known that most of the drugs using in medicine are synthetic but some of them are 
of natural origin. Their demand is so high that some of  plants are cultivated to this aim  and 
to get enough biomass for the extraction of the drugs. 
To satisfy the demand and protect the natural resources, has been developed alternative 
methods as Biotechnology plant cell tissue culture or the chemical synthesis and has been 
observed better results comparing with the traditional methods (Bougard, et al., 2001; 
Murphy, 2011). 
Except to cultivated plants (e.g. Papaver somniferum) most of secondary metabolites are 
accumulated after certain age or maturity of the plant e.g. trees or shrubs (Cinchona, 
Rauwolfia, Campotheca, Ochrosia, etc) 
The plants obtain their maturity before accumulate the active principles in higher amounts 
and is difficult increase the plantation to particular species. To avoid all of these limitations 
is required alternative methods to get a constant material all the year. To collect the plants in 
their natural environment is difficult but also put in risk of extinction some of them. When 
the plant material is not obtained during the year in enough amount to industrial scale and 
the chemical synthesis is not possible  particularly in the case of complex molecules, the 
biotechnological methods give an excellent alternative. However to get this option should be 
consider cost/benefit of the product and then justify its its production (Bourgard, et al., 
2001; Murphy, 2011). 
E. americana had a wide distribution in México but recently its natural populations have 
started down because to the disappearance of its habitats. 
This species also have interest because by the production of alkaloids with pharmacological 
and antimicrobial properties. Also has been explored the possibility of the in vitro tissue 
culture. In a first approach was obtained calluses from cotyledons of germinated seeds and 
maintained in a MS medium. These calluses were analyzed in the production of alkaloids 
and were observed that erythraline and the erythtroidines are the major alkaloids (Garcia-
Mateos, et al., 1999; San Miguel-Chávez, et al., 2003.) 
Subsequently cell suspension culture were induced from calluses what showed an efficient 
production of alkaloids in MS medium plus sucrose. The alkaloids obtained in these tissue 
culture were erythraline, 8-oxo-erythraline erysodine, α-and β-erythroidine, erysotramidine, 
and 8-oxo-α-erythroidine, but with levels below of those of the calluses (San Miguel-Chávez, 
et al., 2003). Trying to increase the alkaloid production in cell suspension culture, the 
concentration and type of plant growth regulation has been managed, and kinetin, indol 
acetic acid, naphthalene  acetic acid and 2,4-phenoxyacetic acid have been tested and the 
treatment with MS medium plus 2,4-D+ kinetin (2 mg l-1each one) gave the best results  (San 
Miguel-Chávez, et.al., 2003). 
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In another step it has been elicited the cell suspension culture with jasmonic acid and only 
erysodine increased its production (San Miguel-Chávez, et al., 2007). 
10. Compounds of non alkaloid composition 
Besides of the presence of alkaloids in the Erythrina plants, has been detected the presence of 
diverse metabolites, for example glucoproteins or lectins with the characteristic to 
agglutinate cells (Ortega, et al. 1990).  Stojanovic & coworkers , characterized a lectin 
isolated from E. velutina which is a good agglutinant agent of erytrocites A, B and O in 
human beings (Stojanovic, et al., 1994). 
The saponins sigmoidin C and D were isolated from the steam bark of E. sigmoidea Hua and 
have been used in Cameroon as antimicrobial agents (Mbafor, et al., 1997). Also from this 
species have been recently isolated a new antibacterial triterpenoid saponin called 
Sigmoiside E (Kouam, et al., 2007). In E. crista-galli were isolated 3 new pterocapans: 
cristacarpin, erystagallin and phaseollidin   with  phytoalexin properties  and possessing 
antimicrobial activity against Gram- positive bacteria (Tanaka, et al., 1997). The erystagallin-
A also isolated from the stem bark of E. variegata L. showed significant anti-cancer activity 
against breast cancer T47D cell-lines in vitro using the Sulforhodamine B(SRB) assay and 
anti-malarial activity against Plasmodium falciparum  in vitro using the lactate dehydrogenase 
(LDH) assay (Tati, et al., 2011). It is interesting to note that the pterocarpene, erycristagallin   
isolated from root bark of  E. mildbraedii (Njamen, et al., 2003)  showed  anti-inflammatory 
properties through  its capacity to inhibit the arachidonic acid metabolism via the 5-
lipooxygenase pathway. 
Fomum and coworkers (1986)  found in the bark of E.sigmoidea three new phenyl flavanones:  
sigmoidine A, B and C with a notorious activity against, Gram- positive bacteria (Fomum, et 
al., 1986). 
In the seeds of Erythrina also have been detected protease inhibitors, for  instance  Joubet & 
coworkers  found this kind of compounds against  tripsine, which acts as activator of the 
plasminogen tissue (Joubet, et al. 1987). In this way, continue an intense research with 
diverse species of Erythrina with the aim to characterize other compounds with notorious 
antibiotic activity and anticancer for example Cui & coworkers described four new 
chalcones 1 to 4 called abyssinones A-D isolated from E. abyssinica. They showed a moderate 
cytotoxic against Caco2 cell line of human colorectal cancer with  IC50 13.3, 15.1 and 11.1 µM 
respectively( Cui, et al. 2008). 
Previously in this species Yenesew & coworkers (2004)  found in the ethyl acetate extract of 
the bark, anti plasmodial activity against the chloroquine sensible (D6) and chloroquine-
resistant (W-2) strains in Plasmodium falciparum with values of IC30 of 7.9 ± 1.1 and 5.3 I 0.7 
mg ml respectively (Yenesew, et al. 2003, 2004). 
Also several flavonoids (Chacha, et al. 2005; Chukwujekwu, et al., 2011; Doughari, 2011), 
isoflavonoids (Sato, et al., 2006; Kamdem Waffo, et al., 2006; Redko, et al., 2007) and 
pterocarpanes (Rukachaisirikul, et al., 2007a; 2007b) have been mentioned as antimicotic and 
antibacterial agents. For instance,  an arylbenzofuran, erypoegin F and four isoflavonoids, 
erypoegins G-J were isolated from the roots of E. poeppigiana and their structure were 
elucidated by spectroscopic evidence (Tanaka, et al., 2003). 
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Also is important to mention the study done by Tanaka & coworkers (Tanaka, et al. 2010) in 
which they isolated two new compounds from the roots of E. herbaceae, erybacin A and 
erybacin B, as a 1-hydroxy-1,3-diphenylpropan-2-one derivatives. These compounds were 
evaluated for their antibacterial activities against 13 strains of methicillin resistant 
Staphylococcus aureus (MRSA), the erybacy B showed a potent bactericidal activity against 
MRSA. 
The stem bark of E. senegalensis studied by its hepatoprotective properties have been  
recently studied  by the presence of prenyl  isoflavonoids as novel HIV-1 protease inhibitors 
(Lee, et al., 2009). These authors found that the prenyl isoflavonoids had a dose-dependant 
inhibitory activities on HIV-1 PR with IC50 values from 0.5 to 30 μM and mention that the 
isoflavonoid with  prenyl groups at 6 and 8 positions of the ring A and one hydroxyl group 
in the 4´ position of B ring  was the most potent HIV-1 PR inhibitor. 
11. Conclusions 
This review represents the work done in the last seventy five years in the knowledge of the 
Erythrina genus, a group of 120 species of the Leguminosae, with seventy of them in the 
Neotropics, 50 species are in Mexico, Central  America and Caribbean where is used as 
ornamental (coral or lucky bean tree) , shade tree, timber (construction, implements), living 
fences and enclosures, green manure, livestock,  fodder, medicine and seeds are used for 
necklaces. 
These features have contributed to a deep research of their chemical constituents as 
alkaloids, flavonoids, isoflavonoids, saponins and lectins.  The  review remarked the 
potential which  each type of compounds have  now days. 
Alkaloids for instance with their unique structure have attracted   attention for their 
synthesis and structural elucidation or their pharmacological potential given by the relaxant 
properties. 
The flavonoids and isoflavonoids represent other of the potentials of the genus because in 
recent years the literature has described not only novel structures but also notorious  
biological activity mainly related with  antimicrobial agents. 
Their impact is large in developing countries due to  a relative unvailability of medicines 
and the emergence of widespread drug resistance. Therefore researchers are increasingly  
diverting  their attention to folk medicine,  looking for new leads to develop better drugs 
against microbial infections 
It is hoped that this review can stimulate the development of new strategies in the manage 
of these kind of compounds and possibly to find new active agents from this beautiful genus 
of plants.   
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anti-malarial activity against Plasmodium falciparum  in vitro using the lactate dehydrogenase 
(LDH) assay (Tati, et al., 2011). It is interesting to note that the pterocarpene, erycristagallin   
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mg ml respectively (Yenesew, et al. 2003, 2004). 
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1. Introduction  
Natural products have been used for thousands of years for the benefit of mankind, as 
important sources of food, clothing, cosmetics, building materials, tools, medicines and crop 
protection agents. They have made enormous contributions to human health through 
compounds such as quinine, morphine, aspirin (a natural product analog), digitoxin and 
many others. Researches in this field are becoming more numerous, to the point of getting 
about half of pharmaceuticals and pesticides from natural sources (Newman & Cragg, 2007). 
The main reasons because natural products are so important to undertake research are that 
they can be a source of new compounds because they produce many bioactive secondary 
metabolites that are used as a chemical defense against predators. Also, in the past, they 
have provided many new drugs, some of which can’t be obtained by other sources and 
because they can provide the necessary templates to design new products in the future 
(Colegate and Molyneux, 2008; Kaufman et al., 2006; Cragg et al., 2005). 
Dissatisfied therapeutic needs in the treatment of bacterial, parasitic, viral and fungal 
infections, cancer, Alzheimer's and AIDS, among other diseases, have led to the search of 
new substances with therapeutic applications. Although for most diseases there is a 
treatment, many of them have begun to be ineffective due to the development of resistance 
to medicaments that were initially effective and to the low security that they exhibit for 
patients. Consequently, the development of effective and safe therapeutic alternatives is 
essential to ensure the availability of new products that reduce mortality and morbidity due 
to diseases (Pan et al., 2010; Nwaka & Hudson, 2006; Segal & Elad, 2006; Waldvogel, 2004). 
The search for new phytosanitary agents to control plant pests and diseases that affect many 
plant sources of food and/or industrial use is also of great interest, because the indiscriminate 
and permanent use of agrochemicals has led to the emergence of resitant pests and 
phytopathogenic microorganisms, that can cause partial or complete loss of crops (Agrios, 
2005; Strand, 2000). 
Research in plants represents an invaluable source discovering new substances, considering 
that each of these can contain hundreds or even thousands of secondary metabolites. From 
the 250,000 to 300,000 plant species reported, only a small part has been the subject of 
phytochemical and biological activity studies (Tringali, 2001). 
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1. Introduction  
Natural products have been used for thousands of years for the benefit of mankind, as 
important sources of food, clothing, cosmetics, building materials, tools, medicines and crop 
protection agents. They have made enormous contributions to human health through 
compounds such as quinine, morphine, aspirin (a natural product analog), digitoxin and 
many others. Researches in this field are becoming more numerous, to the point of getting 
about half of pharmaceuticals and pesticides from natural sources (Newman & Cragg, 2007). 
The main reasons because natural products are so important to undertake research are that 
they can be a source of new compounds because they produce many bioactive secondary 
metabolites that are used as a chemical defense against predators. Also, in the past, they 
have provided many new drugs, some of which can’t be obtained by other sources and 
because they can provide the necessary templates to design new products in the future 
(Colegate and Molyneux, 2008; Kaufman et al., 2006; Cragg et al., 2005). 
Dissatisfied therapeutic needs in the treatment of bacterial, parasitic, viral and fungal 
infections, cancer, Alzheimer's and AIDS, among other diseases, have led to the search of 
new substances with therapeutic applications. Although for most diseases there is a 
treatment, many of them have begun to be ineffective due to the development of resistance 
to medicaments that were initially effective and to the low security that they exhibit for 
patients. Consequently, the development of effective and safe therapeutic alternatives is 
essential to ensure the availability of new products that reduce mortality and morbidity due 
to diseases (Pan et al., 2010; Nwaka & Hudson, 2006; Segal & Elad, 2006; Waldvogel, 2004). 
The search for new phytosanitary agents to control plant pests and diseases that affect many 
plant sources of food and/or industrial use is also of great interest, because the indiscriminate 
and permanent use of agrochemicals has led to the emergence of resitant pests and 
phytopathogenic microorganisms, that can cause partial or complete loss of crops (Agrios, 
2005; Strand, 2000). 
Research in plants represents an invaluable source discovering new substances, considering 
that each of these can contain hundreds or even thousands of secondary metabolites. From 
the 250,000 to 300,000 plant species reported, only a small part has been the subject of 
phytochemical and biological activity studies (Tringali, 2001). 
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This chapter shows information about the importance of ethnobotany, phytochemistry and 
biological activities of species of the genus Zanthoxylum, information that can be the base for 
undertaking future research. 
2. Overview of Zanthoxylum genus 
Zanthoxylum genus belongs to the Rutaceae family. It is economically important because of 
their alimentary, industrial and medicinal applications (Seidemann, 2005; Chase et al., 1999). 
Zanthoxylum comes from the word Xanthoxylum wich derives from Greek: "xanthon xylon" 
that means "yellow wood", hence the use of the terms Xanthoxylum or Zanthoxylum by some 
authors. The genus Zanthoxylum was created by Linné in 1757 and since its inception has 
been confused with the genus Fagara. In 1896, Engler made the distinction between the two 
genera by the following characteristics: species of the genus Zanthoxylum have a simple 
perianth, while in species of the genus Fagara is twofold. Brizicky in 1962, discovered some 
species with intermediate perianth, which showed that simple perianth of Zanthoxylum drift 
from the Fagara due to failure of some sepals, and concluded that Fagara and Zanthoxylum 
genus are the same. Finally, in 1966, Hartley grouped Zanthoxylum and Fagara under the 
name of Zanthoxylum. However, some authors still use the term Fagara (Chaaib, 2004). 
Zanthoxylum comprises about 549 species distributed worldwide mainly in tropical and 
temperate regions (Global Biodiversity Information Facility, 2010). This genus includes trees 
and shrubs, usually dioecious. The trees have leafy crown, with few branches and reach up 
to 20 meters. The species of this genus are characterized by the presence of recurved spines 
on its trunk and branches. The leaves are varied, may be alternate or opposite, simple or 
composed, imparipanadas or parimpanadas with up to 15 pairs of leaflets. The 
inflorescences are usually in form of panicles or umbels compound, axillary or terminal of 
small flowers. The flowers are actinomorphic, hermaphrodite and unisexual, rarely bisexual, 
usually white or green. The fruits are follicles or esquizocarp, contains from one to five 
carpels usually aromatic, and the are ordinarily bivalve with a single red or black, shiny 
seeds (Melo & Zickel, 2004; Silva & Paoli, 2004). 
The genus Zanthoxylum has great importance due to its ethnobotanics, phytochemistry and 
biological activity, and it is a promising source of various secondary metabolites including 
benzophenanthridine alkaloids. 
3. Ethnobotanical uses 
Species of this genus are of economic importance as sources of edible fruits, oils, wood, raw 
materials for industries, medicinal plants, ornamentals, culinary applications, and are 
characterized by a satin wood commonly used in woodworking (Yang, 2008; Da Silva et al., 
2006; Adesina, 2005; Seidemann, 2005). For example in Africa is used the wood of Z. gillettii, 
Z. tessmannii, Z. lemairei and Z. leprieurii for houses, buildings, drums and ships 
construction, and for decorative woodwork, carpentry, and paper industry. In some 
countries of this continent, root bark and stem of many species of Zanthoxylum for used as a 
vermifuge, febrifuge and piscicides (Adesina, 2005).  
Zanthoxylum species are also used in the field of perfumery and food industry because of its 
essential oils from leaves, fruits and inflorescences. The most used essential oils are obtained 
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from Z. xanthoxyloides (Ngassoum et al., 2003), Z. gillettii (Jirovetz et al., 1999) and Z. 
simulans (Chyau et al., 1996). 
A common feature of almost all species of the genus Zanthoxylum is the ability to produce 
tires, which could be used in the pharmaceutical industry as encapsulants, emulsifying 
agents or diluents. Some investigations have been conducted on the rubber collected on the 
bark of Z. tessmannii (Adesina, 2005). 
Many species of the Zanthoxylum genus have been used in different parts of the world 
especially in Asia, Africa and America to treat a number of diseases in humans and animals  
(McGaw et al., 2008; Rochfort et al., 2008; Adesina, 2005; Chaaib, 2004; Diéguez et al., 2004; 
Patiño, 2004). For example, the bark of Z. integrifolioum is used in traditional medicine by Ya-
Mei and Lanyu indigenous tribes in Taiwan, as a remedy for snakebite, dyspepsia and as an 
aromatic tonic for fever. The bark of Z. liebmannianum, is used in Mexico for the treatment of 
stomach pains, amebiasis, intestinal parasites and as a local anesthetic agent (Ross et al., 
2004). Some species are used for the treatment of malaria, such is the case of Z. rhoifolium 
(Jullian et al., 2006; Bertani et al., 2005), Z. acutifolium (Arruda et al., 1992), Z. chalybeum 
(Jullian et al., 2006) and Z. usambarense (Kirira et al., 2006). Venezuelan traditional medicine 
is known to use Z. monophyllum in the treatment of runny nose or nasal mucosal 
inflammation, jaundice, ophthalmia and as an anesthetic (Gomez et al., 2007; Diaz & Ortega, 
2006). Another use has been given as a textile dye (De Garcia et al., 1989). 
According to reports of ethnobotanical properties of the Zanthoxylum genus, in general it is 
emphasized that the most commonly used extraction methods are infusion and decoction, 
using mainly water as solvent. In Table 1 are summarized the main ethnobotanical uses of 45 
species of the genus Zanthoxylum, as well as the plant part used and method of preparation. 
The major ethnobotanical properties attributed to these plant species are: relief of dental 
problems, treatment of malaria, gastrointestinal disorders, gonorrhea and lung diseases, 
antidiarrheal use in animals and humans, emmenagogue action, effective for rheumatism, 
anthelmintic use in animals and humans, aphrodisiac, analgesic, action against various skin 
diseases, febrifuge, antihemorrhagic, effective for genitourinary diseases, anticancer, diuretic, 
stomachic, anti-convulsive, tonic and stimulant. In addition to the medicinal properties, some 
species are also used as pesticides, building materials and textile dyes. 
Some plants have been used as components of natural medicines, because of the important 
ethnomedical properties of Zanthoxylum genus species. Z. tingoassuiba has been marketed 
since 1923 by Flora Medicinal J. Monteiro da Silva Laboratory, as part of herbal medicinal 
product called Uva do Mato®, which is prescribed for muscle cramps and spasms (Da Silva 
et al., 2008). Z. rhoifolium also has been commercialized in Brazil as a component of herbal 
tea mixtures sold in drugstores, supermarkets and popular markets (Pereira et al., 2010; Da 
Silva et al., 2007a).  
4. Phytochemistry 
Phytochemical studies carried out on species of the genus Zanthoxylum, alkaloids of various 
types, lignans, coumarins amides are commonly secondary metabolites reported and have 
chemotaxonomic importance to the genre. Also, other metabolites have been isolated such 
as flavonoids, sterols and terpenes, among others (Adesina, 2005; Patiño, 2004, Waterman & 
Grundon, 1983). 
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The alkaloids are most important compounds for the genus Zanthoxylum, because they are 
present in most species and have been found in all plant organs, being abundant in the 
trunk and root bark (Dieguez et al., 2004). The main isolated alkaloids from the genus are of 
two types: isoquinolines (benzophenanthridine, benzylisoquinoline, aporphine, 
protoberberine and berberine) and quinolines (Krane et al. 1984; Waterman & Grundon, 
1983; Cordell, 1981). Other types of alkaloids have also been found in some species of the 
genus. 
4.1.1 Isoquinoline alkaloids 
The benzophenanthridines are the most frequently reported type of alkaloid in the genus 
Zanthoxylum and have great interest due to important and varied biological activity that 
they present, among which highlights the antitumor activity (Maiti & Kumar, 2009; 
Tillequin, 2007; Maiti & Kumar, 2007; Dvorak et al., 2006; Nyangulu et al., 2005; Eun & Koh, 
2004; Tang et al. 2003; Slaninová et al., 2001; Simeon et al., 1989). Representatives of these 
alkaloids have exhibited antimalarial (Nyangulu et al., 2005; Ross et al., 2004), antileukemic 
(Dupont et al., 2005), antioxidant (Pérez et al., 2003), nematicide (Matsuhashi et al., 2002), 
HIV (Chang et al., 2003), antibacterial (Gonzaga et al., 2003), antimicrobial (Nissanka et al., 
2001) and antifungal activities (Queiroz et al., 2006), among others. Their distribution is very 
limited in plants, and only they have been isolated from some genera belonging to the 
families Papaveraceae, Rutaceae and Fumiraceae mainly, where they are considered 
chemotaxonomic markers. In Rutaceae family they are present in species of the genera 
Phellodendron, Fagaropsis, Tetradium, Toddalia and Zanthoxylum (including Fagara), the latter 
with a majority presence of these alkaloids from the others (Krane et al., 1984; Cordell, 
1981). The main representatives of this type of alkaloids are fagaronine 1, nitidine 2, 
chelerythrine 3 and sanguinarine 4. Compounds with similar chemical structure to 
iwamide 5 and integriamide 6, isolated from various species of the genus Zanthoxylum, 
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of malaria.  
 
Used to treat 
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as an anti-venom 
serum, anti-tumor 
and in the treatment 
of hemorrhoids.  
 
 
Oral route (infusion 






Oral route (decoction 
bark) 
 





da Silva et al., 
2007a 
Z. schinifolium 




Used as culinary 
applications and 
drugs for epigastric 
pain. 
Oral route (macerated 
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crushed material). 
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Used against cough, 
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digestive aid and 
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generally used as 
chewing sticks for 
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Oral route (crushed 
seeds) 
 










Local and oral routes; 
rectal and vaginal 
injections (macerated 
or decoction powder, 
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Ngane et al., 
2000 
Table 1. Main ethnobotanical uses of some species of the Zanthoxylum genus. 
Benzylisoquinoline alkaloids have a restricted distribution in plants similar to that of 
benzophenanthridines. In the Rutaceae family they are present in a group of five genera 
named proto-Rutaceae (Phellodendron, Fagaropsis, Tetradium, Toddalia and Zanthoxylum) (Ling et 
al., 2009; Waterman, 2007). In the genus Zanthoxylum they are not the most common but have 
been found in some species, such as quaternary alkaloids (R)-(+)- isotembetarine 7 and (S)-(-)- 
xylopinidine 8 that have been isolated from the bark of Z. quinduense (Patiño & Cuca, 2010). 
Berberine and protoberberine alkaloids have been reported in several species of the genus 
Zanthoxylum, for example tetrahydroberberines such as N-methyltetrahydrocolumbamine 9 
and N-methyltetrahydropalmatine 10, have been isolated from the bark of Z. quinduense 
(Patiño & Cuca, 2010). Berberine 11 is characterized by its significant leishmanicidal and 
antimicrobial activities and is usually the responsible for the yellowing observed in wood 
and bark of some species of this genus, as in the case of Z. monophyllum that is used as a dye 
(Patiño & Cuca, 2011). 
In the genus Zanthoxylum, aporphine alkaloids there are not the most representative, but 
they have been isolated from various species and are of great importance because several 
have antitumoral activity (Adesina, 2005). For example, N,N-dimethyllindicarpine 12, 
obtained from the root bark of Z. zanthoxyloides (Queiroz et al., 2006). 
 
Bioactive Compounds in Phytomedicine 
 
194 
ex Willd.  
Leaves 
 























and in the treatment 
of malaria.  
 
Used to treat 
toothache and 
earache, also is used 
as an anti-venom 
serum, anti-tumor 
and in the treatment 
of hemorrhoids.  
 
 
Oral route (infusion 






Oral route (decoction 
bark) 
 





da Silva et al., 
2007a 
Z. schinifolium 




Used as culinary 
applications and 
drugs for epigastric 
pain. 
Oral route (macerated 
or decoction powder, 
crushed material). 
Cao et al., 2009 
Cui et al., 2009 




Used for snake bites 
and gastrointestinal 
disorders 
Oral route (macerated 
powder). 
Chen et al., 
























and in the paper and 
pulp industry. 
Oral route (macerated 
















Wight and Arn. Stem bark 








Nissanka et al., 
2001 
Z. tingoassuiba 








Oral route (teas or 
infusions). 
 














Oral route (infusion 
or decoction powder). 
 
Local route (cleaning 














For respiratory tract 
infections, malaria 
and catarrhal fevers. 
the teeth with twigs). 
 
Oral route (Grinding, 
hot decoction) 

















































Used against cough, 
fever, colds, 
toothache and snake 
bite. 
 




Used as antiseptic, 
anti-sickler, 
digestive aid and 
parasticide. Also are 
generally used as 
chewing sticks for 




digestive aid and 
parasticide. 
Oral route (crushed 
seeds) 
 










Local and oral routes; 
rectal and vaginal 
injections (macerated 
or decoction powder, 
paste, sticks). 
 

























Ngane et al., 
2000 
Table 1. Main ethnobotanical uses of some species of the Zanthoxylum genus. 
Benzylisoquinoline alkaloids have a restricted distribution in plants similar to that of 
benzophenanthridines. In the Rutaceae family they are present in a group of five genera 
named proto-Rutaceae (Phellodendron, Fagaropsis, Tetradium, Toddalia and Zanthoxylum) (Ling et 
al., 2009; Waterman, 2007). In the genus Zanthoxylum they are not the most common but have 
been found in some species, such as quaternary alkaloids (R)-(+)- isotembetarine 7 and (S)-(-)- 
xylopinidine 8 that have been isolated from the bark of Z. quinduense (Patiño & Cuca, 2010). 
Berberine and protoberberine alkaloids have been reported in several species of the genus 
Zanthoxylum, for example tetrahydroberberines such as N-methyltetrahydrocolumbamine 9 
and N-methyltetrahydropalmatine 10, have been isolated from the bark of Z. quinduense 
(Patiño & Cuca, 2010). Berberine 11 is characterized by its significant leishmanicidal and 
antimicrobial activities and is usually the responsible for the yellowing observed in wood 
and bark of some species of this genus, as in the case of Z. monophyllum that is used as a dye 
(Patiño & Cuca, 2011). 
In the genus Zanthoxylum, aporphine alkaloids there are not the most representative, but 
they have been isolated from various species and are of great importance because several 
have antitumoral activity (Adesina, 2005). For example, N,N-dimethyllindicarpine 12, 
obtained from the root bark of Z. zanthoxyloides (Queiroz et al., 2006). 
 




4.1.2 Quinoline alkaloids 
Quinoline alkaloids are very common in the genus Zanthoxylum, usually have been found 
two types: furoquinolines and pyranoquinolines. Many of them are characterized by contain 
a carbonyl group in position 2 of the simple quinolinic nucleus and are called 2-quinolones 
(Waterman & Grundon, 1983). Alkaloids of this type have been isolated from the bark of Z. 
budrunga founding two pyranoquinoline: N-methylflindersine 13 and zanthobungeanine 14, 
together with two furoquinolines dictamine 15 and skimmianine 16 (Rahman et al., 2005). 
From Z. simulans also have been isolated pyranoquinoline alkaloids as zhantosimulin 17 and 
huajiaosimulim 18, with cytotoxic activity (Chen et al., 1997). 
 
4.1.3 Other alkaloids 
Bishoderninyl terpene, indolopyridoquinazoline, canthin-6-one, quinazoline and carbazole 
alkaloids, among others, are not very common in the genus Zanthoxylum, they have been 
found in some particular species. Bishoderninyl terpene alkaloids such as 19 have been 
isolated from the leaves of Z. integrifoliolum (Liu et al., 2000). Indolopyridoquinazoline 
alkaloids with significant antiplatelet activity as 1-hydroxyrutaecarpine 20, rutaecarpine 21, 
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et al., 1996). Canthin-6-one alkaloids of importance for its leishmanicidal activity are rare in  
the family Rutaceae, are found in a few genders including Zanthoxylum. For example from 
Z. rugosum (Diehl et al., 2000), Z. chiloperone (Ferreira et al., 2002) and Z. budrunga (Rahman 
et al., 2005), have been isolated canthin-6-one 23 and 5-methoxycanthin-6-one 24. 
Quinazoline alkaloids have been isolated from Z. budrunga, as is the case lunacridina 25 
(Ahmad et al., 2003). Carbazole alkaloids such as 3-methoxy-9-methyl-9H-carbazol-2-ol 26 
were obtained from the wood of Z. rhoifolium (Taborda & Cuca, 2007). Recently, from the 
bark of Z. monophyllum was isolated an alkaloid derived from proline, called monophyllidin 
27 with antibacterial activity against Enterococcus faecalis (Patiño & Cuca, 2011). 
4.2 Lignans 
Lignans are also widely distributed in higher plants and have numerous biological activities 
among which include the antimicrobial, antioxidant, antitumor, antiviral, antihepatotoxic, 
antituberculous, insecticides and inhibit specifically certain enzymes. At the ecological level, 
there is the evidence that lignans play a role in plant-fungus, plant-plant and plant-insect 
interactions. Some lignans are toxic to fungi and insects. They are biogenetically derived by the 
oxidative dimerization of two C6-C3 units, that is, two characteristic phenylpropanoid units. 
The degree of oxidation and types of substituents determine the emerging lignan structure. 
There are also naturally occurring dimers that exhibit peculiar-type linkages. Different types of 
lignans has been described in a large number of plants from the Rutaceae family, but in the 
genus Zanthoxylum the lignans most reported have been of two types, diarylbutirolactones and 
2,6-diaryl-3,7-dioxabicyclo[3.3.0]octanes. Neolignans also have been reported in some 
species of Zanthoxylum (Adesina, 2005; Waterman & Grundon, 1983). 
Furofuranic lignans as syringaresinol 28 were obtained from Z. quinduense and Z. monophyllum 
(Patiño and Cuca, 2010; 2011). From Z integrifoliolum (Chen et al., 1999), Z. culantrillo (Cuca et 
al., 1998) and Z. naranjillo (Bastos et al., 1999) ha been isolated (+)-sesamin 29. 
Diarylbutirolactonic lignans such as (-)-cubebin 30 with trypanocidal activity has been isolated 
from Z. monophyllum (Cuca et al., 1998) and Z. naranjillo (Bastos et al., 1999). A nor-neolignan, 
ailanthoidol 31, was isolated from the wood of Z. ailanthoides, as tree used in folk medicine in 
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Biologically, coumarins are very useful and many of them have exhibited antibacterial, anti-
tumour, vasodilatory (in coronary vessels) and anticoagulant activities. It was long noted 
that most coumarins are free from toxic side effects and may be given for years without side 
effects; overdose, however, causes haemorrhages (Murray et al., 1989). Coumarins are 
widespread in the Angiosperms but they are rather rare in Gymnosperms and lower plants. 
They are occur in great structural variety especially in the Apiaceae and Rutaceae and are 
additionally found in many other plants families like the Asteraceae, Poaceae and Rubiaceae 
(Ribeiro & Kaplan, 2002). The family Rutaceae belongs to the order Rutales characterized by 
the occurrence of coumarins in all families that comprise it. Coumarins, although are very 
frequent in the family as a whole, are confined to four sub-families (Aurantioideae, 
Flindersioideae, Toddalioideae and Rutoideae). In the subfamily Rutoideae is present the 
genus Zanthoxylum, which is characterized by the presence of different types of coumarins 
(simple, linear, dihydrofurocoumarins, furocoumarins and pyranocoumarins). The linear 
and angular dihydrofurocoumarins and precursors have been identified in several species of 
the genus, but angular dihydrofurocoumarins are not common in other species of the family 
Rutaceae, so it can be chemotaxonomic value for the genus Zanthoxylum. The fact that prenyl 
substitution at C-8 is much less frequent than that at C-6 could explain why angular 
furanocoumarins are rather rare in the Rutaceae (Murray et al., 1989; Waterman & Grundon, 
1983). 
From stem of Z. shinifolium was isolated larcinatin 32, a terpenylcoumarin with significant 
inhibitory activity against the enzyme monoamine oxidase (MAO), which is one of the two 
isozymes, MAO-B is associated with Parkinson's disease (Jo et al., 2002). In studies done on 
this species, from the bark of Z. schinifolium were isolated auraptene 33 and collinine 34, 
terpenylcoumarins with antiplatelet activity and inhibitory activity of DNA replication in 
hepatitis B virus (Tsai et al., 2000). Furanocoumarins with cytotoxic activity against human 









Amides are compounds that have chemotaxonomic importance for the genus Zanthoxylum 
and have been found mainly in the pericarp of the fruit, stems and roots of these species. 
The genus Zanthoxylum is characterized chemically by the frequent accumulation of olefinic 
alkamides (unsaturated aliphatic acid amides) and biogenetic capacity derived from the 
condensation of fatty acids such as linolenic and linoleic acids with isobutyl amines. 
Biologically, the isobutyl amides have been shown to have strong insecticidal properties. 
Alkamides have been used medicinally since ancient times as sialogogues, antitussive and 
analgesic and their presence in the Zanthoxylum genus may be of immense benefit to 
medicine (Adesina, 2005; Chaaib, 2004). An example of such amides is provided by the α-
sanshool 36, isolated from Z. liebmannianum and is known for its anthelmintic properties 
(Navarrete & Hong, 1996). 
Other types of amides encountered in the Zanthoxylum genus are the aromatic amides 
described occasionally also as alkaloids or trans-cinnamoylamides. A typical example is the 
active antiplasmodial syncarpamide 37, isolated from Z. syncarpum (Ross et al., 2004). 
 
4.5 Flavonoids 
Flavonoids are phenolic compounds widely available in this genus. They are present in 
almost all plant organs and play an important role in the antioxidant defense system. These 
secondary metabolites are known for their diverse biological properties, such as 
antioxidants, antiinflammatory, antithrombotic, antibacterial, antihepatotoxic, antitumor, 
antihypertensive, antiviral, antiallergic and estrogenic (Andersson et al. 1996; Harborne & 
Williams, 2000). 
In Zanthoxylum genus, flavonoids are mainly represented by glycosides of flavones, 
flavonols and flavanones. Flavonoids found in the genus Zanthoxylum, like those isolated in 
other genera of the Rutaceae family are characterized to be polymethoxylated (Waterman & 
Grundon, 1983). Research carried out on fruits of Z. integrifoliolum lead to the isolation of 
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Amides are compounds that have chemotaxonomic importance for the genus Zanthoxylum 
and have been found mainly in the pericarp of the fruit, stems and roots of these species. 
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4.5 Flavonoids 
Flavonoids are phenolic compounds widely available in this genus. They are present in 
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antioxidants, antiinflammatory, antithrombotic, antibacterial, antihepatotoxic, antitumor, 
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4.6 Terpenes and sterols 
Most species belonging to the family Rutaceae contain glands that secrete volatile 
substances in different organs of plants such as fruits, leaves, bark, wood, roots, rhizomes 
and seeds. The essential oils obtained are often complex mixtures of monoterpenes and 
sesquiterpenes. Zanthoxylum genus accumulates volatile oils in leaves, flowers and fruits. 
Recently was determined the chemical composition of essential oils isolated from fruits of Z. 
monophyllum, Z. rhoifolium and Z. fagara by steam distillation, as well as were testing their 
antifungal and insecticidal activities. Gas chromatography-mass spectrometry (GC/MS) 
analysis allows identified 57 compounds. The main constituents in Z. rhoifolium oil were β-
myrcene 39 (59.03%), β-phellandrene 40 (21.47%), and germacrene D 41 (9.28%), the major 
constituents of Z. monophyllum oil were sabinene 42 (25.71%), 1,8-cineole 43 (9.19%), and cis-
4-thujanol 44 (9.19%), whereas fruit oil of Z. fagara mainly contained germacrene D-4-ol 459 
(21.1%), elemol 46 (8.35%), and α-cadinol 47 (8.22%). Z. fagara showed the highest activity on 
Colletotrichum acutatum (EC50 153.9 μL L-1 air), and Z. monophyllum was the most active 
against Fusarium oxysporum f. sp. lycopersici (EC50 140.1 μL L-1 air). Z. monophyllum essential 
oil showed significant fumigant activity against Sitophilus oryzae (Prieto et al., 2011). 
 
Sterols are common components of many plants and have been isolated from virtually all 
plants. Whereas β-sitosterol 48 appears ubiquitous in nature, the triterpene lupeol 49 
appears restricted to the Zanthoxylum genus. Lupeol, β-sitosterol, usually associated with 
stigmasterol 50, campesterol 51 and β-amyrin 52 have been isolated from the various 








5. Biological activity of Zanthoxylum genus 
As noted in previous sections, Zanthoxylum genus is well known for their chemical diversity 
and ethnobotanical properties, characteristics that have been the basis for developing 
various biological activity studies, which have helped to find new bioactive extracts and 
compounds, some of which have good potential for the development of new drugs and 
different industrial products. 
The biological activities for certain species of the genus Zanthoxylum are mainly associated 
with the evaluation of antimicrobial, insecticidal, anti-inflammatory, antioxidant, 
antiparasitic, antitumor, antihelmitic, antinociceptive and antiviral activities, as well as 
studies of enzyme inhibition and effects on the central nervous system and cellular 
components of blood. The information in this section is organized by type biological 
activity, including the most representative results found for the genus Zanthoxylum. 
5.1 Allelopathic activity 
There are few reports on allelopathic activity of Zanthoxylum species. One report shows a 
bioguided fractionation of the ethyl acetate extract of the Z. limonella fruits led to the 
isolation of xanthoxyline, a substance with allelopathic effects of on Chinese amaranth 
(Amaranthus tricolor L.) and Barnyardgrass (Echinochloa crus-galli (L.) Beauv.). At a 
concentration of 2500 µM, xanthoxyline completely inhibited seed germination and growth 
of Chinese amaranth, and showed a significantly inhibitory effect on seed germination of 
Barnyardgrass by 43.59% (Charoenying et al., 2010). 
5.2 Analgesic activity 
Studies of analgesic activity in the genus Zanthoxylum have been focused mainly to validate 
its traditional uses. An example is the study of analgesic activity made with the aqueous 
extract of root bark of Z. xanthozyloides. This study showed that the extract induced 
analgesia, probably, by inhibiting prostaglandin production, because some isolated and 
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purified alkaloids of the root bark of Z. xanthoxyloides have anti-prostaglandin synthetase 
activity (Prempeh & Mensah-Attipoe, 2008). 
5.3 Anticonvulsant activity  
The reports on anticonvulsant activity of Zanthoxylum species are few. A recent study of 
anticonvulsant activity was carried out with the methanol and aqueous extracts from leaves 
of Z. capense. In this report was investigated the effect of both extracts on seizures induced 
by pentylenetetrazole, bicuculline, picrotoxin, N-methyl-DL-aspartic acid and strychnine in 
mice. Both extracts showed significant activity in the tests carried out with the five seizures 
inducing agents, finding that these substances in some cases delay seizures and in some 
cases act as agonists (Amabeoku & Kinyua, 2010). 
5.4 Antihelmitic activity 
Antihelmitic activity studies have been advanced mainly in the specie Z. xanthoxyloides. Two 
recent studies reveal that acetone: water (70:30) and ethanol extracts from leaves of Z. 
xanthoxyloides showed promising activity against Asaris lumbricoides, Haemonchus contortus, 
Trichostrongylus colubriformis, three nematodes that of these nematodes provokes production 
losses, clinical signs and even can lead to deaths in sheep or goats worldwide (Azando et al., 
2011; Barnabas et al., 2011). 
5.5 Anti-inflamatory activity 
The anti-inflammatory effects of the extracts and isolated compounds of some Zanthoxylum 
species have been evaluated employed mainly four methods: 1) paw edema induced by 
carragenin in rats; 2) ear edema induced by phorbol myristate acetate (PMA), arachidonic 
acid (AA) and 12-o-tetradecanoyl-phorbol acetate (TPA) in mice; 3) inhibition of superoxide 
anion generation and 4) elastase release in fMLP/CB-activated human neutrophils in a 
concentration-dependent manner. In different studies, ethanolic extracts of bark from Z. 
elephantiasis, Z. fagara, Z. martinicense and Z. coriaceum, and hexane, ethyl acetate and 
ethanolic extracts of leaf from Z. chiloperone have presented promising results of anti-
inflammatory activity (Villalba et al., 2007; Márquez et al., 2005; Bastos, 2001). 
Other studies involving phytochemical and biological activity reported the isolation of 
various secondary metabolites with anti-inflammatory activity. From the hexane extract of 
Z. naranjillo was isolated a dibenzylbutirolactonic lignan (cubebin) with antiinflammatory 
properties (Bastos et al., 2001). In the methanol extract of stem wood from Z. nitidum were 
identified benzophenanthridine alkaloids, quinolone alkaloids, lignans and coumarins with 
promising anti-inflammatory activity (Chen et al., 2011). For the methanol extract of stem 
wood of Z. integrifoliolum and Z. avicennae have been reported the presence of 
phenylpropenoids, lignans, coumarins, quinolone alkaloids and quinoline alkaloids with 
anti-inflammatory potential (Chen et al., 2008; Chen et al., 2007). 
One compound which has gained wide attention of medical professionals, pharmaceutical 
marketers and researchers all around the world is a dietary triterpene knows as lupeol. This 
compound is found in most species of the genus presented Zanyhoxylum, and has been 
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extensively studied for its inhibitory effects on inflammation under in vitro and in animal 
models of inflammation (Saleem, 2009). 
5.6 Antimicrobial activity 
Most reports of biological activity of the Zanthoxylum genus are related to the evaluation of 
antimicrobial activity. This activity has been evaluated mainly using human pathogenic 
strains, with few cases in which phytopathogenic strains are used. Most studies of 
antimicrobial activity have been made using disk diffusion method. Here are some 
examples of antimicrobial activity studies performed with species of the genus Zanthoxylum. 
The antifungal and antibacterial activities of some compounds isolated from Z. tessmannii 
were determined against Bacillus subtilis, Escherichia coli, Staphylococcus aureus, Streptomyces 
viridochromogenes, Mucor miehei, Candida albicans, Chlorella vulgaris, Chlorella sorokiniana and 
Scenedesmus subspicatus. 2,6-dimethoxy-1,4-benzoquinone showed activities against seven of 
the nine strains employed, while 3β-acetoxy-16β-hydroxybetulinic acid showed weak 
activities against Bacillus subtilis and Escherichia coli, and 3β, 16β-hydroxybetulinic acid 
showed weak activities against Bacillus subtilis and Candida albicans (Mbaze et al., 2007). 
The fruits extract of Z. armatum has been tested for their antibacterial activity against S. 
aureus, E. coli, Pseudomonas aeruginosa and Shigella boydii. This ethanolic extract was inactive 
against P. aeruginosa, while showed positive activity on the other three strains. These results 
indicate that the ethanolic extract from fruits of Z. armatum may have broad spectrum 
antibacterial activity because it shows activity against Gram-positive and Gram-negative 
bacteria (Panthi & Chaudhary, 2006). 
The essential oils of Z. xanthoxyloides and Z. leprieurii, two Cameroonian plants used as 
spices in local food, showed antibacterial and antifungal activity against E. coli, S. aureus, 
Klebsiella pneumoniae, Enterococcus faecalis, Corynebacterium glutamicum, B. cereus, B. subtilis 
and Aspergillus flavus (Tatsadjieu et al., 2003). 
Aqueous, hexane and methanol extracts of leaves, roots and stem bark obtained from Z. 
chalybeum and Z. usambarense were screened for in-vitro antibacterial activity using Gram-
positive bacteria (B. subtilis, Micrococcus luteus and S. aureus). The root and stem-bark extracts 
of the two Zanthoxylum species showed high antibacterial activity (Matu & Staden, 2003). 
Aqueous, hexane and methanol extracts of leaves, roots and stem bark obtained from Z. 
chalybeum and Z. usambarense were screened for in vitro antibacterial activity using Gram-
positive bacteria (B. subtilis, Micrococcus luteus and S. aureus). The root and stem-bark extracts 
of the two Zanthoxylum species showed high antibacterial activity (Matu & Staden, 2003). 
Ethanolic extracts of bark of Z.fagara, Z. elephantiasis and Z.martinicense were evaluated 
against C. albicans, Saccharomyces cerevisiae, Aspergillus niger, A. flavus, Microsporum canis and 
Trichophyton mentagrophytes to determined their antifungal activity. All of the extracts 
assayed showed activity against common dermatophytes of domestic animals, the one being 
most significant is that exhibited by the ethanolic extract of the bark of Z. fagara (Diéguez-
Hurtado et al, 2003). 
Leaf, fruit, stem, bark and root extracts of Z. americanum were investigated for antifungal 
activity with 11 strains of fungi. All extracts demonstrated a broad spectrum of antifungal 
activity and inhibited at least eight fungal species, being the fruit and leaf extracts the most 
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active in general. The results provide a basis for the very widespread use of Z. americanum in 
indigenous North American ethnomedical tradition for conditions that may be related to 
fungal infections (Bafi-Yeboa et al., 2005). 
Chelerythrine, N-methyltetrahydrocolumbamine, N-methyltetrahydropalmatine and 
berberine, four alkaloids isolated from Z. quinduense, have exhibited promising antibacterial 
activity against different Gram-positive and Gram-negative bacteria, being chelerythrine the 
most active compound, showing an antibacterial activity comparable to that of the 
antibiotics kanamycine, tetracycline and anthracycline (Patiño et al., 2011). 
5.7 Antinociceptive activity 
In order to contribute towards the pharmacological knowledge about Zanthoxylum genus, as 
well as demonstrate the popular uses of some species as a painkiller, have been advanced 
antinociceptive activity studies with extracts of hexane, ethyl acetate and ethanol obtained 
from leaves of Z. chilipirone and with stem bark ethanolic extract (EtOH), its fractions of 
partition (hexane, ethyl acetate, aqueous) and lupeol obtained of Z. rhoifolium, employing 
animal models of chemically induced acute pain. The study carried out with Z. chilipirone 
shows that with doses of 100 and 200 mg/kg of each extract is possible to detect 
significantly inhibition in the paw lick, results that suggest that the extracts from Z. 
chiloperone possess constituents with antinociceptive activity (Villalba et al., 2007). Moreover, 
the study with extracts of Z. rhoifolium sought to confirm its popular use, and shows for the 
first time that ethanol extract of Z. rhoifolium stem bark, its fractions and one of the major 
constituents (lupeol) have antinociceptive activity when administered orally in different 
models of chemical nociception in mice (Pereira et al., 2010). 
5.8 Antioxidant activity 
To determine the antioxidant activity of substances isolated from species of Zanthoxylum 
genus have been used more than ten methods, most based on the determination of free 
radical scavenging activity. The most common methods are: 1) Total phenolic content; 2) 
DPPH radical scavenging assay; 3) ABTS radical scavenging activity and 4) superoxide 
anion scavenging assay.  
Studies of antioxidant activity of Zanthoxylum species have been advanced mainly extracts 
from fruits and seeds. For example, the essential oil of seeds of Z. bungeanum (Xia et al., 
2011), the ethanol extract of fruits of Z. alatum (Batool et al., 2010); extracts of hexane, ethyl 
ether, ethyl acetate and methanol obtained from fruits of Z. piperitum (Lee & Lim, 2008; 
Hisatomi et al., 2000), as well as extracts of hexane, acetone and ethanol from fruits of Z. 
achanthopodium (Suryanto et al., 2004), have demonstrated an interesting antioxidant power. 
In a study made by Yamazaki and co-workers shows the isolation of two glycosylated 
flavonoids (hyperoside and quercitrin) of methanol extract from fruits of Z. piperitum, these 
substances scavenged DPPH radical strongly with IC50 values of 16 and 18 µM, respectively 
(Yamazaki et al., 2007). 
5.9 Antiparasitary activity 
In the frame of the search for new leads against the most neglegted parasitic diseases, it is of 
particular interest to evaluate the antimalarial, trypanocidal and antileishmanial potencial of 
some of the most frequently traditional drugs used. 
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The information on the frequently utilized antimalarial plant species is an important lead to 
the species that can be targeted for pharmacological, toxicological and phytochemical tests. 
The most important antimalarial properties have been observed in alkaloids, sesquiterpene 
lactones, coumarins, triterpenoids and limonoids. Z. chalybeum, Z. syncarpum, Z. zanthoxyloides, 
Z. gilletii, Z. limonella, Z. rhoifolium and Z. usambarense, among others, are some of the species of 
Zanthoxylum genus that have showed interesting antimalarial properties.  
Zanthoxylum chalybeum root bark (IC50 of 4.2µg/ml) and some quinoline alkaloids isolated 
from this species have been exhibited strong antiplasmodial activity on chloroquine 
resistant Plasmodioum falciparum strain (Nguta et al., 2010). Syncarpamide and decarine, two 
compounds isolated from Z. syncarpum have showed strong in vitro antiplasmodial activity 
against D6 (chloroquine sensitive clone) and W2 (chloroquine resistant clone) P. falciparum 
strains, having IC50 values lower than 6.1 µM (Kaur et al., 2009; Ross et al., 2005; Ross et al., 
2004). The crude alkaloid extract obtained from the bark of Z. zanthoxyloides and fagaronine, 
a benzophenanthridine alkaloid derived from the root extract of Z. zanthoxyloides; inhibited 
P. falciparum growth in vitro at low IC50 (Adebayo & Krettli, 2011; Gansane et al., 2010). Also 
have been reported positive results of antimalarial activity for the ethanolic extract from 
stem bark of Z. guilletti (Zirihi et al, 2009) and for the chloroform crude extract from fruits of 
Z. limonella (Charoenying et al., 2008). 
Anti-plasmodial activity of stem bark extracts from Z. usambarense was performed against P. 
knowlesi and P. berghei. The aqueous extract was remarkably active against the two parasites, 
while all organic solvents extracts being inactive. These results suggest that the 
antiplasmodial activity of Z. usambarense is due mainly to polar substances (Were et al., 
2010). 
A study of antimalarial properties of Z. rhoifolium bark carried out in order to validate its 
use and confirm the previously detected in vivo activity, lead to the isolation of antimalarial 
compounds. The antiplasmodial activity of Z. rhoifolium bark was concentrated in the 
alkaloid fractions showed approximately 44% inhibition of P. falciparum growth at 
10µg/mL, using LDH micromethod. Three of the seven isolated compounds from alkaloidal 
fraction displayed antiplasmodial activity, ranging from good (nitidine, the most potent 
compound) to moderate (avicine and fagaridine) (Jullian et al., 2006). In other research of the 
antiplasmodial activity of Z. rhoifolium was determined that the water infusion from bark 
inhibited more than 50% the P. falciparum development with doses higher than 500 mg/kg 
(Bertani et al, 2005). 
Recently, has been reported the trypanocidal effect of ethanolic extracts of leaves, fruits, 
stem bark and root bark, canthin-6-one alkaloids and some of its analogs obtained from Z. 
chiloperone, using in vitro methods and the mouse model of acute or chronic infection to 
evaluate the trypanocidal activity. These results demonstrate the anti-Trypanozoma activity 
of canthinones. Additionally, considering the low toxicity of canthin-6-one, is possible to 
propose this natural product as a possible advantageous phytotherapeutic compared to the 
current chemotherapy of Chagas disease (Ferreira et al., 2011; Ferreira et al., 2007). In a 
study carried out with the hexane extract from leaves of Z. naranjillo seven lignans were 
isolated and evaluated as trypanocidals. Four of the seven lignans showed trypanocidal 
activity in an in vitro assay, being (-)-methylpluviatolide the most active compound (Bastos 
et al., 1999). 
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active in general. The results provide a basis for the very widespread use of Z. americanum in 
indigenous North American ethnomedical tradition for conditions that may be related to 
fungal infections (Bafi-Yeboa et al., 2005). 
Chelerythrine, N-methyltetrahydrocolumbamine, N-methyltetrahydropalmatine and 
berberine, four alkaloids isolated from Z. quinduense, have exhibited promising antibacterial 
activity against different Gram-positive and Gram-negative bacteria, being chelerythrine the 
most active compound, showing an antibacterial activity comparable to that of the 
antibiotics kanamycine, tetracycline and anthracycline (Patiño et al., 2011). 
5.7 Antinociceptive activity 
In order to contribute towards the pharmacological knowledge about Zanthoxylum genus, as 
well as demonstrate the popular uses of some species as a painkiller, have been advanced 
antinociceptive activity studies with extracts of hexane, ethyl acetate and ethanol obtained 
from leaves of Z. chilipirone and with stem bark ethanolic extract (EtOH), its fractions of 
partition (hexane, ethyl acetate, aqueous) and lupeol obtained of Z. rhoifolium, employing 
animal models of chemically induced acute pain. The study carried out with Z. chilipirone 
shows that with doses of 100 and 200 mg/kg of each extract is possible to detect 
significantly inhibition in the paw lick, results that suggest that the extracts from Z. 
chiloperone possess constituents with antinociceptive activity (Villalba et al., 2007). Moreover, 
the study with extracts of Z. rhoifolium sought to confirm its popular use, and shows for the 
first time that ethanol extract of Z. rhoifolium stem bark, its fractions and one of the major 
constituents (lupeol) have antinociceptive activity when administered orally in different 
models of chemical nociception in mice (Pereira et al., 2010). 
5.8 Antioxidant activity 
To determine the antioxidant activity of substances isolated from species of Zanthoxylum 
genus have been used more than ten methods, most based on the determination of free 
radical scavenging activity. The most common methods are: 1) Total phenolic content; 2) 
DPPH radical scavenging assay; 3) ABTS radical scavenging activity and 4) superoxide 
anion scavenging assay.  
Studies of antioxidant activity of Zanthoxylum species have been advanced mainly extracts 
from fruits and seeds. For example, the essential oil of seeds of Z. bungeanum (Xia et al., 
2011), the ethanol extract of fruits of Z. alatum (Batool et al., 2010); extracts of hexane, ethyl 
ether, ethyl acetate and methanol obtained from fruits of Z. piperitum (Lee & Lim, 2008; 
Hisatomi et al., 2000), as well as extracts of hexane, acetone and ethanol from fruits of Z. 
achanthopodium (Suryanto et al., 2004), have demonstrated an interesting antioxidant power. 
In a study made by Yamazaki and co-workers shows the isolation of two glycosylated 
flavonoids (hyperoside and quercitrin) of methanol extract from fruits of Z. piperitum, these 
substances scavenged DPPH radical strongly with IC50 values of 16 and 18 µM, respectively 
(Yamazaki et al., 2007). 
5.9 Antiparasitary activity 
In the frame of the search for new leads against the most neglegted parasitic diseases, it is of 
particular interest to evaluate the antimalarial, trypanocidal and antileishmanial potencial of 
some of the most frequently traditional drugs used. 
 
Zanthoxylum Genus as Potential Source of Bioactive Compounds 
 
205 
The information on the frequently utilized antimalarial plant species is an important lead to 
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Canthin-6-one alkaloids have exhibited interesting antileishmanial activity. For example, in 
a study carried out with the alkaloidal extract of Z. chiloperone stem bark reported that this 
extract inhibited the growth of Leishmania braziliensis, L. amazonensis and L. donovani at 100 
µg/mL and mentioned that the compounds canthin-6-one and 5-methoxy-canthin-6-one 
were the two major active constituents (Ferreira et al., 2002). Also has been reported that 
meglumine antimonate isolated from Z. chiloperone showed activity against L. amazonensis at 
dose of 28 mg/kg (Sen & Chatterjee, 2011). 
5.10 Antiplatelet activity 
The methanolic extract of the stem of Z. beecheyanum showed strong antiplatelet activity in 
vitro using the turbidimetric method. In washed rabbit platelets, thrombin (0.1 U/mL), 
arachidonic acid (AA 100 M), collagen (100 g/mL), and PAF (2 ng/mL) all caused about 90-
95% aggregation. 
5.11 Antiviral activity 
Zanthoxylum species were used in experiments to test their influence on inhibition of 
multiplication of porcine epidemic diarrhea virus (PEDV). The extracts of Z. coreanum root, 
Z. planispinum leaf and stem, Z. schinifolium leaf exhibited antiviral activity with the IC50 of 
1.0, 6.4, 7.5 and 3.7 μg/mL against PEDV, respectively.  
In an anti-HIV screening program, three Zanthoxylum species, including the root bark of Z. 
ailanthoides, the root wood of Z. integrifoliolum, and the stem bark of Z. scandens showed anti-
HIV activity. The anti-HIV principles of Z. ailanthoides have already been proved to be two 
alkaloids (decarine and fagarine) and an aromatic amide ((+)-tembamide). Thus, the former 
two constituents, decarine and fagarine, also isolated of Z. integrifoliolum, can be considered 
as the anti-HIV constituents of the root wood of this species. 
5.12 Citotoxic activity 
Cancer is the leading cause of death worldwide. Finding a cure for this disease is always an 
important objective for human endeavor. Natural products have long been considered as 
potential drug candidates for cancer prevention and treatment (Chou et al., 2011). 
Zanthoxylum species are potential sources for find new antitumor agents, because diverse 
substances obtained from some of this species have showed strong citotoxic activity against 
different tumor cell lines. Following are some examples of reports about citotoxic activity of 
some species of Zanthoxylum genus. 
The anti-tumor properties of the volatile oil from Z. rhoifolium leaves and some terpenes (α-
humulene, β-caryophyllene, α-pinene and β-pinene) were investigated in vitro and in vivo 
using the Ehrlich ascites tumor model. Volatile oil and β-caryophyllene exhibited little direct 
activity against Ehrlich tumor cells in vitro, while α-humulene, α-pinene and β-pinene did 
not such activity. Additionally, volatile oil exhibits anti-tumor efficacy and significative 
immunomodulatory action in vivo, which may be related to β- caryophyllene associated to 
the synergism of other natural compounds presented in volatile oil from Z. rhoifolium leaves 
(Da Silva et al., 2007a). Other study about the citotoxic activity of essential oil from leaves of 
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Z. rhoifolium permitted to confirm that the essential oil is cytotoxic against tumoral cells 
(CD50 = 82.3, 90.7 and 113.6 μg/ml for A-549 (human lung carcinoma), HeLa (human 
cervical carcinoma) and HT-29 (human colon adenocarcinoma) cell lines, respectively), 
while it did not show cytotoxicity against non-tumoral cells (Vero and mice macrophages). 
Thus, the essential oil from Z. rhoifolium leaves seems to present a possible therapeuthic role 
due to its selective cytotoxic activity against tumoral cell lines (Da Silva et al., 2007b). 
The chloroform-soluble fraction of the crude extract of leaves from Z. ailanthoides showed 
cytotoxic activity against human promyelocytic leukemia (HL-60) and myelomonocytic 
leukemia (WEHI-3) cells with IC50 values of 73.06 and 42.22 µg/mL, respectively. From this 
fraction were obtained four pheophorbide derivatives, where three of these compounds 
showed cytotoxic activities against both leukemia cells with IC50 value in the range of 46.76–
79.43 nM (Chou et al., 2011). 
The chemical investigation carried out with roots and fruits of Z. leprieurii led to the 
isolation of four acridone derivatives alkaloids were found to be moderately active 
against lung carcinoma cells (A549), colorectal adenocarcinoma cells (DLD-1) and normal 
cells (WS1) with IC50 values ranging from 27 to 77 µM (Kuete et al., 2011; Ngoumfo et al., 
2010). 
A chemical and citotoxic studies of the root bark of Z. simulans led the isolation of two 
citotoxic pyranoquinoline alkaloids (zanthosimuline and huajiaosimulin). These compounds 
were evaluated against thirteen cultured human cancer cell lines, where zanthosimuline was 
active against all cell lines employed, while huajiaosimulin only was active against six of the 
thirteen cell lines (Chen et al., 1994b). 
Benzophenanthridine alkaloids are secondary metabolites commonly isolated from species of 
Zanthoxylum genus and are characterized by their potent antitumor activity, being fagaronine 
and nitidine the most active substances (Tillequin, 2007). Hexahydrobenzophenanthridine 
alkaloids are also of interest for its cytotoxic activity. Currently the alkaloid chelidonin is used 
in experimental oncology as the main component of Ukrain ®, an anti-cancer medicament 
(McManus, et al., 2007). 
Berberine, an alkaloid isolated from the bark of Z. monophyllum showed activity against HT-
29 (colorectal cancer), MCF-7 (breast cancer), HEp-2 (larynx cancer) and MKN-45 (gastric 
cancer) cell lines (Cordero et al., 2004). Nitidine chloride and 6-methoxy-5,6-dihydronitidine, 
two benzophenanthridine alkaloids isolated from Z. macrophylla seeds also have exhibited 
antitumor activity against different human cell lines (Kuete et al., 2011).  
6. Conclusions 
Zanthoxylum genus has proven to be a very valuable genus to the discovery and utilization 
of medicinal and agrochemical natural products. The collected information provides a 
means to understand the latest developments in the biological activity and phytochemistry 
of the genus. The potential for development of leads from Zanthoxylum continues to grow, 
particularly in the development of new antiparasitary, antitumor and antimicrobial agents. 
The information summarized here is intended to serve as a reference tool to people in all 
fields of ethnobothany, pharmacology and natural products chemistry. 
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There are significant concerns regarding the potential side effects from the chronic 
use of conventional drugs such as corticosteroids, especially in children. Herbal 
therapy is less expensive,  more readily available, and increasingly becoming common 
practice all over the world. Such practices have both their benefits and risks. However, 
herbal self-therapy might have serious health consequences due to incorrect self-
diagnosis, inappropriate choice of herbal remedy or adulterated herbal product. In 
addition, absence of clinical trials and other traditional safety mechanisms before 
medicines are introduced to the wider market results in questionable safe dosage 
ranges which may produce adverse and unexpected outcomes. Therefore, the use of 
herbal remedies requires sufficient knowledge about the efficacy, safety and proper 
use of such products. Hence, it is necessary to have baseline data regarding the use of 
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